File No. 333 -       

 

As filed on July 12, 2005

 

U.S. SECURITIES AND EXCHANGE COMMISSION

 

Washington, DC 20549

 

FORM N-14

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ý

Pre-Effective Amendment No.  o

Post-Effective Amendment No.  o

(Check appropriate box or boxes)

 

American Skandia Trust

(Exact Name of Registrant as Specified in Charter)

 

(203) 926-1888

(Area Code and Telephone Number)

 

Gateway Center Three

100 Mulberry Street

Newark, NJ 07102

Address of Principal Executive Offices:

(Number, Street, City, State, Zip Code)

 

Deborah A. Docs, Esq.

Secretary, American Skandia Trust

Gateway Center Three

100 Mulberry Street

Newark, NJ 07102

Name and Address of Agent for Service:

(Number and Street) (City) (State) (Zip Code)

 

Copies to:

 

Christopher E. Palmer, Esq.

Goodwin Procter LLP

901 New York Avenue, NW

Washington, D.C. 20001

 

Approximate Date of Proposed Public Offering:  As soon as

practicable after this Registration Statement becomes effective

under the Securities Act of 1933, as amended.

 

IT IS PROPOSED THAT THIS FILING WILL BECOME EFFECTIVE ON AUGUST 11, 2005 PURSUANT TO RULE 488 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

 

Title of the securities being registered:  Shares of beneficial interest of the AST AllianceBernstein Managed Index 500 Portfolio of American Skandia Trust.  No filing fee is due because Registrant is relying on Section 24(f) of the Investment Company Act of 1940, as amended.

 

 


 


 

American Skandia Trust

Gateway Center Three

100 Mulberry Street

Newark, NJ 07102

Telephone 800-752-6342

 

August [     ], 2005

 

Dear Valued Customer,

 

As a contract owner or policy holder who beneficially owns shares of the AST AllianceBernstein Growth + Value Portfolio (“Growth + Value Portfolio”) of American Skandia Trust (the “Trust”), you are cordially invited to a special meeting of the shareholders of the Growth + Value Portfolio to be held at the offices of the Trust, Gateway Center Three, 100 Mulberry Street, Newark, NJ 07102, on October 14, 2005 at 10:00 a.m. Eastern time.

 

The special meeting is very important to the future of the Growth + Value Portfolio.   At the special meeting, shareholders are being asked to approve or disapprove, as more fully described in the attached Prospectus/Proxy Statement, a Plan of Reorganization that would result in shares of the Growth + Value Portfolio that you beneficially own being exchanged for those of the AST AllianceBernstein Managed Index 500 Portfolio of the Trust (“Managed Index 500 Portfolio” and, together with Growth + Value Portfolio, the “Portfolios”).  The Trustees of the Trust unanimously recommend that you consider and approve this proposal.  If the shareholders of the Growth + Value Portfolio approve the proposal, you will beneficially own shares of the Managed Index 500 Portfolio equal in value to your investment in the Growth + Value Portfolio.  You will no longer beneficially own shares of the Growth + Value Portfolio, and the Growth + Value Portfolio will no longer exist.

 

You will not have a taxable gain or loss on the exchange of shares in the proposed transaction.

 

American Skandia Investment Services, Incorporated and Prudential Investments LLC, the Portfolios’ investment managers, believe that combining the assets of the Portfolios is appropriate and that the single, larger fund that would result from the transaction may be able to benefit from reduced trading costs and increased operational efficiencies, leading to reductions in the expenses that are borne by shareholders for the operation of the Growth + Value Portfolio.

 

Your vote is important no matter how large or small your holdings.  We urge you to read the Prospectus/Proxy Statement thoroughly and to indicate your voting instructions on the enclosed voting instruction card(s), date and sign it, and return it promptly in the envelope provided to be received by the Trust on or before the close of business on October 13, 2005.  The shares that you beneficially own will be voted in accordance with instructions received by that date.  All shares of the Growth + Value Portfolio for which instructions are not received will be voted in the same proportion as the votes cast by contract owners on the issues presented.

 

Any questions or concerns you may have regarding the special meeting or the voting instruction card should be directed to your financial representative.

 

Sincerely,

 

David R. Odenath, Jr.

President

American Skandia Trust

 



 

SPECIAL MEETING OF SHAREHOLDERS

OF THE AST GROWTH + VALUE PORTFOLIO

OF

AMERICAN SKANDIA TRUST

To be held

October 14, 2005

 

To the Shareholders of the AST AllianceBernstein Growth + Value Portfolio of American Skandia Trust:

 

Notice is hereby given that a Special Meeting of Shareholders of the AST AllianceBernstein Growth + Value Portfolio (“Growth + Value Portfolio”) of American Skandia Trust (the “Trust”), will be held at Gateway Center Three, 100 Mulberry Street, Newark, NJ 07102 on October 14, 2005 at 10:00 a.m. Eastern time, or at such adjourned time as may be necessary to vote (the “Meeting”), for the following purposes:

 

I.                                          To approve a Plan of Reorganization of the Trust on behalf of the Growth + Value Portfolio and the AST AllianceBernstein Managed Index 500 Portfolio of the Trust (“Managed Index 500 Portfolio”), that provides for the acquisition of all of the net assets of Growth + Value Portfolio in exchange for shares of the Managed Index 500 Portfolio, the distribution of such shares to the shareholders of the Growth + Value Portfolio, and the complete liquidation and dissolution of the Growth + Value Portfolio.

 

II.                                      To transact such other business as may properly come before the Meeting or any adjournment thereof.

 

A copy of the Plan of Reorganization is attached as Exhibit A to the Prospectus/Proxy Statement.

 

The matters referred to above are discussed in detail in the Prospectus/Proxy Statement attached to this Notice.  The Board of Trustees has fixed the close of business on August 1, 2005 as the record date for determining shareholders entitled to notice of, and to vote at, the Meeting, and only holders of record of shares at the close of business on that date are entitled to notice of, and to vote at, the Meeting.  Each share of the Growth + Value Portfolio is entitled to one vote on each proposal.

 

You are cordially invited to attend the Meeting.  If you do not expect to attend, you are requested to complete, date and sign the enclosed voting instruction card and return it promptly in the envelope provided for that purpose.  Alternatively, you may vote by telephone as described in the Prospectus/Proxy Statement.  The enclosed proxy is being solicited on behalf of the Board of Trustees.

 

YOUR VOTE IS IMPORTANT.  IN ORDER TO AVOID THE UNNECESSARY EXPENSE OF FURTHER SOLICITATION, WE URGE YOU TO INDICATE VOTING INSTRUCTIONS ON THE ENCLOSED VOTING INSTRUCTION CARD, DATE AND SIGN IT, AND RETURN IT PROMPTLY IN THE ENVELOPE PROVIDED, NO MATTER HOW LARGE OR SMALL YOUR HOLDINGS MAY BE.  YOU MAY REVOKE IT AT ANY TIME PRIOR TO ITS USE.  THEREFORE, BY APPEARING AT A MEETING, AND REQUESTING REVOCATION PRIOR TO THE VOTING, YOU MAY REVOKE THE VOTING INSTRUCTION CARD AND YOU CAN THEN VOTE IN PERSON.

 

By order of the Board of Trustees

 

Deborah A. Docs

Secretary

American Skandia Trust

 

 

August [    ], 2005

 



 

AMERICAN SKANDIA TRUST

Gateway Center Three

100 Mulberry Street

Newark, New Jersey 07102

 

PROSPECTUS/PROXY STATEMENT

August [    ], 2005

 

Acquisition of the Assets of the

 

AST AllianceBernstein Growth + Value Portfolio

 

By and in exchange for shares of the AST AllianceBernstein Managed Index 500 Portfolio

 

This Prospectus/Proxy Statement is furnished in connection with a Special Meeting (the “Meeting”) of shareholders of the AST AllianceBernstein Growth + Value Portfolio (the “Growth + Value Portfolio”), a series of American Skandia Trust (the “Trust”), called by the Trust to approve or disapprove a Plan of Reorganization (the “Plan”).  If shareholders of the Growth + Value Portfolio vote to approve the Plan, you will receive an investment in the AST AllianceBernstein Managed Index 500 Portfolio (the “Managed Index 500 Portfolio” and, together with the Growth + Value Portfolio, each, a “Portfolio” and collectively, the “Portfolios”), a series of the Trust, equal in value to your investment in the Growth + Value Portfolio, as provided in the Plan and described at greater length below.  The Growth + Value Portfolio will then be liquidated and dissolved.

 

The Meeting will be held at Gateway Center Three, 100 Mulberry Street, Newark, New Jersey on October 14, 2005 at 10:00 a.m. Eastern time.  The Board of Trustees of the Trust is soliciting these voting instructions on behalf of the Growth + Value Portfolio.  This Prospectus/Proxy Statement will first be sent to contract owners on or about August [   ], 2005.

 

The Trust serves as an underlying mutual fund for variable annuity contracts and variable life insurance policies (the “Contracts”) issued by life insurance companies (“Participating Insurance Companies”), including Pruco Life Insurance Company and Pruco Life Insurance Company of New Jersey (collectively, “Prudential”) and American Skandia Life Assurance Corporation (“ASLAC”), affiliates of the Trust’s investment managers, Prudential Investments LLC (“PI”) and American Skandia Investment Services, Incorporated (“ASISI”), as well as Kemper Investors Life Insurance Company.  Each Participating Insurance Company holds assets invested in these Contracts in various separate accounts, each of which is divided into sub-accounts investing exclusively in a mutual fund or in a portfolio of a mutual fund.  Therefore, Contract owners who have allocated their account values to applicable sub-accounts are indirectly invested in the Growth + Value Portfolio through the Contracts and should consider themselves shareholders of the Growth + Value Portfolio for purposes of this Prospectus/Proxy Statement.  Each Participating Insurance Company is required to offer Contract owners the opportunity to instruct it, as owner of record of shares held in the Growth + Value Portfolio by its separate accounts, how it should vote on the Plan at the Meeting and at any adjournments thereof.

 

The investment objectives of the Portfolios are comparable.  The investment objective of the Growth + Value Portfolio is to seek capital growth.  The investment objective of the Managed Index 500 Portfolio is to outperform the Standard & Poor’s 500 Composite Stock Price Index (the “S&P 500® Index”).

 

This Prospectus/Proxy Statement gives the information about the proposed reorganization and issuance of shares of the Portfolio that you should know before investing or voting on the Plan.  You should read it carefully and retain it for future reference.  Additional information about the Managed Index 500 Portfolio and the proposed reorganization has been filed with the Securities and Exchange Commission (“SEC”) and can be found in the following documents:

 

                  The Prospectus for the Managed Index 500 Portfolio dated May 1, 2005, which is incorporated herein by reference and is included with and considered a part of this Prospectus/Proxy Statement; and

 

1



 

                  The Trust’s Annual Report to Shareholders for the fiscal year ended December 31, 2004, which is included with and considered a part of this Prospectus/Proxy Statement.

 

You may request a free copy of a Statement of Additional Information (“SAI”) relating to this Prospectus/Proxy Statement or other documents related to the Trust without charge by calling 800-752-6342 or by writing to the Trust at Gateway Center Three, 100 Mulberry Street, Newark, NJ  07102.  The SEC maintains a website (www.sec.gov) that contains the SAI and other material incorporated by reference and considered part of this Prospectus/Proxy Statement, together with other information regarding the Trust.

 

The SEC has not approved or disapproved these securities or passed upon the adequacy of this Prospectus/Proxy Statement.  Any representation to the contrary is a criminal offense.

 

Mutual fund shares are not deposits or obligations of, or guaranteed or endorsed by, any bank, and are not insured by the Federal Deposit Insurance Corporation or any other U.S. government agency.  Mutual fund shares involve investment risks, including the possible loss of principal.

 

2



 

SUMMARY

 

This section is only a summary of certain information contained in this Prospectus/Proxy Statement.  You should read the more complete information in the rest of this Prospectus/Proxy Statement, including the Plan (Exhibit A) and the Prospectus for the Managed Index 500 Portfolio (Exhibit B).

 

The Proposal

 

You are being asked to consider and approve a Plan of Reorganization that will have the effect of combining the Growth + Value Portfolio and the Managed Index 500 Portfolio into a single mutual fund.  If shareholders of the Growth + Value Portfolio vote to approve the Plan, the net assets of the Growth + Value Portfolio will be transferred to the Managed Index 500 Portfolio in exchange for a then equal value of shares of the Managed Index 500 Portfolio.  Shareholders of the Growth + Value Portfolio will have their shares exchanged for shares of the Managed Index 500 Portfolio of equal dollar value based upon the value of the shares at the time the Growth + Value Portfolio’s net assets are transferred to the Managed Index 500 Portfolio.  After the transfer of net assets and exchange of shares have been completed, the Growth + Value Portfolio will be liquidated and dissolved.  The proposed reorganization is referred to in this Prospectus/Proxy Statement as the “Transaction.”  As a result of the Transaction, you will cease to be a beneficial shareholder of the Growth + Value Portfolio and will become a beneficial shareholder of the Managed Index 500 Portfolio.

 

For the reasons set forth in the “Reasons for the Transaction” section, the Board of Trustees of the Trust has determined that the Transaction is in the best interests of the shareholders of the Growth + Value Portfolio and the Managed Index 500 Portfolio, and has also concluded that no dilution in value would result to the shareholders of either Portfolio as a result of the Transaction.

 

The Board of Trustees of the Trust, on behalf of the Growth + Value Portfolio and the Managed Index 500 Portfolio, has approved the Plan and unanimously recommends that you vote to approve the Plan.

 

Shareholder Voting

 

Each Contract owner invested in the Growth + Value Portfolio at the close of business on August 1, 2005 (the “Record Date”) will be entitled to instruct the relevant Participating Insurance Company how to vote at the Meeting, and will be entitled to give voting instructions equivalent to one vote for each full share and a fractional vote for each fractional share of the Growth + Value Portfolio that he or she beneficially owns.  In addition, each Participating Insurance Company as record owner of the shares, will vote all shares of the Growth + Value Portfolio for which it does not receive voting instructions, and it will vote those shares in the same proportion as the votes cast by Contract owners.  To approve the Transaction for the reorganization of the Growth + Value Portfolio, the affirmative vote of the holders of a majority of the total number of shares of the Growth + Value Portfolio outstanding and entitled to vote thereon must be voted in favor of the Plan.

 

Please provide voting instructions as soon as you receive this Prospectus/Proxy Statement.  You may provide your voting instructions by completing and signing the enclosed voting instruction card or by phone.  If you vote by either of these methods, your votes will be officially cast at the Meeting by the relevant Participating Insurance Company acting through the persons appointed as proxies.

 

You can revoke or change your voting instructions at any time until the vote is taken at the Meeting.  For more details about shareholder voting, see the “Voting Information” section of this Prospectus/Proxy Statement.

 

3



 

COMPARISONS OF IMPORTANT FEATURES OF THE PORTFOLIOS

 

This section describes the investment policies of the Growth + Value Portfolio and the Managed Index 500 Portfolio and the differences between them.  For a complete description of the investment policies and risks of the Managed Index 500 Portfolio , you should read the Prospectus for that Portfolio included as Exhibit B.  For additional information about both Portfolios, please refer to the documents described in “Additional Information About the Company and the Portfolios,” below.

 

The Investment Objectives and Strategies of the Portfolios

 

The investment objective and investment policies of the Portfolios are similar.  The investment objective of the Growth + Value Portfolio is capital growth.  T he investment objective of the Managed Index 500 Portfolio is to outperform the S&P 500® Composite Stock Price Index (the “S&P 500® Index”).  The investment objectives are non-fundamental, which means they may be changed by the Board without shareholder approval.  There can be no assurance that either Portfolio will achieve its investment objective.

 

Each Portfolio pursues its investment objective through various investment strategies that are employed by Alliance Capital Management, L.P. (“ AllianceBernstein ”) as the Sub-advisor to both Portfolios.  After the reorganization is completed, it is expected that the combined fund will be managed according to the investment objective and policies of the Managed Index 500 Portfolio.

 

The Growth + Value Portfolio invests primarily in common stocks of large U.S. companies included in the Russell 1000® Index (the “Russell 1000®”). The Russell 1000® is a market capitalization-weighted index that measures the performance of the 1,000 largest U.S. companies. As of December 31, 2004, the weighted average market capitalization of the companies in the Russell 1000 Index® was approximately $82.8 billion.

 

Normally, about 65-105 companies will be represented in the Portfolio, with 25-35 companies primarily from the Russell 1000® Growth Index (the “Growth Index”) constituting approximately 50% of the Portfolio’s net assets, and 40-70 companies primarily from the Russell 1000® Value Index (the “Value Index”) constituting the remainder of the Portfolio’s net assets. Daily purchases and reinvested distributions and redemptions and expense items will be divided between the two portfolio segments for purposes of maintaining the targeted allocation between growth and value stocks (the “Target Allocation”). Normally, while it is not expected that the allocation of assets between portfolio segments will deviate more than 10% from the Target Allocation, it is possible that this deviation may be higher. Factors such as market fluctuation, economic conditions, corporate transactions and declaration of dividends may result in deviations from the Target Allocation. In the event the allocation of assets to the portfolio segments differs by more than 10% from the Target Allocation (e.g., 60% of the Portfolio’s net assets invested in growth stocks and 40% of the Portfolio’s net assets invested in value stocks), the Sub-advisor will rebalance each portfolio segment’s assets in order to maintain the Target Allocation. As a consequence, assets may be allocated from the portfolio segment that has appreciated more or depreciated less to the other. Rebalancing may entail transaction costs which over time may be significant.

 

In seeking its investment objective, the Sub-advisor emphasizes stock selection.  The Sub-advisor relies heavily upon the fundamental analysis and rigorous research of its internal research staff.  Investments in growth stocks are based on strong management, superior industry positions, excellent balance sheets and superior earnings growth, where all of these strengths have not been reflected in the company’s stock price.  When investing in value stocks, the Sub-advisor measures each stock’s long-term expected return by comparing the price of the security to the company’s long-term cash flows.  The Sub-advisor will only purchase those stocks in which it has above-average confidence in the reliability of its analysts’ forecasts.  The Sub-advisor may delay its purchase of securities if recent weakness in the stock or negative earnings revisions by analysts indicate that the stock price is likely to decline in the near future, and it may delay its sale of securities if recent strength in the stock or upward earnings revisions indicate the stock is likely to rise soon.

 

The Managed Index 500 Portfolio invests, under normal circumstances, at least 80% of its net assets in securities included in the S&P 500 â Index.  The Portfolio is actively managed and seeks to outperform the S&P

 

4



 

500® Index through the Sub-advisor’s stock selection resulting in different weightings of common stocks relative to the index. The S&P 500® Index is an index of 500 common stocks, most of which trade on the New York Stock Exchange Inc. (the “NYSE”).

 

In seeking to outperform the S&P 500® Index, the Sub-advisor starts with a portfolio of stocks representative of the holdings of the index.  It then uses a set of quantitative criteria that are designed to indicate whether a particular stock will predictably perform better or worse than the S&P 500® Index. Based on these criteria, the Sub-advisor determines whether the Portfolio should over-weight, under-weight or hold a neutral position in the stock relative to the proportion of the S&P 500® Index that the stock represents.  In addition, the Sub-advisor may determine based on the quantitative criteria that (1) certain S&P 500® Index stocks should not be held by the Portfolio in any amount, and (2) certain equity securities that are not included in the S&P 500® Index should be held by the Portfolio.  The Portfolio may invest up to 15% of its total assets in equity securities not included in the S&P 500® Index.  While the Portfolio attempts to outperform the S&P 500® Index, it is not expected that any outperformance will be substantial.  The Portfolio also may underperform the S&P 500® Index over short or extended periods.

 

About the S&P 500® Index.   The S&P 500® Index is a well-known stock market index that includes common stocks of 500 companies from several industrial sectors representing a significant portion of the market value of all common stocks publicly traded in the United States. Stocks in the S&P 500® Index are weighted according to their market capitalization (the number of shares outstanding multiplied by the stock’s current price). The composition of the S&P 500® Index is determined by S&P based on such factors as market capitalization, trading activity, and whether the stock is representative of stocks in a particular industry group. The composition of the S&P 500® Index may be changed from time to time. “Standard & Poor’s®,” “S&P 500®,” “Standard & Poor’s 500,” and “500” are trademarks of The McGraw-Hill Companies, Inc. and have been licensed for use by the Investment Manager.

 

The Managed Index 500 Portfolio is not sponsored, endorsed, sold or promoted by Standard &Poor’s, a division of The McGraw-Hill Companies, Inc. (“S&P”). S&P makes no representation or warranty, express or implied, to the shareholders of the Portfolio or any member of the public regarding the advisability of investing in securities generally or in the Portfolio particularly or the ability of the S&P 500® to track general stock market performance. S&P’s only relationship to the Investment Manager or the Sub-advisor is a license provided to the Investment Manager of certain trademarks and trade names of S&P and of the S&P 500®, which is determined, composed and calculated by S&P without regard to the Investment Manager, Sub-advisor, or Portfolio. S&P has no obligation to take the needs of the Investment Manager, Sub-advisor or the shareholders of the Portfolio into consideration in determining, composing or calculating the S&P 500®. S&P is not responsible for and has not participated in the determination of the prices and amount of the Portfolio or the timing of the issuance or sale of the Portfolio, or in the determination or calculation of the Portfolio’s net asset value. S&P has no obligation or liability in connection with the administration, marketing or trading of the Portfolio.

 

S&P does not guarantee the accuracy and/or the completeness of the S&P 500® or any data included therein and shall have no liability for any errors, omissions, or interruptions therein. S&P makes no warranty, express or implied, as to the results to be obtained by the Portfolio, shareholders of the Portfolio, or any other person or entity from the use of the S&P 500® or any data included therein. S&P makes no express or implied warranties and expressly disclaims all warranties of merchantability or fitness for a particular purpose or use with respect to the S&P 500® or any data included therein. Without limiting any of the foregoing, in no event shall S&P have any liability for any special, punitive, indirect or consequential damages (including lost profits), even if notified of the possibility of such damages.

 

Comparison of Other Policies of the Portfolios

 

The following investment restrictions are applicable to both the Growth + Value Portfolio and the Managed Index 500 Portfolio.

 

1.              Neither Portfolio may issue senior securities, except as permitted under the 1940 Act.

 

2                                           Neither Portfolio may borrow money, except that a Portfolio may (i) borrow money for non-

 

5



 

leveraging, temporary or emergency purposes, and (ii) engage in reverse repurchase agreements and make other investments or engage in other transactions, which may involve a borrowing, in a manner consistent with the Portfolio’s investment objective and policies; provided that the combination of (i) and (ii) shall not exceed 33 1/3% of the value of the Portfolio’s assets (including the amount borrowed) less liabilities (other than borrowings) or such other percentage permitted by law.  Any borrowings which come to exceed this amount will be reduced in accordance with applicable law.  Subject to the above limitations, a Portfolio may borrow from persons to the extent permitted by applicable law, including the Investment Company Act of 1940, or to the extent permitted by any exemption from the Investment Company Act of 1940 that may be granted by the SEC, or any SEC releases, no-action letters or similar relief or interpretive guidance.

 

3.                                        Neither Portfolio may underwrite securities issued by other persons, except to the extent that the Portfolio may be deemed to be an underwriter (within the meaning of the Securities Act of 1933) in connection with the purchase and sale of portfolio securities.

 

4.                                        Neither Portfolio may purchase or sell real estate unless acquired as a result of the ownership of securities or other instruments; provided that this restriction shall not prohibit a Portfolio from investing in securities or other instruments backed by real estate or in securities of companies engaged in the real estate business.

 

5.                                        Neither Portfolio may purchase or sell physical commodities unless acquired as a result of the ownership of securities or instruments; provided that this restriction shall not prohibit a Portfolio from (i) engaging in permissible options and futures transactions and forward foreign currency contracts in accordance with the Portfolio’s investment policies, or (ii) investing in securities of any kind.

 

6.                                        Neither Portfolio may make loans, except that a Portfolio may (i) lend portfolio securities in accordance with the Portfolio’s investment policies in amounts up to 33 1/3% of the total assets of the Portfolio taken at market value, (ii) purchase money market securities and enter into repurchase agreements, (iii) acquire publicly distributed or privately placed debt securities, and (iv) make loans of money to other investment companies to the extent permitted by the Investment Company Act of 1940 or any exemption therefrom that may be granted by the SEC or any SEC releases, no-action letters or similar relief or interpretive guidance.

 

7.                                        Neither Portfolio may purchase any security if, as a result, more than 25% of the value of the Portfolio’s assets would be invested in the securities of issuers having their principal business activities in the same industry; provided that this restriction does not apply to investments in obligations issued or guaranteed by the U.S. Government or any of its agencies or instrumentalities (or repurchase agreements with respect thereto).

 

8.                                        Neither Portfolio may, with respect to 75% of the value of its total assets, purchase the securities of any issuer (other than securities issued or guaranteed by the U.S. Government or any of its agencies or instrumentalities) if, as a result, (i) more than 5% of the value of the Portfolio’s total assets would be invested in the securities of such issuer, or (ii) more than 10% of the outstanding voting securities of such issuer would be held by the Portfolio.

 

If a restriction on a Portfolio’s investments is adhered to at the time an investment is made, a subsequent change in the percentage of Portfolio assets invested in certain securities or other instruments, or change in average duration of the Portfolio’s investment portfolio, resulting from changes in the value of the Portfolio’s total assets, will not be considered a violation of the restriction; provided, however, that the asset coverage requirement applicable to borrowings shall be maintained in the manner contemplated by

 

6



 

applicable law.

 

With respect to investment restrictions (2) and (6), a Portfolio will not borrow or lend to any other fund unless it applies for and receives an exemptive order from the SEC, if so required, or the SEC issues rules permitting such transactions.

 

With respect to investment restriction (6), the restriction on making loans is not considered to limit a Portfolio’s investments in loan participations and assignments.

 

Risks of Investing in the Portfolios

 

Because each Portfolio invests primarily in stocks, each Portfolio is subject to the risks associated with stock investments, and the Portfolio’s share price therefore may fluctuate substantially. A Portfolio’s share price will be affected by changes in the stock markets generally, and factors specific to a company or an industry will affect the prices of particular stocks held by the Portfolio (for example, poor earnings, loss of major customers, availability of basic resources or supplies, major litigation against a company, or changes in governmental regulation affecting an industry).  Because both Portfolios emphasize large, more-established companies, this may mean that their level of risk is lower than a fund investing primarily in smaller companies.  Because the Growth + Value Portfolio invests in a smaller number of securities than many other funds, changes in the value of a single security may have a more significant effect, either negative or positive, on the Portfolio’s share price.

 

Federal Income Tax Considerations

 

Each Portfolio is treated as a separate entity for federal income tax purposes.  Each Portfolio has qualified and elected or intends to qualify and elect to be treated as a “regulated investment company” under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”), and intends to continue to so qualify in the future.  As a regulated investment company, a Portfolio must, among other things, (a) derive at least 90% of its gross income from dividends, interest, payments with respect to loans of stock and securities, gains from the sale or other disposition of stock, securities or foreign currency and other income (including but not limited to gains from options, futures, and forward contracts) derived with respect to its business of investing in such stock, securities or foreign currency; and (b) diversify its holdings so that, at the end of each quarter of its taxable year, (i) at least 50% of the value of the Portfolio’s total assets is represented by cash, cash items, U.S. Government securities, securities of other regulated investment companies, and other securities limited, in respect of any one issuer, to an amount not greater than 5% of the Portfolio’s total assets, and 10% of the outstanding voting securities of such issuer, and (ii) not more than 25% of the value of its total assets is invested in the securities of any one issuer (other than U.S. Government securities or securities of other regulated investment companies) or of two or more issuers controlled by the Portfolio that are determined, under applicable regulations, to be engaged in the same or similar trades or businesses or related trades or businesses.  As a regulated investment company, a Portfolio (as opposed to its shareholders) will not be subject to federal income taxes on the net investment income and capital gain that it distributes to its shareholders, provided that at least 90% of its net investment income and realized net short-term capital gain in excess of net long-term capital loss for the taxable year is distributed in accordance with the Code’s distribution requirements

 

The Transaction may entail various tax consequences, which are discussed under the caption “Tax Consequences of the Transaction.”

 

Management of the Trust and the Portfolios

 

Investment Managers:   American Skandia Investment Services, Incorporated (“ASISI”), One Corporate Drive, Shelton, Connecticut, has served as Investment Manager to the Trust since 1992, and serves as co-investment manager to a total of 60 investment company portfolios (including the Portfolios of the Trust). ASISI serves as co-manager of the Trust along with Prudential Investments LLC (“PI”) (each an “Investment Manager” and together the “Investment Managers”). PI is located at Gateway Center Three, 100 Mulberry Street, Newark, New Jersey, and also serves as investment manager to the investment companies that comprise the

 

7



 

Prudential mutual funds. As co-manager, PI also provides supervision and oversight of ASISI’s investment management responsibilities with respect to the Trust.

 

The Trust’s Investment Management Agreements, on behalf of each Portfolio, with ASISI and PI (the “Management Agreements”), provide that the Investment Managers will furnish each applicable Portfolio with investment advice and administrative services subject to the supervision of the Board of Trustees and in conformity with the stated policies of the applicable Portfolio. The Investment Managers have engaged Sub-advisors to conduct the investment programs of each Portfolio, including the purchase, retention and sale of portfolio securities. The Investment Managers are responsible for monitoring the activities of the Sub-advisors and reporting on such activities to the Trustees. The Investment Managers must also provide, or obtain and supervise, the executive, administrative, accounting, custody, transfer agent and shareholder servicing services that are deemed advisable by the Trustees.

 

The Trust has obtained an exemption from the SEC that permits the Investment Managers, subject to approval by the Board of Trustees of the Trust, to change Sub-advisors for a Portfolio and to enter into new sub-advisory agreements, without obtaining shareholder approval of the changes. This exemption (which is similar to exemptions granted to other investment companies that are organized in a similar manner as the Trust) is intended to facilitate the efficient supervision and management of the Sub-advisors by the Investment Managers and the Trustees.

 

Sub-advisor:   Information about the Sub-advisor for each Portfolio is set forth below.  The Trust’s Statement of Additional Information provides additional information about each portfolio manager’s compensation, other accounts that each portfolio manager manages, and ownership of Trust securities by each portfolio manager.

 

Alliance Capital Management, L.P.   (“AllianceBernstein”), 1345 Avenue of the Americas, New York, NY 10105, serves as Sub-advisor for the Managed Index 500 Portfolio and the Growth + Value Portfolio.  AllianceBernstein is a leading global investment adviser with assets under management as of March 31, 2005 totaling approximately $534 billion.

 

Day-to-day investment management decisions for the Managed Index 500 Fund are made by the U.S. Structured Equity Investment Policy Group, which is chaired by Drew W. Demakis. Mr. Demakis is a Senior Vice President of AllianceBernstein and Chairman of the Risk Investment Policy Group. The U.S. Structured Equity Investment Policy Group has managed the Fund since AllianceBernstein became the Fund’s Sub-advisor in May 2000. Mr. Demakis joined the firm in 1998 from BARRA RogersCasey, where he was most recently Managing Director and Head of Research. He has been responsible for the Fund since May 2003.

 

The day-to-day management of and investment decisions for the Growth + Value Portfolio are made by the Style Blend Investment Team, chaired by Seth Masters, Chief Investment Officer for Style Blend Services. The Style Blend Investment Team leverages the investment expertise of the U.S. Value Team and the U.S. Large Cap Growth Team. Mr. Masters has overall responsibility for rebalancing and administration of the growth and value components of the Portfolio. Mr. Masters has been with Alliance, and before that, with Sanford C. Bernstein & Co. LLC, since 1991. He is chairman of the firm’s U.S. and Global Style Blend Investment Policy Groups and a member of the Bernstein Global, International and Emerging Markets Value Investment Policy Group.

 

Additional Information About the Portfolio Managers

 

Set out below is additional information with respect to the portfolio managers for the Funds. Unless noted otherwise, all information is provided as of December 31, 2004.

 

Other Accounts Managed by Portfolio Manager

 

The table below identifies, for the portfolio manager, the number of accounts managed and the total assets in such accounts, within each of the following categories: registered investment companies (RICs), other pooled

 

8



 

investment vehicles and other accounts.  For each category, the number of accounts and total assets in the accounts whose fees are based on performance is indicated in italics typeface.

 

Growth + Value Portfolio

 

Portfolio
Manager

 

RIC
Account
Managed

 

Assets
of RIC
Managed

 

Other
Pooled
Accounts
Managed

 

Assets of
Other
Pooled
Accounts
Managed

 

Other
Accounts
Managed

 

Assets of
Other
Accounts
Managed

 

Seth Masters

 

3

 

$10.4 billion

 

0

 

N/A

 

17

 

$3.5 billion

 

 

 

0

 

N/A

 

0

 

N/A

 

2

 

$119 million

 

 

Security Ownership.  Seth Masters does not beneficially own any securities issued by the Growth + Value Portfolio.

 

Managed Index 500 Portfolio

 

Portfolio
Manager

 

RIC
Account
Managed

 

Assets
of RIC
Managed

 

Other
Pooled
Accounts
Managed

 

Assets of
Other
Pooled
Accounts
Managed

 

Other
Accounts
Managed

 

Assets of
Other
Accounts
Managed

 

Drew Demakis

 

12

 

$3.1 billion

 

0

 

N/A

 

18

 

$842 million

 

 

 

0

 

N/A

 

0

 

N/A

 

0

 

N/A

 

 

Security Ownership. Drew Demarkis does not beneficially own any securities issued by the Managed Index 500 Portfolio.

 

Compensation Structure and Method(s)/Material Conflicts of Interest

 

AllianceBernstein’s compensation program for investment professionals ( i.e. , portfolio managers and research analysis) is designed to be competitive and appropriate to attract and retain the highest caliber employees.  Compensation of investment professionals primarily reflects their ability to generate long-term investment success for our clients, including shareholders of the AllianceBernstein Mutual Funds.

 

Investment professionals are compensated on an annual basis through a combination of the following:  (i) fixed base salary; (ii) discretionary incentive compensation in the form of an annual cash bonus; (iii) discretionary incentive compensation in the form of awards under AllianceBernstein’s Partners Compensation Plan (“deferred awards”) and (iv) discretionary long-term incentive compensation in the form of restricted unit grants. Investment professionals also receive contributions under AllianceBernstein’s Profit Sharing/401(k) Plan.  AllianceBernstein’s overall profitability determines the total amount of incentive compensation available to investment professionals.  Deferred awards, for which there are various investment options, vest over a four-year period and are generally forfeited if the employee resigns or AllianceBernstein terminates his/her employment.  Investment options under the deferred awards plan include many of the same AllianceBernstein Mutual Funds offered to mutual fund investors, thereby creating a closer alignment between the investment professionals and AllianceBernstein’s clients and mutual fund shareholders.  AllianceBernstein also permits deferred award recipients to allocate up to 50% of their award to investments in AllianceBernstein’s publicly traded equity securities.

 

9



 

An investment professional’s total compensation is determined through a subjective process that evaluates numerous quantitative and qualitative factors, including the investment success of the portfolios managed by the individual.  Investment professionals do not receive any direct compensation based upon the investment returns of any individual client account.  Not all factors apply to each investment professional and there is no particular weighting or formula for considering certain factors.

 

Among the factors considered are: relative investment performance of portfolios (although there are no specific benchmarks or periods of time used in measuring performance); complexity of investment strategies; participation in the investment team/discipline’s dialogue; contribution to business results and overall business strategy; success of marketing/business development efforts and client servicing; seniority/length of service with the firm; management and supervisory responsibilities and fulfillment of AllianceBernstein’s leadership criteria.

 

Potential Conflicts of Interest

 

As an investment adviser and fiduciary, AllianceBernstein owes its clients and shareholders an undivided duty of loyalty.  AllianceBernstein recognizes that conflicts of interest are inherent in its business and accordingly has developed policies, procedures and disclosures reasonably designed to detect, manage and mitigate the effects of potential conflicts of interest in the area of employee personal trading, managing multiple accounts for multiple clients, including Funds (hereinafter “Clients”) and allocating investment opportunities. Investment professionals, including portfolio managers and research analysts, are subject to the above-mentioned policies and oversight to help ensure that all clients are treated equitably.  As stated in these conflicts-related policies, AllianceBernstein places the interests of its clients first and expects all of its employees to live up to AllianceBernstein’s fiduciary duty.

 

Employee Personal Trading and the Code of Business Conduct and Ethics AllianceBernstein has policies to avoid conflicts of interest when investment professionals and other personnel of AllianceBernstein own, buy or sell securities also owned by, or bought or sold for clients. AllianceBernstein permits its employees to engage in personal securities transactions, and also allows them to allocate investments in the AllianceBernstein Mutual Funds through direct purchase, 401K/profit sharing plan investment and/or notionally connected with deferred incentive compensation awards. Personal securities transactions by an employee may raise a potential conflict of interest when an employee owns or trades in a security that is owned or considered for purchase or sale by a client, or recommended for purchase or sale by an employee to a client. AllianceBernstein has adopted a Code of Business Conduct and Ethics (“Code”) that is designed to detect and prevent such conflicts of interest.

 

Managing Multiple Accounts for Multiple Clients The investment professional or investment professional teams for each Fund have responsibilities for managing all or a portion of the investments of multiple accounts with a common investment strategy, including other registered investment companies, unregistered investment vehicles, such as hedge funds, pension plans, separate accounts, collective trusts and charitable foundations.  Potential conflicts of interest may arise when an investment professional has responsibilities for the investments of more than one account because the investment professional may be unable to devote equal time and attention to each account.  Accordingly, AllianceBernstein has compliance policies and oversight to manage these conflicts.

 

Allocating Investment Opportunities In addition, the investment professionals may have to decide how to select and allocate investment opportunities among accounts.  Portfolio holdings, position sizes, and industry and sector exposures tend to be similar across similar accounts, which minimizes the potential for conflicts of interest.  Nevertheless, investment opportunities may be allocated differently among accounts due to the particular characteristics of an account, such as cash position, tax status, risk tolerance and investment restrictions or for other reasons.  Potential conflicts of interest may also occur where AllianceBernstein would have an incentive, such a performance-based management fee, relating to an account.  An investment professional may perceive that he or she has an incentive to devote more time to developing and analyzing investment strategies and opportunities or allocating securities preferentially to accounts for which AllianceBernstein could share in investment gains.  As referenced above, AllianceBernstein has procedures designed to ensure that information relevant to investment decisions is disseminated fairly and investment opportunities are allocated equitably among different clients.

 

10



 

Investment Management Fees

 

Pursuant to the Management Agreement, ASISI receives a monthly investment management fee for the performance of its services.  The investment management fee is accrued daily for the purposes of determining the sale and redemption price of a Portfolio’s shares.  Under the Management Agreement, the Growth + Value Portfolio is obligated to pay ASISI an investment management fee equal to an annual rate of 0.90% of its average daily net assets.  Under the Management Agreement, the Managed Index 500 Portfolio is obligated to pay ASISI an annual investment management fee equal to 0.60% of its average daily net assets.

 

The Transaction, if approved by the shareholders of the Growth + Value Portfolio , will result in a decrease in the management fee rate for current investors in the Growth + Value Portfolio from 0.90% to 0.60%.  During the fiscal year ended December 31, 2004, the Growth + Value Portfolio paid $618,479 in investment management fees to ASISI.  If the fee rate applicable to the Managed Index 500 Portfolio had been in effect during the period, the Growth + Value Portfolio would have paid $412,319 in investment management fees to PI.

 

ASISI pays the Sub-advisor a portion of the investment management fee that it receives from each Portfolio. ASISI pays such subadvisery fees without any additional expense to a Portfolio.

 

With respect to the Managed Index 500 Portfolio , ASISI pays Alliance a fee equal to an annual rate of 0.1533% of average daily net assets to $300 million; and 0.10% of average daily net assets over $300 million, when the assets equal or exceed $300 million.  For each day that daily net assets do not exceed $300 million, the following fee schedule is applicable:  0.40% on the first $10 million of average daily net assets; 0.30% of the next $40 million of average daily net assets; 0.20% of the next $50 million of average daily net assets; 0.10% on the next $200 million of average daily net assets.

 

With respect to the Growth + Value Portfolio, ASISI pays Alliance a fee equal to 0.40% of average daily net assets.

 

Valuation

 

The net asset value per share (“NAV”) of each Portfolio is determined as of the time of the close of regular trading on the New York Stock Exchange (the “NYSE”) (which is normally 4:00 p.m. Eastern Time) on each day that the NYSE is open for business. NAV is determined by dividing the value of a Portfolio’s total assets, less any liabilities, by the number of total shares of that Portfolio outstanding. In general, the assets of each Portfolio are valued on the basis of market quotations. However, in certain circumstances where market quotations are not readily available or are believed to be inaccurate, assets are valued by methods that are believed to accurately reflect their fair value.  Because NAV is calculated and purchases may be made only on business days, and because securities traded on foreign exchanges may trade on other days, the value of a Portfolio’s investments may change on days when shares cannot be purchased or redeemed.

 

As above, each Portfolio’s portfolio securities holdings are valued based upon market quotations or, if not readily available, at fair value as determined in good faith under procedures established by the Board. A Portfolio also may use fair value pricing if it determines that the market quotation is not reliably based, among other things, on events or market conditions that occur after the quotation is derived or after the close of the primary market on which the security is traded, but before the time that the Portfolio’s NAV is determined. This use of fair value pricing most commonly occurs with securities that are primarily traded outside the U.S. because such securities present time-zone arbitrage opportunities when events or conditions affecting the prices of specific securities or the prices of securities traded in such markets generally occur after the close of the foreign markets but prior to the time the Portfolio determines its NAV. The Portfolio may also use fair value pricing with respect to U.S.-traded securities if, for example, trading in a particular security is halted and does not resume before the Portfolio calculates its NAV or the exchange on which a security is traded closes early. In addition, fair value pricing is used for securities where the pricing agent or principal market maker does not provide a valuation or methodology or provides a valuation or methodology that, in the judgment of the Investment Managers (or Sub-advisors) does not represent fair value.

 

11



 

Different valuation methods may result in differing values for the same security. The fair value of a portfolio security that a Portfolio uses to determine its NAV may differ from the security’s quoted or published price. If a Portfolio needs to implement fair value pricing after the NAV publishing deadline, but before shares of a Portfolio are processed, the NAV you receive or pay may differ from the published NAV price. For purposes of computing a Portfolio’s NAV, the Portfolio’s futures contracts will be valued 15 minutes after the close of trading on the New York Stock Exchange (“NYSE”). Except when the Portfolio fair values securities, each foreign security held by a Portfolio is normally valued as of the close of the security’s primary market. Fair value pricing procedures are designed to result in prices for the Portfolio’s securities and its net asset value that are reasonable in light of the circumstances which make or have made market quotations unavailable or unreliable, and may have the effect of reducing arbitrage opportunities available to short-term traders. There is no assurance, however, that fair value pricing will more accurately reflect the market value of a security than the market price of such security on that day or that it will prevent dilution of the Portfolio’s NAV by short-term traders.

 

Each Portfolio ’s NAV is determined once each business day at the close of regular trading on the NYSE, usually 4:00 p.m. New York time. The NYSE is closed on most national holidays and Good Friday. On days when the NYSE is closed but the primary markets for the Portfolio ’s foreign securities are open, the Portfolio will not price, and you will not be able to purchase, redeem or exchange a Portfolio ’s shares even though the value of these securities may have changed. Conversely, each Portfolio will ordinarily price its shares, and you may purchase, redeem or exchange shares on days that the NYSE is open but foreign securities markets are closed. On days there are no orders to purchase, sell or exchange the Portfolio ’s shares, or when changes in the value of the Portfolio ’s portfolio do not materially affect its NAV, the Portfolio s’ NAVs may not be determined.

 

Portfolio Holdings

 

Each Portfolio’s portfolio holdings are made public, as required by law, in the Trust’s annual and semi-annual reports. These reports are filed with the SEC and mailed to shareholders within 60 days after the end of the relevant period.  In addition, each Portfolio’s portfolio holdings are reported to the SEC as required by law within 60 days after the end of each Portfolio’s fiscal quarter.  In addition, a Portfolio may post its month-end full Portfolio holdings to the Trust’s website with a 30-day lag, and may post its top ten holdings, sector and country breakdowns, and largest industries on a monthly basis to the Trust’s website within 15 days after the end of each month.

 

When authorized by an officer of the Trust, portfolio holdings information may be disseminated more frequently or at different periods than as described above to intermediaries that distribute a Portfolio’s shares, third-party providers of auditing, custody, proxy voting and other services for a Portfolio, rating and ranking organizations, and certain affiliated persons of the Trust. As of the date of this Statement of Additional Information, each Portfolio will provide:

 

Traditional External Recipients/Vendors

 

                  Full holdings on a daily basis to Investor Responsibility Research Center (IRRC), Institutional Shareholder Services (ISS) or Automatic Data Processing, Inc. (ADP) (proxy voting agents) at the end of each day;

 

                  Full holdings on a daily basis to each Portfolio’s Sub-advisor(s) (if any), Custodian, Sub-Custodian (if any) and Accounting Agents at the end of each day. Where a Portfolio has more than one Sub-advisor, each Sub-advisor receives holdings information only with respect to the “sleeve” or segment” of the Portfolio for which the Sub-advisor has responsibility.

 

                  Full holdings to the Trust’s independent accountants at the Trust’s fiscal year-end or on an as-needed basis; and

 

                  Full holdings to financial printers at the end of the Trust’s quarterly, semi and annual period-ends.

 

12



 

Analytical Service Providers

 

                  All trades on a quarterly basis to Abel/Noser Corp. (an agency-only broker and transaction cost analysis company) at the Trust’s fiscal quarter-end;

 

                  For each Portfolio with international holdings:  Full holdings on a daily basis to FT Interactive Data (a fair value information service) at the end of each day; and

 

                  Full holdings on a daily basis to FactSet (an online investment research provider) at the end of each day.

 

In each case, the information disclosed must be for a legitimate business purpose and is subject to a confidentiality agreement intended to prohibit the recipient from trading on or further disseminating such information. Such arrangements will be reviewed by the Trust’s Chief Compliance Officer and PI’s Law Department on an annual basis.

 

In addition, certain employees of PI receive portfolio holdings information on a quarterly, monthly or daily basis or upon request, in order to perform their business functions.

 

In connection with the ongoing arrangements to make available information about a Portfolio’s portfolio holdings, the Trust may require the party receiving such information to maintain assets in the Portfolio or in other investment companies or accounts managed by the Trust’s Investment Manager or by an affiliated person of the Investment Manager.

 

The Board of Trustees has approved PI’s Policy for the Dissemination of Portfolio Holdings.  The Board shall, on a quarterly basis, receive a report from PI detailing the recipients of the portfolio holdings information and the reason for such disclosure.  There can be no assurance that the Trust’s policies and procedures on portfolio holdings information will protect the Trust and its Portfolios from the potential misuse of such information by individuals or entities that come into possession of the information.

 

Purchases and Redemptions of Shares and Distributions

 

Purchases of shares of the Portfolios may be made only by separate accounts of the Participating Insurance Company for the purpose of investing assets attributable to variable annuity contracts and variable life insurance policies held by contract owners.  The separate accounts place orders to purchase and redeem shares of the Trust based on, among other things, the amount of premium payments to be invested and the amount of surrender and transfer requests to be effected on that day under the variable annuity contracts and variable life insurance policies.  Orders are effected on days on which the NYSE is open for trading.  Orders received by the Participating Insurance Company before the end of regular trading on the NYSE (which is normally 4:00 p.m. Eastern Standard Time) are effected at the NAV determined as of the NYSE close on that same day. Orders received after the NYSE close are effected at the NAV calculated the next business day. Payment for redemptions will be made within seven days after the request is received. The Trust does not assess any transaction or other surrender fees, either when it sells or when it redeems its securities. However, surrender charges, mortality and expense risk fees, and other charges may be assessed by the Participating Insurance Company under the variable annuity contracts or variable life insurance policies. Please refer to the prospectuses for the variable annuity contracts and variable insurance policies for further information on these fees and charges.

 

Frequent Trading

 

The Trust is part of the group of investment companies advised by PI and/or ASISI that seeks to prevent patterns of frequent purchases and redemptions of shares by its investors (the “PI funds”). Frequent purchases and redemptions may adversely affect performance and the interests of long-term investors. When an investor engages in frequent or short-term trading, the PI funds may have to sell portfolio securities to have the cash necessary to pay the redemption amounts. This can happen when it is not advantageous to sell any securities, so the PI funds’ performance may be hurt. When large dollar amounts are involved, frequent trading can also make it difficult to use long-term investment strategies because the PI funds cannot predict how much cash they will have to invest.

 

13



 

In addition, if a PI fund is forced to liquidate investments due to short-term trading activity, it may incur increased brokerage and tax costs. Similarly, the PI funds may bear increased administrative costs as a result of the asset level and investment volatility that accompanies patterns of short-term trading.  Moreover, frequent or short-term trading by certain investors may cause dilution in the value of PI fund shares held by other investors. PI funds that invest in foreign securities may be particularly susceptible to frequent trading because time zone differences among international stock markets can allow an investor engaging in short-term trading to exploit fund share prices that may be based on closing prices of foreign securities established some time before the fund calculates its own share price. PI funds that invest in certain fixed income securities, such as high-yield bonds or certain asset-backed securities, may also constitute effective vehicles for an investor’s frequent trading strategies.

 

The Boards of Directors/Trustees of the PI funds, including the Trust, have adopted policies and procedures designed to discourage or prevent frequent trading by investors.  The policies and procedures for the Trust are limited, however, because ASLAC, Prudential and other insurance companies maintain the individual contract owner accounts for investors in the Trust’s Portfolios.  In particular, each insurance company submits to the Trust transfer agent aggregate orders combining the transactions of many investors, and therefore the Trust and its transfer agent cannot monitor investments by individual investors.  The policies and procedures require the Trust to communicate in writing to each Participating Insurance Company that the Trust expects the insurance company to impose restrictions on transfers by contract owners.  In addition, the Fund receives reports on the trading restrictions imposed by ASLAC and Prudential on variable contract owners investing in the Portfolios, and the Trust monitors the aggregate cash flows received from unaffiliated insurance companies. The Trust also employs fair value pricing procedures to deter frequent trading. Finally, the Trust and its transfer agent reserve the right to reject all or a portion of a purchase order from a Participating Insurance Company.  If a purchase order is rejected, the purchase amount will be returned to the Participating Insurance Company.

 

Investors seeking to engage in frequent trading activities may use a variety of strategies to avoid detection and, despite the efforts of the Trust and the Participating Insurance Companies to prevent such trading, there is no guarantee that the Trust or the Participating Insurance Companies will be able to identify these investors or curtail their trading practices. Therefore, some Trust investors may be able to engage in frequent trading, and, if they do, the other Trust investors would bear any harm caused by that frequent trading. The Trust does not have any arrangements intended to permit trading in contravention of the policies described above.

 

For information about trading limitations applicable to you, please see the prospectus for your variable contract or contact your insurance company.

 

Distributions

 

Each Portfolio will distribute annually substantially all of its income and capital gains to the separate accounts.

 

Fees and Expenses

 

The following table describes the fees and expenses that Contract owners may pay if they invest in the Growth + Value Portfolio and the Managed Index 500 Portfolio, as well as the projected fees and expenses of the Managed Index 500 Portfolio after the Transaction.  The following table does not reflect any Contract charges.  Because Contract charges are not included, the total fees and expenses that you will incur will be higher than the fees and expenses set forth below.  The Contract charges will not change as a result of the Transaction.  See your Contract prospectus for more information about Contract charges.

 

14



 

 

 

Growth +
Value
Portfolio
(1)

 

Managed
Index 500
Portfolio(1)

 

Managed Index
500
Portfolio
Pro Forma Surviving

 

Shareholder Fees
(fees paid directly from your investment)

 

 

 

 

 

 

 

Maximum Sales Charge (Load) Imposed on Purchases

 

None

 

None

 

None

 

Maximum Deferred Sales Charge (Load)

 

None

 

None

 

None

 

Maximum Sales Charge (Load) Imposed on Reinvested Dividends

 

None

 

None

 

None

 

Redemption Fee

 

None

 

None

 

None

 

Exchange Fee

 

None

 

None

 

None

 

 

 

 

 

 

 

 

 

Annual Portfolio Operating Expenses
(expenses that are deducted from Portfolio assets)

 

 

 

 

 

 

 

Management Fees

 

0.90

%

0.60

%

0.60

%

Distribution (12b-1) Fees

 

None

(3)

None

(3)

None

(3)

Other Expenses

 

0.32

%

0.17

%

0.16

%

Total Annual Portfolio Operating Expenses

 

1.22

%

0.77

%

0.76

%

 


(1) Expenses are based upon the expenses for the year ended December 31, 2004.

 

(2) Projected expenses based on current and anticipated Managed Index 500 Portfolio expenses after the Transaction.

 

(3) Until November 18, 2004, the Trust had a Distribution Plan under Rule 12b-1 to permit an affiliate of the Trust’s Investment Managers to receive brokerage commissions in connection with purchases and sales of securities held by the Portfolios, and to use these commissions to promote the sale of shares of the Portfolios.  The Distribution Plan was terminated effective November 18, 2004.  The total annual portfolio operating expenses do not reflect any brokerage commissions paid pursuant to the Distribution Plan prior to the Plan’s termination.

 

Expense Examples These examples are intended to help you compare the cost of investing in the Growth + Value Portfolio or the Managed Index 500 Portfolio with the cost of investing in other mutual funds, and the cost of investing in the Managed Index 500 Portfolio after the Transaction.  The examples assume that you invest $10,000, that you receive a 5% return each year, and that the Portfolios’ total operating expenses remain the same.  Although your actual costs may be higher or lower, based on the above assumptions your costs would be:

 

 

 

1 Year

 

3 Years

 

5 Years

 

10 Years

 

Growth + Value Portfolio

 

$

124

 

$

387

 

$

670

 

$

1,477

 

Managed Index 500 Portfolio

 

$

79

 

$

246

 

$

428

 

$

954

 

Managed Index 500 Portfolio
(Projected after the Transaction)

 

$

78

 

$

243

 

$

422

 

$

942

 

 

Performance

 

The bar charts below show the performance of each Portfolio for each full calendar year the Portfolio has been in operation.  The first table below each bar chart shows the Portfolio’s best and worst quarters during the periods included in the bar chart.  The second table shows the average annual total returns for each Portfolio for 2004 and since inception.

 

This information may help provide an indication of each Portfolio’s risks by showing changes in performance from year to year and by comparing each Portfolio’s performance with that of a broad-based securities index.  The charts and tables do not reflect Contract charges.  If the Contract charges were included, the annual returns would have been lower than those shown.  All figures assume reinvestment of dividends.  Past performance does not necessarily indicate how a Portfolio will perform in the future.

 

15



 

GROWTH + VALUE PORTFOLIO*

 

 

Best Quarter

 

Worst Quarter

Up 13.15%, 2 nd quarter 2003

 

Down 16.46%, 3 rd  quarter 2002

 

Average Annual Returns**

(as of 12/31/04)

 

 

 

Portfolio

 

Index:
Standard & Poor’s
500 Index

 

Index:
Russell 1000
®
Index

 

1 year

 

10.07

%

10.87

%

11.40

%

Since Inception (5/1/01)

 

0.32

%

3.10

%

1.36

%

 


*                     Prior to May 1, 2005, The Growth + Value Portfolio was known as the AST Alliance/Bernstein Growth + Value Portfolio and Sanford C. Bernstein & Co., LLC served as Sub-advisor for the portion of the Portfolio invested in value stocks.

 

**              These annual returns do not include contract charges.  If contract charges were included, the annual returns would have been lower than those shown.  See your contract prospectus.

 

16



 

MANAGED INDEX 500 PORTFOLIO*

 

 

Best Quarter

 

Worst Quarter

Up 15.61%, 4 th quarter 1999

 

Down 17.53%, 3 rd quarter 2002

 

Average Annual Returns**

(as of 12/31/04)

 

 

 

Portfolio

 

Index:
Standard & Poor’s 500
Index

 

1 year

 

9.98

%

10.87

%

5 years

 

-1.83

%

-2.30

%

Since Inception (1/2/98)

 

5.08

%

4.77

%

 


*                     Prior to May 1, 2005, the Portfolio was known as the AST Sanford Bernstein Managed Index 500 Portfolio and Sanford C. Bernstein & Co., LLC served as its Sub-advisor. Prior to May 1, 2000, the Portfolio was known as the AST Bankers Trust Managed Index 500 Portfolio, and Bankers Trust Company served as its Sub-adviser. Between May 1, 2000 and March 2005, the Portfolio was known as the AST Sanford Bernstein Managed Index 500 Portfolio.

 

**              These annual returns do not include contract charges.  If contract charges were included, the annual returns would have been lower than those shown.  See your contract prospectus.

 

Other Key Features of the Portfolios

 

Each Portfolio of the Trust complies with the diversification requirements of Section 817(h) of the Code.  In general, each Portfolio declares and distributes a dividend from its net investment income annually, and distributes any net realized long- and short-term capital gains at least annually, either during or after the close of the Portfolio’s fiscal year.  Distributions are made to the various separate accounts (not to Contract owners) in the form of additional shares (not in cash).

 

The Transaction may entail various federal income tax consequences, which are discussed below under the caption “Federal Income Tax Consequences of the Transaction.”

 

REASONS FOR THE TRANSACTION

 

The Trustees, including all of the Trustees who are not “interested persons” of the Trust (the “Independent Trustees”), have unanimously determined that the Transaction would be in the best interests of the shareholders of the Growth + Value Portfolio and the Managed Index 500 Portfolio, and that the interests of the shareholders of the Growth + Value Portfolio and the Managed Index 500 Portfolio would not be diluted as a

 

17



 

result of the Transaction.  At a meeting held on June 7,  2005, the Board considered a number of factors, including the following:

 

                  the compatibility of the Portfolios’ investment objectives, policies and restrictions;

 

                  the relative past and current growth in assets and investment performance of the Portfolios and their respective future prospects for growth;

 

                  the relative expense ratios of the Portfolios, and the impact of the proposed Transaction on the expense ratios;

 

                  the estimated costs of the Transaction;

 

                  the anticipated federal income tax consequences of the Transaction with respect to each Portfolio and its shareholders;

 

                  the relative size of the Growth + Value Portfolio as compared to the Managed Index 500 Portfolio; and

 

                  the potential benefits of the proposed Transaction to the shareholders of each Portfolio, including long-term economies of scale.

 

At the June 7, 2005 meeting, PI and ASISI recommended the Transaction to the Board.  In recommending the Transaction, PI and ASISI advised the Board that the Portfolios have comparable investment objectives, policies, and portfolios. PI and ASISI also advised the Board that, as a result of the Transaction, shareholders of the Growth + Value Portfolio would pay lower management fees and would incur lower overall Portfolio operating expenses.

 

PI and ASISI further advised the Board that the Managed Index 500 Portfolio had a greater amount of net assets than the Growth + Value Portfolio.  As of May 31, 2005, the Growth + Value Portfolio had attracted net assets of approximately $74 million and the Managed Index 500 Portfolio had net assets of approximately $523 million.  Accordingly, by combining the Portfolios, the Growth + Value Portfolio’s shareholders would enjoy a greater asset base over which expenses could be spread.  The Board considered the view of PI and ASISI that if the Transaction were approved, shareholders of the Growth + Value Portfolio should likely realize a significant reduction in both the net annual operating expenses and the gross annual operating expenses (that is, without any waivers or reimbursements) paid on their investment, although there can be no assurance that operational savings will be realized. PI and ASISI also informed the Board that the performance track record was stronger for the Managed Index 500 Portfolio than for the Growth + Value Portfolio.  The board also considered the views of PI and ASISI regarding the portfolio management teams of each Portfolio.

 

The Trust’s current management fee structure includes a shareholder services fee that compensates for certain costs related to changes to portfolios.  PI and ASISI recommended to the Board that each Portfolio bear its remaining pro rata expense, not attributable to the shareholder services fee, related to executing the transactions.  These costs include legal fees, audit, and typesetting of the proxies.  PI and ASISI projected that the Transaction will cost the Portfolios approximately $85,000.

 

The Board, including a majority of the Independent Trustees, unanimously concluded that the Transaction is in the best interests of the shareholders of the Growth + Value Portfolio and the Managed Index 500 Portfolio, and that no dilution of value would result to the shareholders of the Growth + Value Portfolio or the Managed Index 500 Portfolio from the Transaction.  Consequently, the Board approved the Plan and recommended that shareholders of the Growth + Value Portfolio vote to approve the Transaction.  The Board also considered that, in the opinion of counsel, the exchange of shares pursuant to the Transaction would not result in a taxable gain or loss for U.S. federal income tax purposes for Growth + Value Portfolio shareholders.

 

For the reasons discussed above, the Board of Trustees unanimously recommends that you vote FOR the Plan.

 

If shareholders of the Growth + Value Portfolio do not approve the Plan, the Board will consider other possible courses of action for the Growth + Value Portfolio, including, among others, consolidation of the Growth

 

18



 

+ Value Portfolio with one or more funds of the Trust, other than the Managed Index 500 Portfolio, or unaffiliated funds.

 

INFORMATION ABOUT THE TRANSACTION

 

This section is only a summary of the Plan.  You should read the actual Plan attached as Exhibit A.

 

Closing of the Transaction

 

If shareholders of the Growth + Value Portfolio approve the Plan, the Transaction will take place after various conditions are satisfied by the Fund on behalf of the Growth + Value Portfolio and the Managed Index 500 Portfolio, including the preparation of certain documents.  The Trust will determine a specific date for the actual Transaction to take place.  This is called the “closing date.”  If the shareholders of the Growth + Value Portfolio do not approve the Plan, the Transaction will not take place, and the Board will consider alternative courses of actions, as described above.

 

If the shareholders of the Growth + Value Portfolio approve the Plan, the Growth + Value Portfolio will deliver to the Managed Index 500 Portfolio all of its assets on the closing date.  Prudential then will make a conforming exchange of units between the applicable sub-accounts in its separate accounts.  As a result, shareholders of the Growth + Value Portfolio will beneficially own shares of the Managed Index 500 Portfolio that, as of the date of the exchange, have an aggregate value equal to the dollar value of the assets delivered to the Managed Index 500 Portfolio.  The stock transfer books of the Growth + Value Portfolio will be permanently closed on the closing date.  Requests to transfer or redeem assets allocated to the Growth + Value Portfolio may be submitted at any time before the close of the NYSE on the closing date, and requests that are received in proper form prior to that time will be effected prior to the closing.

 

To the extent permitted by law, the Trust may amend the Plan without shareholder approval.  It may also agree to terminate and abandon the Transaction at any time before or, to the extent permitted by law, after the approval by shareholders of the Growth + Value Portfolio.

 

Expenses of the Transaction

 

As stated above, the expenses resulting from the Transaction will be paid by the Portfolios.  Each Portfolio will bear its pro rata expense related to the Transaction (based on the net assets of the Portfolios).  PI estimates the total cost of the expenses related to the Transaction to be borne by the Portfolios at $85,000. PI expects that the portfolio securities of the Growth + Value Portfolio will be transferred in-kind to the Managed Index 500 Portfolio.

 

Federal Income Tax Consequences of the Transaction

 

The Transaction is intended to qualify for U.S. federal income tax purposes as a tax-free reorganization under the Code.  It is a condition to each Portfolio’s obligation to complete the Transaction that the Portfolios will have received an opinion from Shearman & Sterling LLP, Special Tax Counsel to the Trust, based upon representations made by each Portfolio, and upon certain assumptions, substantially to the effect that:

 

(1)           The acquisition by the Managed Index 500 Portfolio of the assets of the Growth + Value Portfolio in exchange solely for voting shares of the Managed Index 500 Portfolio and the assumption by the Managed Index 500 Portfolio of the liabilities, if any, of the Growth + Value Portfolio, followed by the distribution of the Managed Index 500 Portfolio shares acquired by the Growth + Value Portfolio pro rata to its shareholders, will constitute a reorganization within the meaning of Section 368(a) of the Code, and the Managed Index 500 Portfolio and the Growth + Value Portfolio each will be “a party to a reorganization” within the meaning of Section 368(b) of the Code;

 

19



 

(2)           The shareholders of the Growth + Value Portfolio will not recognize gain or loss upon the exchange of all of their shares of the Growth + Value Portfolio solely for shares of the Managed Index 500 Portfolio, as described in this Proxy Statement and the Plan;

 

(3)           No gain or loss will be recognized by the Growth + Value Portfolio upon the transfer of its net assets to the Managed Index 500 Portfolio in exchange solely for voting shares of the Managed Index 500 Portfolio and the assumption by the Managed Index 500 Portfolio of the liabilities, if any, of the Growth + Value Portfolio.  In addition, no gain or loss will be recognized by the Growth + Value Portfolio on the distribution of such shares to the shareholders of the Growth + Value Portfolio (in liquidation of the Growth + Value Portfolio);

 

(4)           No gain or loss will be recognized by the Managed Index 500 Portfolio upon the acquisition of the net assets of the Growth + Value Portfolio in exchange solely for shares of the Managed Index 500 Portfolio and the assumption of the liabilities, if any, of the Growth + Value Portfolio;

 

(5)           The Managed Index 500 Portfolio’s tax basis for the assets acquired from the Growth + Value Portfolio will be the same as the tax basis of these assets when held by the Growth + Value Portfolio immediately before the transfer, and the holding period of such assets acquired by the Managed Index 500 Portfolio will include the holding period of such assets when held by the Growth + Value Portfolio;

 

(6)           The Growth + Value Portfolio’s shareholders’ tax basis for the shares of the Managed Index 500 Portfolio to be received by them pursuant to the reorganization will be the same as their tax basis in the Growth + Value Portfolio shares exchanged therefor and

 

(7)           The holding period of the Managed Index 500 Portfolio shares to be received by the shareholders of the Growth + Value Portfolio will include the holding period of their Growth + Value Portfolio shares exchanged therefore, provided such Growth + Value Portfolio shares were held as capital assets on the date of exchange.

 

An opinion of counsel is not binding on the Internal Revenue Service (IRS) or the courts. Shareholders of the Growth + Value Portfolio should consult their tax advisors regarding the tax consequences to them of the Transaction in light of their individual circumstances. The Growth + Value Portfolio has capital loss carryforwards of $3,705,536 as of December 31, 2004, which will have an annual limitation on the amount of utilization under certain conditions defined in the Internal Revenue Code of 1986, as amended, as a result of the Transaction.

 

Contract owners should consult the prospectuses of their Contracts on the federal tax consequences of owning the Contract.  Contract owners should also consult their tax advisors as to state and local tax consequences, if any, of the Transaction, because this discussion only relates to the federal income tax consequence s.

 

Characteristics of the Managed Index 500 Portfolio Shares

 

Shares of the Managed Index 500 Portfolio will be distributed to shareholders of the Growth + Value Portfolio and will have the same legal characteristics as the shares of the Growth + Value Portfolio with respect to such matters as voting rights, assessibility, conversion rights, and transferability.

 

Capitalizations of the Portfolios and Capitalization after the Transaction

 

The following table sets forth, as of December 31, 2004, the capitalization of shares of the Growth + Value Portfolio and the Managed Index 500 Portfolio.  The table also shows the projected capitalization of the Managed Index 500 Portfolio shares as adjusted to give effect to the proposed Transaction.  The capitalization of the Managed Index 500 Portfolio is likely to be different when the Transaction is consummated.

 

20



 

 

 

Growth +
Value
Portfolio

 

Managed
Index 500
Portfolio

 

Adjustments

 

Managed Index 500
Portfolio Projected after
Transaction

 

 

 

(unaudited)

 

(unaudited)

 

 

 

(unaudited)

 

Net assets (thousands)

 

$

77,922

 

 

$

561,666

 

 

 

 

$

639,588

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total shares outstanding (thousands)

 

 

7,824

 

 

 

46,916

 

 

(1,315

)

 

 

53,425

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net asset value per share

 

$

9.96

 

 

$

11.97

 

 

 

 

$

11.97

 

 

 

VOTING INFORMATION

 

The affirmative vote of a majority of the total number of outstanding shares of the Growth + Value Portfolio is necessary to approve the Plan.  Each Contract owner will be entitled to give voting instructions equivalent to one vote for each full share, and a fractional vote for each fractional share, of the Growth + Value Portfolio beneficially owned at the close of business on the Record Date.  If sufficient votes to approve the Plan are not received by the date of the Meeting, the Meeting may be adjourned to permit further solicitations of proxies.

 

In accordance with requirements of the SEC, the Participating Insurance Company, as record owner of the shares of the Growth + Value Portfolio, will vote the shares for which it does not receive instruction from the Contract owner beneficially owning the shares, and the Participating Insurance Company will vote those shares (for the Plan, against the Plan, and abstain) in the same proportion as the votes cast in accordance with instructions received from Contract owners.  Therefore, the presence at the Meeting of the Participating Insurance Company will be sufficient to constitute a quorum and all of the shares of the Growth + Value Portfolio will be voted in some manner by the Participating Insurance Company.

 

An abstention is not counted as an affirmative vote of the type necessary to approve the Plan and, therefore, instructions to the Participating Insurance Company to abstain will have the same effect as a vote against the Plan.

 

How to Vote

 

You can vote your shares in any one of three ways:

 

                  By mail, with the enclosed proxy card,

                  In person at the Meeting, or

                  By phone.

 

If you simply sign and date the proxy but give no voting instructions, your shares will be voted by Prudential in favor of the Plan and in accordance with the views of management upon any unexpected matters that come before the Meeting or adjournment of the Meeting.

 

21



 

Revoking Voting Instructions

 

Contract owners executing and returning voting instructions may revoke such instructions at any time prior to exercise of those instructions by written notice of such revocation to the Secretary of the Trust, by execution of subsequent voting instructions, or by voting in person at the Meeting.

 

Other Matters

 

The Board of Trustees of the Trust does not intend to bring any matters before the Meeting other than those described in this Prospectus/Proxy Statement.  It is not aware of any other matters to be brought before the Meeting by others.  If any other matter legally comes before the Meeting, it is intended that the persons named in the enclosed proxy will vote in accordance with their judgment.

 

Solicitation of Voting Instructions

 

Voting instructions will be solicited principally by mailing this Prospectus/Proxy Statement and its enclosures, but instructions also may be solicited by telephone, facsimile, through electronic means such as email, or in person by officers or representatives of the Trust or the Participating Insurance Company.  If the record owner of a Contract is a custodian, nominee, or fiduciary, the Trust may send proxy materials to the record owner for any beneficial owners that such record owner may represent.  The Trust may reimburse custodians, nominees, and fiduciaries for their reasonable expenses incurred in connection with proxy solicitations of such beneficial owners.

 

ADDITIONAL INFORMATION ABOUT THE TRUST AND THE PORTFOLIOS

 

The Growth + Value Portfolio and the Managed Index 500 Portfolio are separate series of the Trust, which is an open-end management investment company registered with the SEC under the Investment Company Act.  Each Portfolio is, in effect, a separate mutual fund.

 

Additional information about the Managed Index 500 Portfolio is included in Appendix B.  Additional information about the Growth + Value Portfolio is included in the prospectus for the Trust, dated May 1, 2005, and the portions of that prospectus relating to the Growth + Value Portfolio are incorporated herein by reference.  Further information about both Portfolios is included in the Statement of Additional Information of the Trust, dated May 1, 2005, and the portions of that document relating to the Portfolios are incorporated herein by reference.  These documents are available upon request and without charge by calling 800-752-6342 or by writing to the Trust at Gateway Center Three, 100 Mulberry Street, Newark, NJ 07102.

 

The Trust, on behalf of the Portfolios, files proxy materials, reports, and other information with the SEC in accordance with the informational requirements of the Securities Exchange Act of 1934 and the Investment Company Act.  The Trust also prepares an annual report, which includes the management discussion and analysis.  The annual report is available both from the SEC and from the Trust.  These materials can be inspected and copied at: the SEC’s Public Reference Room at 450 Fifth Street NW, Washington, DC  20549, and at the Regional Offices of the SEC located in New York City at 233 Broadway, New York, NY 10279.  Also, copies of such material can be obtained from the SEC’s Public Reference Section, Washington, DC 20549-6009, upon payment of prescribed fees, or from the SEC’s Internet address at http://www.sec.gov.

 

22



 

PRINCIPAL HOLDERS OF SHARES

 

As of the Record Date, all of the shares of both the Growth + Value Portfolio and the Managed Index 500 Portfolio are owned as of record by various Participating Insurance Company separate accounts related to the Contracts.   As noted above, the Participating Insurance Company is required to offer Contract owners the opportunity to instruct it as to how to vote Portfolio shares.  The table below sets forth, as of the Record Date, each shareholder that owns beneficially more than 5% of either Portfolio.

 

Portfolio

 

Beneficial Owner Name*

 

Address

 

Percent
Ownership

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


*As defined by the Commission, a security is beneficially owned by a person if that person has or shares voting power or investment power with respect to the security.

 

As of the Record Date, the Trustees and Officers of the Trust, as a group, beneficially owned less than 1% of the outstanding voting shares of either of the Portfolios.

 

23



 

EXHIBITS TO PROSPECTUS/PROXY STATEMENT

 

Exhibit

 

A                                                                           Form of Plan of Reorganization by American Skandia Trust on behalf of the Growth + Value Portfolio and the Managed Index 500 Portfolio

 

B                                                                             Prospectus for the Managed Index 500 Portfolio, dated May 1, 2005

 

C                                                                             Annual Report for the Managed Index 500 Portfolio, dated May 1, 2005

 

24



EXHIBIT A

 

FORM OF PLAN OF REORGANIZATION

 

THIS PLAN OF REORGANIZATION (the “Plan”) is made as of this           day of           , 2005 by American Skandia Trust (the “Trust”), a business trust organized under the laws of the State of Massachusetts with its principal place of business at Gateway Center Three, 100 Mulberry Street, Newark, NJ 07102, on behalf of the Growth + Value Portfolio (the “Acquired Portfolio”) and the Managed Index 500 Portfolio (the “Acquiring Portfolio”), both series of the Fund.  Together, the Acquired Portfolio and Acquiring Portfolio are referred to as the “Portfolios.”

 

This Plan is intended to be and is adopted as a plan of reorganization for the Acquired Portfolio within the meaning of the Treasury Regulations under Section 368(a) of the Internal Revenue Code of 1986, as amended (the “Code”).  The reorganization (hereinafter referred to as the “Reorganization”) will consist of (i) the acquisition by the Acquiring Portfolio of all of the assets of the Acquired Portfolio and the assumption by the Acquiring Portfolio of all of the liabilities of the Acquired Portfolio in exchange solely for full and fractional shares, par value $0.001 each, of the Acquiring Portfolio (“Acquiring Portfolio Shares”); (ii) the distribution of Acquiring Portfolio Shares to the shareholders of the Acquired Portfolio according to their respective interests in complete liquidation of the Acquired Portfolio; and (iii) the dissolution of the Acquired Portfolio as soon as practicable after the closing (as defined in Section 3, hereinafter called the “Closing”), all upon and subject to the terms and conditions of this Plan hereinafter set forth.

 

In order to consummate the Plan, the following actions shall be taken by the Fund on behalf of the Acquiring Portfolio and the Acquired Portfolio:

 

1.              Sale and Transfer of Assets, Liquidation and Dissolution of Acquired Portfolio.

 

(a)            Subject to the terms and conditions of this Plan, the Trust shall:  (i) transfer all of the assets of the Acquired Portfolio, as set forth in Section 1(b) hereof, to the Acquiring Portfolio; and (ii) cause the Acquiring Portfolio to assume all the liabilities of the Acquired Portfolio as set forth in Section 1(b) hereof.  Such transactions shall take place at the Closing.

 

(b)            The assets of the Acquired Portfolio to be acquired by the Acquiring Portfolio (collectively, the “Assets”) shall consist of all property, including, without limitation, all cash, securities, commodities and futures interests, and dividends or interest receivable that are owned by the Acquired Portfolio, and any deferred or prepaid expenses shown as an asset on the books of the Acquiring Portfolio on the Closing date (as defined in Section 3, hereinafter the “Closing Date”).  All liabilities, expenses, costs, charges and reserves of the Acquired Portfolio, to the extent that they exist at or after the Closing, shall after the Closing attach to the Acquiring Portfolio and may be enforced against the Acquiring Portfolio to the same extent as if the same had been incurred by the Acquiring Portfolio.

 

(c)            Subject to the terms and conditions of this Plan, the Trust on behalf of the Acquiring Portfolio shall at the Closing deliver to the Acquired Portfolio the number of Acquiring Portfolio Shares, determined by dividing the net asset value per share of the shares of the Acquired Portfolio (“Acquired Portfolio Shares”) on the Closing Date by the net asset value per share of the Acquiring Portfolio Shares, and multiplying the result thereof by the number of outstanding Acquired Portfolio Shares as of the close of regular trading on the New York Stock Exchange (the “NYSE”) on the Closing Date.  All such values shall be determined in the manner and as of the time set forth in Section 2 hereof.

 

(d)            Immediately following the Closing, the Acquired Portfolio shall distribute pro rata to its shareholders of record as of the close of business on the Closing Date, the Acquiring Portfolio Shares received by the Acquired Portfolio pursuant to this Section 1 and then shall terminate and dissolve.  Such liquidation and

 

A-1



 

distribution shall be accomplished by the establishment of accounts on the share records of the Trust relating to the Acquiring Portfolio and noting in such accounts the type and amounts of Acquiring Portfolio Shares that former Acquired Portfolio shareholders are due based on their respective holdings of the Acquired Portfolio as of the close of business on the Closing Date.  Fractional Acquiring Portfolio Shares shall be carried to the third decimal place.  The Acquiring Portfolio shall not issue certificates representing the Acquiring Portfolio shares in connection with such exchange.

 

2.              Valuation.

 

(a)            The value of the Acquired Portfolio’s Assets to be transferred to the Acquiring Portfolio hereunder shall be computed as of the close of regular trading on the NYSE on the Closing Date (the “Valuation Time”) using the valuation procedures set forth in Trust’s current effective prospectus.

 

(b)            The net asset value of a share of the Acquiring Portfolio shall be determined to the second decimal point as of the Valuation Time using the valuation procedures set forth in the Trust’s current effective prospectus.

 

(c)            The net asset value of a share of the Acquired Portfolio shall be determined to the second decimal point as of the Valuation Time using the valuation procedures set forth in the Trust’s current effective prospectus.

 

3.              Closing and Closing Date.

 

The consummation of the transactions contemplated hereby shall take place at the Closing (the “Closing”).  The date of the Closing (the “Closing Date”) shall be December 2, 2005, or such later date as determined by the Trust’s officers.  The Closing shall take place at the principal office of the Trust at 5:00 P.M. Eastern time on the Closing Date.  The Trust on behalf of the Acquired Portfolio shall have provided for delivery as of the Closing of the Acquired Portfolio’s Assets to the account of the Acquiring Portfolio at the Acquiring Portfolio’s Custodians.  Also, the Trust on behalf of the Acquired Portfolio shall produce at the Closing a list of names and addresses of the shareholders of record of the Acquired Portfolio Shares and the number of full and fractional shares owned by each such shareholder, all as of the Valuation Time, certified by its transfer agent or by its President to the best of its or his or her knowledge and belief.  The Trust on behalf of the Acquiring Portfolio shall issue and deliver a confirmation evidencing the Acquiring Portfolio Shares to be credited to the Acquired Portfolio’s account on the Closing Date to the Secretary of the Trust, or shall provide evidence satisfactory to the Acquired Portfolio that the Acquiring Portfolio Shares have been registered in an account on the books of the Acquiring Portfolio in such manner as the Fund on behalf of Acquired Portfolio may request.

 

4.              Representations and Warranties by the Fund on behalf of the Acquired Portfolio.

 

The Trust makes the following representations and warranties about the Acquired Portfolio:

 

(a)            The Acquired Portfolio is a series of the Trust, a business trust organized under the laws of the State of Massachusetts and validly existing and in good standing under the laws of that jurisdiction.  The Trust is duly registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end, management investment company and all of the Acquired Portfolio Shares sold were sold pursuant to an effective registration statement filed under the Securities Act of 1933, as amended (the “1933 Act”).

 

(b)            The Trust on behalf of the Acquired Portfolio is authorized to issue an unlimited number of the Acquired Portfolio shares, par value $0.001 each, each outstanding share of which is fully paid, non-assessable, freely transferable and has full voting rights.

 

(c)            The financial statements appearing in the Trust’s Annual Report to Shareholders for the fiscal year ended December 31, 2004, audited by KPMG LLP fairly present the financial position of the Acquired

 

A-2



 

Portfolio as of such date and the results of its operations for the periods indicated in conformity with U.S. generally accepted accounting principles applied on a consistent basis.

 

(d)            The Trust has the necessary power and authority to conduct the Acquired Portfolio’s business as such business is now being conducted.

 

(e)            The Trust on behalf of the Acquired Portfolio is not a party to or obligated under any provision of the Trust’s Declaration of Trust, or any contract or any other commitment or obligation, and is not subject to any order or decree, that would be violated by its execution of or performance under this Plan.

 

(f)             The Acquired Portfolio does not have any unamortized or unpaid organizational fees or expenses.

 

(g)            The Acquired Portfolio has elected to be treated as a regulated investment company (a “RIC”) for federal income tax purposes under Part I of Subchapter M of the Code and the Acquired Portfolio has qualified as a RIC for each taxable year since its inception, and will qualify as of the Closing Date.  The consummation of the transactions contemplated by this Plan will not cause the Acquired Portfolio to fail to satisfy the requirements of subchapter M of the Code.  The Acquired Portfolio also has satisfied the diversification and look-through requirements of Section 817(h) of the Code since its inception and will continue to satisfy such requirements at the Closing.

 

(h)            The Acquired Portfolio, or its agents, (i) holds a valid Form W-8BEN, Certificate of Foreign Status of Beneficial Owner for United States Withholding (or other appropriate series of Form W-8, as the case may be), or Form W-9, Request for Taxpayer Identification Number and Certification, for each Acquired Portfolio shareholder of record, which Form W-8 or Form W-9 can be associated with reportable payments made by the Acquired Portfolio to such shareholder, and/or (ii) has otherwise timely instituted the appropriate nonresident alien or foreign corporation or backup withholding procedures with respect to such shareholder as provided by Sections 1441, 1442, and 3406 of the Code.

 

5.              Representations and Warranties by the Fund on behalf of the Acquiring Portfolio.

 

The Trust makes the following representations and warranties about the Acquiring Portfolio:

 

(a)            The Acquiring Portfolio is a series of the Trust, a corporation organized under the laws of the State of Massachusetts validly existing and in good standing under the laws of that jurisdiction.  The Trust is duly registered under the 1940 Act as an open-end, management investment company and all of the Acquiring Portfolio Shares sold have been sold pursuant to an effective registration statement filed under the 1933 Act.

 

(b)            The Trust on behalf of the Acquiring Portfolio is authorized to issue an unlimited number of the Acquiring Portfolio shares, par value $0.001, each outstanding share of which has full voting rights and is freely paid, non-assessable, and fully transferable.

 

(c)            At the Closing, Acquiring Portfolio Shares will be eligible for offering to the public in those states of the United States and jurisdictions in which the shares of the Acquired Portfolio are presently eligible for offering to the public, and there are a sufficient number of Acquiring Portfolio Shares authorized and registered under the 1933 Act to permit the transfers contemplated by this Plan to be consummated.

 

(d)            The financial statements appearing in the Trust’s Annual Report to Shareholders for the fiscal year ended December 31, 2004, audited by KPMG LLP fairly present the financial position of the Acquiring Portfolio as of such date and the results of its operations for the periods indicated in conformity with U.S. generally accepted accounting principles applied on a consistent basis.

 

(e)            The Trust has the necessary power and authority to conduct the Acquiring Portfolio’s business as such business is now being conducted.

 

A-3



 

(f)             The Trust on behalf of the Acquiring Portfolio is not a party to or obligated under any provision of the Trust’s Declaration of Trust, or any contract or any other commitment or obligation, and is not subject to any order or decree, that would be violated by its execution of or performance under this Plan.

 

(g)            The Acquiring Portfolio has to be treated as a RIC for federal income tax purposes under Part I of Subchapter M of the Code and the Acquiring Portfolio has qualified as a RIC for each taxable year since its inception, and will qualify as of the Closing Date. The consummation of the transactions contemplated by this Plan will not cause the Acquiring Portfolio to fail to satisfy the requirements of subchapter M of the Code.  The Acquiring Portfolio also has satisfied the diversification and look-through requirements of Section 817(h) of the Code since its inception and will continue to satisfy such requirements at the Closing.

 

6.              Representations and Warranties by the Fund on behalf of the Portfolios.

 

The Trust makes the following representations and warranties about the Portfolios:

 

(a)            The statement of assets and liabilities to be created by the Trust for each of the Portfolios as of the Valuation Time for the purpose of determining the number of Acquiring Portfolio Shares to be issued pursuant to Section 1 of this Plan will accurately reflect the Assets in the case of the Acquired Portfolio and the net asset value in the case of the Acquiring Portfolio, and outstanding shares, as of such date, in conformity with generally accepted accounting principles applied on a consistent basis.

 

(b)            At the Closing, the Portfolios will have good and marketable title to all of the securities and other assets shown on the statement of assets and liabilities referred to in Section 6(a) above, free and clear of all liens or encumbrances of any nature whatsoever, except such imperfections of title or encumbrances as do not materially detract from the value or use of the assets subject thereto, or materially affect title thereto.

 

(c)            Except as may be disclosed in the Trust’s current effective prospectus, there is no material suit, judicial action, or legal or administrative proceeding pending or threatened against either of the Portfolios.

 

(d)            There are no known actual or proposed deficiency assessments with respect to any taxes payable by either of the Portfolios.

 

(e)            The execution, delivery, and performance of this Plan have been duly authorized by all necessary actions of the Trust’s Board of Trustees, and this Plan constitutes a valid and binding obligation enforceable in accordance with its terms.

 

(f)             The Trust anticipates that consummation of this Plan will not cause either of the Portfolios to fail to conform to the requirements of Subchapter M of the Code for Federal income taxation as a RIC at the end of each fiscal year or to conform to the requirements of Section 817(h) at the end of each tax quarter.

 

(g)            The Trust has the necessary power and authority to conduct the business of the Portfolios, as such business is now being conducted.

 

7.              Intentions of the Trust on behalf of the Portfolios.

 

(a)            The Trust intends to operate each Portfolio’s respective business as presently conducted between the date hereof and the Closing.

 

(b)            The Trust intends that the Acquired Portfolio will not acquire the Acquiring Portfolio Shares for the purpose of making distributions thereof to anyone other than the Acquired Portfolio’s shareholders.

 

A-4



 

(c)            The Trust on behalf of the Acquired Portfolio intends, if this Plan is consummated, to liquidate and dissolve the Acquired Portfolio.

 

(d)            The Trust intends that, by the Closing, each of the Portfolio’s Federal and other tax returns and reports required by law to be filed on or before such date shall have been filed, and all Federal and other taxes shown as due on said returns shall have either been paid or adequate liability reserves shall have been provided for the payment of such taxes.

 

(e)            At the Closing, the Trust on behalf of the Acquired Portfolio intends to have available a copy of the shareholder ledger accounts, certified by the Trust’s transfer agent or its President or a Vice President to the best of its or his or her knowledge and belief, for all the shareholders of record of Acquired Portfolio Shares as of the Valuation Time who are to become shareholders of the Acquiring Portfolio as a result of the transfer of assets that is the subject of this Plan.

 

(f)             The Trust intends to mail to each shareholder of the Acquired Portfolio entitled to vote at the meeting of its shareholders at which action on this Plan is to be considered, in sufficient time to comply with requirements as to notice thereof, a Combined Proxy Statement and Prospectus that complies in all material respects with the applicable provisions of Section 14(a) of the Securities Exchange Act of 1934, as amended, and Section 20(a) of the 1940 Act, and the rules and regulations, respectively, thereunder.

 

(g)            The Trust intends to file with the U.S. Securities and Exchange Commission a registration statement on Form N-14 under the 1933 Act relating to the Acquiring Portfolio Shares issuable hereunder (“Registration Statement”), and will use its best efforts to provide that the Registration Statement becomes effective as promptly as practicable.  At the time the Registration Statement becomes effective, it will:  (i) comply in all material respects with the applicable provisions of the 1933 Act, and the rules and regulations promulgated thereunder; and (ii) not contain any untrue statement of material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.  At the time the Registration Statement becomes effective, at the time of the shareholders’ meeting of the Acquired Portfolio, and at the Closing Date, the prospectus and statement of additional information included in the Registration Statement will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

8.              Conditions Precedent to be Fulfilled by Trust on behalf of the Portfolios.

 

The consummation of the Plan with respect to the Acquiring Portfolio and the Acquired Portfolio shall be subject to the following conditions:

 

(a)            That:  (i) all the representations and warranties contained herein concerning the Portfolios shall be true and correct as of the Closing with the same effect as though made as of and at such date; (ii) performance of all obligations required by this Plan to be performed by the Trust on behalf of the Portfolios shall occur prior to the Closing; and (iii) the Trust shall execute a certificate signed by the President or a Vice President and by the Secretary or equivalent officer to the foregoing effect.

 

(b)            That the form of this Plan shall have been adopted and approved by the appropriate action of the Board of Trustees of the Trust on behalf of the Portfolios.

 

(c)            That the U.S. Securities and Exchange Commission shall not have issued an unfavorable management report under Section 25(b) of the 1940 Act or instituted or threatened to institute any proceeding seeking to enjoin consummation of the Plan under Section 25(c) of the 1940 Act.  And, further, no other legal, administrative or other proceeding shall have been instituted or threatened that would materially affect the financial condition of a Portfolio or would prohibit the transactions contemplated hereby.

 

A-5



 

(d)            That the Plan contemplated hereby shall have been adopted and approved by the appropriate action of the shareholders of the Acquired Portfolio at an annual or special meeting or any adjournment thereof.

 

(e)            That at or immediately prior to the Closing, the Acquired Portfolio shall have declared and paid a dividend or dividends which, together will all previous such dividends, shall have the effect of distributing to the Acquired Portfolio’s shareholders all of such Acquired Portfolio’s investment company taxable income for taxable years ending at or prior to the Closing and all of its net capital gain, if any, realized in taxable years ending at or prior to the Closing (after reduction for any capital loss carry-forward).

 

(f)             The Trust shall have received with respect to the Acquired Fund on or before the Closing Date, an opinion of Shearman & Sterling LLP, in form and substance satisfactory to the Company, substantially to the effect that, for federal income tax purposes,

 

(1)           the transfer of the assets of the Acquired Fund in exchange solely for the Acquiring Fund Shares and the assumption by Acquiring Fund of the liabilities of the Acquired Fund, if any, as provided for in the Plan, will constitute a “reorganization” within the meaning of Section 368(a) of the Code, and the Acquired Fund and the Acquiring Fund each will be deemed to be a “party to a reorganization” within the meaning of Section 368(b) of the Code;

 

(2)           in accordance with Section 361(a) of the Code, no gain or loss will be recognized by the Acquired Fund under Section 361(c)(1) of the Code as a result of the transfer of its assets solely in exchange for Acquiring Fund, if any, Shares and the assumption by the Acquiring Fund of the liabilities of the Acquired Fund or on the distribution of the Acquiring Fund Shares to the shareholders of the Acquired Fund, as provided for in the Plan;

 

(3)           under Section 1032 of the Code, no gain or loss will be recognized by the Acquiring Fund Shares and the assumption by the Acquiring Fund of the liabilities of the Acquired Fund, if any, as provided for in the Plan;

 

(4)           in accordance with Section 354(a)(1) of the Code, no gain or loss will be recognized by the shareholders of the Acquired Fund on the receipt of Acquiring Fund Shares in exchange for their shares of the Acquired Fund;

 

(5)           in accordance with Section 362(b) of the Code, the tax basis of the Acquiring Fund in the assets of the Acquired Fund will be the same as the tax basis of such assets in the hands of the Acquired Fund immediately prior to the consummation of the transactions contemplated by the Plan;

 

(6)           in accordance with Section 358 of the Code, immediately after the consummation of the transactions contemplated by the Plan, the tax basis of the Acquiring Fund Shares received by the shareholders of the Acquired Fund will be equal, in the aggregate, to the tax basis of their shares of the Acquired Fund surrendered in exchange therefor;

 

(7)           in accordance with Section 1223 of the Code, the holding period for the Acquiring Fund Shares received by the shareholders of the Acquired Fund will be determined by including the period for which such shareholder held their shares of the Acquired Fund exchanged therefore; provided , that the shares of the Acquired Fund Shares were held as capital assets for federal income tax purposes;

 

(8)           in accordance with Section 1223 of the Code, the holding period of the Acquiring Fund with respect to the assets of the Acquired Fund acquired by it in accordance with the Plan will include the period for which such assets were held by the Acquired Fund; and

 

(9)           pursuant to Section 381(a) of the Code and regulations thereunder, the Acquiring Fund will succeed to and take into account certain tax attributes of the Acquired Fund, such as earnings and profits and method of tax accounting.

 

In giving the opinions set forth above, counsel may state that it is relying on certificates of the officers of the Trust with regard to certain matters.

 

(g)            That there shall be delivered to the Trust on behalf of the Portfolios an opinion in form and substance satisfactory to it from Goodwin Procter LLP, to the effect that, subject in all respects to the effects of

 

A-6



 

bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, and other laws now or hereafter affecting generally the enforcement of creditors’ rights:

 

(1)            Acquiring Portfolio Shares to be issued pursuant to the terms of this Plan have been duly authorized and, when issued and delivered as provided in this Plan, will have been validly issued and fully paid and will be non-assessable by the Trust, on behalf of the Acquiring Portfolio;

 

(2)            All actions required to be taken by the Trust and/or Portfolios to authorize and effect the Plan contemplated hereby have been duly authorized by all necessary action on the part of the Trust and the Portfolios;

 

(3)            Neither the execution, delivery, nor performance of this Plan by the Trust violates any provision of the Trust’s Declaration of Trust, or the provisions of any agreement or other instrument known to such counsel to which the Trust is a party or by which the Portfolios are otherwise bound; this Plan is the legal, valid, and binding obligation of the Trust and each Portfolio and is enforceable against the Trust and/or each Portfolio in accordance with its terms; and

 

(4)            The Trust’s registration statement, of which the prospectus dated May 1, 2005 relating to each Portfolio (the “Prospectus”) is a part, is, at the time of the signing of this Plan, effective under the 1933 Act, and, to the best knowledge of such counsel, no stop order suspending the effectiveness of such registration statement has been issued, and no proceedings for such purpose have been instituted or are pending before or threatened by the U.S. Securities and Exchange Commission under the 1933 Act, and nothing has come to counsel’s attention that causes it to believe that, at the time the Prospectus became effective, or at the time of the signing of this Plan, or at the Closing, such Prospectus (except for the financial statements and other financial and statistical data included therein, as to which counsel need not express an opinion), contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and such counsel knows of no legal or government proceedings required to be described in the Prospectus, or of any contract or document of a character required to be described in the Prospectus that is not described as required.

 

In giving the opinions set forth above, counsel may state that it is relying on certificates of the officers of the Trust with regard to matters of fact, and certain certifications and written statements of governmental officials with respect to the good standing of the Trust.

 

(h)            That the Trust’s Registration Statement with respect to the Acquiring Portfolio Shares to be delivered to the Acquired Portfolio’s shareholders in accordance with this Plan shall have become effective, and no stop order suspending the effectiveness of the Registration Statement or any amendment or supplement thereto, shall have been issued prior to the Closing Date, or shall be in effect at Closing, and no proceedings for the issuance of such an order shall be pending or threatened on that date.

 

(i)             That the Acquiring Portfolio Shares to be delivered hereunder shall be eligible for sale by the Acquiring Portfolio with each state commission or agency with which such eligibility is required in order to permit the Acquiring Portfolio Shares lawfully to be delivered to each shareholder of the Acquired Portfolio.

 

9.              Expenses.

 

(a)            The Trust represents and warrants that there are no broker or finders’ fees payable by it in connection with the transactions provided for herein.

 

(b)            The expenses of entering into and carrying out the provisions of this Plan shall be borne by the Portfolios, pro rata based on net assets of the Portfolios.

 

A-7



 

10.                                Termination; Postponement; Waiver; Order.

 

(a)            Anything contained in this Plan to the contrary notwithstanding, this Plan may be terminated and abandoned at any time (whether before or after approval thereof by the shareholders of an Acquired Portfolio) prior to the Closing, or the Closing may be postponed by the Fund on behalf of a Portfolio by resolution of the Board of Trustees, if circumstances develop that, in the opinion of the Board, make proceeding with the Plan inadvisable.

 

(b)            If the transactions contemplated by this Plan have not been consummated by December 31, 2005, the Plan shall automatically terminate on that date, unless a later date is agreed to by the Trust on behalf of the relevant Portfolios.

 

(c)            In the event of termination of this Plan pursuant to the provisions hereof, the same shall become void and have no further effect with respect to the Acquiring Portfolio or Acquired Portfolio, and neither the Trust, the Acquiring Portfolio nor the Acquired Portfolio, nor the trustees, officers, agents or shareholders shall have any liability in respect of this Plan.

 

(d)            At any time prior to the Closing, any of the terms or conditions of this Plan may be waived by the party who is entitled to the benefit thereof by action taken by the Trust’s Board of Trustees if, in the judgment of such Board of Trustees, such action or waiver will not have a material adverse affect on the benefits intended under this Plan to its shareholders, on behalf of whom such action is taken.

 

(e)            The respective representations and warranties contained in Sections 4 to 6 hereof shall expire with and be terminated by the Plan of Reorganization, and neither the Trust nor any of its officers, trustees, agents or shareholders nor the Portfolios nor any of their shareholders, shall have any liability with respect to such representations or warranties after the Closing.  This provision shall not protect any officer, trustee, agent or shareholder of any of the Portfolios or the Trust against any liability to the entity for which that officer, director, agent or shareholder so acts or to any of the Trust’s shareholders to which that officer, trustee, agent or shareholder would otherwise be subject by reason of willful misfeasance, bad faith, gross negligence, or reckless disregard of the duties in the conduct of such office.

 

(f)             If any order or orders of the U.S. Securities and Exchange Commission with respect to this Plan shall be issued prior to the Closing and shall impose any terms or conditions that are determined by action of the Board of Directors of the Trust on behalf of the Portfolios to be acceptable, such terms and conditions shall be binding as if a part of this Plan without further vote or approval of the shareholders of the Acquired Portfolio, unless such terms and conditions shall result in a change in the method of computing the number of Acquiring Portfolio Shares to be issued to the Acquired Portfolio, in which event, unless such terms and conditions shall have been included in the proxy solicitation material furnished to the shareholders of the Acquired Portfolio prior to the meeting at which the transactions contemplated by this Plan shall have been approved, this Plan shall not be consummated and shall terminate, unless the Trust on behalf of the Acquired Portfolio shall promptly call a special meeting of shareholders at which such conditions so imposed shall be submitted for approval.

 

11.           Entire Plan and Amendments.

 

This Plan embodies the entire plan of the Trust on behalf of the Portfolios, and there are no agreements, understandings, restrictions, or warranties between the parties other than those set forth or provided for herein.  This Plan may be amended only by the Trust on behalf of a Portfolio in writing.  Neither this Plan nor any interest herein may be assigned without the prior written consent of the Trust on behalf of the Portfolio corresponding to the Portfolio making the assignment.

 

A-8



 

12.           Notices.

 

Any notice, report, or demand required or permitted by any provision of this Plan shall be in writing and shall be deemed to have been given if delivered or mailed, first class postage prepaid, addressed to the Trust at Gateway Center Three, 100 Mulberry Street, Newark, NJ 07102, Attention:  Secretary.

 

13.           Governing Law.

 

This Plan shall be governed by and carried out in accordance with the laws of the State of New Jersey.

 

IN WITNESS WHEREOF, American Skandia Trust, on behalf of the Growth + Value Portfolio and the Managed Index 500 Portfolio, has executed this Plan by its duly authorized officer, all as of the date and year first-above written.

 

 

 

AMERICAN SKANDIA TRUST

 

 

on behalf of

 

 

Growth + Value Portfolio and

 

 

Managed Index 500 Portfolio

 

 

 

Attest:

 

By:

 

 

 

 

 

A-9



EXHIBIT B

 

MANAGED INDEX 500 PORTFOLIO PROSPECTUS DATED MAY 1, 2005

 

PROSPECTUS

 

MAY 1, 2005

 

AMERICAN SKANDIA TRUST

One Corporate Drive, Shelton, Connecticut 06484

 

American Skandia Trust (the “Trust”) is an investment company made up of the following 37 separate portfolios (“Portfolios”). This Prospectus discusses the following Portfolio:

 

AST AllianceBernstein Managed Index 500 Portfolio

 

 

THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION NOR HAS THE COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

 

The Trust is an investment vehicle for life insurance companies (“Participating Insurance Companies”) writing variable annuity contracts and variable life insurance policies. Shares of the Trust may also be sold directly to certain tax-deferred retirement plans. Each variable annuity contract and variable life insurance policy involves fees and expenses not described in this Prospectus. Please read the Prospectus for the variable annuity contract or variable life insurance policy for information regarding the contract or policy, including its fees and expenses.

 

The Trust received an order from the Securities and Exchange Commission permitting its Investment Managers, subject to approval by its Board of Trustees, to change sub-advisors of each Portfolio without shareholder approval. For more information, please see this Prospectus under “Management of the Trust.”

 

B-1



 

TABLE OF CONTENTS

 

 

 

Caption

 

 

 

B-3

 

RISK/RETURN SUMMARY

 

B-5

 

PAST PERFORMANCE

 

B-7

 

FEES AND EXPENSES OF THE PORTFOLIOS:

 

B-10

 

INVESTMENT OBJECTIVES AND POLICIES:

 

B-11

 

AST ALLIANCEBERNSTEIN MANAGED INDEX 500 PORTFOLIO:

 

B-13

 

PORTFOLIO TURNOVER:

 

B-13

 

NET ASSET VALUE:

 

B-13

 

PURCHASE AND REDEMPTION OF SHARES:

 

B-14

 

MANAGEMENT OF THE TRUST:

 

B-18

 

TAX MATTERS:

 

B-18

 

CERTAIN RISK FACTORS AND INVESTMENT METHODS:

 

F-1

 

FINANCIAL HIGHLIGHTS

 

 

B-2



 

RISK/RETURN SUMMARY

 

American Skandia Trust (the “Trust”) is comprised of thirty-seven investment portfolios (the “Portfolios”). The Portfolios are designed to provide a wide range of investment options. Each Portfolio has its own investment goal and style (and, as a result, its own level of risk). Some of the Portfolios offer potential for high returns with correspondingly higher risk, while others offer stable returns with relatively less risk. It is possible to lose money when investing even in the most conservative of the Portfolios. Investments in the Portfolios are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency.

 

This Prospectus discusses one Portfolio: the AST AllianceBernstein Managed Index 500 Portfolio (the “Portfolio”).

 

It is not possible to provide an exact measure of the risk to which a Portfolio is subject, and a Portfolio’s risk will vary based on the securities that it holds at a given time. Nonetheless, based on the Portfolio’s investment style and the risks typically associated with that style, it is possible to assess in a general manner the risks to which a Portfolio will be subject. The following discussion highlights the investment strategies and risks of the Portfolio. Additional information about the Portfolio’s potential investments and its risks is included in this Prospectus under “Investment Objectives and Policies.”

 

B-3



 

Growth and Income Portfolio:

 

Portfolio:

 

Investment Goal:

 

Primary Investments:

 

AllianceBernstein Managed Index 500

 

To outperform the S&P 500® Stock Index

 

The Portfolio invests primarily in common stocks included in the S&P 500®.

 

 

Principal Investment Strategies:

 

The AST AllianceBernstein Managed Index 500 Portfolio (formerly known as the AST Sanford Bernstein Managed Index 500 Portfolio) will invest, under normal circumstances, at least 80% of its net assets in securities included in the Standard & Poor’s 500 Composite Stock Price Index (the “S&P 500 â “). The Portfolio is actively managed and seeks to outperform the S&P 500® through the Sub-advisor’s stock selection resulting in different weightings of common stocks relative to the index. The S&P 500® is an index of 500 common stocks, most of which trade on the New York Stock Exchange Inc. (the “NYSE”).

 

In seeking to outperform the S&P 500®, the Sub-advisor starts with a portfolio of stocks representative of the holdings of the index. It then uses a set of quantitative criteria that are designed to indicate whether a particular stock will predictably perform better or worse than the S&P 500®. Based on these criteria, the Sub-advisor determines whether the Portfolio should over-weight, under-weight or hold a neutral position in the stock relative to the proportion of the S&P 500® that the stock represents. In addition, the Sub-advisor may determine based on the quantitative criteria that (1) certain S&P 500® stocks should not be held by the Portfolio in any amount, and (2) certain equity securities that are not included in the S&P 500® should be held by the Portfolio. The Portfolio may invest up to 15% of its total assets in equity securities not included in the S&P 500®.

 

While the Portfolio attempts to outperform the S&P 500®, it is not expected that any outperformance will be substantial. The Portfolio also may underperform the S&P 500® over short or extended periods.

 

B-4



 

PAST PERFORMANCE

 

The bar charts show the performance of the Portfolio for each full calendar year the Portfolio has been in operation. The tables below each bar chart show the Portfolio’s best and worst quarters during the periods included in the bar chart, as well as average annual total returns for the Portfolio for one, five, and ten years (or since inception, if shorter). This information provides some indication of the Portfolio’s risks by showing changes in performance from year to year and by comparing the Portfolio’s performance with that of a broad-based securities index. The performance figures do not reflect any charges associated with the variable insurance contracts through which Portfolio shares are purchased; the performance figures would be lower if they did. All figures assume reinvestment of dividends. Past performance does not necessarily indicate how a Portfolio will perform in the future.

 

B-5



 

AST ALLIANCEBERNSTEIN MANAGED INDEX 500 PORTFOLIO*

 

 

Best Quarter

 

Worst Quarter

 

Up 15.61%, 4 th quarter 1999

 

Down 17.53%, 3 rd quarter 2002

 

 

Average annual total returns
For periods ended 12/31/04**

 

 

 

Portfolio

 

Index:
Standard & Poors 500
Index

 

1 year

 

9.98

%

10.87

%

5 years

 

-1.83

%

-2.30

%

Since Inception (1/2/98)

 

5.08

%

4.77

%

 


*        Prior to May 1, 2005, the Portfolio was known as the AST Sanford Bernstein Managed Index 500 Portfolio and Sanford C. Bernstein & Co., LLC served as its Sub-advisor. Prior to May 1, 2000, the Portfolio was known as the AST Bankers Trust Managed Index 500 Portfolio, and Bankers Trust Company served as its Sub-advisor. Between May 1, 2000 and March 2005, the Portfolio was known as the AST Sanford Bernstein Managed Index 500 Portfolio.

 

**    These annual returns do not include contract charges.  If contract charges were included, the annual returns would have been lower than those shown.  See your contract prospectus.

 

B-6



 

FEES AND EXPENSES OF THE PORTFOLIO:

 

The table below describes the fees and expenses that you may pay if you buy and hold shares of the Portfolio. Unless otherwise indicated, the expenses shown below are for the year ending December 31, 2004.

 

SHAREHOLDER TRANSACTION EXPENSES (fees paid directly from your investment):

 

Maximum Sales Charge (Load) Imposed on Purchases

 

NONE*

Maximum Deferred Sales Charge (Load)

 

NONE*

Maximum Sales Charge (Load) Imposed on Reinvested Dividends

 

NONE*

Redemption Fees

 

NONE*

Exchange Fee

 

NONE*


*       Because shares of the Portfolio may be purchased through variable insurance products, the prospectus of the relevant product should be carefully reviewed for information on the charges and expenses of those products. This table does not reflect any such charges; and the expenses shown would be higher if such charges were reflected.

 

B-7



 

ANNUAL FUND OPERATING EXPENSES (expenses that are deducted from Portfolio assets, in %):

 

Portfolio:

 

Management Fees

 

Other
Expenses(1),(2)

 

Total Annual
Portfolio Operating
Expenses

 

AST AllianceBernstein Managed Index 500

 

0.60

 

0.17

 

0.77

 

 


(1)    Until November 18, 2004, the Trust had a Distribution Plan under Rule 12b-1 to permit an affiliate of the Trust’s Investment Managers to receive brokerage commissions in connection with purchases and sales of securities held by the Portfolios, and to use these commissions to promote the sale of shares of the Portfolio.  The Distribution Plan was terminated effective November 18, 2004. The total annual portfolio operating expenses do not reflect any brokerage commissions paid pursuant to the Distribution Plan prior to the Plan’s termination.

 

(2)    As noted above, shares of the Portfolios generally are purchased through variable insurance products. The Trust has entered into arrangements with the issuers of the variable insurance products offering the Portfolios under which the Trust compensates the issuers 0.10% for providing ongoing services to Portfolio shareholders in lieu of the Trust providing such services directly to shareholders. Amounts paid under these arrangements are included under “Other Expenses.” See this Prospectus under “Management of the Trust — Distribution Plans” for more information.

 

B-8



 

EXPENSE EXAMPLES:

 

These examples are intended to help you compare the cost of investing in the Portfolio with the cost of investing in other mutual funds.

 

The Examples assume that you invest $10,000 in the Portfolio for the time periods indicated. The Examples also assume that your investment has a 5% return each year, that the Portfolio’s total operating expenses remain the same, and that no expense waivers and reimbursements are in effect. Although your actual costs may be higher or lower, based on these assumptions your costs would be:

 

 

 

After:

 

Portfolio:

 

1 yr.

 

3 yrs.

 

5 yrs.

 

10 yrs.

 

AST AllianceBernstein Managed Index 500

 

$

79

 

$

246

 

$

428

 

$

954

 

 

B-9



 

INVESTMENT OBJECTIVES AND POLICIES:

 

The investment objective, policies and limitations for the Portfolio are described below. The investment objectives and policies of the Portfolio generally are not fundamental policies and may be changed by the Trustees without shareholder approval.

 

There can be no assurance that the investment objective of the Portfolio will be achieved.    Risks relating to certain types of securities and instruments in which the Portfolio may invest are described in this Prospectus under “Certain Risk Factors and Investment Methods.”

 

If approved by the Trustees, the Trust may add more Portfolios and may cease to offer any existing Portfolios in the future.

 

B-10



 

AST ALLIANCEBERNSTEIN MANAGED INDEX 500 PORTFOLIO:

 

Investment Objective: The investment objective of the Portfolio is to outperform the Standard & Poor’s 500 Composite Stock Price Index (the “S&P 500®”) through active stock selection resulting in different weightings of common stocks relative to the index.

 

Principal Investment Policies and Risks:

 

The Portfolio will invest, under normal circumstances, at least 80% of the value of its assets in securities included in the S&P 500®. The 80% investment requirement applies at the time the Portfolio invests its assets.

 

The S&P 500® is an index of 500 common stocks, most of which trade on the New York Stock Exchange Inc. (the “NYSE”). The Sub-advisor believes that the S&P 500® is representative of the performance of publicly traded common stocks in the U.S. in general.

 

In seeking to outperform the S&P 500®, the Sub-advisor starts with a portfolio of stocks representative of the holdings of the index. It then uses a set of fundamental, quantitative criteria that are designed to indicate whether a particular stock will predictably perform better or worse than the S&P 500®. Based on these criteria, the Sub-advisor determines whether the Portfolio should over-weight, under-weight or hold a neutral position in the stock relative to the proportion of the S&P 500® that the stock represents. In addition, the Sub-advisor may determine based on the quantitative criteria that (1) certain S&P 500® stocks should not be held by the Portfolio in any amount, and (2) certain equity securities that are not included in the S&P 500® should be held by the Portfolio. The Portfolio may invest up to 15% of its total assets in equity securities not included in the S&P 500®. The Portfolio is an actively managed fund.

 

As a mutual fund investing primarily in common stocks, the Portfolio is subject to the risk that common stock prices will decline over short or even extended periods. The U.S. stock market tends to be cyclical, with periods when stock prices generally rise and periods when prices generally decline. The Sub-advisor believes that the various quantitative criteria used to determine which stocks to over- or under-weight will balance each other so that the overall risk of the Portfolio is not likely to differ materially from the risk of the S&P 500® itself. While the Portfolio attempts to outperform the S&P 500®, it is not expected that any outperformance will be substantial. The Portfolio also may underperform the S&P 500® over short or extended periods.

 

About the S&P 500®.   The S&P 500® is a well-known stock market index that includes common stocks of 500 companies from several industrial sectors representing a significant portion of the market value of all common stocks publicly traded in the United States. Stocks in the S&P 500® are weighted according to their market capitalization (the number of shares outstanding multiplied by the stock’s current price). The composition of the S&P 500® is determined by S&P based on such factors as market capitalization, trading activity, and whether the stock is representative of stocks in a particular industry group. The composition of the S&P 500® may be changed from time to time. “Standard & Poor’s®”, “S&P 500®”, “Standard & Poor’s 500”, and “500” are trademarks of The McGraw-Hill Companies, Inc. and have been licensed for use by the Investment Manager.

 

The Portfolio is not sponsored, endorsed, sold or promoted by Standard &Poor’s, a division of The McGraw-Hill Companies, Inc. (“S&P”). S&P makes no representation or warranty, express or implied, to the shareholders of the Portfolio or any member of the public regarding the advisability of investing in securities generally or in the Portfolio particularly or the ability of the S&P 500® to track general stock market performance. S&P’s only relationship to the Investment Manager or the Sub-advisor is a license provided to the Investment Manager of certain trademarks and trade names of S&P and of the S&P 500®, which is determined, composed and calculated by S&P without regard to the Investment Manager, Sub-advisor, or Portfolio. S&P has no obligation to take the needs of the Investment Manager, Sub-advisor or the shareholders of the Portfolio into consideration in determining, composing or calculating the S&P 500®. S&P is not responsible for and has not participated in the determination of the prices and amount of the Portfolio or the timing of the issuance or sale of the Portfolio, or in the determination or calculation of the Portfolio’s net asset value. S&P has no obligation or liability in connection with the administration, marketing or trading of the Portfolio.

 

S&P does not guarantee the accuracy and/or the completeness of the S&P 500® or any data included therein and shall have no liability for any errors, omissions, or interruptions therein. S&P makes no warranty, express or implied, as to the results to be obtained by the Portfolio, shareholders of the Portfolio, or any other person or entity from the use of the S&P 500® or any data included therein. S&P makes no express or implied warranties and expressly disclaims all warranties of merchantability or fitness for a particular purpose or use with respect to the S&P 500® or any data included therein.

 

B-11



 

Without limiting any of the foregoing, in no event shall S&P have any liability for any special, punitive, indirect or consequential damages (including lost profits), even if notified of the possibility of such damages.

 

Other Investments:

 

Derivatives.   The Portfolio may invest in various instruments that are or may be considered derivatives, including securities index futures contracts and related options, warrants and convertible securities. These instruments may be used for several reasons: to simulate full investment in the S&P 500® while retaining cash for fund management purposes, to facilitate trading, to reduce transaction costs or to seek higher investment returns when the futures contract, option, warrant or convertible security is priced more attractively than the underlying equity security or the S&P 500®. The Portfolio will not use derivatives for speculative purposes or to leverage its assets. The Portfolio will limit its use of securities index futures contracts and related options so that, at all times, margin deposits for futures contracts and premiums on related options do not exceed 5% of the Portfolio’s assets and provided that the percentage of the Portfolio’s assets being used to cover its obligations under futures and options does not exceed 50%.

 

Additional information about these derivative instruments and their risks is included in this Prospectus under “Certain Risk Factors and Investment Methods.”

 

Temporary Investments.   The Portfolio may maintain up to 25% of its assets in short-term debt securities and money market instruments to meet redemption requests or to facilitate investment in the securities of the S&P 500®. These securities include obligations issued or guaranteed by the U.S. Government or its agencies or instrumentalities or by any of the states, repurchase agreements, commercial paper, and certain bank obligations. The Portfolio will not invest in these securities as part of a temporary defensive strategy to protect against potential market declines.

 

B-12



 

PORTFOLIO TURNOVER:

 

The Portfolio may sell its portfolio securities, regardless of the length of time that they have been held, if the Sub-advisor and/or the Investment Manager determines that it would be in the Portfolio’s best interest to do so. It may be appropriate to buy or sell portfolio securities due to economic, market, or other factors that are not within the Sub-advisor’s or Investment Manager’s control. Such transactions will increase the Portfolio’s “portfolio turnover.”  A 100% portfolio turnover rate would occur if all of the securities in a portfolio of investments were replaced during a given period.

 

A high rate of portfolio turnover involves correspondingly higher brokerage commission expenses and other transaction costs, which are borne by a Portfolio and will reduce its performance.

 

Although turnover rates may vary substantially from year to year, for the year ended December 31, 2004, the Portfolio’s annual portfolio turnover rate was less than 100%.

 

NET ASSET VALUE:

 

The net asset value per share (“NAV”) of the Portfolio is determined as of the time of the close of regular trading on the New York Stock Exchange (the “NYSE”) (which is normally 4:00 p.m. Eastern Time) on each day that the NYSE is open for business. NAV is determined by dividing the value of the Portfolio’s total assets, less any liabilities, by the number of total shares of the Portfolio outstanding. In general, the assets of the Portfolio are valued on the basis of market quotations. However, in certain circumstances where market quotations are not readily available or are believed to be inaccurate, assets are valued by methods that are believed to accurately reflect their fair value.  Because NAV is calculated and purchases may be made only on business days, and because securities traded on foreign exchanges may trade on other days, the value of the Portfolio’s investments may change on days when shares cannot be purchased or redeemed.

 

PURCHASE AND REDEMPTION OF SHARES:

 

Purchases of shares of the Portfolio may be made only by separate accounts of Participating Insurance Companies for the purpose of investing assets attributable to variable annuity contracts and variable life insurance policies (“Contractholders”), or by qualified plans. The separate accounts of the Participating Insurance Companies place orders to purchase and redeem shares of the Trust based on, among other things, the amount of premium payments to be invested and the amount of surrender and transfer requests to be effected on that day under the variable annuity contracts and variable life insurance policies. Orders are effected on days on which the NYSE is open for trading. Orders received by the Participating Insurance Company before the regular trading on the NYSE (which is normally 4:00 P.M. Eastern Standard Time) are effected at the NAV determined as of the NYSE close on that same day. Orders received after the NYSE close are effected at the NAV calculated the next business day. Payment for redemptions will be made within seven days after the request is received. The Trust does not assess any transaction or other surrender fees, either when it sells or when it redeems its securities. However, surrender charges, mortality and expense risk fees and other charges may be assessed by Participating Insurance Companies under the variable annuity contracts or variable life insurance policies. Please refer to the prospectuses for the variable annuity contracts and variable insurance policies for further information on these fees.

 

As of the date of this Prospectus, American Skandia Life Assurance Corporation (“ASLAC”), Pruco Life Insurance Company and Pruco Life Insurance Company of New Jersey (collectively, “Prudential Insurance”), and Kemper Investors Life Insurance Company are the only Participating Insurance Companies. Certain conflicts of interest may arise as a result of investment in the Trust by various insurance companies for the benefit of their Contractholders and by various qualified plans. These conflicts could arise because of differences in the tax treatment of the various investors, because of actions of the Participating Insurance Companies and/or the qualified plans, or other reasons. The Trust does not currently expect that any material conflicts of interest will arise. Nevertheless, the Trustees intend to monitor events in order to identify any material irreconcilable conflicts and to determine what action, if any, should be taken in response to such conflicts. Should any conflict arise that would require a substantial amount of assets to be withdrawn from the Trust, orderly portfolio management could be disrupted.

 

The Trust is part of the group of investment companies advised by PI and/or ASISI that seeks to prevent patterns of frequent purchases and redemptions of shares by its investors (the “PI funds”). Frequent purchases and redemptions may adversely affect performance and the interests of long-term investors. When an investor engages in frequent or short-term trading, the PI funds may have to sell portfolio securities to have the cash necessary to pay the redemption amounts. This can happen when it is not advantageous to sell any securities, so the PI funds’ performance may be hurt. When large dollar

 

B-13



 

amounts are involved, frequent trading can also make it difficult to use long-term investment strategies because the PI funds cannot predict how much cash they will have to invest. In addition, if a PI fund is forced to liquidate investments due to short-term trading activity, it may incur increased brokerage and tax costs. Similarly, the PI funds may bear increased administrative costs as a result of the asset level and investment volatility that accompanies patterns of short-term trading. Moreover, frequent or short-term trading by certain investors may cause dilution in the value of PI fund shares held by other investors. PI funds that invest in foreign securities may be particularly susceptible to frequent trading because time zone differences among international stock markets can allow an investor engaging in short-term trading to exploit fund share prices that may be based on closing prices of foreign securities established some time before the fund calculates its own share price. PI funds that invest in certain fixed income securities, such as high-yield bonds or certain asset-backed securities, may also constitute effective vehicles for an investor’s frequent trading strategies.

 

The Boards of Directors/Trustees of the PI funds, including the Trust, have adopted policies and procedures designed to discourage or prevent frequent trading by investors. The policies and procedures for the Trust are limited, however, because ASLAC, Prudential Insurance and other insurance companies maintain the individual contract owner accounts for investors in the Trust Portfolios. In particular, each insurance company submits to the Trust transfer agent aggregate orders combining the transactions of many investors, and therefore the Trust and its transfer agent cannot monitor investments by individual investors. The policies and procedures require the Trust to communicate in writing to each Participating Insurance Company that the Trust expects the insurance company to impose restrictions on transfers by contract owners. In addition, the Fund receives reports on the trading restrictions imposed by ASLAC and Prudential Insurance on variable contract owners investing in the Portfolios, and the Trust monitors the aggregate cash flows received from unaffiliated insurance companies. The Trust also employs fair value pricing procedures to deter frequent trading. Finally, the Trust and its transfer agent reserve the right to reject all or a portion of a purchase order from a Participating Insurance Company. If a purchase order is rejected, the purchase amount will be returned to the Participating Insurance Company.

 

Investors seeking to engage in frequent trading activities may use a variety of strategies to avoid detection and, despite the efforts of the Trust and the Participating Insurance Companies to prevent such trading, there is no guarantee that the Fund or the Participating Insurance Companies will be able to identify these investors or curtail their trading practices. Therefore, some Trust investors may be able to engage in frequent trading, and, if they do, the other Trust investors would bear any harm caused by that frequent trading. The Trust does not have any arrangements intended to permit trading in contravention of the policies described above.

 

For information about the trading limitations applicable to you, please see the prospectus for your variable contract or contact your insurance company.

 

MANAGEMENT OF THE TRUST:

 

Investment Managers:   ASISI, One Corporate Drive, Shelton, Connecticut, has served as Investment Manager to the Trust since 1992, and serves as co-investment manager to a total of 60 investment company portfolios (including the Portfolios of the Trust). ASISI serves as co-manager of the Trust along with Prudential Investments LLC (“PI”) (each an “Investment Manager” and together the “Investment Managers”). PI is located at Gateway Center Three, 100 Mulberry Street, Newark, New Jersey, and also serves as investment manager to the investment companies that comprise the Prudential mutual funds. As co-manager, PI also provides supervision and oversight of ASISI’s investment management responsibilities with respect to the Trust.

 

The Trust’s Investment Management Agreements, on behalf of each Portfolio, with ASISI and PI, (the “Management Agreements”), provide that the Investment Managers will furnish each applicable Portfolio with investment advice and administrative services subject to the supervision of the Board of Trustees and in conformity with the stated policies of the applicable Portfolio. The Investment Managers have engaged Sub-advisors to conduct the investment programs of each Portfolio, including the purchase, retention and sale of portfolio securities. The Investment Managers are responsible for monitoring the activities of the Sub-advisors and reporting on such activities to the Trustees. The Investment Managers must also provide, or obtain and supervise, the executive, administrative, accounting, custody, transfer agent and shareholder servicing services that are deemed advisable by the Trustees.

 

The Trust has obtained an exemption from the Securities and Exchange Commission that permits the Investment Managers, subject to approval by the Board of Trustees of the Trust, to change sub-advisors for a Portfolio and to enter into new sub-advisory agreements, without obtaining shareholder approval of the changes. This exemption (which is similar to

 

B-14



 

exemptions granted to other investment companies that are organized in a similar manner as the Trust) is intended to facilitate the efficient supervision and management of the Sub-advisors by the Investment Managers and the Trustees.

 

Sub-advisors:  Information about the Portfolio’s Sub-advisors is set forth below. The Trust’s Statement of Additional Information provides additional information about each portfolio manager’s compensation, other accounts that each portfolio manager manages, and ownership of Trust securities by each portfolio manager.

 

Alliance Capital Management, L.P.    (“AllianceBernstein”) , 1345 Avenue of the Americas, New York, NY 10105, serves as Sub-advisor for the AST AllianceBernstein Managed Index 500 Portfolio . AllianceBernstein is a leading global investment adviser with assets under management as of December 31, 2004 totaling approximately $539 billion.

 

Day-to-day investment management decisions for the AST AllianceBernstein Managed Index 500 Fund are made by the U.S. Structured Equity Investment Policy Group, which is chaired by Drew W. Demakis. Mr. Demakis is a Senior Vice President of AllianceBernstein and Chairman of the Risk Investment Policy Group. The U.S. Structured Equity Investment Policy Group has managed the Fund since Bernstein became the Fund’s Sub-advisor in May 2000. Mr. Demakis joined the firm in 1998 from BARRA RogersCasey, where he was most recently Managing Director and Head of Research. He has been responsible for the Fund since May 2003.

 

B-15



 

Fees and Expenses:

 

Investment Management Fees.    ASISI receives a fee, payable each month, for the performance of its services. ASISI pays each Sub-advisor a portion of such fee for the performance of the Sub-advisory services at no additional cost to any Portfolio. The Investment Management fee for each Portfolio will differ, reflecting the differing objectives, policies and restrictions of each Portfolio. Each Portfolio’s fee is accrued daily for the purposes of determining the sale and redemption price of the Portfolio’s shares. The Portfolios do not pay any fee to PI.

 

B-16



 

The fees paid to ASISI for the fiscal year ended December 31, 2004, stated as a percentage of the Portfolio’s average daily net assets, were as follows:

 

Portfolio:

 

Annual Rate:

 

AST AllianceBernstein Managed Index 500

 

0.60

 

 

For more information about investment management fees, including voluntary fee waivers and the fee rates applicable at various asset levels, and the fees payable by ASISI to each of the Sub-advisors, please see the Trust’s SAI under “Investment Advisory and Other Services.”

 

Other Expenses.   In addition to Investment Management fees, the Portfolio pays other expenses, including costs incurred in connection with the maintenance of its securities law registrations, printing and mailing prospectuses and

 

B-17



 

statements of additional information to shareholders, certain office and financial accounting services, taxes or governmental fees, brokerage commissions, custodial, transfer and shareholder servicing agent costs, expenses of outside counsel and independent accountants, preparation of shareholder reports and expenses of trustee and shareholder meetings. The Trust may also pay Participating Insurance Companies for printing and delivery of certain documents (including prospectuses, semi-annual and annual reports and any proxy materials) to holders of variable annuity contracts and variable life insurance policies whose assets are invested in the Trust as well as for other services. Currently, each Portfolio pays each Participating Insurance Company 0.10% on assets attributable to that company.

 

Distribution Plan.   Until November 18, 2004, the Trust utilized a Distribution Plan (the “Distribution Plan”) under Rule 12b-1 under the Investment Company Act of 1940 that permitted American Skandia Marketing, Incorporated (“ASM”) and affiliates of ASISI and PI (the “Distributor”) to receive brokerage commissions in connection with purchases and sales of securities held by the Portfolios, and to use those commissions to promote the sale of shares of the Portfolio. Under the Distribution Plan, transactions for the purchase and sale of securities for the Portfolio were directed to certain brokers for execution (“clearing brokers”) who agreed to pay part of the brokerage commissions received on these transactions to the Distributor for “introducing” transactions to the clearing broker. In turn, the Distributor used the brokerage commissions received as an introducing broker to pay various distribution-related expenses, such as advertising, printing of sales materials, and payments to dealers. The Portfolio did not pay any separate fees or charges under the Distribution Plan, and it was expected that the brokerage commissions paid by the Portfolio would not increase as the result of the Distribution Plan. The Distribution Plan was terminated by the Board of Trustees of the Trust effective November 18, 2004.

 

TAX MATTERS:

 

The Portfolio intends to distribute substantially all its net investment income. Dividends from investment income are expected to be declared and distributed annually, although the Trustees of the Trust may decide to declare dividends at other intervals. Similarly, any net realized long- and short-term capital gains of the Portfolio will be declared and distributed at least annually either during or after the close of the Portfolio’s fiscal year. Distributions will be made to the various separate accounts of the Participating Insurance Companies and to qualified plans (not to holders of variable insurance contracts or to plan participants) in the form of additional shares (not in cash). The result is that the investment performance of the Portfolio, either in the form of dividends or capital gains, will be reflected in the value of the variable contracts or the qualified plans.

 

Holders of variable annuity contracts or variable life insurance policies should consult the prospectuses of their respective contracts or policies for information on the federal income tax consequences to such holders, and plan participants should consult any applicable plan documents for information on the federal income tax consequences to such participants. In addition, variable contract owners and qualified plan participants may wish to consult with their own tax advisors as to the tax consequences of investments in the Trust, including the application of state and local taxes.

 

CERTAIN RISK FACTORS AND INVESTMENT METHODS:

 

The following is a description of certain securities and investment methods that the Portfolio may invest in or use, and certain of the risks associated with such securities and investment methods. The primary investment focus of the Portfolio is described above under “Investment Objective and Policies” and an investor should refer to that section to obtain information about the Portfolio. In general, whether a Portfolio may invest in a specific type of security or use an investment method is described above or in the Trust’s SAI under “Investment Objectives and Policies.” As noted below, however, certain risk factors and investment methods apply to the Portfolio.

 

DERIVATIVE INSTRUMENTS:

 

To the extent permitted by the investment objectives and policies of the Portfolio, the Portfolio may invest in securities and other instruments that are commonly referred to as “derivatives.” For instance, the Portfolio may purchase and write (sell) call and put options on securities, securities indices and foreign currencies, enter into futures contracts and use options on futures contracts, and enter into swap agreements with respect to foreign currencies, interest rates, and securities indices. In general, derivative instruments are securities or other instruments whose value is derived from or related to the value of some other instrument or asset.

 

B-18



 

There are many types of derivatives and many different ways to use them. Some derivatives and derivative strategies involve very little risk, while others can be extremely risky and can lead to losses in excess of the amount invested in the derivative. A Portfolio may use derivatives to hedge against changes in interest rates, foreign currency exchange rates or securities prices, to generate income, as a low cost method of gaining exposure to a particular securities market without investing directly in those securities, or for other reasons.

 

The use of these strategies involves certain special risks, including the risk that the price movements of derivative instruments will not correspond exactly with those of the investments from which they are derived. In addition, strategies involving derivative instruments that are intended to reduce the risk of loss can also reduce the opportunity for gain. Furthermore, regulatory requirements for a Portfolio to set aside assets to meet its obligations with respect to derivatives may result in a Portfolio being unable to purchase or sell securities when it would otherwise be favorable to do so, or in a Portfolio needing to sell securities at a disadvantageous time. A Portfolio may also be unable to close out its derivatives positions when desired. There is no assurance that a Portfolio will engage in derivative transactions. Certain derivative instruments and some of their risks are described in more detail below.

 

Options.  The Portfolio may purchase or write (sell) call or put options on securities, financial indices or currencies. The purchaser of an option on a security or currency obtains the right to purchase (in the case of a call option) or sell (in the case of a put option) the security or currency at a specified price within a limited period of time. Upon exercise by the purchaser, the writer (seller) of the option has the obligation to buy or sell the underlying security at the exercise price. An option on a securities index is similar to an option on an individual security, except that the value of the option depends on the value of the securities comprising the index, and all settlements are made in cash.

 

The Portfolio will pay a premium to the party writing the option when it purchases an option. In order for a call option purchased by a Portfolio to be profitable, the market price of the underlying security must rise sufficiently above the exercise price to cover the premium and other transaction costs. Similarly, in order for a put option to be profitable, the market price of the underlying security must decline sufficiently below the exercise price to cover the premium and other transaction costs.

 

Generally, the Portfolios will write call options only if they are covered ( i.e. , the Portfolio owns the security subject to the option or has the right to acquire it without additional cost or, if additional cash consideration is required, cash or other assets determined to be liquid in such amount are segregated on the Portfolios’ records). By writing a call option, a Portfolio assumes the risk that it may be required to deliver a security for a price lower than its market value at the time the option is exercised. Effectively, a Portfolio that writes a covered call option gives up the opportunity for gain above the exercise price should the market price of the underlying security increase, but retains the risk of loss should the price of the underlying security decline. A Portfolio will write call options in order to obtain a return from the premiums received and will retain the premiums whether or not the options are exercised, which will help offset a decline in the market value of the underlying securities. A Portfolio that writes a put option likewise receives a premium, but assumes the risk that it may be required to purchase the underlying security at a price in excess of its current market value.

 

A Portfolio may sell an option that it has previously purchased prior to the purchase or sale of the underlying security. Any such sale would result in a gain or loss depending on whether the amount received on the sale is more or less than the premium and other transaction costs paid on the option. A Portfolio may terminate an option it has written by entering into a closing purchase transaction in which it purchases an option of the same series as the option written.

 

Futures Contracts and Related Options.    The Portfolio may enter into financial futures contracts and related options. The seller of a futures contract agrees to sell the securities or currency called for in the contract and the buyer agrees to buy the securities or currency at a specified price at a specified future time. Financial futures contracts may relate to securities indices, interest rates or foreign currencies. Futures contracts are usually settled through net cash payments rather than through actual delivery of the securities underlying the contract. For instance, in a stock index futures contract, the two parties agree to take or make delivery of an amount of cash equal to a specified dollar amount times the difference between the stock index value when the contract expires and the price specified in the contract.  The Portfolio may use futures contracts to hedge against movements in securities prices, interest rates or currency exchange rates, or as an efficient way to gain exposure to these markets.

 

B-19



 

An option on a futures contract gives the purchaser the right, in return for the premium paid, to assume a position in the contract at the exercise price at any time during the life of the option. The writer of the option is required upon exercise to assume the opposite position.

 

Under regulations of the Commodity Futures Trading Commission (“CFTC”), no Portfolio will:

 

(i)   purchase or sell futures or options on futures contracts or stock indices for purposes other than bona fide hedging transactions (as defined by the CFTC) if as a result the sum of the initial margin deposits and premiums required to establish positions in futures contracts and related options that do not fall within the definition of bona fide hedging transactions would exceed 5% of the fair market value of each Portfolio’s net assets; and

 

(ii)  enter into any futures contracts if the aggregate amount of that Portfolio’s commitments under outstanding futures contracts positions would exceed the market value of its total assets.

 

Risks of Options and Futures Contracts.   Options and futures contracts can be highly volatile and their use can reduce a Portfolio’s performance. Successful use of these strategies requires the ability to predict future movements in securities prices, interest rates, currency exchange rates, and other economic factors. If a Sub-advisor seeks to protect a Portfolio against potential adverse movements in the relevant financial markets using these instruments, and such markets do not move in the predicted direction, the Portfolio could be left in a less favorable position than if such strategies had not been used. A Portfolio’s potential losses from the use of futures extends beyond its initial investment in such contracts.

 

Among the other risks inherent in the use of options and futures are (a) the risk of imperfect correlation between the price of options and futures and the prices of the securities or currencies to which they relate, (b) the fact that skills needed to use these strategies are different from those needed to select portfolio securities and (c) the possible need to defer closing out certain positions to avoid adverse tax consequences. With respect to options on stock indices and stock index futures, the risk of imperfect correlation increases the more the holdings of the Portfolio differ from the composition of the relevant index. These instruments may not have a liquid secondary market. Option positions established in the over-the-counter market may be particularly illiquid and may also involve the risk that the other party to the transaction fails to meet its obligations.

 

FOREIGN SECURITIES:

 

Investments in securities of foreign issuers may involve risks that are not present with domestic investments. While investments in foreign securities can reduce risk by providing further diversification, such investments involve “sovereign risks” in addition to the credit and market risks to which securities generally are subject. Sovereign risks includes local political or economic developments, potential nationalization, withholding taxes on dividend or interest payments, and currency blockage (which would prevent cash from being brought back to the United States). Compared to United States issuers, there is generally less publicly available information about foreign issuers and there may be less governmental regulation and supervision of foreign stock exchanges, brokers and listed companies. Foreign issuers are not generally subject to uniform accounting and auditing and financial reporting standards, practices and requirements comparable to those applicable to domestic issuers. In some countries, there may also be the possibility of expropriation or confiscatory taxation, difficulty in enforcing contractual and other obligations, political or social instability or revolution, or diplomatic developments that could affect investments in those countries.

 

Securities of some foreign issuers are less liquid and their prices are more volatile than securities of comparable domestic issuers. Further, it may be more difficult for the Trust’s agents to keep currently informed about corporate actions and decisions that may affect the price of portfolio securities. Brokerage commissions on foreign securities exchanges, which may be fixed, may be higher than in the United States. Settlement of transactions in some foreign markets may be less frequent or less reliable than in the United States, which could affect the liquidity of investments. For example, securities that are traded in foreign markets may trade on days (such as Saturday or Holidays) when a Portfolio does not compute its price or accept purchase or redemption orders. As a result, a shareholder may not be able to act on developments taking place in foreign countries as they occur.

 

American Depositary Receipts (“ADRs”), European Depositary Receipts (“EDRs”), Global Depositary Receipts (“GDRs”), and International Depositary Receipts (“IDRs”).    ADRs are U.S. dollar-denominated receipts generally issued by a domestic bank evidencing its ownership of a security of a foreign issuer. ADRs generally are publicly traded in the United States. ADRs are subject to many of the same risks as direct investments in foreign securities, although ownership of ADRs may

 

B-20



 

reduce or eliminate certain risks associated with holding assets in foreign countries, such as the risk of expropriation. EDRs, GDRs and IDRs are receipts similar to ADRs that typically trade in countries other than the United States.

 

Depositary receipts may be issued as sponsored or unsponsored programs. In sponsored programs, the issuer makes arrangements to have its securities traded as depositary receipts. In unsponsored programs, the issuer may not be directly involved in the program. Although regulatory requirements with respect to sponsored and unsponsored programs are generally similar, the issuers of unsponsored depositary receipts are not obligated to disclose material information in the United States and, therefore, the import of such information may not be reflected in the market value of such securities.

 

Developing Countries.   Although the Portfolio may not invest primarily in securities of issuers in developing countries, from time to time it may invest in these securities to some degree. Many of the risks described above with respect to investing in foreign issuers are accentuated when the issuers are located in developing countries. Developing countries may be politically and/or economically unstable, and the securities markets in those countries may be less liquid or subject to inadequate government regulation and supervision. Developing countries have often experienced high rates of inflation or sharply devalued their currencies against the U.S. dollar, causing the value of investments in companies located in these countries to decline. Securities of issuers in developing countries may be more volatile and, in the case of debt securities, more uncertain as to payment of interest and principal. Investments in developing countries may include securities created through the Brady Plan, under which certain heavily-indebted countries have restructured their bank debt into bonds.

 

Currency Fluctuations.   Investments in foreign securities may be denominated in foreign currencies. The value of a Portfolio’s investments denominated in foreign currencies may be affected, favorably or unfavorably, by exchange rates and exchange control regulations. A Portfolio’s share price may, therefore, also be affected by changes in currency exchange rates. Foreign currency exchange rates generally are determined by the forces of supply and demand in foreign exchange markets, including perceptions of the relative merits of investment in different countries, actual or perceived changes in interest rates or other complex factors. Currency exchange rates also can be affected unpredictably by the intervention or the failure to intervene by U.S. or foreign governments or central banks, or by currency controls or political developments in the U.S. or abroad. In addition, a Portfolio may incur costs in connection with conversions between various currencies.

 

Foreign Currency Transactions.   A Portfolio that invests in securities denominated in foreign currencies will need to engage in foreign currency exchange transactions. Such transactions may occur on a “spot” basis at the exchange rate prevailing at the time of the transaction. Alternatively, a Portfolio may enter into forward foreign currency exchange contracts. A forward contract involves an obligation to purchase or sell a specified currency at a specified future date at a price set at the time of the contract. A Portfolio may enter into a forward contract to increase exposure to a foreign currency when it wishes to “lock in” the U.S. dollar price of a security it expects to or is obligated to purchase or sell in the future. This practice may be referred to as “transaction hedging.” In addition, when a Portfolio’s Sub-advisor believes that the currency of a particular country may suffer or enjoy a significant movement compared to another currency, the Portfolio may enter into a forward contract to sell or buy the first foreign currency (or a currency that acts as a proxy for such currency). This practice may be referred to as “portfolio hedging.” In any event, the precise matching of the forward contract amounts and the value of the securities involved generally will not be possible. No Portfolio will enter into a forward contract if it would be obligated to sell an amount of foreign currency in excess of the value of the Fund’s securities or other assets denominated in or exposed to that currency, or will sell an amount of proxy currency in excess of the value of securities denominated in or exposed to the related currency unless open positions in forwards used for non-hedging purposes are covered by the segregation on the Portfolios’ records of assets determined to be liquid and marked to market daily. The effect of entering into a forward contract on a Portfolio’s share price will be similar to selling securities denominated in one currency and purchasing securities denominated in another. Although a forward contract may reduce a Portfolio’s losses on securities denominated in foreign currency, it may also reduce the potential for gain on the securities if the currency’s value moves in a direction not anticipated by the Sub-advisor. In addition, foreign currency hedging may entail significant transaction costs.

 

COMMON AND PREFERRED STOCKS:

 

Stocks represent shares of ownership in a company. Generally, preferred stock has a specified dividend and ranks after bonds and before common stocks in its claim on the company’s income for purposes of receiving dividend payments and on the company’s assets in the event of liquidation. (Some of the Sub-advisors consider preferred stocks to be equity securities for purposes of the various Portfolios’ investment policies and restrictions, while others consider them fixed income securities.) After other claims are satisfied, common stockholders participate in company profits on a pro rata basis; profits

 

B-21



 

may be paid out in dividends or reinvested in the company to help it grow. Increases and decreases in earnings are usually reflected in a company’s stock price, so common stocks generally have the greatest appreciation and depreciation potential of all corporate securities.

 

FIXED INCOME SECURITIES:

 

Notwithstanding that the Portfolio invests primarily in equity securities, it may invest to some degree in bonds, notes, debentures and other obligations of corporations and governments. Fixed-income securities are generally subject to two kinds of risk: credit risk and market risk. Credit risk relates to the ability of the issuer to meet interest and principal payments as they come due. The ratings given a security by Moody’s Investors Service, Inc. (“Moody’s”) and Standard & Poor’s Corporation (“S&P”), which are described in detail in the Appendix to the Trust’s SAI, provide a generally useful guide as to such credit risk. The lower the rating, the greater the credit risk the rating service perceives to exist with respect to the security. Increasing the amount of Portfolio assets invested in lower-rated securities generally will increase the Portfolio’s income, but also will increase the credit risk to which the Portfolio is subject. Market risk relates to the fact that the prices of fixed income securities generally will be affected by changes in the level of interest rates in the markets generally. An increase in interest rates will tend to reduce the prices of such securities, while a decline in interest rates will tend to increase their prices. In general, the longer the maturity or duration of a fixed income security, the more its value will fluctuate with changes in interest rates.

 

Lower-Rated Fixed Income Securities.   Lower-rated high-yield bonds (commonly known as “junk bonds”) are those that are rated lower than the four highest categories by a nationally recognized statistical rating organization (for example, lower than Baa by Moody’s or BBB by S&P), or, if not rated, are of equivalent investment quality as determined by the Sub-advisor. Lower-rated bonds are generally considered to be high risk investments as they are subject to greater credit risk than higher-rated bonds. In addition, the market for lower-rated bonds may be thinner and less active than the market for higher-rated bonds, and the prices of lower-rated high-yield bonds may fluctuate more than the prices of higher-rated bonds, particularly in times of market stress. Because the risk of default is higher in lower-rated bonds, a Sub-advisor’s research and analysis tend to be very important ingredients in the selection of these bonds. In addition, the exercise by an issuer of redemption or call provisions that are common in lower-rated bonds may result in their replacement by lower yielding bonds.

 

Bonds rated in the four highest ratings categories are frequently referred to as “investment grade.” However, bonds rated in the fourth category (Baa or BBB) are considered medium grade and may have speculative characteristics.

 

MORTGAGE-BACKED SECURITIES:

 

Mortgage-backed securities are securities representing interests in “pools” of mortgage loans on residential or commercial real property and that generally provide for monthly payments of both interest and principal, in effect “passing through” monthly payments made by the individual borrowers on the mortgage loans (net of fees paid to the issuer or guarantor of the securities). Mortgage-backed securities are frequently issued by U.S. Government agencies or Government-sponsored enterprises, and payments of interest and principal on these securities (but not their market prices) may be guaranteed by the full faith and credit of the U.S. Government or by the agency only, or may be supported by the issuer’s ability to borrow from the U.S. Treasury. Mortgage-backed securities created by non-governmental issuers may be supported by various forms of insurance or guarantees.

 

Like other fixed-income securities, the value of a mortgage-backed security will generally decline when interest rates rise. However, when interest rates are declining, their value may not increase as much as other fixed-income securities, because early repayments of principal on the underlying mortgages (arising, for example, from sale of the underlying property, refinancing, or foreclosure) may serve to reduce the remaining life of the security. If a security has been purchased at a premium, the value of the premium would be lost in the event of prepayment. Prepayments on some mortgage-backed securities may necessitate that a Portfolio find other investments, which, because of intervening market changes, will often offer a lower rate of return. In addition, the mortgage securities market may be particularly affected by changes in governmental regulation or tax policies.

 

Collateralized Mortgage Obligations (CMOs).   CMOs are a type of mortgage pass-through security that are typically issued in multiple series with each series having a different maturity. Principal and interest payments from the underlying collateral are first used to pay the principal on the series with the shortest maturity; in turn, the remaining series are paid in

 

B-22



 

order of their maturities. Therefore, depending on the type of CMOs in which a Portfolio invests, the investment may be subject to greater or lesser risk than other types of mortgage-backed securities.

 

Stripped Mortgage-Backed Securities.   Stripped mortgage-backed securities are mortgage pass-through securities that have been divided into interest and principal components. “IOs” (interest only securities) receive the interest payments on the underlying mortgages while “POs” (principal only securities) receive the principal payments. The cash flows and yields on IO and PO classes are extremely sensitive to the rate of principal payments (including prepayments) on the underlying mortgage loans. If the underlying mortgages experience higher than anticipated prepayments, an investor in an IO class of a stripped mortgage-backed security may fail to recoup fully its initial investment, even if the IO class is highly rated or is derived from a security guaranteed by the U.S. Government. Conversely, if the underlying mortgage assets experience slower than anticipated prepayments, the price on a PO class will be affected more severely than would be the case with a traditional mortgage-backed security. Unlike other fixed-income and other mortgage-backed securities, the value of IOs tends to move in the same direction as interest rates.

 

ASSET-BACKED SECURITIES:

 

Asset-backed securities conceptually are similar to mortgage pass-through securities, but they are secured by and payable from payments on assets such as credit card, automobile or trade loans, rather than mortgages. The credit quality of these securities depends primarily upon the quality of the underlying assets and the level of credit support or enhancement provided. In addition, asset-backed securities involve prepayment risks that are similar in nature to those of mortgage pass-through securities.

 

CONVERTIBLE SECURITIES AND WARRANTS:

 

The Portfolio may invest in convertible securities. Convertible securities are bonds, notes, debentures and preferred stocks that may be converted into or exchanged for shares of common stock. Many convertible securities are rated below investment grade because they fall below ordinary debt securities in order of preference or priority on the issuer’s balance sheet. Convertible securities generally participate in the appreciation or depreciation of the underlying stock into which they are convertible, but to a lesser degree. Frequently, convertible securities are callable by the issuer, meaning that the issuer may force conversion before the holder would otherwise choose.

 

Warrants are options to buy a stated number of shares of common stock at a specified price any time during the life of the warrants. The value of warrants may fluctuate more than the value of the securities underlying the warrants. A warrant will expire without value if the rights under such warrant are not exercised prior to its expiration date.

 

B-23



 

ILLIQUID AND RESTRICTED SECURITIES:

 

Subject to guidelines adopted by the Trustees of the Trust, the Portfolio may invest up to 5% of its net assets in illiquid securities. Illiquid securities are those that, because of the absence of a readily available market or due to legal or contractual restrictions on resale, cannot be sold within seven days in the ordinary course of business at approximately the amount at which the Portfolio has valued the investment. Therefore, the Portfolio may find it difficult to sell illiquid securities at the time considered most advantageous by its Sub-advisor and may incur expenses that would not be incurred in the sale of securities that were freely marketable.

 

Certain securities that would otherwise be considered illiquid because of legal restrictions on resale to the general public may be traded among qualified institutional buyers under Rule 144A of the Securities Act of 1933. These Rule 144A securities, and well as commercial paper that is sold in private placements under Section 4(2) of the Securities Act, may be deemed liquid by the Portfolio’s Sub-advisor under the guidelines adopted by the Trustees of the Trust. However, the liquidity of a Portfolio’s investments in Rule 144A securities could be impaired if trading does not develop or declines.

 

REPURCHASE AGREEMENTS:

 

The Portfolio may enter into repurchase agreements. Repurchase agreements are agreements by which a Portfolio purchases a security and obtains a simultaneous commitment from the seller to repurchase the security at an agreed upon price and date. The resale price is in excess of the purchase price and reflects an agreed upon market rate unrelated to the coupon rate on the purchased security. Repurchase agreements must be fully collateralized and can be entered into only with well-established banks and broker-dealers that have been deemed creditworthy by the Sub-advisor.  Repurchase transactions are intended to be short-term transactions, usually with the seller repurchasing the securities within seven days. Repurchase agreements that mature in more than seven days are subject to a Portfolio’s limit on illiquid securities.

 

A Portfolio that enters into a repurchase agreement may lose money in the event that the other party defaults on its obligation and the Portfolio is delayed or prevented from disposing of the collateral. A Portfolio also might incur a loss if the value of the collateral declines, and it might incur costs in selling the collateral or asserting its legal rights under the agreement. If a defaulting seller filed for bankruptcy or became insolvent, disposition of collateral might be delayed pending court action.

 

B-24



 

BORROWING:

 

The Portfolio may borrow money from banks or broker/dealers. Each Portfolio’s borrowings are limited so that immediately after such borrowing the value of the Portfolio’s assets (including borrowings) less its liabilities (not including borrowings) is at least three times the amount of the borrowings. Should a Portfolio, for any reason, have borrowings that do not meet the above test, such Portfolio must reduce such borrowings so as to meet the necessary test within three business days.  If a Portfolio borrows money, its share price may fluctuate more widely until the borrowing is repaid.

 

LENDING PORTFOLIO SECURITIES:

 

The Portfolio may lend securities with a value of up to 33 1 ¤ 3% of its total assets to broker-dealers, institutional investors, or others (collectively, a “Borrower”) for the purpose of realizing additional income. Voting rights on loaned securities typically pass to the borrower, although the Portfolio has the right to terminate a securities loan, usually within three business days, in order to vote on significant matters or for other reasons. All securities loans will be collateralized by cash or securities issued or guaranteed by the U.S. Government or its agencies at least equal in value to the market value of the loaned securities. Any cash collateral received by the Portfolio in connection with such loans normally will be invested in short-term instruments, which may not be immediately liquid under certain circumstances. Any losses resulting from the investment of cash collateral would be borne by the lending Portfolio. The Portfolio could also suffer a loss where the value of the collateral falls below the market value of the borrowed securities, in the event of a Borrower’s default. These events could trigger adverse tax consequences to the Portfolio. Lending securities involves certain other risks, including the risk that the Portfolio will be delayed or prevented from recovering the collateral if the borrower fails to timely return a loaned security and the risk that an increase in interest rates may result in unprofitable securities loans made to Borrowers.

 

OTHER INVESTMENT COMPANIES:

 

Investments of Uninvested Cash.   The Trust has made arrangements with certain unaffiliated money market mutual funds so that the Sub-advisors for the various Portfolios can “sweep” excess cash balances of the Portfolios to those funds for temporary investment purposes. Under the Investment Company Act of 1940, as amended, a Portfolio’s investment in such unaffiliated money market mutual funds is limited to (a) 3% of the total voting stock of any one investment company; (b) 5% of a Portfolio’s total assets with respect to any one investment company; and (c) 10% of a Portfolio’s total assets in the aggregate. Certain Sub-advisors may invest Portfolio assets in money market funds that they advise or in other investment companies after obtaining appropriate exemptive relief from certain provisions of the Act. Pursuant to an exemptive order issued by the Commission, the Sub-advisors can also “sweep” excess cash balances of the Portfolios to one or more affiliated money market mutual funds or short-term bond funds for temporary investment purposes, so long as no more than 25% of a Portfolio’s total assets are invested in shares of an affiliated money market mutual fund or short-term bond fund.

 

Investments in Other Investment Companies.   Investments by the Portfolio in other investment companies will result in an additional layer of fees for Portfolio shareholders. The additional layer of fees is charged to the Portfolio in its capacity as a shareholder in the other investment company. Under the Investment Company Act of 1940, as amended, a Portfolio’s investment in other investment companies is limited to (a) 3% of the total voting stock of any one investment company; (b) 5% of the Portfolio’s total assets with respect to any one investment company; and (c) 10% of the Portfolio’s total assets in the aggregate.

 

EXCHANGE-TRADED FUNDS (ETFs):

 

ETFs are a type of investment company bought and sold on a securities exchange. An ETF represents a fixed portfolio of securities designed to track a particular market index. Consistent with their respective investment objectives and when otherwise permissible, the various portfolios could purchase an ETF to temporarily gain exposure to a portion of the U.S. or a foreign market while awaiting purchase of underlying securities. The risks of owning an ETF generally reflect the risks

 

B-25



 

of owning the underlying securities they are designed to track, although lack of liquidity in an ETF could result in it being more volatile. ETFs have management fees which increase their costs.

 

INITIAL PUBLIC OFFERINGS:

 

The Portfolio may participate in the initial public offering (“IPO”) market, and a portion of a Portfolio’s returns may be attributable to Portfolio investments in IPOs. There is no guarantee that as a Portfolio’s assets grow it will be able to experience significant improvement in performance by investing in IPOs. A Portfolio’s purchase of shares issued as part of, or a short period after, companies’ IPOs, exposes it to the risks associated with companies that have little operating history as public companies, as well as to the risks inherent in those sectors of the market where these new issuers operate. The market for IPO issuers has been volatile, and share prices of newly-public companies have fluctuated in significant amounts over short periods of time.

 

DISCLOSURE OF PORTFOLIO HOLDINGS:

 

A description of the Trust’s policies and procedures with respect to the disclosure of the Portfolio’s portfolio securities is described in the Trust’s Statement of Additional Information and on the Trust’s website at www.americanskandia.prudential.com . The Trust will provide a full list of each Portfolio’s portfolio holdings as of the end of the fiscal quarter on its website within 60 days after the end of its fiscal quarter. In addition, the Trust may release each Portfolio’s top ten holdings, sector and country breakdowns, and largest industries on a monthly basis. Such information will be posted to the Trust’s website no earlier than 15 days after the end of each month. These postings can be located at www.americanskandia.prudential.com

 

B-26



 

AMERICAN SKANDIA TRUST

FINANCIAL HIGHLIGHTS

PER SHARE DATA (FOR A SHARE OUTSTANDING THROUGHOUT EACH YEAR)

 

 

 

 

 

 

 

Increase (Decrease) from

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment Operations

 

Less Distributions

 

 

 

 

 

Net Asset

 

 

 

Net

 

 

 

 

 

 

 

 

 

 

 

 

 

Value

 

Net

 

Realized &

 

Total from

 

From Net

 

From Net

 

 

 

 

 

Year

 

Beginning

 

Investment

 

Unrealized

 

Investment

 

Investment

 

Realized

 

Total

 

Portfolio

 

Ended

 

of Year

 

Income

 

Gain (Loss)

 

Operations

 

Income

 

Gains

 

Distributions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AST AllianceBernstein Managed Index 500

 

12/31/04

 

$  10.98

 

 

$  0.15

 

 

$   0.94

 

 

$  1.09

 

 

$  (0.10

)

 

$   —

 

 

$  (0.10)

 

 

 

 

12/31/03

 

8.75

 

 

0.11

 

 

2.24

 

 

2.35

 

 

(0.12

)

 

 

 

(0.12)

 

 

 

 

12/31/02

 

11.14

 

 

0.11

 

 

(2.39)

 

 

(2.28)

 

 

(0.11

)

 

 

 

(0.11)

 

 

 

 

12/31/01

 

12.63

 

 

0.11

 

 

(1.36)

 

 

(1.25)

 

 

(0.11

)

 

(0.13

)

 

(0.24)

 

 

 

 

12/31/00

 

14.96

 

 

0.10

 

 

(1.40)

 

 

(1.30)

 

 

(0.08

)

 

(0.95

)

 

(1.03)

 

 

 


*                  Includes commissions received by American Skandia Marketing, Inc. under the Portfolio’s Distribution Plan.

**           These annual total returns do not consider the effect of sales load or insurance contract charges.

 

F-1



 

 

 

 

 

 

 

 

 

 

 

Ratios of Expenses

 

 

 

 

 

 

 

Supplemental Data

 

to Average Net Assets*

 

 

 

 

 

Net Asset

 

 

 

 

 

 

 

After Advisory

 

Before Advisory

 

Ratio of Net

 

 

 

Value

 

 

 

Net Assets at

 

Portfolio

 

Fee Waiver

 

Fee Waiver

 

Investment Income

 

 

 

End

 

Total

 

End of Year

 

Turnover

 

and Expense

 

and Expense

 

to Average

 

Portfolio

 

of Year

 

Return**

 

(in 000's)

 

Rate

 

Reimbursement

 

Reimbursement

 

Net Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

AST AllianceBernstein Managed Index 500

 

$  11.97

 

 

9.98%

 

 

$  561,666

 

 

41%

 

0.81%

 

0.81%

 

1.27%

 

 

 

10.98

 

 

27.32%

 

 

541,492

 

 

45%

 

0.84%

 

0.84%

 

1.03%

 

 

 

8.75

 

 

(20.64)%

 

 

441,169

 

 

36%

 

0.84%

 

0.84%

 

1.04%

 

 

 

11.14

 

 

(10.01)%

 

 

623,363

 

 

54%

 

0.77%

 

0.78%

 

0.95%

 

 

 

12.63

 

 

(8.82)%

 

 

704,897

 

 

84%

 

0.78%

 

0.78%

 

0.84%

 

 

F-2



 

Mailing Address

 

 

American Skandia Trust

 

 

Gateway Center Three

 

 

100 Mulberry Street

 

 

Newark, NJ 07102

 

 

 

 

 

Investment Managers

 

 

American Skandia Investment Services, Incorporated

 

Prudential Investments LLC

One Corporate Drive

 

Gateway Center Three, 100 Mulberry Street

Shelton, CT 06484

 

Newark, NJ 07102

 

 

 

Sub-Advisors

 

 

Alliance Capital Management L.P.

 

 

 

 

 

Custodian

 

 

PFPC Trust Company

 

 

400 Bellevue Parkway

 

 

Wilmington, DE 19809

 

 

 

 

 

Administrator

 

 

Transfer and Shareholder Servicing Agent

 

 

PFPC Inc.

 

 

103 Bellevue Parkway

 

 

Wilmington, DE 19809

 

 

 

 

 

Independent Registered Public Accounting Firm

 

 

KPMG LLP

 

 

345 Park Avenue

 

 

New York, NY 10154

 

 

 

 

 

Legal Counsel

 

Counsel to the Independent Trustees

Goodwin Procter LLP

 

Bell, Boyd & Lloyd LLC

901 New York Avenue, N.W.

 

70 West Madison Street

Washington, D.C. 20001

 

Chicago, IL 60602

 



 

INVESTOR INFORMATION SERVICES:

 

Shareholder inquiries should be made by calling (800) 752-6342 or by writing to the American Skandia Trust at Gateway Center Three, 100 Mulberry Street, Newark, NJ 07102.

 

Additional information about the Portfolio is included in a Statement of Additional Information, which is incorporated by reference into this Prospectus. Additional information about the Portfolio’s investments is available in the annual and semi-annual reports to holders of variable annuity contracts and variable life insurance policies. In the annual reports, you will find a discussion of the market conditions and investment strategies that significantly affected the Portfolio’s performance during its last fiscal year. The Statement of Additional Information and additional copies of annual and semi-annual reports are available without charge by calling the above number.

 

Delivery of Prospectus and other Documents to Households.   To lower costs and eliminate duplicate documents sent to your address, the Trust, in accordance with applicable laws and regulations, may begin mailing only one copy of the Trust’s prospectus, prospectus supplements, annual and semi-annual reports, proxy statements and information statements, or any other required documents to your address even if more than one shareholder lives there. If you have previously consented to have any of these documents delivered to multiple investors at a shared address, as required by law, and wish to revoke this consent or otherwise would prefer to continue to receive your own copy, you should call 1-800-SKANDIA or write to “American Skandia Trust, c/o American Skandia Life Assurance Corporation.” at P.O. Box 7038, Bridgeport, CT 06601-9642. The Trust will begin sending individual copies to you within thirty days of receipt of revocation.

 

The information in the Trust’s filings with the Securities and Exchange Commission (including the Statement of Additional Information) is available from the Commission. Copies of this information may be obtained, upon payment of duplicating fees, by electronic request to publicinfo@sec.gov or by writing the Public Reference Section of the Commission, Washington, D.C. 20549-0102. The information can also be reviewed and copied at the Commission’s Public Reference Room in Washington, D.C. Information on the operation of the Public Reference Room may be obtained by calling the Commission at 1-202-942-8090. Finally, information about the Trust is available on the EDGAR database on the Commission’s Internet site at http://www.sec.gov.

 

Investment Company Act File No. 811-5186

 



Exhibit C

 

ANNUAL REPORT DATED DECEMBER 31, 2004

 

Managed Index 500 Portfolio’s Annual Report to Shareholders for the fiscal year ended on December 31, 2004, is incorporated by reference into this Prospectus/Proxy Statement and will be included in the proxy solicitation mailing to shareholders.

 

C-1



 

PROSPECTUS/PROXY STATEMENT

TABLE OF CONTENTS

 

Cover Page

 

Summary

3

The Proposal

3

Shareholder Voting

3

Comparisons of Some Important Features of the Portfolios

4

The Investment Objective and Strategies of the Portfolios

4

Other Non-Fundamental Investment Policies of the Portfolios

 

Fundamental Investment Restrictions of the Portfolios

 

Risks of Investing in the Portfolios

7

Federal Income Tax Considerations

7

Management of the Fund and the Portfolios

7

Valuation

11

Purchases, Redemptions, Exchanges and Distributions

13

Fees and Expenses

14

Expense examples

15

Performance

15

AST AllianceBernstein Growth + Value Portfolio

16

AST AllianceBernstein Managed Index 500 Portfolio

17

Other Key Features of the Portfolios

17

Reasons for the Transaction

17

Information about the Transaction

19

Closing of the Transaction

19

Expenses of the Transaction

19

Federal Income Tax Consequences of the Transaction

19

Characteristics of the AST AllianceBernstein Managed Index 500 Portfolio Shares

20

Capitalization of the Portfolios and Capitalization after the Transaction

20

Voting Information

21

How to Vote

21

Revoking Voting Instructions

22

Other Matters

22

Solicitation of Voting Instructions

22

Additional Information about the Company and the Portfolios

22

Principal Holders of Shares

23

Exhibits to Prospectus/Proxy Statement

24

Exhibit A – Plan of Reorganization

A-1

Exhibit B – Prospectus for the AST AllianceBernstein Managed Index 500 Portfolio dated May 1, 2005

B-1

Exhibit C – Annual Report for the Managed Index 500 Portfolio, dated December 31, 2004

C-1

 



 

PART B

 

STATEMENT OF ADDITIONAL INFORMATION

 

TO PROSPECTUS/PROXY STATEMENT

 

Acquisition of the Assets of the

 

AST ALLIANCEBERNSTEIN GROWTH + VALUE PORTFOLIO

 

By and in exchange for the Shares of the

 

AST ALLIANCEBERNSTEIN MANAGED INDEX 500 PORTFOLIO

 

This Statement of Additional Information (The “SAI”) expands upon and supplements information contained in the combined Prospectus and Proxy Statement (the “Prospectus/Proxy Statement” dated August [  ], 2005 and relates specifically to the proposed delivery of all of the net assets of the AST AllianceBernstein Growth + Value Portfolio (“Growth + Value Portfolio”) in exchange for shares of the AST AllianceBernstein Managed Index 500 Portfolio (“Managed Index 500 Portfolio”).  The Growth + Value Portfolio and the Managed Index 500 Portfolio are both series of American Skandia Trust (“AST”).

 

This SAI consists of this Cover Page and the Statement of Additional Information on Form N-1A of AST dated May 1, 2005, which is incorporated herein by reference (which means that those portions are legally part of this SAI), and the pro forma financial statements for the Growth + Value Portfolio and the Managed Index 500 Portfolio after giving effect to the proposed transaction.

 

This SAI is not a Prospectus; you should read this SAI in conjunction with the Prospectus/Proxy Statement dated August [  ], 2005, which relates to the above-referenced transaction.  You can request a copy of the Prospectus/Proxy Statement by calling 800-752-6342 or by writing to the Trust at Gateway Center Three, 100 Mulberry Street, Newark, NJ 07102.  The Securities and Exchange Commission (“SEC”) maintains a website (www.sec.gov) that contains the SAI and other material incorporated by reference and considered part of this Prospectus/Proxy Statement, together with other information regarding the Fund.

 

S-2           Attachment to SAI

 

F-1           Pro Forma Financial Statements of the Transaction (unaudited)

 

F-2          Pro Forma Statement of Operations for the Transaction (unaudited)

 

F-3           Pro Forma Statements of Assets and Liabilities for the Transaction (unaudited)

 

F-4           Pro Forma Portfolio of Investments for the Transaction (unaudited)

 

F-10         Notes to Pro Forma Financial Statements for the Transaction (unaudited)

 



 

ATTACHMENT TO SAI

 

The American Skandia Trust (the “Trust”) Statement of Additional Information (SAI) dated May 1, 2005, is incorporated herein by reference to the electronic filings with the SEC of the Trust’s SAI dated May 1, 2005 on Form N-1A under Rule 485 (b) and is part of this SAI and will be provided to all shareholders requesting this SAI.

 

S-2



 

PRO FORMA FINANCIAL STATEMENTS (UNAUDITED) FOR THE TRANSACTION

 

The following tables set forth the unaudited pro forma Statement of Operations, the unaudited pro forma Statements of Assets and Liabilities and the unaudited pro forma Portfolio of Investments, each for the year ended December 31, 2004 for the AST AllianceBernstein Growth + Value Portfolio and AST AllianceBernstein Managed Index 500 Portfolio, as adjusted, giving effect to the Transaction.  The unaudited pro forma combined financial statements included in this SAI are presented for the information of the reader and may not necessarily be representative of what the actual combined financial statements would have been had the transaction occurred on December 31, 2004.  The statements have been derived from the books and records of the Portfolios utilized in calculating daily net asset value at the date indicated above for both Portfolios under accounting principles generally accepted in the United States of America and the investment company industry.  The historical cost of investment securities will be carried forward to the surviving entity and the results of operations of the AST AllianceBernstein Growth + Value Portfolio and the AST AllianceBernstein Managed Index 500 Portfolio for pre-combination periods will not be restated.  As of December 31, 2004, all securities held by the target fund would comply with the compliance guidelines and/or investment restrictions of the acquiring fund.

 

F-1



 

Pro Forma Statement of Operations

For the Year ended  12/31/ 2004

(Unaudited)

 

 

 

AST Alliance
Bernstein Growth
& Value

 

AST Alliance
Bernstein
Managed
Index 500

 

Pro-Forma
Adjustments

 

Pro-forma
Combined AST
Alliance Bernstein
Managed Index 500

 

Income

 

 

 

 

 

 

 

 

 

Interest

 

$

48

 

$

512

 

 

 

$

560

 

Dividends

 

1,287,498

 

11,092,793

 

 

 

12,380,291

 

Security Lending

 

13,406

 

43,970

 

 

 

57,376

 

Foreign taxes Withheld

 

(6,532

)

(4,186

)

 

 

(10,718

)

Total Income

 

1,294,420

 

11,133,089

 

 

 

12,427,509

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

Advisory Fees

 

618,479

 

3,289,927

 

(206,160

)(a)

3,702,246

 

Distribution Fees

 

 

242,565

 

 

 

242,565

 

Shareholder Servicing Fees and Expenses

 

69,000

 

548,000

 

 

 

617,000

 

Administration and Accounting Fees

 

69,000

 

181,000

 

(61,000

)(b)

189,000

 

Custodian Fees and Expenses

 

15,000

 

65,000

 

(9,000

)(b)

71,000

 

Audit and Legal Fees

 

41,000

 

24,000

 

(41,000

)(b)

24,000

 

Trustees Fees

 

12,000

 

19,000

 

(12,000

)(b)

19,000

 

Interest Expense

 

 

10,742

 

 

 

10,742

 

Miscellaneous

 

13,855

 

49,141

 

(13,000

)(b)

49,996

 

 

 

 

 

 

 

 

 

 

 

Total expenses

 

838,334

 

4,429,375

 

(342,160

)

4,925,549

 

Less: Advisory fees & expense reimbursement

 

 

 

 

 

Less: Fees Paid Directly

 

 

(242,565

)

 

(242,565

)

Net expenses

 

838,334

 

4,186,810

 

(342,160

)

4,682,984

 

 

 

 

 

 

 

 

 

 

 

Net investment Income

 

456,086

 

6,946,279

 

342,160

 

7,744,525

 

 

 

 

 

 

 

 

 

 

 

Realized and Unrealized Gain on Investments:

 

 

 

 

 

 

 

 

 

Net Realized Gain on:

 

 

 

 

 

 

 

 

 

Investments

 

1,877,289

 

6,382,969

 

 

 

8,260,258

 

 

 

 

 

 

 

 

 

 

 

Net Change in Unrealized Appreciation on

 

 

 

 

 

 

 

 

 

Investments

 

4,406,550

 

34,494,253

 

 

 

38,900,803

 

 

 

 

 

 

 

 

 

 

 

Net gain on investments

 

6,283,839

 

40,877,222

 

 

 

47,161,061

 

 

 

 

 

 

 

 

 

 

 

Net Increase in Net Assets Resulting from Operations

 

$

6,739,925

 

$

47,823,501

 

$

342,160

 

$

54,905,586

 

 


(a) Represent adjustments to advisory fees based on the survivng portfolio’s fee schedule.

(b) Reflects the elimination of duplicate services or fees.

 

F-2



 

PRO FORMA STATEMENTS OF ASSETS AND LIABILITIES

December 31,2004

(UNAUDITED)

 

 

 

AST Alliance
Bernstein Growth
& Value

 

AST Alliance
Bernstein
Managed
Index 500

 

Pro-Forma
Adjustments

 

Pro-forma
Combined AST
Alliance Bernstein
Managed Index 500

 

ASSETS:

 

 

 

 

 

 

 

 

 

Investments in Securities at Value (A)

 

 

 

 

 

 

 

 

 

Including Securities Loaned at Value (B)

 

$

91,313,935

 

$

617,027,079

 

 

 

$

708,341,014

 

Receivable For:

 

 

 

 

 

 

 

 

 

Securities Sold

 

2,096,667

 

0

 

 

 

2,096,667

 

Dividends and Interest

 

82,405

 

718,716

 

 

 

801,121

 

Fund Shares Sold

 

29,125

 

7,534

 

 

 

36,659

 

Prepaid Expenses

 

1,275

 

10,980

 

 

 

12,255

 

Total Assets

 

93,523,407

 

617,764,309

 

 

 

711,287,716

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES:

 

 

 

 

 

 

 

 

 

Payable to Investment Manager

 

28,142

 

70,349

 

 

 

98,491

 

Payable to Broker for Collateral for Securities on Loan

 

14,735,515

 

55,778,525

 

 

 

70,514,040

 

Payable For:

 

 

 

 

 

 

 

 

 

Securities Purchased

 

798,833

 

0

 

 

 

798,833

 

Fund Shares Redeemed

 

361

 

181,016

 

 

 

181,377

 

Shareholder Servicing Fees Payable

 

426

 

3,087

 

 

 

3,513

 

Deferred Director’s Fees

 

436

 

9,337

 

 

 

9,773

 

Accrued Expenses and Other Liabilities

 

37,905

 

56,237

 

 

 

94,142

 

Total Liabilities

 

15,601,618

 

56,098,551

 

 

 

71,700,169

 

Net Assets

 

$

77,921,789

 

$

561,665,758

 

 

 

$

639,587,547

 

 

 

 

 

 

 

 

 

 

 

Components of Net Assets

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock, at $0.001 Par Value

 

$

7,824

 

$

46,916

 

$

(1,315

)

$

53,425

 

Additional Paid-In Capital

 

69,841,285

 

639,067,894

 

1,315

 

708,910,494

 

 

 

69,849,109

 

639,114,810

 

 

 

708,963,919

 

Accumulated Net Investment Loss

 

455,649

 

6,886,856

 

 

 

7,342,505

 

Accumulated Net Realized Gain on Investments

 

(3,801,166

)

(156,516,831

)

 

 

(160,317,997

)

Net Unrealized Appreciation on Investments

 

11,418,197

 

72,180,923

 

 

 

83,599,120

 

Net Assets

 

$

77,921,789

 

$

561,665,758

 

 

 

$

639,587,547

 

 

 

 

 

 

 

 

 

 

 

Shares of Common Stock Outstanding

 

7,823,763

 

46,915,834

 

(1,314,971

)(a)

53,424,626

 

Net Asset Value

 

9.96

 

11.97

 

 

 

11.97

 

(A) Investments at Cost

 

$

79,895,738

 

$

544,846,156

 

 

 

$

624,741,894

 

(B) Securities Loaned at Value

 

$

14,205,920

 

$

53,818,285

 

 

 

$

68,024,205

 

 


See Notes to Pro-Forma Financial Statements

 

(a)           Represents the difference between total additional shares to be issued (see note 2) and current AST AllianceBernstein Managed Index 500 shares outstanding

 

See Notes to Pro-Forma Financial Statements

 

F-3



 

Pro Forma Portfolio of Investments

December 31, 2004

(UNAUDITED)

 

AST AllianceBernstein
Growth + Value

 

AST AllianceBernstein
Managed Index 500

 

ProForma
Adjustment

 

ProForma Combined

 

 

 

AST AllianceBernstein
Growth + Value

 

AST AllianceBernstein
Managed Index 500

 

ProForma
Adjustment

 

ProForma
Combined

 

Shares

 

Shares

 

Shares

 

 

 

 

 

Value

 

Value

 

 

 

Value

 

 

 

 

 

 

 

 

 

LONG-TERM INVESTMENTS – 96.3, 99.5%, 99.1%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COMMON STOCK

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Advertising - 0.0%, 0.1%, 0.1%

 

 

 

 

 

 

 

 

 

 

 

61,000

 

 

 

61,000

 

Interpublic Group of Cos., Inc. (The)* (a)

 

 

 

$

818,740

 

 

 

$

818,740

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Aerospace 0.7%, 1.8%, 1.6%

 

 

 

 

 

 

 

 

 

10,800

 

71,300

 

 

 

82,100

 

Boeing Co.

 

559,116

 

3,691,201

 

 

 

4,250,317

 

 

 

28,700

 

 

 

28,700

 

Goodrich Corp.

 

 

 

936,768

 

 

 

936,768

 

 

 

51,100

 

 

 

51,100

 

United Technologies Corp.

 

 

 

5,281,185

 

 

 

5,281,185

 

 

 

 

 

 

 

 

 

 

 

559,116

 

9,909,154

 

 

 

10,468,270

 

 

 

 

 

 

 

 

 

Automobile Manufacturers 0.0%, 0.6%, 0.5%

 

 

 

 

 

 

 

 

 

 

 

81,000

 

 

 

81,000

 

General Motors Corp.(a)

 

 

 

3,244,860

 

 

 

3,244,860

 

 

 

 

 

 

 

 

 

Automotive Parts 0.8%, 0.3%, 0.3%

 

 

 

 

 

 

 

 

 

 

 

177,600

 

 

 

177,600

 

Delphi Corp. (a)

 

 

 

1,601,952

 

 

 

1,601,952

 

7,700

 

 

 

 

 

7,700

 

Magna International, Inc. (Class “A” Stock)

 

635,635

 

 

 

 

 

635,635

 

 

 

 

 

 

 

 

 

 

 

635,635

 

1,601,952

 

 

 

2,237,587

 

 

 

 

 

 

 

 

 

Beverages 0.6%, 1.7%, 1.6%

 

 

 

 

 

 

 

 

 

 

 

61,700

 

 

 

61,700

 

Coca-Cola Co.

 

 

 

2,568,571

 

 

 

2,568,571

 

9,600

 

135,100

 

 

 

144,700

 

PepsiCo, Inc.

 

501,120

 

7,052,220

 

 

 

7,553,340

 

 

 

 

 

 

 

 

 

 

 

501,120

 

9,620,791

 

 

 

10,121,911

 

 

 

 

 

 

 

 

 

Broadcasting 1.0%, 0.4%, 0.5%

 

 

 

 

 

 

 

 

 

16,800

 

 

 

 

 

16,800

 

Scripps (E.W.) Co. (Class “A” Stock)

 

811,104

 

 

 

 

 

811,104

 

 

 

50,000

 

 

 

50,000

 

Univision Communications, Inc. (Class “A” Stock)*

 

 

 

1,463,500

 

 

 

1,463,500

 

 

 

28,900

 

 

 

28,900

 

Westwood One, Inc.*

 

 

 

778,277

 

 

 

778,277

 

 

 

 

 

 

 

 

 

 

 

811,104

 

2,241,777

 

 

 

3,052,881

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Building Materials 0.0%, 1.0%, 0.8%

 

 

 

 

 

 

 

 

 

 

 

57,000

 

 

 

57,000

 

American Standard Cos., Inc.*

 

 

 

2,355,240

 

 

 

2,355,240

 

 

 

66,400

 

 

 

66,400

 

Masco Corp.

 

 

 

2,425,592

 

 

 

2,425,592

 

 

 

13,900

 

 

 

13,900

 

Sherwin-Williams Co. (The)

 

 

 

620,357

 

 

 

620,357

 

 

 

 

 

 

 

 

 

 

 

 

 

5,401,189

 

 

 

5,401,189

 

 

 

 

 

 

 

 

 

Business Services 0.0%, 0.1%, 0.1%

 

 

 

 

 

 

 

 

 

 

 

19,000

 

 

 

19,000

 

Fiserv, Inc.*

 

 

 

763,610

 

 

 

763,610

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cable Television 0.8%, 0.4%, 0.5%

 

 

 

 

 

 

 

 

 

19,100

 

64,800

 

 

 

83,900

 

Comcast Corp. (Special Class “A” Stock)* (a)

 

627,244

 

2,156,544

 

 

 

2,783,788

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Chemicals 0.0%, 1.5%, 1.3%

 

 

 

 

 

 

 

 

 

 

 

24,200

 

 

 

24,200

 

Dow Chemical Co.

 

 

 

1,198,142

 

 

 

1,198,142

 

 

 

52,200

 

 

 

52,200

 

DuPont, (E.I.) de Nemours & Co.

 

 

 

2,560,410

 

 

 

2,560,410

 

 

 

9,000

 

 

 

9,000

 

Eastman Chemical Co.(a)

 

 

 

519,570

 

 

 

519,570

 

 

 

11,300

 

 

 

11,300

 

FMC Corp.*

 

 

 

545,790

 

 

 

545,790

 

 

 

44,600

 

 

 

44,600

 

Hercules, Inc.* (a)

 

 

 

662,310

 

 

 

662,310

 

 

 

35,700

 

 

 

35,700

 

Lubrizol Corp.

 

 

 

1,315,902

 

 

 

1,315,902

 

 

 

22,000

 

 

 

22,000

 

PPG Industries, Inc.

 

 

 

1,499,520

 

 

 

1,499,520

 

 

 

 

 

 

 

 

 

 

 

 

 

8,301,644

 

 

 

8,301,644

 

 

 

 

 

 

 

 

 

Clothing & Apparel 0.7%, 0.3%, 0.4%

 

 

 

 

 

 

 

 

 

10,200

 

 

 

 

 

10,200

 

Jones Apparel Group, Inc.

 

373,014

 

 

 

 

 

373,014

 

3,600

 

34,375

 

 

 

37,975

 

VF Corp.

 

199,368

 

1,903,688

 

 

 

2,103,056

 

 

 

 

 

 

 

 

 

 

 

572,382

 

1,903,688

 

 

 

2,476,070

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Computer Hardware 5.0%, 3.7%, 3.9%

 

 

 

 

 

 

 

 

 

65,600

 

195,185

 

 

 

260,785

 

Dell, Inc.*

 

2,764,384

 

8,225,096

 

 

 

10,989,480

 

52,750

 

239,760

 

 

 

292,510

 

Hewlett-Packard Co.

 

1,106,168

 

5,027,767

 

 

 

6,133,935

 

 

 

33,200

 

 

 

33,200

 

Ingram Micro, Inc. (Class “A” Stock)*

 

 

 

690,560

 

 

 

690,560

 

 

 

70,600

 

 

 

70,600

 

International Business Machines Corp.

 

 

 

6,959,748

 

 

 

6,959,748

 

 

 

 

 

 

 

 

 

 

 

3,870,552

 

20,903,171

 

 

 

24,773,723

 

 

 

 

 

 

 

 

 

Computer Services & Software 6.4%, 6.7%, 6.6%

 

 

 

 

 

 

 

 

 

37,300

 

306,400

 

 

 

343,700

 

Cisco Systems, Inc.*

 

719,890

 

5,913,520

 

 

 

6,633,410

 

22,100

 

50,000

 

 

 

72,100

 

Electronic Arts, Inc.*

 

1,363,128

 

3,084,000

 

 

 

4,447,128

 

 

 

29,300

 

 

 

29,300

 

Electronic Data Systems Corp.

 

 

 

676,830

 

 

 

676,830

 

 

 

143,400

 

 

 

143,400

 

EMC Corp.*

 

 

 

2,132,358

 

 

 

2,132,358

 

 

 

16,900

 

 

 

16,900

 

Mercury Interactive Corp.*(a)

 

 

 

769,795

 

 

 

769,795

 

93,700

 

600,800

 

 

 

694,500

 

Microsoft Corp.

 

2,502,727

 

16,047,368

 

 

 

18,550,095

 

 

 

322,600

 

 

 

322,600

 

Oracle Corp.*

 

 

 

4,426,072

 

 

 

4,426,072

 

16,000

 

110,600

 

 

 

126,600

 

Symantec Corp.*

 

412,160

 

2,849,056

 

 

 

3,261,216

 

 

 

33,000

 

 

 

33,000

 

Tech Data Corp.* (a)

 

 

 

1,498,200

 

 

 

1,498,200

 

 

 

 

 

 

 

 

 

 

 

4,997,905

 

37,397,199

 

 

 

42,395,104

 

 

F-4



 

AST AllianceBernstein
Growth + Value

 

AST AllianceBernstein
Managed Index 500

 

ProForma
Adjustment

 

ProForma Combined

 

 

 

AST AllianceBernstein
Growth + Value

 

AST AllianceBernstein
Managed Index 500

 

ProForma
Adjustment

 

ProForma
Combined

 

 

 

 

 

 

 

 

 

Conglomerates – 1.9%, 3.4%, 3.2%

 

 

 

 

 

 

 

 

 

 

 

13,900

 

 

 

13,900

 

3M Co.

 

 

 

1,140,773

 

 

 

1,140,773

 

11,950

 

154,900

 

 

 

166,850

 

Altria Group, Inc.

 

730,145

 

9,464,390

 

 

 

10,194,535

 

 

 

93,000

 

 

 

93,000

 

Cendant Corp.

 

 

 

2,174,340

 

 

 

2,174,340

 

 

 

44,900

 

 

 

44,900

 

Honeywell International, Inc.

 

 

 

1,589,909

 

 

 

1,589,909

 

10,600

 

20,000

 

 

 

30,600

 

Textron, Inc.

 

782,280

 

1,476,000

 

 

 

2,258,280

 

 

 

88,100

 

 

 

88,100

 

Tyco International Ltd.(a)

 

 

 

3,148,694

 

 

 

3,148,694

 

 

 

 

 

 

 

 

 

 

 

1,512,425

 

18,994,106

 

 

 

20,506,531

 

 

 

 

 

 

 

 

 

Construction - 0.0%, 0.3%, 0.3%

 

 

 

 

 

 

 

 

 

 

 

15,700

 

 

 

15,700

 

Lennar Corp. (Class “A” Stock)

 

 

 

889,876

 

 

 

889,876

 

 

 

12,800

 

 

 

12,800

 

Pulte Homes, Inc.

 

 

 

816,640

 

 

 

816,640

 

 

 

 

 

 

 

 

 

 

 

 

 

1,706,516

 

 

 

1,706,516

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumer Products & Services – 2.5%, 4.2%, 4.0%

 

 

 

 

 

 

 

 

 

22,900

 

74,000

 

 

 

96,900

 

Avon Products, Inc. (a)

 

886,230

 

2,863,800

 

 

 

3,750,030

 

 

 

12,100

 

 

 

12,100

 

Fortune Brands, Inc.

 

 

 

933,878

 

 

 

933,878

 

 

 

101,800

 

 

 

101,800

 

Johnson & Johnson

 

 

 

6,456,156

 

 

 

6,456,156

 

4,425

 

 

 

 

 

4,425

 

Kimberly-Clark Corp.

 

291,209

 

 

 

 

 

291,209

 

 

 

41,400

 

 

 

41,400

 

Newell Rubbermaid, Inc.

 

 

 

1,001,466

 

 

 

1,001,466

 

13,400

 

189,500

 

 

 

202,900

 

Procter & Gamble Co.

 

738,072

 

10,437,660

 

 

 

11,175,732

 

 

 

26,800

 

 

 

26,800

 

Reynolds, (R.J.) Tobacco Holdings, Inc. (a)

 

 

 

2,106,480

 

 

 

2,106,480

 

 

 

 

 

 

 

 

 

 

 

1,915,511

 

23,799,440

 

 

 

25,714,951

 

 

 

 

 

 

 

 

 

Containers & Packaging –0.6%, 0.1%, 0.2%

 

 

 

 

 

 

 

 

 

25,600

 

 

 

 

 

25,600

 

Smurfit-Stone Container Corp.* (a)

 

478,208

 

 

 

 

 

478,208

 

 

 

20,500

 

 

 

20,500

 

Sonoco Products Co.

 

 

 

607,825

 

 

 

607,825

 

 

 

 

 

 

 

 

 

 

 

478,208

 

607,825

 

 

 

1,086,033

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Electronic Components & Equipment – 5.1%, 5.3%, 5.3%

 

 

 

 

 

 

 

 

 

 

 

28,700

 

 

 

28,700

 

Avnet, Inc.* (a)

 

 

 

523,488

 

 

 

523,488

 

 

 

47,700

 

 

 

47,700

 

Eastman Kodak Co. (a)

 

 

 

1,538,325

 

 

 

1,538,325

 

 

 

14,000

 

 

 

14,000

 

Emerson Electric Co.(a)

 

 

 

981,400

 

 

 

981,400

 

35,800

 

31,000

 

 

 

66,800

 

Flextronics International Ltd.*(a)

 

494,756

 

428,420

 

 

 

923,176

 

81,600

 

641,670

 

 

 

723,270

 

General Electric Co.

 

2,978,400

 

23,420,955

 

 

 

26,399,355

 

 

 

21,000

 

 

 

21,000

 

Hubbell, Inc. (Class “B” Stock)

 

 

 

1,098,300

 

 

 

1,098,300

 

87,697

 

260,000

 

 

 

347,697

 

Solectron Corp.* (a)

 

467,425

 

1,385,800

 

 

 

1,853,225

 

 

 

25,000

 

 

 

25,000

 

Vishay Intertechnology, Inc.*

 

 

 

375,500

 

 

 

375,500

 

 

 

 

 

 

 

 

 

 

 

3,940,581

 

29,752,188

 

 

 

33,692,769

 

 

 

 

 

 

 

 

 

Entertainment & Leisure –1.6%, 3.0, 2.9%

 

 

 

 

 

 

 

 

 

7,000

 

30,900

 

 

 

37,900

 

Carnival Corp.(a)

 

403,410

 

1,780,767

 

 

 

2,184,177

 

 

 

47,100

 

 

 

47,100

 

Disney, (Walt) Co.

 

 

 

1,309,380

 

 

 

1,309,380

 

 

 

50,600

 

 

 

50,600

 

Harley-Davidson, Inc.(a)

 

 

 

3,073,950

 

 

 

3,073,950

 

 

 

59,000

 

 

 

59,000

 

International Game Technology Group, Inc. (a)

 

 

 

2,028,420

 

 

 

2,028,420

 

44,000

 

358,000

 

 

 

402,000

 

Time Warner, Inc.*

 

855,360

 

6,959,520

 

 

 

7,814,880

 

 

 

50,400

 

 

 

50,400

 

Viacom, Inc. (Class “B” Stock)

 

 

 

1,834,056

 

 

 

1,834,056

 

 

 

 

 

 

 

 

 

 

 

1,258,770

 

16,986,093

 

 

 

18,244,863

 

 

 

 

 

 

 

 

 

Farming & Agriculture –0.0%, 0.3%, 0.3%

 

 

 

 

 

 

 

 

 

 

 

32,300

 

 

 

32,300

 

Bunge Ltd. (a)

 

 

 

1,841,423

 

 

 

1,841,423

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial - Bank & Trust –4.2%, 5.5%, 5.4%

 

 

 

 

 

 

 

 

 

24,794

 

213,252

 

 

 

238,046

 

Bank of America Corp.

 

1,165,070

 

10,020,711

 

 

 

11,185,781

 

 

 

43,300

 

 

 

43,300

 

Comerica, Inc.

 

 

 

2,642,166

 

 

 

2,642,166

 

 

 

25,000

 

 

 

25,000

 

Commerce Bancorp, Inc. (a)

 

 

 

1,610,000

 

 

 

1,610,000

 

 

 

34,200

 

 

 

34,200

 

Huntington Bancshares, Inc.(a)

 

 

 

847,476

 

 

 

847,476

 

21,700

 

95,400

 

 

 

117,100

 

National City Corp.

 

814,835

 

3,582,270

 

 

 

4,397,105

 

 

 

31,950

 

 

 

31,950

 

North Fork Bancorp, Inc.

 

 

 

921,758

 

 

 

921,758

 

 

 

15,176

 

 

 

15,176

 

Regions Financial Corp.

 

 

 

540,114

 

 

 

540,114

 

7,300

 

45,000

 

 

 

52,300

 

SunTrust Banks, Inc.

 

539,324

 

3,324,600

 

 

 

3,863,924

 

 

 

71,000

 

 

 

71,000

 

U.S. Bancorp

 

 

 

2,223,720

 

 

 

2,223,720

 

14,650

 

62,800

 

 

 

77,450

 

Wachovia Corp.

 

770,590

 

3,303,280

 

 

 

4,073,870

 

 

 

30,800

 

 

 

30,800

 

Wells Fargo & Co.

 

 

 

1,914,220

 

 

 

1,914,220

 

 

 

 

 

 

 

 

 

 

 

3,289,819

 

30,930,315

 

 

 

34,220,134

 

 

 

 

 

 

 

 

 

Financial Services – 11.4%, 9.6%, 9.7%

 

 

 

 

 

 

 

 

 

 

 

61,000

 

 

 

61,000

 

American Express Co. (a)

 

 

 

3,438,570

 

 

 

3,438,570

 

 

 

30,300

 

 

 

30,300

 

Bank of New York Co., Inc. (The)

 

 

 

1,012,626

 

 

 

1,012,626

 

67,000

 

342,900

 

 

 

409,900

 

Citigroup, Inc.

 

3,228,059

 

16,520,921

 

 

 

19,748,980

 

11,500

 

9,500

 

 

 

21,000

 

Fannie Mae (a)

 

818,915

 

676,495

 

 

 

1,495,410

 

7,000

 

 

 

 

 

7,000

 

Freddie Mac

 

515,900

 

 

 

 

 

515,900

 

 

 

900

 

 

 

900

 

Franklin Resources, Inc.

 

 

 

62,685

 

 

 

62,685

 

3,300

 

26,900

 

 

 

30,200

 

Goldman Sachs Group, Inc.

 

343,332

 

2,798,676

 

 

 

3,142,008

 

32,500

 

196,776

 

 

 

229,276

 

J.P. Morgan Chase & Co.

 

1,267,825

 

7,676,232

 

 

 

8,944,057

 

 

 

76,000

 

 

 

76,000

 

KeyCorp (a)

 

 

 

2,576,400

 

 

 

2,576,400

 

 

 

21,750

 

 

 

21,750

 

Legg Mason, Inc.

 

 

 

1,593,405

 

 

 

1,593,405

 

7,200

 

41,300

 

 

 

48,500

 

Lehman Brothers Holdings, Inc. (a)

 

629,856

 

3,612,924

 

 

 

4,242,780

 

70,200

 

183,500

 

 

 

253,700

 

MBNA Corp.

 

1,978,938

 

5,172,865

 

 

 

7,151,803

 

 

F-5



 

AST AllianceBernstein
Growth + Value

 

AST AllianceBernstein
Managed Index 500

 

ProForma
Adjustment

 

ProForma Combined

 

 

 

AST AllianceBernstein
Growth + Value

 

AST AllianceBernstein
Managed Index 500

 

ProForma
Adjustment

 

ProForma
Combined

 

 

 

59,000

 

 

 

59,000

 

Merrill Lynch & Co., Inc.

 

 

 

3,526,430

 

 

 

3,526,430

 

 

 

46,900

 

 

 

46,900

 

Morgan Stanley Dean Witter & Co.

 

 

 

2,603,888

 

 

 

2,603,888

 

 

 

39,100

 

 

 

39,100

 

PNC Financial Services Group

 

 

 

2,245,904

 

 

 

2,245,904

 

 

 

 

 

 

 

 

 

 

 

8,782,825

 

53,518,021

 

 

 

62,300,846

 

 

 

 

 

 

 

 

 

Food – 1.2%, 1.3%, 1.3%

 

 

 

 

 

 

 

 

 

 

 

23,200

 

 

 

23,200

 

Albertsons, Inc. (a)

 

 

 

554,016

 

 

 

554,016

 

 

 

52,808

 

 

 

52,808

 

Archer-Daniels-Midland Co.

 

 

 

1,178,146

 

 

 

1,178,146

 

 

 

20,800

 

 

 

20,800

 

Dean Foods Co.*

 

 

 

685,360

 

 

 

685,360

 

 

 

63,500

 

 

 

63,500

 

General Mills, Inc.

 

 

 

3,156,585

 

 

 

3,156,585

 

28,275

 

86,100

 

 

 

114,375

 

Safeway, inc.* (a)

 

558,149

 

1,699,614

 

 

 

2,257,763

 

6,000

 

 

 

 

 

6,000

 

Unilever NV

 

400,260

 

 

 

 

 

400,260

 

 

 

 

 

 

 

 

 

 

 

958,409

 

7,273,721

 

 

 

8,232,130

 

 

 

 

 

 

 

 

 

Healthcare Services – 4.9%, 2.4%, 2.7%

 

 

 

 

 

 

 

 

 

10,500

 

85,700

 

 

 

96,200

 

Caremark Rx, Inc.* (a)

 

414,015

 

3,379,151

 

 

 

3,793,166

 

14,600

 

24,200

 

 

 

38,800

 

HCA, Inc.(a)

 

583,416

 

967,032

 

 

 

1,550,448

 

 

 

80,000

 

 

 

80,000

 

Health Management Associates, Inc. (Class “A” Stock) (a)

 

 

 

1,817,600

 

 

 

1,817,600

 

16,300

 

 

 

 

 

16,300

 

Medco Health Solutions, Inc.*

 

678,080

 

 

 

 

 

678,080

 

24,000

 

86,000

 

 

 

110,000

 

UnitedHealth Group, Inc.

 

2,112,720

 

7,570,580

 

 

 

9,683,300

 

 

 

 

 

 

 

 

 

 

 

3,788,231

 

13,734,363

 

 

 

17,522,594

 

 

 

 

 

 

 

 

 

Industrial Products – 0.5%, 0.2%, 0.2%

 

 

 

 

 

 

 

 

 

6,300

 

13,900

 

 

 

20,200

 

Cooper Industries Ltd. (Class “A” Stock)

 

427,707

 

943,671

 

 

 

1,371,378

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Insurance – 5.1%, 6.4%, 6.3%

 

 

 

 

 

 

 

 

 

 

 

42,500

 

 

 

42,500

 

ACE Ltd.

 

 

 

1,816,875

 

 

 

1,816,875

 

 

 

21,300

 

 

 

21,300

 

AFLAC, Inc.

 

 

 

848,592

 

 

 

848,592

 

 

 

32,000

 

 

 

32,000

 

Allstate Corp. (The)

 

 

 

1,655,040

 

 

 

1,655,040

 

21,200

 

183,487

 

 

 

204,687

 

American International Group, Inc.

 

1,392,204

 

12,049,591

 

 

 

13,441,795

 

 

 

45,400

 

 

 

45,400

 

Axis Capital Holdings Ltd.

 

 

 

1,242,144

 

 

 

1,242,144

 

14,500

 

33,900

 

 

 

48,400

 

Chubb Corp. (a)

 

1,115,050

 

2,606,910

 

 

 

3,721,960

 

 

 

20,200

 

 

 

20,200

 

CIGNA Corp.

 

 

 

1,647,714

 

 

 

1,647,714

 

 

 

47,100

 

 

 

47,100

 

Hartford Financial Services Group, Inc. (The)

 

 

 

3,264,501

 

 

 

3,264,501

 

 

 

44,800

 

 

 

44,800

 

Lincoln National Corp.

 

 

 

2,091,264

 

 

 

2,091,264

 

14,500

 

 

 

 

 

14,500

 

MetLife, Inc.

 

587,395

 

 

 

 

 

587,395

 

12,698

 

64,695

 

 

 

77,393

 

St. Paul Cos., Inc.

 

470,715

 

2,398,244

 

 

 

2,868,959

 

1,200

 

 

 

 

 

1,200

 

Torchmark Corp.

 

68,568

 

 

 

 

 

68,568

 

 

 

35,300

 

 

 

35,300

 

WellPoint, Inc.*

 

 

 

4,059,500

 

 

 

4,059,500

 

4,300

 

30,500

 

 

 

34,800

 

XL Capital Ltd. (Class “A” Stock) (a)

 

333,895

 

2,368,325

 

 

 

2,702,220

 

 

 

 

 

 

 

 

 

 

 

3,967,827

 

36,048,700

 

 

 

40,016,527

 

 

 

 

 

 

 

 

 

Internet Services – 7.0%, 3.3%, 3.7%

 

 

 

 

 

 

 

 

 

16,200

 

82,800

 

 

 

99,000

 

eBay, Inc.* (a)

 

1,883,736

 

9,627,984

 

 

 

11,511,720

 

2,300

 

 

 

 

 

2,300

 

Google, Inc. (Class “A” Stock)* (a)

 

444,130

 

 

 

 

 

444,130

 

34,800

 

67,100

 

 

 

101,900

 

Juniper Networks, Inc.*(a)

 

946,212

 

1,824,449

 

 

 

2,770,661

 

56,800

 

182,200

 

 

 

239,000

 

Yahoo!, Inc.*(a)

 

2,140,224

 

6,865,296

 

 

 

9,005,520

 

 

 

 

 

 

 

 

 

 

 

5,414,302

 

18,317,729

 

 

 

23,732,031

 

 

 

 

 

 

 

 

 

Machinery & Equipment – 0.0%, 0.4%, 0.3%

 

 

 

 

 

 

 

 

 

 

 

28,700

 

 

 

28,700

 

Eaton Corp.

 

 

 

2,076,732

 

 

 

2,076,732

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Medical Supplies & Equipment – 5.6%, 4.2%, 4.4%

 

 

 

 

 

 

 

 

 

 

 

17,700

 

 

 

17,700

 

Abbott Laboratories

 

 

 

825,705

 

 

 

825,705

 

11,000

 

16,600

 

 

 

27,600

 

Alcon, Inc. (Switzerland)

 

886,600

 

1,337,960

 

 

 

2,224,560

 

29,600

 

132,200

 

 

 

161,800

 

Amgen, Inc.*

 

1,898,840

 

8,480,630

 

 

 

10,379,470

 

 

 

55,000

 

 

 

55,000

 

Applera Corp. - Applied Biosystems Group

 

 

 

1,150,050

 

 

 

1,150,050

 

 

 

22,200

 

 

 

22,200

 

Beckman Coulter, Inc.

 

 

 

1,487,178

 

 

 

1,487,178

 

12,500

 

124,200

 

 

 

136,700

 

Boston Scientific Corp.*

 

444,375

 

4,415,310

 

 

 

4,859,685

 

9,400

 

68,000

 

 

 

77,400

 

St. Jude Medical, Inc.*

 

394,142

 

2,851,240

 

 

 

3,245,382

 

9,600

 

40,400

 

 

 

50,000

 

Zimmer Holdings, Inc.*

 

769,152

 

3,236,848

 

 

 

4,006,000

 

 

 

 

 

 

 

 

 

 

 

4,393,109

 

23,784,921

 

 

 

28,178,030

 

 

 

 

 

 

 

 

 

Metals & Mining – 0.0%, 0.9%, 0.8%

 

 

 

 

 

 

 

 

 

 

 

19,000

 

 

 

19,000

 

Alcan, Inc. (Canada)

 

 

 

931,760

 

 

 

931,760

 

 

 

29,800

 

 

 

29,800

 

Alcoa, Inc.

 

 

 

936,316

 

 

 

936,316

 

 

 

50,400

 

 

 

50,400

 

United States Steel Corp. (a)

 

 

 

2,583,000

 

 

 

2,583,000

 

 

 

29,200

 

 

 

29,200

 

Worthington Industries, Inc.

 

 

 

571,736

 

 

 

571,736

 

 

 

 

 

 

 

 

 

 

 

 

 

5,022,812

 

 

 

5,022,812

 

 

 

 

 

 

 

 

 

Office Equipment – 0.0%, 0.1%, 0.1%

 

 

 

 

 

 

 

 

 

 

 

13,000

 

 

 

13,000

 

Pitney Bowes, Inc.

 

 

 

601,640

 

 

 

601,640

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Oil & Gas – 5.7%, 6.5%, 6.4%

 

 

 

 

 

 

 

 

 

 

 

47,400

 

 

 

47,400

 

Baker Hughes, Inc.

 

 

 

2,022,558

 

 

 

2,022,558

 

13,900

 

18,100

 

 

 

32,000

 

BP PLC [ADR] (United Kingdom)

 

811,760

 

1,057,040

 

 

 

1,868,800

 

13,700

 

127,876

 

 

 

141,576

 

ChevronTexaco Corp.

 

719,387

 

6,714,769

 

 

 

7,434,156

 

12,800

 

56,453

 

 

 

69,253

 

ConocoPhillips

 

1,111,424

 

4,901,814

 

 

 

6,013,238

 

 

 

79,500

 

 

 

79,500

 

El Paso Corp.

 

 

 

826,800

 

 

 

826,800

 

 

 

256,900

 

 

 

256,900

 

Exxon Mobil Corp.

 

 

 

13,168,694

 

 

 

13,168,694

 

 

F-6



 

AST AllianceBernstein
Growth + Value

 

AST AllianceBernstein
Managed Index 500

 

ProForma
Adjustment

 

ProForma Combined

 

 

 

AST AllianceBernstein
Growth + Value

 

AST AllianceBernstein
Managed Index 500

 

ProForma
Adjustment

 

ProForma
Combined

 

 

 

16,100

 

 

 

16,100

 

FMC Technologies, Inc.*

 

 

 

518,420

 

 

 

518,420

 

 

 

48,000

 

 

 

48,000

 

Marathon Oil Corp.

 

 

 

1,805,280

 

 

 

1,805,280

 

14,900

 

36,500

 

 

 

51,400

 

Nabors Industries Ltd.*

 

764,221

 

1,872,085

 

 

 

2,636,306

 

18,200

 

38,300

 

 

 

56,500

 

Occidental Petroleum Corp.

 

1,062,152

 

2,235,188

 

 

 

3,297,340

 

 

 

46,000

 

 

 

46,000

 

XTO Energy, Inc.

 

 

 

1,627,480

 

 

 

1,627,480

 

 

 

 

 

 

 

 

 

 

 

4,468,944

 

36,750,128

 

 

 

41,219,072

 

 

 

 

 

 

 

 

 

Paper & Forest Products – 1.0%, 0.5%, 0.6%

 

 

 

 

 

 

 

 

 

 

 

14,700

 

 

 

14,700

 

GeorgiaPacific Corp.

 

 

 

550,956

 

 

 

550,956

 

7,000

 

38,600

 

 

 

45,600

 

International Paper Co.

 

294,000

 

1,621,200

 

 

 

1,915,200

 

14,600

 

 

 

 

 

14,600

 

MeadWestvaco Corp.

 

494,794

 

 

 

 

 

494,794

 

1

 

 

 

 

 

1

 

Neenah Paper, Inc.*

 

33

 

 

 

 

 

33

 

 

 

9,100

 

 

 

9,100

 

Temple-Inland, Inc.

 

 

 

622,440

 

 

 

622,440

 

 

 

 

 

 

 

 

 

 

 

788,827

 

2,794,596

 

 

 

3,583,423

 

 

 

 

 

 

 

 

 

Personal Services 0.0%, 0.5%, 0.4%

 

 

 

 

 

 

 

 

 

 

 

33,400

 

 

 

33,400

 

Apollo Group, Inc. (Class “A” Stock)* (a)

 

 

 

2,695,714

 

 

 

2,695,714

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Pharmaceuticals – 3.4%, 3.4%, 3.4%

 

 

 

 

 

 

 

 

 

 

 

60,600

 

 

 

60,600

 

BristolMeyers Squibb Co. (a)

 

 

 

1,552,572

 

 

 

1,552,572

 

 

 

24,000

 

 

 

24,000

 

Cephalon, Inc.*

 

 

 

1,221,120

 

 

 

1,221,120

 

 

 

54,600

 

 

 

54,600

 

Forest Laboratories, Inc.* (a)

 

 

 

2,449,356

 

 

 

2,449,356

 

6,200

 

 

 

 

 

6,200

 

GlaxoSmithKline PLC [ADR] (United Kingdom)

 

293,818

 

 

 

 

 

293,818

 

 

 

6,500

 

 

 

6,500

 

Lilly, (Eli) & Co.

 

 

 

368,875

 

 

 

368,875

 

 

 

41,200

 

 

 

41,200

 

Merck & Co., Inc.(a)

 

 

 

1,324,168

 

 

 

1,324,168

 

57,700

 

461,120

 

 

 

518,820

 

Pfizer, Inc.

 

1,551,553

 

12,399,517

 

 

 

13,951,070

 

26,300

 

 

 

 

 

26,300

 

Teva Pharmaceutical Industries Ltd. [ADR] (Israel) (a)

 

785,318

 

 

 

 

 

785,318

 

 

 

 

 

 

 

 

 

 

 

2,630,689

 

19,315,608

 

 

 

21,946,297

 

 

 

 

 

 

 

 

 

Printing & Publishing – 0.0%, 0.3%, 0.3%

 

 

 

 

 

 

 

 

 

 

 

48,000

 

 

 

48,000

 

Donnelley, (R.R.) & Sons Co.

 

 

 

1,693,920

 

 

 

1,693,920

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Railroads – 3.7%, 0.7%, 1.1%

 

 

 

 

 

 

 

 

 

19,000

 

15,000

 

 

 

34,000

 

Burlington Northern Santa Fe Corp.

 

898,890

 

709,650

 

 

 

1,608,540

 

18,900

 

47,300

 

 

 

66,200

 

CSX Corp.

 

757,512

 

1,895,784

 

 

 

2,653,296

 

33,400

 

38,400

 

 

 

71,800

 

Norfolk Southern Corp.

 

1,208,746

 

1,389,696

 

 

 

2,598,442

 

 

 

 

 

 

 

 

 

 

 

2,865,148

 

3,995,130

 

 

 

6,860,278

 

 

 

 

 

 

 

 

 

Real Estate – 0.0%, 0.5%, 0.4%

 

 

 

 

 

 

 

 

 

 

 

44,500

 

 

 

44,500

 

Equity Office Properties Trust [REIT]

 

 

 

1,295,840

 

 

 

1,295,840

 

 

 

35,000

 

 

 

35,000

 

Equity Residential Properties Trust [REIT]

 

 

 

1,266,300

 

 

 

1,266,300

 

 

 

 

 

 

 

 

 

 

 

 

 

2,562,140

 

 

 

2,562,140

 

 

 

 

 

 

 

 

 

Restaurants – 1.3%, 1.4%, 1.3%

 

 

 

 

 

 

 

 

 

18,000

 

63,200

 

 

 

81,200

 

McDonald’s Corp.

 

577,080

 

2,026,192

 

 

 

2,603,272

 

6,600

 

69,000

 

 

 

75,600

 

Starbucks Corp.* (a)

 

411,576

 

4,302,840

 

 

 

4,714,416

 

 

 

33,000

 

 

 

33,000

 

Wendy’s International, Inc.

 

 

 

1,295,580

 

 

 

1,295,580

 

 

 

 

 

 

 

 

 

 

 

988,656

 

7,624,612

 

 

 

8,613,268

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Retail & Merchandising –5.4%, 7.1%, 6.8%

 

 

 

 

 

 

 

 

 

7,000

 

31,400

 

 

 

38,400

 

Bed Bath & Beyond, Inc.* (a)

 

278,810

 

1,250,662

 

 

 

1,529,472

 

4,600

 

33,900

 

 

 

38,500

 

Federated Department Stores, Inc.

 

265,834

 

1,959,081

 

 

 

2,224,915

 

 

 

178,700

 

 

 

178,700

 

Home Depot, Inc.

 

 

 

7,637,638

 

 

 

7,637,638

 

34,000

 

 

 

 

 

34,000

 

Kroger Co. (The) * (a)

 

596,360

 

 

 

 

 

596,360

 

20,300

 

108,400

 

 

 

128,700

 

Lowe’s Cos., Inc. (a)

 

1,169,077

 

6,242,756

 

 

 

7,411,833

 

 

 

39,500

 

 

 

39,500

 

May Department Stores Co. (a)

 

 

 

1,161,300

 

 

 

1,161,300

 

23,300

 

 

 

 

 

23,300

 

Office Depot, Inc.*

 

404,488

 

 

 

 

 

404,488

 

 

 

21,400

 

 

 

21,400

 

OfficeMax, Inc.

 

 

 

671,532

 

 

 

671,532

 

 

 

183,100

 

 

 

183,100

 

Rite Aid Corp. *

 

 

 

670,146

 

 

 

670,146

 

 

 

30,000

 

 

 

30,000

 

Saks, Inc. (a)

 

 

 

435,300

 

 

 

435,300

 

 

 

31,900

 

 

 

31,900

 

SUPERVALU, Inc.

 

 

 

1,101,188

 

 

 

1,101,188

 

20,400

 

94,300

 

 

 

114,700

 

Target Corp.

 

1,059,372

 

4,896,999

 

 

 

5,956,371

 

 

 

100,100

 

 

 

100,100

 

TJX Cos., Inc.

 

 

 

2,515,513

 

 

 

2,515,513

 

7,900

 

171,200

 

 

 

179,100

 

WalMart Stores, Inc.

 

417,278

 

9,042,784

 

 

 

9,460,062

 

 

 

51,500

 

 

 

51,500

 

WilliamsSonoma, Inc.*

 

 

 

1,804,560

 

 

 

1,804,560

 

 

 

 

 

 

 

 

 

 

 

4,191,219

 

39,389,459

 

 

 

43,580,678

 

 

 

 

 

 

 

 

 

Semiconductors – 1.5%, 1.5%, 1.5%

 

 

 

 

 

 

 

 

 

24,500

 

36,900

 

 

 

61,400

 

Broadcom Corp. (Class “A” Stock)*

 

790,860

 

1,191,132

 

 

 

1,981,992

 

 

 

8,612

 

 

 

8,612

 

Freescale Semiconductor, Inc. (Class “B” Stock)*

 

 

 

158,116

 

 

 

158,116

 

 

 

268,880

 

 

 

268,880

 

Intel Corp.

 

 

 

6,289,104

 

 

 

6,289,104

 

11,100

 

26,600

 

 

 

37,700

 

Marvell Technology Group Ltd.*

 

393,717

 

943,502

 

 

 

1,337,219

 

 

 

 

 

 

 

 

 

 

 

1,184,577

 

8,581,854

 

 

 

9,766,431

 

 

 

 

 

 

 

 

 

Telecommunications – 4.3%, 4.3%, 4.3%

 

 

 

 

 

 

 

 

 

 

 

14,000

 

 

 

14,000

 

ALLTEL Corp.

 

 

 

822,640

 

 

 

822,640

 

 

 

76,000

 

 

 

76,000

 

BellSouth Corp.

 

 

 

2,112,040

 

 

 

2,112,040

 

74,300

 

78,000

 

 

 

152,300

 

Corning, Inc.*(a)

 

874,511

 

918,060

 

 

 

1,792,571

 

 

 

259,000

 

 

 

259,000

 

Lucent Technologies, Inc.*

 

 

 

973,840

 

 

 

973,840

 

 

 

78,000

 

 

 

78,000

 

Motorola, Inc.

 

 

 

1,341,600

 

 

 

1,341,600

 

 

F-7



 

AST AllianceBernstein
Growth + Value

 

AST AllianceBernstein
Managed Index 500

 

ProForma
Adjustment

 

ProForma Combined

 

 

 

AST AllianceBernstein
Growth + Value

 

AST AllianceBernstein
Managed Index 500

 

ProForma
Adjustment

 

ProForma
Combined

 

 

 

67,400

 

 

 

67,400

 

Nextel Communications, Inc. (Class “A” Stock)* (a)

 

 

 

2,022,000

 

 

 

2,022,000

 

36,700

 

 

 

 

 

36,700

 

Nortel Networks Corp. (Canada)*

 

128,083

 

 

 

 

 

128,083

 

29,000

 

124,000

 

 

 

153,000

 

Qualcomm, Inc.

 

1,229,600

 

5,257,600

 

 

 

6,487,200

 

4,400

 

 

 

 

 

4,400

 

Research in Motion Ltd. (Canada) * (a)

 

362,648

 

 

 

 

 

362,648

 

 

 

145,200

 

 

 

145,200

 

SBC Communications, Inc.

 

 

 

3,741,804

 

 

 

3,741,804

 

19,100

 

64,000

 

 

 

83,100

 

Sprint Corp.

 

474,635

 

1,590,400

 

 

 

2,065,035

 

30,700

 

70,000

 

 

 

100,700

 

Tellabs, Inc.*

 

263,713

 

601,300

 

 

 

865,013

 

 

 

117,700

 

 

 

117,700

 

Verizon Communications, Inc.

 

 

 

4,768,027

 

 

 

4,768,027

 

 

 

 

 

 

 

 

 

 

 

3,333,190

 

24,149,311

 

 

 

27,482,501

 

 

 

 

 

 

 

 

 

Transportation – 0.0%, 1.1%, 1.0%

 

 

 

 

 

 

 

 

 

 

 

71,600

 

 

 

71,600

 

United Parcel Service, Inc. (Class “B” Stock) (a)

 

 

 

6,118,936

 

 

 

6,118,936

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Utilities – 2.4%, 2.2%, 2.3%

 

 

 

 

 

 

 

 

 

21,600

 

61,160

 

 

 

82,760

 

American Electric Power Co., Inc.(a)

 

741,744

 

2,100,234

 

 

 

2,841,978

 

 

 

20,700

 

 

 

20,700

 

Constellation Energy Group, Inc.

 

 

 

904,797

 

 

 

904,797

 

 

 

42,000

 

 

 

42,000

 

DTE Energy Co.(a)

 

 

 

1,811,460

 

 

 

1,811,460

 

9,900

 

26,500

 

 

 

36,400

 

Entergy Corp.

 

669,141

 

1,791,135

 

 

 

2,460,276

 

 

 

50,500

 

 

 

50,500

 

FirstEnergy Corp.

 

 

 

1,995,255

 

 

 

1,995,255

 

 

 

5,600

 

 

 

5,600

 

FPL Group, Inc.

 

 

 

418,600

 

 

 

418,600

 

 

 

15,900

 

 

 

15,900

 

PPL Corp.

 

 

 

847,152

 

 

 

847,152

 

 

 

42,500

 

 

 

42,500

 

Progress Energy, Inc.

 

 

 

1,922,700

 

 

 

1,922,700

 

12,500

 

22,900

 

 

 

35,400

 

Sempra Energy (a)

 

458,500

 

839,972

 

 

 

1,298,472

 

 

 

 

 

 

 

 

 

 

 

1,869,385

 

12,631,305

 

 

 

14,500,690

 

 

 

 

 

 

 

 

 

TOTAL LONGTERM INVESTMENTS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Cost $63,605,220, $486,326,325, $549,931,545)

 

75,023,417

 

558,507,248

 

 

 

633,530,665

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Par

 

Par

 

 

 

Par

 

 

 

 

 

 

 

 

 

 

 

(000)

 

(000)

 

 

 

(000)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SHORTTERM INVESTMENTS – 20.9%,10.4%, 11.7%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Certificate of Deposit – 4.5%, 1.0%, 1.4%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Banco Santander PR

 

 

 

 

 

 

 

 

 

1,688

 

 

 

 

 

1,688

 

2.315%, 01/07/05 (b) (c)

 

1,687,929

 

 

 

 

 

1,687,929

 

 

 

 

 

 

 

 

 

Canadian Imperial Bank of Commerce

 

 

 

 

 

 

 

 

 

 

 

3,026

 

 

 

3,026

 

1.72%, 05/25/05 (b) (c)

 

 

 

3,025,125

 

 

 

3,025,125

 

 

 

 

 

 

 

 

 

First Boston Corp.

 

 

 

 

 

 

 

 

 

779

 

1,263

 

 

 

2,042

 

2.36%, 01/24/05 (b)

 

779,625

 

1,262,630

 

 

 

2,042,255

 

 

 

 

 

 

 

 

 

Skandinaviska Enskilda Banken

 

 

 

 

 

 

 

 

 

482

 

 

 

 

 

482

 

2.35%, 01/28/05 (b)

 

481,688

 

 

 

 

 

481,688

 

 

 

 

 

 

 

 

 

Societe Generale

 

 

 

 

 

 

 

 

 

564

 

955

 

 

 

1,519

 

2.357%, 01/14/05 (b)

 

563,966

 

954,405

 

 

 

1,518,371

 

 

 

 

 

 

 

 

 

UBS Bank

 

 

 

 

 

 

 

 

 

 

 

105

 

 

 

105

 

2.315%, 01/18/05 (b)

 

 

 

105,118

 

 

 

105,118

 

 

 

 

 

 

 

 

 

 

 

3,513,208

 

5,347,278

 

 

 

8,860,486

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial Paper – 2.7%, 0.0%, 0.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Citigroup, Inc.

 

 

 

 

 

 

 

 

 

1,749

 

22

 

 

 

1,771

 

2.304%, 01/10/05 (b)

 

1,745,363

 

21,786

 

 

 

1,767,149

 

 

 

 

 

 

 

 

 

Ticonderoga Funding, LLC

 

 

 

 

 

 

 

 

 

335

 

 

 

 

 

335

 

2.35%, 01/14/05 (b)

 

334,720

 

 

 

 

 

334,720

 

 

 

 

 

 

 

 

 

 

 

2,080,083

 

21,786

 

 

 

2,101,869

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate Obligations – 8.5%, 7.4%, 7.6%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bear Stearns

 

 

 

 

 

 

 

 

 

 

 

2,460

 

 

 

2,460

 

2.28%, 01/03/05 (b) (c)

 

 

 

2,459,670

 

 

 

2,459,670

 

 

 

180

 

 

 

180

 

2.28%, 01/03/05 (b) (c)

 

 

 

179,928

 

 

 

179,928

 

 

 

 

 

 

 

 

 

Goldman Sachs Group, Inc.

 

 

 

 

 

 

 

 

 

2,969

 

8,692

 

 

 

11,661

 

2.33%, 01/03/05 (b) (c)

 

2,969,376

 

8,691,531

 

 

 

11,660,907

 

 

 

 

 

 

 

 

 

Merrill Lynch & Co., Inc.

 

 

 

 

 

 

 

 

 

2,409

 

11,625

 

 

 

14,034

 

2.38%,01/03/05 (b) (c)

 

2,408,753

 

11,624,810

 

 

 

14,033,563

 

 

 

 

 

 

 

 

 

Morgan Stanley

 

 

 

 

 

 

 

 

 

 

 

3,174

 

 

 

3,174

 

2.33%, 01/03/05 (b) (c)

 

 

 

3,174,290

 

 

 

3,174,290

 

 

 

4,655

 

 

 

4,655

 

2.33%, 01/03/05 (b) (c)

 

 

 

4,655,074

 

 

 

4,655,074

 

 

 

 

 

 

 

 

 

Natexis Banque NY

 

 

 

 

 

 

 

 

 

1,180

 

7,008

 

 

 

8,188

 

2.297%, 01/03/05 (b) (c)

 

1,179,637

 

7,007,179

 

 

 

8,186,816

 

 

 

 

 

 

 

 

 

Sedna Finance Corporation

 

 

 

 

 

 

 

 

 

 

 

479

 

 

 

479

 

2.372%, 01/14/05 (b) (c)

 

 

 

478,899

 

 

 

478,899

 

 

 

 

 

 

 

 

 

Swedbank NY

 

 

 

 

 

 

 

 

 

53

 

3,987

 

 

 

4,040

 

2.362%, 01/18/05 (b) (c)

 

53,099

 

3,986,611

 

 

 

4,039,710

 

 

 

 

 

 

 

 

 

 

 

6,610,865

 

42,257,992

 

 

 

48,868,857

 

 

 

 

 

 

 

 

 

Time Deposit – 0.7%, 0.5%, 0.5%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Bank of America NA

 

 

 

 

 

 

 

 

 

579

 

2,554

 

 

 

3,133

 

1.50%, 01/03/05 (b)

 

578,634

 

2,554,326

 

 

 

3,132,960

 

 

F-8



 

AST AllianceBernstein
Growth + Value
Shares

 

AST AllianceBernstein
Managed Index 500
Shares

 

ProForma
Adjustment
Shares

 

ProForma Combined

 

 

 

AST AllianceBernstein
Growth + Value

 

AST AllianceBernstein
Managed Index 500

 

ProForma
Adjustment

                       

ProForma
Combined

 

 

 

 

 

 

 

 

 

NonRegistered Investment Company – 2.5%, 1.0%, 1.2%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

BlackRock Institutional Money Market

 

 

 

 

 

 

 

 

 

1,952,725

 

5,597,143

 

 

 

7,549,868

 

Trust (b)(d)

 

1,952,725

 

5,597,143

 

 

 

7,549,868

 

 

 

 

 

 

 

 

 

Registered Investment Companies – 2.0%, 0.5%, 0.7%

 

 

 

 

 

 

 

 

 

777,502

 

1,370,653

 

 

 

2,148,155

 

BlackRock Provident Institutional Funds

 

777,502

 

1,370,653

 

 

 

2,148,155

 

 

 

 

 

 

 

 

 

TempCash Portfolio (d)

 

 

 

 

 

 

 

 

 

777,501

 

1,370,653

 

 

 

2,148,154

 

BlackRock Provident Institutional Funds

 

777,501

 

1,370,653

 

 

 

2,148,154

 

 

 

 

 

 

 

 

 

TempFund Portfolio (d)

 

1,555,003

 

2,741,306

 

 

 

4,296,309

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

TOTAL SHORT-TERM INVESTMENTS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Cost $16,290,518, $58,519,831, $74,810,349)

 

16,290,518

 

58,519,831

 

 

 

74,810,349

 

 

 

 

 

 

 

 

 

Total Investments — 117.2%, 109.9%, 110.7%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Cost $79,895,738, $544,846,156, $624,741,894; Note 5)

 

91,313,935

 

617,027,079

 

 

 

708,341,014

 

 

 

 

 

 

 

 

 

Liabilities in Excess of Other Assets — (17.2%), (9.9%), (10.7%)

 

(13,392,146

)

(55,361,321

)

 

 

(68,753,467

)

 

 

 

 

 

 

 

 

Net Assets — 100.0%

 

$

77,921,789

 

$

561,665,758

 

 

 

$

639,587,547

 

 

The following abbreviations and annotations are used throughout the Schedule of Investments:

ADR                                                  American Depository Receipt

REIT                                                  Real Estate Investment Trust

 


The following annotations are used throughout the Schedule of Investments.

 

*

 

Non-income producing security.

(a)

 

All or a portion of securities on loan. Securities on loan have an aggregate market value of $14,205,920, $53,818,285 and $68,024,205, respectively; cash collateral of $14,735,515, $55,778,525 and $70,514,040, respectively, was received with which the portfolio purchased highly liquid short-term investments.

(b)

 

Represents security purchased with collateral for securities on loan.

(c)

 

Indicates a variable rate security. The maturity date presented for these instruments is the next date on which the rate of interest is adjusted. The interest rate show reflects the rate in effect at December 31, 2004.

(d)

 

Security available to institutional investors only.

 

See Notes to Pro Forma Financial Statements.

 

F-9



 

American Skandia Trust

Notes to Pro-Forma Financial Statements for the merger of
AST AllianceBernstein Growth + Value Portfolio into AST AllianceBernstein Managed Index 500 Portfolio

(Unaudited)

 

1.               Basis of Combination – The Pro-Forma Statement of Assets and Liabilities, including the Pro Forma Schedule of Investments at December 31, 2004 and the related Pro Forma Statement of Operations (“Pro Forma Statements”) for the year ended December 31, 2004, reflect the accounts of the AST AllianceBernstein Growth + Value Portfolio and the AST AllianceBernstein Managed Index 500 Portfolio, each a “Portfolio.”

 

The Pro Forma Statements give effect to the proposed transfer of all assets and liabilities of AST AllianceBernstein Growth + Value Portfolio in exchange for shares of AST AllianceBernstein Managed Index 500 Portfolio. The Pro Forma Statements should be read in conjunction with the historical financial statements of each Portfolio included in their respective Statement of Additional Information.  As of December 31, 2004, all of the securities held by the AST AllianceBernstein Growth + Value Portfolio would comply with the compliance guidelines and investment restrictions of the AST AllianceBernstein Managed Index 500 Portfolio.  Following the proposed reorganization, the AST AllianceBernstein Managed Index 500 Portfolio will be the accounting survivor.

 

2.      Common Stock – The pro-forma net asset value per share assumes the issuance of additional shares of AST AllianceBernstein Managed Index 500 Portfolio , which would have been issued on December 31, 2004 in connection with the proposed reorganization. Shareholders of AST AllianceBernstein Growth + Value Portfolio would become shareholders of AST AllianceBernstein Managed Index 500 Portfolio, receiving shares of AST AllianceBernstein Managed Index 500 Portfolio, equal to the value of their holdings in AST AllianceBernstein Growth + Value Portfolio.  The amount of additional shares assumed to be issued has been calculated based on the December 31, 2004 net assets of AST AllianceBernstein Growth + Value Portfolio and AST AllianceBernstein Managed Index 500 Portfolio. The net asset value per share of $11.97 was used to calculate additional 6,508,792 shares of AST AllianceBernstein Managed Index 500 Portfolio for the $77,921,789 of net assets of AST AllianceBernstein Growth + Value.

 

3.               Pro Forma Operations – The Pro Forma Statement of Operations assumes similar rates of gross investment income for the investments of each Portfolio.  Accordingly, the combined gross investment income is equal to the sum of each Portfolio’s gross investment income.  Certain expenses have been adjusted to reflect the expected expenses of the combined entity.  The pro forma advisory fees of the combined Portfolio are based on the fee schedule in effect for the AST AllianceBernstein Managed Index 500 Portfolio at the combined level of average net assets for the twelve months ended December 31, 2004.  The Pro Forma Statement of Operations does not include the effect of any realized gains or losses, or transaction fees incurred in connection with the realignment of the Portfolio.  No securities have been sold or will be sold in anticipation of the merger.

 

4.               Security Valuation – Securities listed on a securities exchange are valued at the last sale price on such exchange on the day of valuation or, if there was no sale on such day, at the mean between the last reported bid and asked prices, or at the last bid price on such day in the absence of an asked price.  Securities traded via NASDAQ are valued at the NASDAQ official closing price (NOCP) on the day of valuation, or if there was no NOCP, at the last sale price.  Securities that are actively traded in the over-the-counter market, including listed securities for which the co-managers, in consultation with the Sub-advisor, believe the primary market to be over-the-counter are valued by an independent agent or principal market maker.  Options on securities and indices traded on an exchange are valued at the last sale price as of the close of trading on the applicable exchange or, if there was no sale, at the mean between the most recently quoted bid and asked prices on such exchange.  Futures contracts and options thereon traded on a commodities exchange or board of trade are valued at the last sale price at the closing of trading on such exchange or board of trade or, if there was no sale on the applicable commodities exchange or board of trade on such day, at the mean between the most recently quoted bid and asked prices on such exchange or board of trade or at the last bid price in the absence of an asked price.  Securities for which market quotations are not readily available, or whose values have

 

F-10



 

been affected by events occurring after the close of the security’s foreign market and before the Portfolio’s normal pricing time, are valued at fair value in accordance with procedures approved by the Board of Trustees.  Using fair value to price securities may result in a value that is different from a security’s most recent closing price and from the price used by other mutual funds to collect their net asset values.  Investments in mutual funds are valued at their net assets value as of the close of the New York Stock Exchange on the date of the valuation.  Short-term securities that are held in the Portfolios and that mature in more than 60 days are valued at current market quotations, and those short-term securities that mature in 60 days or less are valued at amortized cost, which approximates market value.  The amortized cost method values a security at cost at the time of purchase and thereafter assumes a constant amortization to maturity of any discount or premium.

 

5.               Estimates – The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements.  Actual results could differ from those estimates.

 

6.               Taxes – For federal income tax purposes, each Portfolio in the Trust is treated as a separate taxpaying entity.  It is each Portfolio’s policy to continue to meet the requirements of the Internal Revenue Code applicable to regulated investment companies and to distribute all of its taxable net income and capital gains, if any, to shareholders.  Therefore, no federal income tax provision is required. The AST AllianceBernstein Growth + Value Portfolio has a capital loss carryforward of $3,705,536 as of December 31, 2004, which will have an annual limitation on the amount of utilization under section 382 of the Internal Revenue Code of 1986, as amended. The AST AllianceBernstein Managed Index 500 Portfolio has a capital loss carryforward of $154,475,129 as of December 31, 2004.

 

F-11



 

PART C.         OTHER INFORMATION

 

ITEM 15.                 Indemnification

 

Section 5.2 of the Registrant’s Amended and Restated Declaration of Trust provides as follows:

 

The Trust shall indemnify each of its Trustees, Trustees Emeritus, officers, employees, and agents (including persons who serve at its request as directors, officers, employees, agents or trustees of another organization in which it has any interest as a shareholder, creditor or otherwise) against all liabilities and expenses (including amounts paid in satisfaction of judgments, in compromise, as fines and penalties, and as counsel fees) reasonably incurred by him in connection with the defense or disposition of any action, suit or other proceeding, whether civil or criminal, in which he may be involved or with which he may be threatened, while in office or thereafter, by reason of his being or having been such a trustee, trustee emeritus, officer, employee or agent, except with respect to any matter as to which he shall have been adjudicated to be liable to the Trust or its Shareholders by reason of having acted in bad faith, willful misfeasance, gross negligence or reckless disregard of his duties; provided, however, that as to any matter disposed of by a compromise payment by such person, pursuant to a consent decree or otherwise, no indemnification either for said payment or for any other expenses shall be provided unless approved as in the best interests of the Trust, after notice that it involves such indemnification, by at least a majority of the disinterested Trustees acting on the matter (provided that a majority of the disinterested Trustees then in office act on the matter) upon a determination, based upon a review of readily available facts, that (i) such person acted in good faith in the reasonable belief that his or her action was in the best interests of the Trust and (ii) is not liable to the Trust or the Shareholders by reason of willful misfeasance, bad faith, gross negligence or reckless disregard of duties; or the trust shall have received a written opinion from independent legal counsel approved by the Trustees to the effect that (x) if the matter of good faith and reasonable belief as to the best interests of the Trust, had been adjudicated, it would have been adjudicated in favor of such person, and (y) based upon a review of readily available facts such trustee, officer, employee or agent did not engage in willful misfeasance, gross negligence or reckless disregard of duty.  The rights accruing to any Person under these provisions shall not exclude any other right to which he may be lawfully entitled; provided that no Person may satisfy any right of indemnity or reimbursement granted herein or in Section 5.1 or to which he may be otherwise entitled except out of the property of the Trust, and no Shareholder shall be personally liable to any Person with respect to any claim for indemnity or reimbursement or otherwise.  The Trustees may make advance payments in connection with indemnification under this Section 5.2, provided that the indemnified person shall have given a written undertaking to reimburse the Trust in the event it is subsequently determined that he is not entitled to such indemnification and, provided further, that the Trust shall have obtained protection, satisfactory in the sole judgement of the disinterested Trustees acting on the matter (provided that a majority of the disinterested Trustees then in office act on the matter), against losses arising out of such advance payments or such Trustees , or independent legal counsel, in a written opinion, shall have determined, based upon a review of readily available facts that there is reason to believe that such person will be found to be entitled to such indemnification.

 

With respect to liability of the Investment Manager to Registrant or to shareholders of Registrant’s Portfolios under the Investment Management Agreements, reference is made to Section 13 or 14 of each form of Investment Management Agreement filed herewith or incorporated by reference herein.

 

With respect to the Sub-Advisors’ indemnification of the Investment Manager and its affiliated and controlling persons, and the Investment Manager’s indemnification of each Sub-advisor and its affiliated and controlling persons, reference is made to Section 14 of each form of Sub-Advisory Agreement filed herewith or incorporated by reference herein.

 

Insofar as indemnification for liability arising under the Securities Act of 1933 may be permitted to trustees, trustees emeritus, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission (the “Commission”) such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable.  In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant or expenses incurred or paid by a trustee, trustee emeritus, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such trustee, trustee emeritus, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

 

ITEM 16.                 Exhibits

 

(1).           Amended and Restated Declaration of Trust of Registrant. Filed as an exhibit to Post-Effective Amendment No. 50 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on February 18, 2005, and is incorporated herein by reference.

 

(2).           By-laws of Registrant. Filed as an exhibit to Post-Effective Amendment No. 50 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on February 18, 2005, and is incorporated herein by reference.

 

(3).           None.

 

(4).           Plan of Reorganization by American Skandia Trust on behalf of AST AllianceBernstein Growth + Value Portfolio and AST AllianceBernstein Managed Index 500 Portfolio: Filed herewith as Exhibit A to the Proxy Statement/Prospectus contained within this Form N-1A Registration Statement.

 

(5).           None.

 

(6).           (a)            Form of Investment Management Agreement among the Registrant, American Skandia Investment Services, Incorporated and Prudential Investments LLC for the various portfolios of the Registrant.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(b)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Goldman Sachs Asset Management for the AST Goldman Sachs Concentrated Growth Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(c)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Wells Capital Management, Inc. for the AST Money Market Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(d)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Goldman Sachs Asset Management for the AST Goldman Sachs High Yield Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(e)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and T. Rowe Price Associates, Inc. for the AST T. Rowe Price Asset Allocation Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(f)             Sub-advisory Agreement among American Skandia Investment Services Incorporated, Prudential Investments LLC and Pacific Investment Management Company for the AST PIMCO Total Return Bond Portfolio.  Filed as an exhibit to Post-Effective Amendment

 



 

No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(g)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and T. Rowe Price Associates, Inc. for the AST T. Rowe Price Natural Resources Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(h)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Pacific Investment Management Company for the AST PIMCO Limited Maturity Bond Portfolio. Filed as an Exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(i)             Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and T. Rowe Price International, Inc. for the AST T. Rowe Price Global Bond Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(j)             Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and William Blair & Company LLC for the AST William Blair International Growth Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(k)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and LSV Asset Management for the LSV International Value Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 50 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on February 18, 2005, and is incorporated herein by reference.

 

(l)             Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and American Century Investment Management, Inc. for the AST American Century Strategic Balanced Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(m)           Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and American Century Investment Management, Inc. for the AST American Century Income & Growth Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(n)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated and J. P. Morgan Investment Management, Inc. for the AST JPMorgan International Equity Portfolio. Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A,

 



 

which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(o)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated and Hotchkis and Wiley Capital Management LLC for the AST Hotchkis & Wiley Large-Cap Value Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(p)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Goldman Sachs Asset Management for the AST Goldman Sachs Small-Cap Value Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(q)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Cohen & Steers Capital Management, Inc. for the AST Cohen & Steers Realty Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(r)             Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Marsico Capital Management, LLC for the AST Marsico Capital Growth Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(s)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Neuberger Berman Management, Incorporated for the AST Neuberger Berman Mid-Cap Value Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(t)             Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Neuberger Berman Management, Incorporated for the AST Neuberger Berman Mid-Cap Growth Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(u)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Neuberger Berman Management, Inc. for the AST Small-Cap Growth Portfolio.  Filed as an Exhibit to Post-Effective Amendment No. 52 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 29, 2005, and is incorporated herein by reference.

 

(v)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Eagle Asset Management for the AST Small-Cap Growth Portfolio.  Filed as an Exhibit to Post-Effective Amendment No. 52 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 29, 2005, and is incorporated herein by reference.



 

(w)           Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Deutsche Asset Management, Inc. for the AST DeAM Small-Cap Growth Portfolio. Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(x)             Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Massachusetts Financial Services Company for the AST MFS Global Equity Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(y)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Massachusetts Financial Services Company for the AST MFS Growth Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(z)             Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Fred Alger Management, Inc. for the AST Alger All-Cap Growth Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(aa)          Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Goldman Sachs Asset Management for the AST Goldman Sachs Mid-Cap Growth Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(bb)          Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Alliance Capital Management L.P. for the AST Alliance Growth Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(cc)          Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Sanford C. Bernstein & Co., LLC for the AST Sanford Bernstein Managed Index 500 Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(dd)          Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Alliance Capital Management L.P. for the AST Alliance Growth and Income Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 



 

(ee)          Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Federated Investment Counseling for the AST Federated Aggressive Growth Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(ff)            Amendment to Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC for the AST Federated Aggressive Growth Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(gg)          Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Integrity Asset Management for the AST Small-Cap Value Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 50 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on February 18, 2005, and is incorporated herein by reference.

 

(hh)          Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Lee Munder Investments, Ltd. for the AST Small-Cap Value Portfolio. Filed as an exhibit to Post-Effective Amendment No. 50 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on February 18, 2005, and is incorporated herein by reference.

 

(ii)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and J.P. Morgan Investment Management, Inc. for the AST Small-Cap Value Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 50 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on February 18, 2005, and is incorporated herein by reference.

 

(jj)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and GAMCO Investors, Inc. for the AST Gabelli All-Cap Value Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(kk)          Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Deutsche Asset Management, Inc. for the AST DeAM Large-Cap Value Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(ll)            Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Lord Abbett & Co. for the AST Lord Abbett Bond-Debenture Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 



 

(mm)        Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC, Alliance Capital Management L.P. and Sanford C. Bernstein & Co., LLC for the AST Alliance/Bernstein Growth + Value Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(nn)          Sub-advisory Agreement among American Skandia Investment Services, Incorporated and Sanford C. Bernstein & Co., LLC for the AST Sanford Bernstein Core Value Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(oo)          Sub-advisory Agreement among American Skandia Investment Services, Incorporated, Prudential Investments LLC and Deutsche Asset Management, Inc. for the AST DeAM Small-Cap Value Portfolio.  Filed as an exhibit to Post-Effective Amendment No. 49 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 30, 2004, and is incorporated herein by reference.

 

(7).           (a)            Sales Agreement between Registrant and American Skandia Life Assurance Corporation.  Filed as an Exhibit to Post-Effective Amendment No. 25 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on March 2, 1998, and is incorporated herein by reference.

 

(b)            Sales Agreement between Registrant and Kemper Investors Life Insurance Company.  Filed as an Exhibit to Post-Effective Amendment No. 20 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on December 24, 1996, and is incorporated herein by reference.

 

(8).           None.

 

(9).           (a)            Amended and Restated Custody Agreement between Registrant and Morgan Stanley Trust Company.  Filed as an Exhibit to Post-Effective Amendment No. 27 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on October 16, 1998, and is incorporated herein by reference.

 

(b)            Foreign Custody Manager Delegation Amendment between Registrant and The Chase Manhattan Bank.  Filed as an Exhibit to Post-Effective Amendment No. 40 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on July 16, 2001, and is incorporated herein by reference.

 

(c)            Amended Custodian Agreement between Registrant and Provident National Bank.  Filed as an Exhibit to Post-Effective Amendment No. 25 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on March 2, 1998, and is incorporated herein by reference.

 

(d)            Amendment to Custodian Services Agreement between Registrant and PNC Bank, N.A.  Filed as an Exhibit to Post-Effective Amendment

 



 

No. 27 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on October 16, 1998, and is incorporated herein by reference.

 

(e)            Amendment to Custodian Services Agreement between Registrant and PFPC Trust Company.  Filed as an Exhibit to Post-Effective Amendment No. 35 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 27, 2000, and is incorporated herein by reference.

 

(f)             Amended Transfer Agency Agreement between Registrant and Provident Financial Processing Corporation.  Filed as an Exhibit to Post-Effective Amendment No. 25 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on March 2, 1998, and is incorporated herein by reference.

 

(10).         Not applicable.

 

(11).         Form of Opinion and Consent of Goodwin Procter LLP, counsel for Registrant.  Filed herewith.

 

(12).         Form of Opinion and Consent of Shearman & Sterling LLP, special tax counsel to Registrant, supporting tax matters and consequences to shareholders: Filed herewith.

 

(13).         (a)            Amended Administration Agreement between Registrant and Provident Financial Processing Corporation.  Filed as an Exhibit to Post-Effective Amendment No. 25 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on March 2, 1998, and is incorporated herein by reference.

 

(b)            Service Agreement between American Skandia Investment Services, Incorporated and Kemper Investors Life Insurance Company.  Filed as an Exhibit to Post-Effective Amendment No. 21 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on February 28, 1997, and is incorporated herein by reference.

 

(c)           Amended and Restated Participation Agreement dated June 8, 2005 by and among Registrant, American Skandia Life Assurance Corporation, American Skandia Investment Services, Inc., Prudential Investments LLC, American Skandia Marketing, Inc. and Prudential Investment Management Services LLC: Filed herewith.

 

(d)           Amended and Restated Participation Agreement dated June 8, 2005 by and among Registrant, Pruco Life Insurance Company, American Skandia Investment Services, Inc., Prudential Investments LLC, American Skandia Marketing, Inc. and Prudential Investment Management Services LLC: Filed herewith.

 

(e)           Amended and Restated Participation Agreement dated June 8, 2005 by and among Registrant, Pruco Life Insurance Company of New Jersey, American Skandia Investment Services, Inc., Prudential Investments LLC, American Skandia Marketing, Inc. and Prudential Investment Management Services LLC: Filed herewith.

 

(14).         Consent of Independent Registered Public Accounting Firm, KPMG LLP.

 

(15).         None.

 

(16).         Powers of Attorney. Filed as an Exhibit to Post-Effective Amendment No. 52 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 29, 2005, and is incorporated herein by reference.

 

(17).         Form of voting instruction card: Filed herewith.

 



 

ITEM 17.                 Undertakings

 

(1)            The undersigned registrant agrees that prior to any public reoffering of the securities registered through the use of a prospectus which is a part of this registration statement by any person or party who is deemed to be an underwriter within the meaning of Rule 145(c) of the Securities Act [17 CFR 230.145c], the reoffering prospectus will contain the information called for by the applicable registration form for the reofferings by persons who may be deemed underwriters, in addition to the information called for by the other items of the applicable form.

 

(2)            The undersigned registrant agrees that every prospectus that is filed under paragraph (1) above will be filed as a part of an amendment to the registration statement and will not be used until the amendment is effective, and that, in determining any liability under the 1933 Act, each post-effective amendment shall be deemed to be a new registration statement for the securities offered therein, and the offering of the securities at that time shall be deemed to be the initial bona fide offering of them.

 



 

SIGNATURES

 

As required by the Securities Act of 1933, as amended, this Registration Statement has been signed on behalf of the Registrant, in the City of Newark and State of New Jersey, on the 12 th day of July, 2005.

 

 

By:

/s/   David R. Odenath

 

 

 

David R. Odenath

 

 

President

 

As required by the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities indicated on the 12 th day of July, 2005.

 

Signature

 

Title

 

 

 

David R. Odenath*

 

 

Trustee and President (Principal

David R. Odenath

 

Executive Officer)

 

 

 

Grace Torres*

 

 

Treasurer (Principal

Grace Torres

 

Financial and Accounting

 

 

Officer)

 

 

 

Delayne Dedrick Gold*

 

 

Trustee

Delayne Dedrick Gold

 

 

 

 

 

Saul K. Fenster*

 

 

Trustee

Sauk K. Fenster, Ph.D.

 

 

 

 

 

Robert F. Gunia*

 

 

Trustee

Robert F. Gunia

 

 

 

 

 

W. Scott McDonald, Jr.*

 

 

Trustee and Vice-Chairman

W. Scott McDonald, Jr.

 

 

 

 

 

Thomas T. Mooney*

 

 

Trustee and Chairman

Thomas T. Mooney

 

 

 

 

 

Thomas M. O’Brien*

 

 

Trustee

Thomas M. O’Brien

 

 

 

 

 

John A. Pileski*

 

 

Trustee

John A. Pileski

 

 

 



 

F. Don Schwartz*

 

 

Trustee

F. Don Schwartz

 

 

 


 

*By:

/s/Jonathan D. Shain

 

 

 

 

 

*       Pursuant to Powers of Attorney filed as Exhibit to Post-Effective Amendment No. 52 to Registration Statement on Form N-1A, which Amendment was filed via EDGAR on April 29, 2005, and is incorporated herein by reference.

 

 

 

 

 



 

Exhibits

 

Table of Contents

 

 

Exhibit Number

 

Description

 

 

 

 

 

(11)

 

 

 

Form of Opinion and Consent of Goodwin Procter LLP, counsel for the Registrant

 

 

 

 

 

(12)

 

 

 

Form of Opinion and Consent of Shearman & Sterling LLP, special tax counsel to the Registrant

 

 

 

 

 

(13)

 

 

 

 

 

 

(c)

 

Amended and Restated Participation Agreement dated June 8, 2005 by and among Registrant, Pruco Life Insurance Company of New Jersey, American Skandia Investment Services, Inc., Prudential Investments LLC, American Skandia Marketing, Inc., and Prudential Investment Management Services LLC.

 

 

 

 

 

 

 

(d)

 

Amended and Restated Participation Agreement dated June 8, 2005 by and among Registrant, Pruco Life Insurance Company, American Skandia Investment Services, Inc., Prudential Investments LLC, American Skandia Marketing, Inc. and Prudential Investment Management Services LLC.

 

 

 

 

 

 

 

(e)

 

Amended and Restated Participation Agreement dated June 8, 2005 by and among Registrant, American Skandia Life Assurance Corporation, American Skandia Investment Services, Inc., Prudential Investments LLC, American Skandia Marketing, Inc. and Prudential Investment Management Services LLC.

 

 

 

 

 

(14)

 

 

 

Consent of Independent Registered Public Accounting Firm, KPMG LLP.

 

 

 

 

 

(17)

 

 

 

Form of voting instruction card

 


Exhibit 99.11

 

[Goodwin Procter Letterhead]

 

 

November    , 2005

 

 

American Skandia Trust
One Corporate Drive
Shelton, CT 06484

 

Ladies and Gentlemen:

 

Reference is made to the Registration Statement on Form N-14 for (the “Registration Statement”) filed with the Securities and Exchange Commission with respect to the issuance of shares (the “Shares”) of the AST AllianceBernstein Managed Index 500 Portfolio, a series of American Skandia Trust (the “Trust”), to be issued in connection with a certain plan of reorganization (the “Reorganization Agreement”) by and between the Trust, on behalf of the AST AllianceBernstein Managed Index 500 Portfolio, and the Trust on behalf of its separate series, the AST AllianceBernstein Growth + Value Portfolio, included in the Registration Statement.

 

We have examined, among other things, copies of such documents, certificates and corporate or other records as we deem necessary or appropriate for purposes of this opinion. We have assumed the genuineness of all signatures, the authenticity of all documents submitted to us, the conformity to original documents of all documents presented to us as copies thereof and the authenticity of the original documents from which any such copies were made, which assumptions we have not independently verified. As to various matters of fact material to this opinion, we have relied upon information provided by Trust officers and included in filings with the Securities and Exchange Commission.

 

In connection with this opinion it should be noted that the Trust is as an entity of the type generally known as a “Massachusetts business trust.” Under Massachusetts law, shareholders of a Massachusetts business trust may, under certain circumstances, be held personally liable for the obligations of the trust. However, the Trust’s Declaration of Trust disclaims shareholder personal liability for Trust obligations, indemnifies any shareholder of the Trust from all claims and liabilities to which such shareholder may become subject by reason of his or her being or having been a shareholder, and provides that the Trust shall reimburse the shareholder for any legal or other expenses reasonably incurred by him or her in connection with a claim or liability to which such shareholder may become subject by reason of his or her being or having been a shareholder of the Trust. Thus, the risk of a shareholder incurring financial loss on account of shareholder’s liability is limited to circumstances in which the Trust itself would be unable to meet the obligations asserted against the Trust’s assets.

 



 

The opinions set forth in this letter are based upon currently existing provisions of Massachusetts law, and rules and regulations and judicial and administrative decisions with respect thereto, and are rendered as of the date hereof. We disclaim any obligation to advise you of any change in any of the foregoing sources of law or subsequent developments in law or changes in facts or circumstances which might affect any matters or opinions set forth herein.

 

Based upon the above-described examination and subject to the foregoing, we are of the opinion that the Shares to be issued pursuant to the Registration Statement, when issued upon the terms provided in the Registration Statement, subject to compliance with the Securities Act of 1933, the Investment Company Act of 1940, and applicable state law regulating the offer and sale of securities, will be legally issued, fully paid and non-assessable by the Trust.

 

We consent to the filing of a copy of this opinion as an exhibit to the Registration Statement.

 

 

Very truly yours,

 

 

 

 

 

Goodwin Procter LLP

 

 

2


Exhibit 99.12

 

DRAFT

 

 

[], 2005

 

 

AST AllianceBernstein Growth + Value Portfolio

AST AllianceBernstein Managed Index 500 Portfolio

 

American Skandia Trust

 

Gateway Center Three, 4 th Floor
100 Mulberry Street
Newark, NJ 07102-4077

 

Ladies and Gentlemen:

 

We are acting as special tax counsel to American Skandia Trust (the “Fund”) in connection with the proposed transfer of all of the assets of AST AllianceBernstein Growth + Value Portfolio, a series of the Fund (the “Acquired Fund”), to AST AllianceBernstein Managed Index 500 Portfolio, a series of the Fund (the “Acquiring Fund”), in exchange for shares of the Acquiring Fund and the assumption by the Acquiring Fund of the Acquired Fund’s liabilities, if any, pursuant to the proposed Plan of Reorganization, filed as an exhibit to the Prospectus (as defined below), by the Fund on behalf of the Acquiring Fund and the Acquired Fund, respectively (the “Plan”). The transactions contemplated by the Plan are referred to herein as the “Reorganization.” All capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Plan. Unless otherwise specifically indicated, all “Section” references are to the Internal Revenue Code of 1986, as amended and currently in effect (the “Code”). In connection with the filing by American Skandia Trust of the Registration Statement on Form N-14 (the “Registration Statement”), you have asked for our opinion regarding certain United States federal income tax consequences of the Reorganization.

 

We have examined the Registration Statement relating, among other things, to the shares of the Acquiring Fund to be offered in exchange for the assets of the Acquired Fund, and containing the Prospectus and Proxy Statement relating to the Reorganization (the “Prospectus”), filed with the Securities and Exchange Commission (the “Commission”) pursuant to the provisions of the Securities Act of 1933, as amended (the “Securities Act”) and the rules and regulations of the Commission thereunder. In addition, in connection with rendering the opinion expressed herein, we have examined originals or copies of such other documents, records and instruments as we have deemed necessary or appropriate for the purpose of rendering this opinion, including the form of the Plan included as an exhibit to the Prospectus.

 



 

In our examination of the foregoing documents, we have assumed the genuineness of all signatures, the authority of each signatory, the due execution and delivery of all documents by all parties, the authenticity of all agreements, documents, certificates and instruments submitted to us as originals, the conformity of the Plan as executed and delivered by the parties with the form of the Plan contained in the Prospectus, and the conformity with originals of all agreements, documents, certificates and instruments submitted to us as copies.

 

In connection with rendering our opinion, we have further assumed that the transactions contemplated by the Plan will be consummated in accordance therewith and as described in the Prospectus and that the information in the Prospectus is true, correct and complete. We have relied on the representations made on behalf of the Acquiring Fund and the Acquired Fund in an Officer’s Certificate, dated [], 2005, and we have assumed that such representations are, and will continue to be, true, correct and complete.

 

Based upon the foregoing, in reliance thereon and subject thereto, and based upon the Code, the Treasury regulations promulgated thereunder, judicial decisions, revenue rulings and revenue procedures of the Internal Revenue Service (the “IRS”), and other administrative pronouncements, all as in effect on the date hereof, we are of the opinion that the Reorganization will constitute a “reorganization” within the meaning of Section 368(a), and that:

 

1.                                        Each of the Acquiring Fund and the Acquired Fund will be “a party to a reorganization” within the meaning of Section 368(b);

 

2.                                        In accordance with Sections 357 and 361, no gain or loss will be recognized by the Acquired Fund as a result of the transfer of the assets of the Acquired Fund solely in exchange for the Acquiring Fund Shares and the assumption by the Acquiring Fund of the liabilities of the Acquired Fund, if any, or upon the distribution (whether actual or constructive) of the Acquiring Fund Shares to the Acquired Fund shareholders, as provided for in the Plan;

 

3.                                        In accordance with Section 1032, no gain or loss will be recognized by the Acquiring Fund upon the receipt of the assets of the Acquired Fund in exchange for the Acquiring Fund Shares and the assumption by the Acquiring Fund of the liabilities of the Acquired Fund, if any, as provided for in the Plan;

 

4.                                        In accordance with Section 362(b), the tax basis of the assets of the Acquired Fund in the hands of the Acquiring Fund will be the same as the tax basis of such assets in the hands of the Acquired Fund immediately prior to the consummation of the Reorganization;

 

5.                                        In accordance with Section 1223, the Acquiring Fund’s holding period with respect to the assets of the Acquired Fund acquired by it will include the period for which such assets were held by the Acquired Fund;

 

6.                                        In accordance with Section 354(a)(l), no gain or loss will be recognized by the shareholders of the Acquired Fund upon the receipt (whether actual or constructive) of the Acquiring Fund Shares in exchange for their shares of the Acquired Fund;

 

2



 

7.                                        In accordance with Section 358, immediately after the Reorganization, the tax basis of the Acquiring Fund Shares received (whether actually or constructively) by the shareholders of the Acquired Fund in the Reorganization will be equal, in the aggregate, to the tax basis of the shares of the Acquired Fund surrendered in exchange therefor;

 

8.                                        In accordance with Section 1223, a shareholder’s holding period for the Acquiring Fund Shares will be determined by including the period for which the shareholder held the shares of the Acquired Fund exchanged therefor, provided that the Acquired Fund shares were held as a capital asset at the time of the exchange; and

 

9.                                        The taxable year of the Acquired Fund will end on the effective date of the Reorganization, and, pursuant to Section 381 (a) and the regulations thereunder, the Acquiring Fund will succeed to and take into account, subject to applicable limitations, certain tax attributes of the Acquired Fund, such as earnings and profits, capital loss carryovers and method of accounting.

 

No opinion is expressed as to any other matter, including the accuracy of the representations or the reasonableness of the assumptions relied upon by us in rendering the opinion set forth above. Our opinion is based on current United States federal income tax law and administrative practice and we do not undertake to advise you as to any future changes in such law or practice that may affect our opinion unless we are specifically retained to do so. Our opinion is not binding upon the IRS or a court and will not preclude the IRS or a court from adopting a contrary conclusion.

 

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the use of our name and to any reference to our firm in the Registration Statement or in the Prospectus constituting a part thereof. In giving such consent, we do not hereby admit that we are the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission thereunder.

 

 

 

Very truly yours,

 

 

RJB/MG

MBS

 

3


Exhibit 99.(13)(c)

 

FUND PARTICIPATION AGREEMENT

 

 

American Skandia Life Assurance Corporation,

 

American Skandia Trust,

 

American Skandia Investment Services, Inc.,

 

Prudential Investments LLC,

 

American Skandia Marketing, Inc.

 

and

 

Prudential Investment Management Services LLC

 

 

May 1, 2005, as Amended and Restated June 8, 2005

 



 

TABLE OF CONTENTS

 

ARTICLE I.

Sale of Fund Shares

4

 

 

 

ARTICLE II.

Representations and Warranties

8

 

 

 

ARTICLE III.

Prospectuses and Proxy Statements; Voting

12

 

 

 

ARTICLE IV.

Sales Material and Information

14

 

 

 

ARTICLE V.

Fees and Expenses

16

 

 

 

ARTICLE VI.

Diversification and Qualification

16

 

 

 

ARTICLE VII.

Potential Conflicts and Compliance With Mixed and Shared Funding Exemptive Order

19

 

 

 

ARTICLE VIII.

Indemnification

22

 

 

 

ARTICLE IX.

Applicable Law

27

 

 

 

ARTICLE X.

Termination

27

 

 

 

ARTICLE XI.

Notices

30

 

 

 

ARTICLE XII.

Miscellaneous

30

 

 

 

SCHEDULE A

Diversification Compliance Report and Certification

37

 



 

PARTICIPATION AGREEMENT

 

Among

 

AMERICAN SKANDIA LIFE ASSURANCE CORPORATION,

 

AMERICAN SKANDIA TRUST,

 

AMERICAN SKANDIA INVESTMENT SERVICES, INC.,

 

PRUDENTIAL INVESTMENTS LLC,

 

AMERICAN SKANDIA MARKETING, INC.

 

and

 

PRUDENTIAL INVESTMENT MANAGEMENT SERVICES LLC

 

THIS AGREEMENT, made and entered into as of this 1 st day of May, 2005 and amended and restated as of June 8, 2005, by and among AMERICAN SKANDIA LIFE ASSURANCE CORPORATION (the “Company”), a Connecticut life insurance company, on its own behalf and on behalf of its separate accounts (the “Accounts”); AMERICAN SKANDIA TRUST, an open-end management investment company organized under the laws of Massachusetts (the “Fund”); AMERICAN SKANDIA INVESTMENT SERVICES, INC., a Connecticut corporation (“ASISI”); PRUDENTIAL INVESTMENTS LLC (“PI,” and collectively with ASISI, the “Advisers” and each an “Adviser”), AMERICAN SKANDIA MARKETING, INC., a Delaware corporation (“ASM”); and PRUDENTIAL INVESTMENT MANAGEMENT SERVICES LLC, a Delaware limited liability company (“PIMS,” and collectively with ASM, the “Distributors” and each a “Distributor”).

 

WHEREAS, the Fund engages in business as an open-end management investment company and is available to act as the investment vehicle for separate accounts established for variable life insurance policies and/or variable annuity contracts (collectively, the “Variable Insurance Products”) to be offered by insurance companies, many of which have entered into

 

2



 

participation agreements similar to this Agreement (hereinafter “Participating Insurance Companies”); and

 

WHEREAS, the beneficial interest in the Fund is divided into several series of shares, each designated a “Portfolio” and representing the interest in a particular managed portfolio of securities and other assets; and

 

WHEREAS, the Fund has obtained an order from the Securities and Exchange Commission (hereinafter the “SEC”), dated August 1, 1995 (File No. 812-9384), granting Participating Insurance Companies and variable annuity and variable life insurance separate accounts exemptions from the provisions of sections 9(a), 13(a), 15(a), and 15(b) of the Investment Company Act of 1940, as amended, (hereinafter the “1940 Act”) and Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit shares of the Fund to be sold to and held by variable annuity and variable life insurance separate accounts of life insurance companies that may or may not be affiliated with one another and qualified pension and retirement plans (“Qualified Plans”) (hereinafter the “Mixed and Shared Funding Exemptive Order”); and

 

WHEREAS, the Fund is registered as an open-end management investment company under the 1940 Act and shares of the Portfolio(s) are registered under the Securities Act of 1933, as amended (hereinafter the “1933 Act”); and

 

WHEREAS, each Adviser is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended; and

 

WHEREAS, each Distributor is duly registered as a broker-dealer under the Securities Exchange Act of 1934, as amended, (the “1934 Act”) and is a member in good standing of the National Association of Securities Dealers, Inc. (the “NASD”); and

 

3



 

WHEREAS, the Company has issued and plans to continue to issue certain variable life insurance policies and variable annuity contracts supported wholly or partially by the Accounts (the “Contracts”); and

 

WHEREAS, each Account is a duly organized, validly existing segregated asset account, established by resolution of the Board of Directors of the Company under the insurance laws of the State of Connecticut, to set aside and invest assets attributable to the Contracts; and

 

WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company intends to continue to purchase shares in the Portfolios on behalf of the Accounts to fund the Contracts, and the Fund is authorized to sell such shares to unit investment trusts such as the Accounts at net asset value; and

 

WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company also intends to continue to purchase shares in other open-end investment companies or series thereof not affiliated with the Fund (the “Unaffiliated Funds”) on behalf of the Accounts to fund the Contracts; and

 

WHEREAS, the parties wish to enter into a written agreement governing the arrangement already existing among the parties.

 

NOW, THEREFORE, in consideration of their mutual promises, the Company, the Fund, the Distributors and the Advisers agree as follows:

 

ARTICLE I.

Sale of Fund Shares

 

1.1.           The Fund agrees to sell to the Company those shares of the Portfolios which the Account orders, executing such orders on each Business Day at the net asset value next computed after receipt by the Fund or its designee of the order for the shares of the Portfolios.  For purposes of this Section 1.1, the Company shall be the designee of the Fund for receipt of such orders and

 

4



 

receipt by such designee shall constitute receipt by the Fund, provided that the Fund receives notice of any such order by 10:00 a.m. Eastern time on the next following Business Day.  “Business Day” shall mean any day on which the New York Stock Exchange is open for trading and on which the Portfolio calculates its net asset value pursuant to the rules of the SEC.  “Valuation Time” shall mean the time as of which the Fund calculates net asset value for the shares of the Portfolios on the relevant Business Day.

 

1.2.           The Fund agrees to make shares of the Portfolios available for purchase at the applicable net asset value per share by the Company and the Accounts on those days on which the Fund calculates its Portfolios’ net asset value pursuant to rules of the SEC, and the Fund shall calculate such net asset value on each day which the New York Stock Exchange is open for trading.  Notwithstanding the foregoing, the Fund may refuse to sell shares of any Portfolio to any person, or suspend or terminate the offering of shares of any Portfolio if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the Fund acting in good faith, necessary or appropriate in the best interests of the shareholders of such Portfolio.  All orders accepted by the Company shall be subject to the terms of the then current prospectus of the Fund.  The Company shall use its best efforts, and shall reasonably cooperate with, the Fund to enforce stated prospectus policies regarding transactions in Portfolio shares.  The Company acknowledges that orders accepted by it in violation of the Fund’s stated policies may be subsequently revoked or cancelled by the Fund and that the Fund shall not be responsible for any losses incurred by the Company or the Contract owner as a result of such cancellation.  In addition, the Company acknowledges that the Fund has the right to refuse any purchase order for any reason, particularly if the Fund determines that a Portfolio would be unable to invest the money effectively in accordance with its investment policies or would otherwise be adversely affected due to the size of the transaction, frequency of trading, or other factors.

 

1.3.           The Fund will not sell shares of the Portfolios to any other Participating Insurance Company separate account unless an agreement containing provisions the substance of which are

 

5



 

the same as Sections 2.1, 2.2 (except with respect to designation of applicable law), 3.5, 3.6, 3.7, and Article VII of this Agreement is in effect to govern such sales.

 

1.4.           The Fund agrees to redeem for cash, on the Company’s request, any full or fractional shares of the Fund held by the Company, executing such requests on each Business Day at the net asset value next computed after receipt by the Fund or its designee of the request for redemption.  For purposes of this Section 1.4, the Company shall be the designee of the Fund for receipt of requests for redemption and receipt by such designee shall constitute receipt by the Fund, provided that the Fund receives notice of any such request for redemption by 10:00 a.m. Eastern time on the next following Business Day.

 

1.5.           The parties hereto acknowledge that the arrangement contemplated by this Agreement is not exclusive; the Fund’s shares may be sold to other Participating Insurance Companies (subject to Section 1.3) and the cash value of the Contracts may be invested in other investment companies.

 

1.6.           The Company shall pay for Fund shares by 3:00 p.m. Eastern time on the next Business Day after an order to purchase Fund shares is received in accordance with the provisions of Section 1.1 hereof.  Payment shall be in federal funds transmitted by wire and/or by a credit for any shares redeemed the same day as the purchase.

 

1.7.           The Fund shall pay and transmit the proceeds of redemptions of Fund shares by 11:00 a.m. Eastern Time on the next Business Day after a redemption order is received in accordance with Section 1.4 hereof; provided, however, that the Fund may delay payment in extraordinary circumstances to the extent permitted under Section 22(e) of the 1940 Act.  Payment shall be in federal funds transmitted by wire and/or a credit for any shares purchased the same day as the redemption.

 

1.8.           Issuance and transfer of the Fund’s shares will be by book entry only.  Stock certificates will not be issued to the Company or the Accounts.  Shares purchased from the Fund

 

6



 

will be recorded in an appropriate title for the relevant Account or the relevant sub-account of an Account.

 

1.9.           The Fund shall furnish same day notice (by electronic communication or telephone, followed by electronic confirmation) to the Company of any income, dividends or capital gain distributions payable on a Portfolio’s shares.  The Company hereby elects to receive all such income dividends and capital gain distributions as are payable on a Portfolio’s shares in additional shares of that Portfolio.  The Company reserves the right to revoke this election and to receive all such income dividends and capital gain distributions in cash.  The Fund shall notify the Company by the end of the next following Business Day of the number of shares so issued as payment of such dividends and distributions.

 

1.10.         The Fund shall make the net asset value per share for each Portfolio available to the Company on each Business Day as soon as reasonably practicable after the net asset value per share is calculated and shall use its best efforts to make such net asset value per share available by 6:00 p.m. Eastern time.  In the event of an error in the computation of a Portfolio’s net asset value per share (“NAV”) or any dividend or capital gain distribution (each, a “pricing error”), an Adviser or the Fund shall immediately notify the Company as soon as possible after discovery of the error.  Such notification may be verbal, but shall be confirmed promptly in writing.  A pricing error shall be corrected as follows:  (a) if the pricing error results in a difference between the erroneous NAV and the correct NAV of less than $0.01 per share, then no corrective action need be taken; (b) if the pricing error results in a difference between the erroneous NAV and the correct NAV equal to or greater than $0.01 per share, but less than 1/2 of 1% of the Portfolio’s NAV at the time of the error, then the Advisers shall reimburse the Portfolio for any loss, after taking into consideration any positive effect of such error; however, no adjustments to Contract owner accounts need be made; and (c) if the pricing error results in a difference between the erroneous NAV and the correct NAV equal to or greater than 1/2 of 1% of the Portfolio’s NAV at the time of the error, then the Advisers shall reimburse the Portfolio for any loss (without taking into consideration any positive effect of such error) and shall reimburse the Company for the costs of adjustments made to correct Contract owner accounts.  If an adjustment is necessary

 

7



 

to correct a material error which has caused Contract owners to receive less than the amount to which they are entitled, the number of shares of the applicable sub-account of such Contract owners will be adjusted and the amount of any underpayments shall be credited by the Advisers to the Company for crediting of such amounts to the applicable Contract owners accounts.  Upon notification by an Adviser of any overpayment due to a material error, the Company shall promptly remit to the Advisers any overpayment that has not been paid to Contract owners.  In no event shall the Company be liable to Contract owners for any such adjustments or underpayment amounts.  A pricing error within categories (b) or (c) above shall be deemed to be “materially incorrect” or constitute a “material error” for purposes of this Agreement.  The standards set forth in this Section 1.10 are based on the parties’ understanding of the views expressed by the staff of the SEC as of the date of this Agreement.  In the event the views of the SEC staff are later modified or superseded by SEC or judicial interpretation, the parties shall amend the foregoing provisions of this Agreement to comport with the appropriate applicable standards, on terms mutually satisfactory to all parties.

 

1.11.         The parties agree to mutually cooperate with respect to any state insurance law restriction or requirement applicable to the Fund’s investments; provided, however, that the Fund reserves the right not to implement restrictions or take other actions required by state insurance law if the Fund or an Adviser determines that the implementation of the restriction or other action is not in the best interest of Fund shareholders.

 

ARTICLE II.

Representations and Warranties

 

2.1.           The Company represents and warrants that:  (a) the securities deemed to be issued by the Accounts under the Contracts are or will be registered under the 1933 Act, or are not so registered in proper reliance upon an exemption from such registration requirements; (b) the Contracts will be issued and sold in compliance in all material respects with all applicable federal and state laws; and (c) the sale of the Contracts shall comply in all material respects with state insurance suitability requirements.

 

8



 

2.2.           The Company represents and warrants that:  (a) it is an insurance company duly organized and in good standing under applicable law; (b) it has legally and validly established each Account prior to any issuance or sale of units thereof as a segregated asset account under Connecticut law; and (c) it has registered each Account as a unit investment trust in accordance with the provisions of the 1940 Act to serve as a segregated investment account for the Contracts will maintain such registration for so long as any Contracts are outstanding as required by applicable law or, alternatively, the Company has not registered one or more Accounts in proper reliance upon an exclusion from such registration requirements.

 

2.3.           The Fund represents and warrants that:  (a) the Fund shares sold pursuant to this Agreement shall be registered under the 1933 Act; (b) the Fund shares sold pursuant to this Agreement shall be duly authorized for issuance and sold in compliance with all applicable federal securities laws including without limitation the 1933 Act, the 1934 Act, and the 1940 Act; (c) the Fund is and shall remain registered under the 1940 Act; and (d) the Fund shall amend the registration statement for its shares under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its shares.

 

2.4.           The parties acknowledge that the Fund reserves the right to adopt one or more plans pursuant to Rule 12b-1 under the 1940 Act and to impose an asset-based or other charge to finance distribution expenses as permitted by applicable law and regulation.  The Fund and the Advisers agree to comply with applicable provisions and SEC interpretation of the 1940 Act with respect to any distribution plan.

 

2.5.           The Fund represents and warrants that it shall register and qualify the shares for sale in accordance with the laws of the various states if and to the extent required by applicable law.

 

2.6.           The Fund represents and warrants that it is lawfully organized and validly existing under the laws of the Commonwealth of Massachusetts and that it does and will comply in all material respects with the 1940 Act.

 

9



 

2.7.           Each Adviser represents and warrants that it is and shall remain duly registered under all applicable federal and state securities laws and that it shall perform its obligations for the Fund in compliance in all material respects with any applicable state and federal securities laws.

 

2.8.           Each Distributor represents and warrants that it is and shall remain duly registered under all applicable federal and state securities laws and that it shall perform its obligations for the Fund in compliance in all material respects with the laws of any applicable state and federal securities laws.

 

2.9.           The Fund and the Advisers represent and warrant that all of their respective officers, employees, investment advisers, and other individuals or entities dealing with the money and/or securities of the Fund are, and shall continue to be at all times, covered by one or more blanket fidelity bonds or similar coverage for the benefit of the Fund in an amount not less than the minimal coverage required by Rule 17g-1 under the 1940 Act or related provisions as may be promulgated from time to time.  The aforesaid bonds shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company.

 

2.10.         The Fund and the Advisers represent and warrant that they will provide the Company with as much advance notice as is reasonably practicable of any material change affecting the Portfolios (including, but not limited to, any material change in the registration statement or prospectus affecting the Portfolios) and any proxy solicitation affecting the Portfolios and consult with the Company in order to implement any such change in an orderly manner, recognizing the expenses of changes and attempting to minimize such expenses by implementing them in conjunction with regular annual updates of the prospectus for the Contracts.

 

2.11          The Company represents and warrants, for purposes other than diversification under Section 817 of the Internal Revenue Code of 1986 as amended (the “Code”), that the

 

10



 

Contracts are currently and at the time of issuance will be treated as annuity contracts or life insurance policies under applicable provisions of the Code, and that it will make every effort to maintain such treatment and that it will notify the Fund, the Distributors and the Advisers immediately upon having a reasonable basis for believing that the Contracts have ceased to be so treated or that they might not be so treated in the future.  In addition, the Company represents and warrants that each Account is a “segregated asset account” and that interests in each Account are offered exclusively through the purchase of or transfer into a “variable contract” within the meaning of such terms under Section 817 of the Code and the regulations thereunder.  The Company will use every effort to continue to meet such definitional requirements, and it will notify the Fund, the Distributors and the Advisers immediately upon having a reasonable basis for believing that such requirements have ceased to be met or that they might not be met in the future.  The Company represents and warrants that it will not purchase Fund shares with assets derived from tax-qualified retirement plans except, indirectly, through Contracts purchased in connection with such plans.

 

2.12          The Company represents and warrants that it is currently in compliance, and will remain in compliance, with all applicable anti-money laundering laws, regulations, and requirements.  In addition, the Company represents and warrants that it has adopted and implemented policies and procedures reasonably designed to achieve compliance with the applicable requirements administered by the Office of Foreign Assets Control (“OFAC”) of the U.S. Department of the Treasury.

 

2.13          The Company represents and warrants that it is currently in compliance, and will remain in compliance, with all applicable laws, rules and regulations relating to consumer privacy, including, but not limited to, Regulation S-P.

 

2.14          The Company represents and warrants that it has adopted, and will at all times during the term of this Agreement maintain, reasonable and appropriate procedures (“Late Trading Procedures”) designed to ensure that any and all orders relating to the purchase, sale or exchange of Fund shares communicated to the Fund to be treated in accordance with Article I of

 

11



 

this Agreement as having been received on a Business Day have been received by the Valuation Time on such Business Day and were not modified after the Valuation Time, and that all orders received from Contract owners but not rescinded by the Valuation Time were communicated to the Fund or its agent as received for that Business Day.  Each transmission of orders by the Company shall constitute a representation by the Company that such orders are accurate and complete and relate to orders received by the Company by the Valuation Time on the Business Day for which the order is to be priced and that such transmission includes all orders relating to Fund shares received from Contract owners but not rescinded by the Valuation Time.  The Company agrees to provide the Fund or its designee with a copy of the Late Trading Procedures and such certifications and representations regarding the Late Trading Procedures as the Fund or its designee may reasonably request.  The Company will promptly notify the Fund in writing of any material change to the Late Trading Procedures.

 

2.15.         The Company represents and warrants that it has adopted, and will at all times during the term of this Agreement maintain, reasonable and appropriate procedures (“Market Timing Procedures”) designed to minimize any adverse impact on other Fund investors due to excessive trading.  The Company agrees to provide the Fund or its designee with a copy of the Market Timing Procedures and such certifications and representations regarding the Market Timing Procedures as the Fund or its designee may reasonably request.  The Company will promptly notify the Fund in writing of any material change to the Market Timing Procedures.  The parties agree to cooperate in light of any conflict between the Market Timing Procedures and actions taken or policies adopted by the Fund designed to minimize any adverse impact on other Fund investors due to excessive trading.

 

ARTICLE III.

Printing and Distribution of Fund Documents and other Administrative Services Provided by the Company to the Fund

 

3.1.           At least annually, an Adviser or Distributor shall provide the Company with camera-ready copy of the Fund’s prospectus and any supplements thereto for printing and delivery by the Company to all Contract owners. If requested by the Company in lieu thereof, an

 

12



 

Adviser, a Distributor or the Fund shall provide camera-ready copy (including an electronic version of the current prospectus) to the Company and other assistance as is reasonably necessary in order for the Company once each year (or more frequently if the prospectus for the Fund is amended) to have the prospectus for the Contracts and the prospectus for the Fund printed together in one document and delivered to all Contract owners

 

3.2.           If applicable state or federal laws or regulations require that the Statement of Additional Information (“SAI”) for the Fund be distributed to all Contract owners, then the Fund, a Distributor and/or an Adviser shall provide the Company with camera-ready copy of the Fund’s SAI and any supplements thereto for printing and delivery to all Contract ownersSchedule B An Adviser, a Distributor and/or the Fund shall also provide camera-ready copy of the SAI to the Company for printing and delivery to any Contract owner or prospective owner who requests such SAI from the Fund.

 

3.3.           The Fund, a Distributor and/or an Adviser shall provide the Company with copies of the Fund’s proxy material, reports to shareholders and other communications to shareholders suitable for printing to permit Schedule B timely distribution thereof by the Company to Contract owners.

 

3.4           The Company shall also provide the following administrative services to the Fund:

 

Maintenance of books and records

 

      In the general ledger, reconcile and balance ASLAC’s separate account investments in the various portfolios of the Fund

 

Purchase and Redemption Orders

 

      Reconcile and provide notice to AST of (a) net cash flow into AST, and (b) cash required for net redemption orders with confirmation thereof to AST

 

AST-Related Contract Owner Services

 

      Assist AST with proxy solicitations, specifically with respect to soliciting voting instructions from contract owners

 

13



 

      Investigate and respond to inquiries from contract owners that relate to AST and not to the separate account

 

Reports

 

      Periodic information reporting to AST

      Preparation of reports regarding AST for third-party reporting services

 

3.5.           It is understood and agreed that, except with respect to information regarding the Company provided in writing by that party, the Company shall not be responsible for the content of the prospectus or SAI for the Fund.  It is also understood and agreed that, except with respect to information regarding the Fund, the Distributors, the Advisers or the Portfolios provided in writing by the Fund, a Distributor or an Adviser, neither the Fund, the Distributors nor the Advisers are responsible for the content of the prospectus or SAI for the Contracts.

 

3.6.           If and to the extent required by law the Company shall:

 

(a)            solicit voting instructions from Contract owners;

 

(b)            vote the Portfolio shares held in the Accounts in accordance with instructions received from Contract owners;

 

(c)            vote Portfolio shares held in the Accounts for which no instructions have been received in the same proportion as Portfolio shares for which instructions have been received from Contract owners, so long as and to the extent that the SEC continues to interpret the 1940 Act to require pass-through voting privileges for variable contract owners; and

 

(d)            vote Portfolio shares held in its general account or otherwise in the same proportion as Portfolio shares for which instructions have been received from Contract owners, so long as and to the extent that the SEC continues to interpret the 1940 Act to require such voting by the insurance company.  The Company reserves the right to vote Fund shares in its own right, to the extent permitted by law.

 

3.7.           The Company shall be responsible for assuring that each of its separate accounts holding shares of a Portfolio calculates voting privileges as directed by the Fund and agreed to by the Company and the Fund.  The Fund agrees to promptly notify the Company of any changes of interpretations or amendments of the Mixed and Shared Funding Exemptive Order.

 

14



 

3.8.           The Fund will comply with all provisions of the 1940 Act requiring voting by shareholders, and in particular the Fund will either provide for annual meetings (except insofar as the SEC may interpret Section 16 of the 1940 Act not to require such meetings) or, as the Fund currently intends, comply with Section 16(c) of the 1940 Act (although the Fund is not one of the trusts described in Section 16(c) of that Act) as well as with Sections 16(a) and, if and when applicable, 16(b).  Further, the Fund will act in accordance with the SEC’s interpretation of the requirements of Section 16(a) with respect to periodic elections of directors or trustees and with whatever rules the SEC may promulgate with respect thereto.

 

ARTICLE IV.

Sales Material and Information

 

4.1.           The Company shall not give any information or make any representations or statements on behalf of the Fund in connection with the sale of the Contracts other than the information or representations contained in the registration statement, including the prospectus or SAI for the Fund shares, as the same may be amended or supplemented from time to time, or in sales literature or other promotional material approved by the Fund, a Distributor or an Adviser, except with the permission of the Fund, a Distributor or an Adviser.

 

4.2.           The Fund, the Distributors and the Advisers shall not give any information or make any representations on behalf of the Company or concerning the Company, the Accounts, or the Contracts other than the information or representations contained in a registration statement, including the prospectus or SAI for the Contracts, as the same may be amended or supplemented from time to time, or in sales literature or other promotional material approved by the Company or its designee, except with the permission of the Company.

 

4.3.           For purposes of Articles IV and VIII, the phrase “sales literature and other promotional material” includes, but is not limited to, advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media;

 

15



 

e.g. , on-line networks such as the Internet or other electronic media), sales literature ( i.e. , any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, and shareholder reports, and proxy materials (including solicitations for voting instructions) and any other material constituting sales literature or advertising under the NASD rules, the 1933 Act or the 1940 Act.

 

4.4.           At the request of any party to this Agreement, each other party will make available to the other party’s independent auditors and/or representatives of the appropriate regulatory agencies, all records, data and access to operating procedures that may be reasonably requested in connection with compliance and regulatory requirements related to this Agreement or any party’s obligations under this Agreement.

 

ARTICLE V.

Fees and Expenses

 

5.1.           In consideration of the services provided by the Company to the Fund that are set forth in sections 3.1, 3.2, 3.3 and 3.4 under Agreement, the Fund will pay the Company 0.10% on an annualized basis of the net asset value of shares of the Fund owned by separate accounts of the Company that are invested in the Fund.  Such amount shall be determined on the last day of each calendar quarter and is payable within 10 days after the end of such calendar quarter.   Except as otherwise provided in this Agreement, the Fund, the Distributors and the Advisers shall pay no fee or other compensation to the Company under this Agreement, and the Company shall pay no fee or other compensation to the Fund, a Distributor or an Adviser under this Agreement.  provided, however, the parties may enter into other agreements relating to the Company’s investment in the Fund, including services agreements.

 

16



 

ARTICLE VI.

Diversification and Qualification

 

6.1.           The Fund, the Distributors and the Advisers represent and warrant that the Fund and each Portfolio thereof will at all times comply with Section 817(h) of the Code and Treasury Regulation §1.817-5, as amended from time to time, and any Treasury interpretations thereof, relating to the diversification requirements for variable annuity, endowment, or life insurance contracts and any amendments or other modifications or successor provisions to such Section or Regulations.  The Fund, a Distributor or an Adviser shall provide to the Company a quarterly written diversification report, in the form attached hereto as Schedule A which shall show the results of the quarterly Section 817(h) diversification test and include a certification as to whether each Portfolio complies with the Section 817(h) diversification requirement.  The diversification report shall be provided to the Company within 10 calendar days of the end of a quarter.

 

6.2.           The Fund, the Distributors and the Advisers agree that shares of the Portfolios will be sold only to Participating Insurance Companies and their separate accounts and to Qualified Plans.  No shares of any Portfolio of the Fund will be sold to the general public.

 

6.3.           The Fund, the Distributors and the Advisers represent and warrant that the Fund and each Portfolio is currently qualified as a Regulated Investment Company under Subchapter M of the Code, and that each Portfolio will maintain such qualification (under Subchapter M or any successor or similar provisions) as long as this Agreement is in effect.

 

6.4.           The Fund, a Distributor or an Adviser will notify the Company immediately upon having a reasonable basis for believing that the Fund or any Portfolio has ceased to comply with the aforesaid Section 817(h) diversification or Subchapter M qualification requirements or might not so comply in the future.

 

6.5.           Without in any way limiting the effect of Sections 8.2, 8.3 and 8.4 hereof and without in any way limiting or restricting any other remedies available to the Company, an Adviser or a Distributor will pay all costs associated with or arising out of any failure, or any anticipated or reasonably foreseeable failure, of the Fund or any Portfolio to comply with

 

17



 

Sections 6.1, 6.2, or 6.3 hereof, including all costs associated with reasonable and appropriate corrections or responses to any such failure; such costs may include, but are not limited to, the costs involved in creating, organizing, and registering a new investment company as a funding medium for the Contracts and/or the costs of obtaining whatever regulatory authorizations are required to substitute shares of another investment company for those of the failed Portfolio (including but not limited to an order pursuant to Section 26(c) of the 1940 Act).

 

6.6.           The Company agrees that if the Internal Revenue Service (“IRS”) asserts in writing in connection with any governmental audit or review of the Company (or, to the Company’s knowledge, of any Contract owner) that any Portfolio has failed to comply with the diversification requirements of Section 817(h) of the Code or the Company otherwise becomes aware of any facts that could give rise to any claim against the Fund, a Distributor or an Adviser as a result of such a failure or alleged failure:

 

(a)            The Company shall promptly notify the Fund, the Distributors and the Advisers of such assertion or potential claim;

 

(b)            The Company shall consult with the Fund, the Distributors and the Advisers as to how to minimize any liability that may arise as a result of such failure or alleged failure;

 

(c)            The Company shall use its best efforts to minimize any liability of the Fund, the Distributors and the Advisers resulting from such failure, including, without limitation, demonstrating, pursuant to Treasury Regulations, Section 1.817-5(a)(2), to the commissioner of the IRS that such failure was inadvertent;

 

(d)            Any written materials to be submitted by the Company to the IRS, any Contract owner or any other claimant in connection with any of the foregoing proceedings or contests (including, without limitation, any such materials to be submitted to the IRS pursuant to Treasury Regulations, Section 1.817-5(a)(2)) shall be provided by the Company to the Fund, the

 

18



 

Distributors and the Advisers (together with any supporting information or analysis) within at least two (2) business days prior to submission;

 

(e)            The Company shall provide the Fund, the Distributors and the Advisers with such cooperation as the Fund, the Distributors and the Advisers shall reasonably request (including, without limitation, by permitting the Fund, the Distributors and the Advisers to review the relevant books and records of the Company) in order to facilitate review by the Fund, the Distributors and the Advisers of any written submissions provided to it or its assessment of the validity or amount of any claim against it arising from such failure or alleged failure;

 

(f)             The Company shall not with respect to any claim of the IRS or any Contract owner that would give rise to a claim against the Fund, the Distributors and the Adviser s(i) compromise or settle any claim, (ii) accept any adjustment on audit, or (iii) forego any allowable administrative or judicial appeals, without the express written consent of the Fund, the Distributors and the Advisers, which shall not be unreasonably withheld; provided that, the Company shall not be required to appeal any adverse judicial decision unless the Fund and the Advisers shall have provided an opinion of independent counsel to the effect that a reasonable basis exists for taking such appeal; and further provided that the Fund, the Distributors and the Advisers shall bear the costs and expenses, including reasonable attorney’s fees, incurred by the Company in complying with this clause (f).

 

ARTICLE VII.

Potential Conflicts and Compliance With Mixed and Shared Funding Exemptive Order

 

7.1.           The Board will monitor the Fund for the existence of any material irreconcilable conflict between the interests of the contract owners of all separate accounts investing in the Fund.  An irreconcilable material conflict may arise for a variety of reasons, including:  (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance, tax, or securities laws or regulations, or a public ruling, private letter ruling, no-action or interpretative letter, or any similar action by insurance, tax, or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the

 

19



 

investments of any Portfolio is being managed; (e) a difference in voting instructions given by variable annuity contract and variable life insurance contract owners or by contract owners of different Participating Insurance Companies; or (f) a decision by a Participating Insurance Company to disregard the voting instructions of contract owners.  The Board shall promptly inform the Company if it determines that an irreconcilable material conflict exists and the implications thereof.

 

7.2.           The Company will report any potential or existing conflicts of which it is aware to the Board.  The Company will assist the Board in carrying out its responsibilities under the Mixed and Shared Funding Exemptive Order, by providing the Board with all information reasonably necessary for the Board to consider any issues raised.  This includes, but is not limited to, an obligation by the Company to inform the Board whenever Contract owner voting instructions are to be disregarded.  Such responsibilities shall be carried out by the Company with a view only to the interests of its Contract owners.

 

7.3.           If it is determined by a majority of the Board, or a majority of its trustees who are not interested persons of the Fund, the Distributor, the Adviser or any subadviser to any of the Portfolios (the “Independent Directors”), that a material irreconcilable conflict exists, the Company and other Participating Insurance Companies shall, at their expense and to the extent reasonably practicable (as determined by a majority of the Independent Directors), take whatever steps are necessary to remedy or eliminate the irreconcilable material conflict, up to and including:  (1) withdrawing the assets allocable to some or all of the separate accounts from the Fund or any Portfolio and reinvesting such assets in a different investment medium, including (but not limited to) another Portfolio, or submitting the question whether such segregation should be implemented to a vote of all affected contract owners and, as appropriate, segregating the assets of any appropriate group ( i.e. , annuity contract owners, life insurance contract owners, or variable contract owners of one or more Participating Insurance Companies) that votes in favor of such segregation, or offering to the affected contract owners the option of making such a change; and (2) establishing a new registered management investment company or managed separate account.

 

20



 

7.4.           If a material irreconcilable conflict arises because of a decision by the Company to disregard Contract owner voting instructions and that decision represents a minority position or would preclude a majority vote, the Company may be required, at the Fund’s election, to withdraw the Account’s investment in the Fund and terminate this Agreement; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the Independent Directors.  Any such withdrawal and termination must take place within six (6) months after the Fund gives written notice that this provision is being implemented, and until the end of that six-month period the Advisers, the Distributors and the Fund shall continue to accept and implement orders by the Company for the purchase (and redemption) of shares of the Fund.

 

7.5.           If a material irreconcilable conflict arises because a particular state insurance regulator’s decision applicable to the Company conflicts with the majority of other state regulators, then the Company will withdraw the Account’s investment in the Fund and terminate this Agreement within six months after the Board informs the Company in writing that it has determined that such decision has created an irreconcilable material conflict; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the Independent Directors.  Until the end of the foregoing six-month period, the Fund shall continue to accept and implement orders by the Company for the purchase (and redemption) of shares of the Fund.

 

7.6.           For purposes of Sections 7.3 through 7.5 of this Agreement, a majority of the Independent Directors shall determine whether any proposed action adequately remedies any irreconcilable material conflict, but in no event will the Fund be required to establish a new funding medium for the Contracts.  The Company shall not be required by Section 7.3 to establish a new funding medium for the Contracts if an offer to do so has been declined by vote of a majority of Contract owners affected by the irreconcilable material conflict.  In the event that the Board determines that any proposed action does not adequately remedy any irreconcilable material conflict, then the Company will withdraw the Account’s investment in the Fund and

 

21



 

terminate this Agreement within six (6) months after the Board informs the Company in writing of the foregoing determination; provided, however, that such withdrawal and termination shall be limited to the extent required by any such material irreconcilable conflict as determined by a majority of the Independent Directors.

 

7.7.           If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the Mixed and Shared Funding Exemptive Order) on terms and conditions materially different from those contained in the Mixed and Shared Funding Exemptive Order, then (a) the Fund and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary to comply with Rules 6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent such rules are applicable: and (b) Sections 3.5, 3.6, 3.7, 7.1, 7.2, 7.3, 7.4, and 7.5 of this Agreement shall continue in effect only to the extent that terms and conditions substantially identical to such Sections are contained in such Rule(s) as so amended or adopted.

 

22



 

ARTICLE VIII.

Indemnification

 

8.1.           Indemnification By The Company

 

(a)            The Company agrees to indemnify and hold harmless the Fund, the Distributors and the Advisers and each of their respective officers and directors or trustees and each person, if any, who controls the Fund, a Distributor or an Adviser within the meaning of Section 15 of the 1933 Act (collectively, the “Indemnified Parties” for purposes of this Section 8.1) against any and all losses, claims, expenses, damages and liabilities (including amounts paid in settlement with the written consent of the Company) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, expenses, damages or liabilities (or actions in respect thereof) or settlements are related to the sale or acquisition of the Fund’s shares or the Contracts and:

 

(i)             arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in the registration statement or prospectus or SAI covering the Contracts or contained in the Contracts or sales literature or other promotional material for the Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this Agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of an Adviser, a Distributor or the Fund for use in the registration statement or prospectus for the Contracts or in the Contracts or sales literature or other promotional material (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or Fund shares; or

 

(ii)            arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus or sales literature or other promotional material of the Fund not supplied by the Company or persons under its control) or wrongful

 

23



 

conduct of the Company or persons under its control, with respect to the sale or distribution of the Contracts or Fund Shares; or

 

(iii)           arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI, or sales literature or other promotional material of the Fund, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, if such a statement or omission was made in reliance upon information furnished in writing to the Fund by or on behalf of the Company; or

 

(iv)           arise as a result of any failure by the Company to provide the services and furnish the materials under the terms of this Agreement; or

 

(v)            arise out of or result from any material breach of any representation and/or warranty made by the Company in this Agreement or arise out of or result from any other material breach of this Agreement by the Company, including without limitation Section 2.11 and Section 6.6 hereof,

 

as limited by and in accordance with the provisions of Sections 8.1(b) and 8.1(c) hereof.

 

(b)            The Company shall not be liable under this indemnification provision with respect to any losses, claims, expenses, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Party’s willful misfeasance, bad faith, or negligence in the performance of such Indemnified Party’s duties or by reason of such Indemnified Party’s reckless disregard of obligations or duties under this Agreement or to any of the Indemnified Parties.

 

(c)            The Company shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Company in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Company of any such claim shall not relieve the Company from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the

 

24



 

extent that the Company has been prejudiced by such failure to give notice.  In case any such action is brought against the Indemnified Parties, the Company shall be entitled to participate, at its own expense, in the defense of such action.  The Company also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action.  After notice from the Company to such party of the Company’s election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Company will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.

 

(d)            The Indemnified Parties will promptly notify the Company of the commencement of any litigation or proceedings against them in connection with the issuance or sale of the Fund Shares or the Contracts or the operation of the Fund.

 

8.2.           Indemnification by the Advisers

 

(a)            Each Adviser agrees to indemnify and hold harmless the Company and its directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the “Indemnified Parties” for purposes of this Section 8.2) against any and all losses, claims, expenses, damages, liabilities (including amounts paid in settlement with the written consent of an Adviser) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Fund’s shares or the Contracts and:

 

(i)             arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement or prospectus or SAI or sales literature or other promotional material of the Fund prepared by the Fund, a Distributor or an Adviser (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the

 

25



 

statements therein not misleading, provided that this Agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to an Adviser, a Distributor or the Fund by or on behalf of the Company for use in the registration statement, prospectus or SAI for the Fund or in sales literature or other promotional material (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or the Fund shares; or

 

(ii)            arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, SAI or sales literature or other promotional material for the Contracts not supplied by the Adviser or persons under its control) or wrongful conduct of the Fund, a Distributor or an Adviser or persons under their control, with respect to the sale or distribution of the Contracts or Fund shares; or

 

(iii)           arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI, or sales literature or other promotional material covering the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished in writing to the Company by or on behalf of an Adviser, a Distributor or the Fund; or

 

(iv)           arise as a result of any failure by the Fund, a Distributor or an Adviser to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification and other qualification requirements specified in Article VI of this Agreement); or

 

(v)            arise out of or result from any material breach of any representation and/or warranty made by the Fund, a Distributor or an Adviser in this Agreement or arise out of or result from any other material breach of this Agreement by an Adviser, a Distributor or the Fund; or

 

(vi)           arise out of or result from the incorrect or untimely calculation or reporting by the Fund, a Distributor or an Adviser of the daily net asset value per share (subject to Section 1.10 of this Agreement) or dividend or capital gain distribution rate;

 

26



 

as limited by and in accordance with the provisions of Sections 8.2(b) and 8.2(c) hereof.  This indemnification is in addition to and apart from the responsibilities and obligations of the Advisers specified in Article VI hereof.

 

(b)            The Advisers shall not be liable under this indemnification provision with respect to any losses, claims, expenses, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Party’s willful misfeasance, bad faith, or negligence in the performance of such Indemnified Party’s duties or by reason of such Indemnified Party’s reckless disregard of obligations or duties under this Agreement or to any of the Indemnified Parties.

 

(c)            The Advisers shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Advisers in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Advisers of any such claim shall not relieve the Advisers from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the extent that the Advisers have been prejudiced by such failure to give notice.  In case any such action is brought against the Indemnified Parties, the Advisers will be entitled to participate, at their own expense, in the defense thereof.  The Advisers also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action.  After notice from the Advisers to such party of the Advisers’ election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Advisers will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.

 

27



 

(d)            The Company agrees promptly to notify the Advisers of the commencement of any litigation or proceedings against it or any of its officers or directors in connection with the issuance or sale of the Contracts or the operation of the Account.

 

ARTICLE IX.

Applicable Law

 

9.1.           This Agreement shall be construed and the provisions hereof interpreted under and in accordance with the laws of the State of New Jersey, without regard to the New Jersey conflict of laws provisions.

 

9.2.           This Agreement shall be subject to the provisions of the 1933, 1934 and 1940 Acts, and the rules and regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the SEC may grant (including, but not limited to, the Mixed and Shared Funding Exemptive Order) and the terms hereof shall be interpreted and construed in accordance therewith.

 

ARTICLE X.

Termination

 

10.1.         This Agreement shall terminate:

 

(a)            at the option of any party, with or without cause, with respect to some or all Portfolios, upon sixty (60) days advance written notice delivered to the other parties; or

 

(b)            at the option of the Company by written notice to the other parties with respect to any Portfolio based upon the Company’s determination that shares of such Portfolio are not reasonably available to meet the requirements of the Contracts; or

 

(c)            at the option of the Company by written notice to the other parties with respect to any Portfolio in the event any of the Portfolio’s shares are not registered, issued or sold in accordance with applicable state and/or federal law or such law precludes the use of such shares as the underlying investment media of the Contracts issued or to be issued by the Company; or

 

(d)            at the option of the Fund, a Distributor or an Adviser in the event that formal administrative proceedings are instituted against the Company by the NASD, the SEC, the Insurance Commissioner or like official of any state or any other regulatory body regarding the

 

28



 

Company’s duties under this Agreement or related to the sale of the Contracts, the operation of any Account, or the purchase of the Fund shares, if, in each case, the Fund, a Distributor or an Adviser, as the case may be, reasonably determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Company to perform its obligations under this Agreement; or

 

(e)            at the option of the Company in the event that formal administrative proceedings are instituted against the Fund, a Distributor or an Adviser by the NASD, the SEC, or any state securities or insurance department or any other regulatory body, if the Company reasonably determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Fund, a Distributor or an Adviser to perform their obligations under this Agreement; or

 

(f)             at the option of the Company by written notice to the Fund with respect to any Portfolio if the Company reasonably believes that the Portfolio will fail to meet the Section 817(h) diversification requirements or Subchapter M qualifications specified in Article VI hereof; or

 

(g)            at the option of any non-defaulting party hereto in the event of a material breach of this Agreement by any party hereto (the “defaulting party”) other than as described in Section 10.1(a)-(h); provided, that the non-defaulting party gives written notice thereof to the defaulting party, with copies of such notice to all other non-defaulting parties, and if such breach shall not have been remedied within thirty (30) days after such written notice is given, then the non-defaulting party giving such written notice may terminate this Agreement by giving thirty (30) days written notice of termination to the defaulting party; or

 

(h)            at any time upon written agreement of all parties to this Agreement.

 

10.2.         Notice Requirement

 

No termination of this Agreement shall be effective unless and until the party terminating this Agreement gives prior written notice to all other parties of its intent to terminate, which notice shall set forth the basis for the termination.  Furthermore,

 

(a)            in the event any termination is based upon the provisions of Article VII, or the provisions of Section 10.1(a) of this Agreement, the prior written notice shall be given in advance of the effective date of termination as required by those provisions unless such notice period is shortened by mutual written agreement of the parties;

 

29



 

(b)            in the event any termination is based upon the provisions of Section 10.1(d), 10.1(e) or 10.1(g) of this Agreement, the prior written notice shall be given at least sixty (60) days before the effective date of termination; and

 

(c)            in the event any termination is based upon the provisions of Section 10.1(b), 10.1(c) or 10.1(f), the prior written notice shall be given in advance of the effective date of termination, which date shall be determined by the party sending the notice.

 

10.3.         Effect of Termination

 

Notwithstanding any termination of this Agreement, other than as a result of a failure by either the Fund or the Company to meet Section 817(h) of the Code diversification requirements, the Fund, the Distributors and the Advisers shall, at the option of the Company, continue to make available additional shares of the Fund pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as “Existing Contracts”).  Specifically, without limitation, the owners of the Existing Contracts shall be permitted to reallocate investments in the Fund, redeem investments in the Fund and/or invest in the Fund upon the making of additional purchase payments under the Existing Contracts.  The parties agree that this Section 10.3 shall not apply to any terminations under Article VII and the effect of such Article VII terminations shall be governed by Article VII of this Agreement.

 

10.4.         Surviving Provisions

 

Notwithstanding any termination of this Agreement, each party’s obligations under Article VIII to indemnify other parties shall survive and not be affected by any termination of this Agreement.  In addition, with respect to Existing Contracts, all provisions of this Agreement shall also survive and not be affected by any termination of this Agreement.

 

30



 

ARTICLE XI.

Notices

 

Any notice shall be sufficiently given when sent by registered or certified mail to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other parties.

 

If to the Company:

 

American Skandia Life Assurance Corporation

One Corporate Drive

Shelton, CT 06484

Attention:  Secretary

 

If to the Fund:

 

American Skandia Trust

One Corporate Drive

Shelton, CT 06484

Attention:  Secretary

 

If to the Advisers:

 

American Skandia Investment Services, Inc.

One Corporate Drive

Shelton, CT 06484

Attention:  Secretary

 

Prudential Investments LLC

Gateway Center Three

100 Mulberry Street, 14 th Floor

Newark, NJ 07102-4077

Attention:  Secretary

 

If to the Distributors:

 

American Skandia Marketing, Inc.

One Corporate Drive

Shelton, CT 06484

Attention:  Secretary

 

31



 

Prudential Investment Management Services LLC

Gateway Center Three

100 Mulberry Street, 14 th Floor

Newark, NJ 07102-4077

Attention:  Secretary

 

ARTICLE XII.

Miscellaneous

 

12.1.         Subject to the requirements of legal process and regulatory authority, each party hereto shall treat as confidential the names and addresses of the owners of the Contracts and all information reasonably identified as confidential in writing by any other party hereto and, except as permitted by this Agreement, shall not disclose, disseminate or utilize such names and addresses and other confidential information without the express written consent of the affected party until such time as such information may come into the public domain.  Without limiting the foregoing, no party hereto shall disclose any information that another party has designated as proprietary.

 

12.2.         The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.

 

12.3.         This Agreement may be executed simultaneously in two or more counterparts, each of which taken together shall constitute one and the same instrument.

 

12.4.         If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.

 

12.5.         Each party hereto shall cooperate with each other party and all appropriate governmental authorities (including without limitation the SEC, the NASD and state insurance regulators) and shall permit such authorities reasonable access to its books and records in

 

32



 

connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.

 

12.6.         Any controversy or claim arising out of or relating to this Agreement, or breach thereof, shall be settled by arbitration in a forum jointly selected by the relevant parties (but if applicable law requires some other forum, then such other forum) in accordance with the Commercial Arbitration Rules of the American Arbitration Association, and judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof.

 

12.7.         The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under state and federal laws.

 

12.8.         This Agreement or any of the rights and obligations hereunder may not be assigned by any party without the prior written consent of all parties hereto.

 

12.9.         The Company agrees that the obligations assumed by the Fund, the Distributors and the Advisers pursuant to this Agreement shall be limited in any case to the Fund, the Distributors and the Advisers and their respective assets and the Company shall not seek satisfaction of any such obligation from the shareholders of the Fund, the Distributors or the Advisers, the Directors, officers, employees or agents of the Fund, a Distributor or an Adviser, or any of them.

 

12.10.       The Fund, the Distributors and the Advisers agree that the obligations assumed by the Company pursuant to this Agreement shall be limited in any case to the Company and its assets and neither the Fund, the Distributors nor the Advisers shall seek satisfaction of any such obligation from the shareholders of the Company, the directors, officers, employees or agents of the Company, or any of them.

 

33



 

12.11.       No provision of this Agreement may be deemed or construed to modify or supersede any contractual rights, duties, or indemnifications, as between the Advisers and the Fund, and the Distributors and the Fund.

 

34



 

IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and on its behalf by its duly authorized representative and its seal to be hereunder affixed hereto as of the date specified below.

 

 

AMERICAN SKANDIA LIFE ASSURANCE CORPORATION,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

 

 

 

 

AMERICAN SKANDIA TRUST,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

 

 

AMERICAN SKANDIA INVESTMENT SERVICES, INC.,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

 

 

PRUDENTIAL INVESTMENTS LLC

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

 

 

 

 

AMERICAN SKANDIA MARKETING, INC.,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

35



 

 

PRUDENTIAL INVESTMENT MANAGEMENT SERVICES LLC,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

36



 

SCHEDULE A

Diversification Compliance Report and Certification

 

Name of fund:

 

Total Market Value as of

 

 

 

 

 

 

Four Largest
Investments

 

Market Value as of

 

Cumulative % of
Assets

 

I.R.C. Limitations
Greater than

 

1

 

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

 

 

 

3

 

 

 

 

 

 

 

 

 

4

 

 

 

 

 

 

 

 

 

5

 

 

 

 

 

 

 

 

 

 

Total Assets

 

 

Note: For purposes of diversification testing, all securities of the same issuer, all interests in the same real property project, and all interests in the same commodity are each treated as a single investment.  In the case of government securities each government agency or instrumentality is treated as a separate issuer.  See Treas. Reg. 1.817-5 for additional information.

 

Special Test for Variable Life Insurance

Where the only contracts based on the account are life insurance contracts (i.e., no annuity contracts), an account is adequately diversified to the extent it is invested in Treasury securities.  Treasury securities held through a custodial arrangement that is treated as a grantor trust (e.g. CATs and TGRs) will be treated as Treasury securities if substantially all of the assets of the trust are represented by Treasury securities.  Options on Treasury securities are not considered Treasury securities.  Where an account is invested in part in Treasury securities, revise the above general diversification test percentage limits by adding to them a product of .5 and the percentage of the value of the total assets invested in Treasury securities.  For example, if an account is 60% invested in Treasury securities, the percentage limit would be increased by 30% (0.5 x 60%) and would be applied to the assets of the account other than Treasury securities.

 

Alternate Test

If the alternative test under IRC Section 851 is used, those testing results should be attached.

 

Certification

The undersigned certifies that this Report and Certification, and any related attachments, have been prepared accurately and provide a true representation of account assets as of the last day of the quarter indicated above, and that the fund complies with IRC
Section 817(h).

 

 

 

 

 

Signed by

 

Date

 

 

37


Exhibit 99.(13)(d)

 

FUND PARTICIPATION AGREEMENT

 

 

Pruco Life Insurance Company,

 

American Skandia Trust,

 

American Skandia Investment Services, Inc.,

 

Prudential Investments LLC,

 

American Skandia Marketing, Inc.

 

and

 

Prudential Investment Management Services LLC

 

 

May 1, 2005, as Amended and Restated June 8, 2005

 



 

TABLE OF CONTENTS

 

ARTICLE I.

Sale of Fund Shares

4

 

 

 

ARTICLE II.

Representations and Warranties

8

 

 

 

ARTICLE III.

Prospectuses and Proxy Statements; Voting

12

 

 

 

ARTICLE IV.

Sales Material and Information

14

 

 

 

ARTICLE V.

Fees and Expenses

16

 

 

 

ARTICLE VI.

Diversification and Qualification

16

 

 

 

ARTICLE VII.

Potential Conflicts and Compliance With Mixed and Shared Funding Exemptive Order

19

 

 

 

ARTICLE VIII.

Indemnification

22

 

 

 

ARTICLE IX.

Applicable Law

27

 

 

 

ARTICLE X.

Termination

27

 

 

 

ARTICLE XI.

Notices

30

 

 

 

ARTICLE XII.

Miscellaneous

30

 

 

 

SCHEDULE A

Diversification Compliance Report and Certification

37

 



 

PARTICIPATION AGREEMENT

 

Among

 

PRUCO LIFE INSURANCE COMPANY,

 

AMERICAN SKANDIA TRUST,

 

AMERICAN SKANDIA INVESTMENT SERVICES, INC.,

 

PRUDENTIAL INVESTMENTS LLC,

 

AMERICAN SKANDIA MARKETING, INC.

 

and

 

PRUDENTIAL INVESTMENT MANAGEMENT SERVICES LLC

 

THIS AGREEMENT, made and entered into as of this 1 st day of May, 2005 and amended and restated as of June 8, 2005, by and among PRUCO LIFE INSURANCE COMPANY (the “Company”), an Arizona life insurance company, on its own behalf and on behalf of its separate accounts (the “Accounts”); AMERICAN SKANDIA TRUST, an open-end management investment company organized under the laws of Massachusetts (the “Fund”); AMERICAN SKANDIA INVESTMENT SERVICES, INC., a Connecticut corporation (“ASISI”); PRUDENTIAL INVESTMENTS LLC (“PI,” and collectively with ASISI, the “Advisers” and each an “Adviser”), AMERICAN SKANDIA MARKETING, INC., a Delaware corporation (“ASM”); and PRUDENTIAL INVESTMENT MANAGEMENT SERVICES LLC, a Delaware limited liability company (“PIMS,” and collectively with ASM, the “Distributors” and each a “Distributor”).

 

WHEREAS, the Fund engages in business as an open-end management investment company and is available to act as the investment vehicle for separate accounts established for variable life insurance policies and/or variable annuity contracts (collectively, the “Variable Insurance Products”) to be offered by insurance companies, many of which have entered into

 

2



 

participation agreements similar to this Agreement (hereinafter “Participating Insurance Companies”); and

 

WHEREAS, the beneficial interest in the Fund is divided into several series of shares, each designated a “Portfolio” and representing the interest in a particular managed portfolio of securities and other assets; and

 

WHEREAS, the Fund has obtained an order from the Securities and Exchange Commission (hereinafter the “SEC”), dated August 1, 1995 (File No. 812-9384), granting Participating Insurance Companies and variable annuity and variable life insurance separate accounts exemptions from the provisions of sections 9(a), 13(a), 15(a), and 15(b) of the Investment Company Act of 1940, as amended, (hereinafter the “1940 Act”) and Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit shares of the Fund to be sold to and held by variable annuity and variable life insurance separate accounts of life insurance companies that may or may not be affiliated with one another and qualified pension and retirement plans (“Qualified Plans”) (hereinafter the “Mixed and Shared Funding Exemptive Order”); and

 

WHEREAS, the Fund is registered as an open-end management investment company under the 1940 Act and shares of the Portfolio(s) are registered under the Securities Act of 1933, as amended (hereinafter the “1933 Act”); and

 

WHEREAS, each Adviser is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended; and

 

WHEREAS, each Distributor is duly registered as a broker-dealer under the Securities Exchange Act of 1934, as amended, (the “1934 Act”) and is a member in good standing of the National Association of Securities Dealers, Inc. (the “NASD”); and

 

3



 

WHEREAS, the Company has issued and plans to continue to issue certain variable life insurance policies and variable annuity contracts supported wholly or partially by the Accounts (the “Contracts”); and

 

WHEREAS, each Account is a duly organized, validly existing segregated asset account, established by resolution of the Board of Directors of the Company under the insurance laws of the State of Connecticut, to set aside and invest assets attributable to the Contracts; and

 

WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company intends to continue to purchase shares in the Portfolios on behalf of the Accounts to fund the Contracts, and the Fund is authorized to sell such shares to unit investment trusts such as the Accounts at net asset value; and

 

WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company also intends to continue to purchase shares in other open-end investment companies or series thereof not affiliated with the Fund (the “Unaffiliated Funds”) on behalf of the Accounts to fund the Contracts; and

 

WHEREAS, the parties wish to enter into a written agreement governing the arrangement already existing among the parties.

 

NOW, THEREFORE, in consideration of their mutual promises, the Company, the Fund, the Distributors and the Advisers agree as follows:

 

ARTICLE I.            Sale of Fund Shares

 

1.1.           The Fund agrees to sell to the Company those shares of the Portfolios which the Account orders, executing such orders on each Business Day at the net asset value next computed after receipt by the Fund or its designee of the order for the shares of the Portfolios.  For purposes of this Section 1.1, the Company shall be the designee of the Fund for receipt of such orders and

 

4



 

receipt by such designee shall constitute receipt by the Fund, provided that the Fund receives notice of any such order by 10:00 a.m. Eastern time on the next following Business Day.  “Business Day” shall mean any day on which the New York Stock Exchange is open for trading and on which the Portfolio calculates its net asset value pursuant to the rules of the SEC.  “Valuation Time” shall mean the time as of which the Fund calculates net asset value for the shares of the Portfolios on the relevant Business Day.

 

1.2.           The Fund agrees to make shares of the Portfolios available for purchase at the applicable net asset value per share by the Company and the Accounts on those days on which the Fund calculates its Portfolios’ net asset value pursuant to rules of the SEC, and the Fund shall calculate such net asset value on each day which the New York Stock Exchange is open for trading.  Notwithstanding the foregoing, the Fund may refuse to sell shares of any Portfolio to any person, or suspend or terminate the offering of shares of any Portfolio if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the Fund acting in good faith, necessary or appropriate in the best interests of the shareholders of such Portfolio.  All orders accepted by the Company shall be subject to the terms of the then current prospectus of the Fund.  The Company shall use its best efforts, and shall reasonably cooperate with, the Fund to enforce stated prospectus policies regarding transactions in Portfolio shares.  The Company acknowledges that orders accepted by it in violation of the Fund’s stated policies may be subsequently revoked or cancelled by the Fund and that the Fund shall not be responsible for any losses incurred by the Company or the Contract owner as a result of such cancellation.  In addition, the Company acknowledges that the Fund has the right to refuse any purchase order for any reason, particularly if the Fund determines that a Portfolio would be unable to invest the money effectively in accordance with its investment policies or would otherwise be adversely affected due to the size of the transaction, frequency of trading, or other factors.

 

1.3.           The Fund will not sell shares of the Portfolios to any other Participating Insurance Company separate account unless an agreement containing provisions the substance of which are

 

5



 

the same as Sections 2.1, 2.2 (except with respect to designation of applicable law), 3.5, 3.6, 3.7, and Article VII of this Agreement is in effect to govern such sales.

 

1.4.           The Fund agrees to redeem for cash, on the Company’s request, any full or fractional shares of the Fund held by the Company, executing such requests on each Business Day at the net asset value next computed after receipt by the Fund or its designee of the request for redemption.  For purposes of this Section 1.4, the Company shall be the designee of the Fund for receipt of requests for redemption and receipt by such designee shall constitute receipt by the Fund, provided that the Fund receives notice of any such request for redemption by 10:00 a.m. Eastern time on the next following Business Day.

 

1.5.           The parties hereto acknowledge that the arrangement contemplated by this Agreement is not exclusive; the Fund’s shares may be sold to other Participating Insurance Companies (subject to Section 1.3) and the cash value of the Contracts may be invested in other investment companies.

 

1.6.           The Company shall pay for Fund shares by 3:00 p.m. Eastern time on the next Business Day after an order to purchase Fund shares is received in accordance with the provisions of Section 1.1 hereof.  Payment shall be in federal funds transmitted by wire and/or by a credit for any shares redeemed the same day as the purchase.

 

1.7.           The Fund shall pay and transmit the proceeds of redemptions of Fund shares by 11:00 a.m. Eastern Time on the next Business Day after a redemption order is received in accordance with Section 1.4 hereof; provided, however, that the Fund may delay payment in extraordinary circumstances to the extent permitted under Section 22(e) of the 1940 Act.  Payment shall be in federal funds transmitted by wire and/or a credit for any shares purchased the same day as the redemption.

 

1.8.           Issuance and transfer of the Fund’s shares will be by book entry only.  Stock certificates will not be issued to the Company or the Accounts.  Shares purchased from the Fund

 

6



 

will be recorded in an appropriate title for the relevant Account or the relevant sub-account of an Account.

 

1.9.           The Fund shall furnish same day notice (by electronic communication or telephone, followed by electronic confirmation) to the Company of any income, dividends or capital gain distributions payable on a Portfolio’s shares.  The Company hereby elects to receive all such income dividends and capital gain distributions as are payable on a Portfolio’s shares in additional shares of that Portfolio.  The Company reserves the right to revoke this election and to receive all such income dividends and capital gain distributions in cash.  The Fund shall notify the Company by the end of the next following Business Day of the number of shares so issued as payment of such dividends and distributions.

 

1.10.         The Fund shall make the net asset value per share for each Portfolio available to the Company on each Business Day as soon as reasonably practicable after the net asset value per share is calculated and shall use its best efforts to make such net asset value per share available by 6:00 p.m. Eastern time.  In the event of an error in the computation of a Portfolio’s net asset value per share (“NAV”) or any dividend or capital gain distribution (each, a “pricing error”), an Adviser or the Fund shall immediately notify the Company as soon as possible after discovery of the error.  Such notification may be verbal, but shall be confirmed promptly in writing.  A pricing error shall be corrected as follows:  (a) if the pricing error results in a difference between the erroneous NAV and the correct NAV of less than $0.01 per share, then no corrective action need be taken; (b) if the pricing error results in a difference between the erroneous NAV and the correct NAV equal to or greater than $0.01 per share, but less than 1/2 of 1% of the Portfolio’s NAV at the time of the error, then the Advisers shall reimburse the Portfolio for any loss, after taking into consideration any positive effect of such error; however, no adjustments to Contract owner accounts need be made; and (c) if the pricing error results in a difference between the erroneous NAV and the correct NAV equal to or greater than 1/2 of 1% of the Portfolio’s NAV at the time of the error, then the Advisers shall reimburse the Portfolio for any loss (without taking into consideration any positive effect of such error) and shall reimburse the Company for the costs of adjustments made to correct Contract owner accounts.  If an adjustment is necessary

 

7



 

to correct a material error which has caused Contract owners to receive less than the amount to which they are entitled, the number of shares of the applicable sub-account of such Contract owners will be adjusted and the amount of any underpayments shall be credited by the Advisers to the Company for crediting of such amounts to the applicable Contract owners accounts.  Upon notification by an Adviser of any overpayment due to a material error, the Company shall promptly remit to the Advisers any overpayment that has not been paid to Contract owners.  In no event shall the Company be liable to Contract owners for any such adjustments or underpayment amounts.  A pricing error within categories (b) or (c) above shall be deemed to be “materially incorrect” or constitute a “material error” for purposes of this Agreement.  The standards set forth in this Section 1.10 are based on the parties’ understanding of the views expressed by the staff of the SEC as of the date of this Agreement.  In the event the views of the SEC staff are later modified or superseded by SEC or judicial interpretation, the parties shall amend the foregoing provisions of this Agreement to comport with the appropriate applicable standards, on terms mutually satisfactory to all parties.

 

1.11.         The parties agree to mutually cooperate with respect to any state insurance law restriction or requirement applicable to the Fund’s investments; provided, however, that the Fund reserves the right not to implement restrictions or take other actions required by state insurance law if the Fund or an Adviser determines that the implementation of the restriction or other action is not in the best interest of Fund shareholders.

 

ARTICLE II.          Representations and Warranties

 

2.1.           The Company represents and warrants that:  (a) the securities deemed to be issued by the Accounts under the Contracts are or will be registered under the 1933 Act, or are not so registered in proper reliance upon an exemption from such registration requirements; (b) the Contracts will be issued and sold in compliance in all material respects with all applicable federal and state laws; and (c) the sale of the Contracts shall comply in all material respects with state insurance suitability requirements.

 

8



 

2.2.           The Company represents and warrants that:  (a) it is an insurance company duly organized and in good standing under applicable law; (b) it has legally and validly established each Account prior to any issuance or sale of units thereof as a segregated asset account under Connecticut law; and (c) it has registered each Account as a unit investment trust in accordance with the provisions of the 1940 Act to serve as a segregated investment account for the Contracts will maintain such registration for so long as any Contracts are outstanding as required by applicable law or, alternatively, the Company has not registered one or more Accounts in proper reliance upon an exclusion from such registration requirements.

 

2.3.           The Fund represents and warrants that:  (a) the Fund shares sold pursuant to this Agreement shall be registered under the 1933 Act; (b) the Fund shares sold pursuant to this Agreement shall be duly authorized for issuance and sold in compliance with all applicable federal securities laws including without limitation the 1933 Act, the 1934 Act, and the 1940 Act; (c) the Fund is and shall remain registered under the 1940 Act; and (d) the Fund shall amend the registration statement for its shares under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its shares.

 

2.4.           The parties acknowledge that the Fund reserves the right to adopt one or more plans pursuant to Rule 12b-1 under the 1940 Act and to impose an asset-based or other charge to finance distribution expenses as permitted by applicable law and regulation.  The Fund and the Advisers agree to comply with applicable provisions and SEC interpretation of the 1940 Act with respect to any distribution plan.

 

2.5.           The Fund represents and warrants that it shall register and qualify the shares for sale in accordance with the laws of the various states if and to the extent required by applicable law.

 

2.6.           The Fund represents and warrants that it is lawfully organized and validly existing under the laws of the Commonwealth of Massachusetts and that it does and will comply in all material respects with the 1940 Act.

 

9



 

2.7.           Each Adviser represents and warrants that it is and shall remain duly registered under all applicable federal and state securities laws and that it shall perform its obligations for the Fund in compliance in all material respects with any applicable state and federal securities laws.

 

2.8.           Each Distributor represents and warrants that it is and shall remain duly registered under all applicable federal and state securities laws and that it shall perform its obligations for the Fund in compliance in all material respects with the laws of any applicable state and federal securities laws.

 

2.9.           The Fund and the Advisers represent and warrant that all of their respective officers, employees, investment advisers, and other individuals or entities dealing with the money and/or securities of the Fund are, and shall continue to be at all times, covered by one or more blanket fidelity bonds or similar coverage for the benefit of the Fund in an amount not less than the minimal coverage required by Rule 17g-1 under the 1940 Act or related provisions as may be promulgated from time to time.  The aforesaid bonds shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company.

 

2.10.         The Fund and the Advisers represent and warrant that they will provide the Company with as much advance notice as is reasonably practicable of any material change affecting the Portfolios (including, but not limited to, any material change in the registration statement or prospectus affecting the Portfolios) and any proxy solicitation affecting the Portfolios and consult with the Company in order to implement any such change in an orderly manner, recognizing the expenses of changes and attempting to minimize such expenses by implementing them in conjunction with regular annual updates of the prospectus for the Contracts.

 

2.11          The Company represents and warrants, for purposes other than diversification under Section 817 of the Internal Revenue Code of 1986 as amended (the “Code”), that the

 

10



 

Contracts are currently and at the time of issuance will be treated as annuity contracts or life insurance policies under applicable provisions of the Code, and that it will make every effort to maintain such treatment and that it will notify the Fund, the Distributors and the Advisers immediately upon having a reasonable basis for believing that the Contracts have ceased to be so treated or that they might not be so treated in the future.  In addition, the Company represents and warrants that each Account is a “segregated asset account” and that interests in each Account are offered exclusively through the purchase of or transfer into a “variable contract” within the meaning of such terms under Section 817 of the Code and the regulations thereunder.  The Company will use every effort to continue to meet such definitional requirements, and it will notify the Fund, the Distributors and the Advisers immediately upon having a reasonable basis for believing that such requirements have ceased to be met or that they might not be met in the future.  The Company represents and warrants that it will not purchase Fund shares with assets derived from tax-qualified retirement plans except, indirectly, through Contracts purchased in connection with such plans.

 

2.12          The Company represents and warrants that it is currently in compliance, and will remain in compliance, with all applicable anti-money laundering laws, regulations, and requirements.  In addition, the Company represents and warrants that it has adopted and implemented policies and procedures reasonably designed to achieve compliance with the applicable requirements administered by the Office of Foreign Assets Control (“OFAC”) of the U.S. Department of the Treasury.

 

2.13          The Company represents and warrants that it is currently in compliance, and will remain in compliance, with all applicable laws, rules and regulations relating to consumer privacy, including, but not limited to, Regulation S-P.

 

2.14          The Company represents and warrants that it has adopted, and will at all times during the term of this Agreement maintain, reasonable and appropriate procedures (“Late Trading Procedures”) designed to ensure that any and all orders relating to the purchase, sale or exchange of Fund shares communicated to the Fund to be treated in accordance with Article I of

 

11



 

this Agreement as having been received on a Business Day have been received by the Valuation Time on such Business Day and were not modified after the Valuation Time, and that all orders received from Contract owners but not rescinded by the Valuation Time were communicated to the Fund or its agent as received for that Business Day.  Each transmission of orders by the Company shall constitute a representation by the Company that such orders are accurate and complete and relate to orders received by the Company by the Valuation Time on the Business Day for which the order is to be priced and that such transmission includes all orders relating to Fund shares received from Contract owners but not rescinded by the Valuation Time.  The Company agrees to provide the Fund or its designee with a copy of the Late Trading Procedures and such certifications and representations regarding the Late Trading Procedures as the Fund or its designee may reasonably request.  The Company will promptly notify the Fund in writing of any material change to the Late Trading Procedures.

 

2.15.         The Company represents and warrants that it has adopted, and will at all times during the term of this Agreement maintain, reasonable and appropriate procedures (“Market Timing Procedures”) designed to minimize any adverse impact on other Fund investors due to excessive trading.  The Company agrees to provide the Fund or its designee with a copy of the Market Timing Procedures and such certifications and representations regarding the Market Timing Procedures as the Fund or its designee may reasonably request.  The Company will promptly notify the Fund in writing of any material change to the Market Timing Procedures.  The parties agree to cooperate in light of any conflict between the Market Timing Procedures and actions taken or policies adopted by the Fund designed to minimize any adverse impact on other Fund investors due to excessive trading.

 

ARTICLE III.

Printing and Distribution of Fund Documents and other Administrative Services Provided by the Company to the Fund

 

3.1.           At least annually, an Adviser or Distributor shall provide the Company with camera-ready copy of the Fund’s prospectus and any supplements thereto for printing and delivery by the Company to all Contract owners. If requested by the Company in lieu thereof, an

 

12



 

Adviser, a Distributor or the Fund shall provide camera-ready copy (including an electronic version of the current prospectus) to the Company and other assistance as is reasonably necessary in order for the Company once each year (or more frequently if the prospectus for the Fund is amended) to have the prospectus for the Contracts and the prospectus for the Fund printed together in one document and delivered to all Contract owners

 

3.2.           If applicable state or federal laws or regulations require that the Statement of Additional Information (“SAI”) for the Fund be distributed to all Contract owners, then the Fund, a Distributor and/or an Adviser shall provide the Company with camera-ready copy of the Fund’s SAI and any supplements thereto for printing and delivery to all Contract ownersSchedule B An Adviser, a Distributor and/or the Fund shall also provide camera-ready copy of the SAI to the Company for printing and delivery to any Contract owner or prospective owner who requests such SAI from the Fund.

 

3.3.           The Fund, a Distributor and/or an Adviser shall provide the Company with copies of the Fund’s proxy material, reports to shareholders and other communications to shareholders suitable for printing to permit Schedule B timely distribution thereof by the Company to Contract owners.

 

3.4           The Company shall also provide the following administrative services to the Fund:

 

Maintenance of books and records

 

      In the general ledger, reconcile and balance ASLAC’s separate account investments in the various portfolios of the Fund

 

Purchase and Redemption Orders

 

      Reconcile and provide notice to AST of (a) net cash flow into AST, and (b) cash required for net redemption orders with confirmation thereof to AST

 

AST-Related Contract Owner Services

 

      Assist AST with proxy solicitations, specifically with respect to soliciting voting instructions from contract owners

 

13



 

      Investigate and respond to inquiries from contract owners that relate to AST and not to the separate account

 

Reports

 

      Periodic information reporting to AST

      Preparation of reports regarding AST for third-party reporting services

 

3.5.           It is understood and agreed that, except with respect to information regarding the Company provided in writing by that party, the Company shall not be responsible for the content of the prospectus or SAI for the Fund.  It is also understood and agreed that, except with respect to information regarding the Fund, the Distributors, the Advisers or the Portfolios provided in writing by the Fund, a Distributor or an Adviser, neither the Fund, the Distributors nor the Advisers are responsible for the content of the prospectus or SAI for the Contracts.

 

3.6.           If and to the extent required by law the Company shall:

 

(a)            solicit voting instructions from Contract owners;

 

(b)            vote the Portfolio shares held in the Accounts in accordance with instructions received from Contract owners;

 

(c)            vote Portfolio shares held in the Accounts for which no instructions have been received in the same proportion as Portfolio shares for which instructions have been received from Contract owners, so long as and to the extent that the SEC continues to interpret the 1940 Act to require pass-through voting privileges for variable contract owners; and

 

(d)            vote Portfolio shares held in its general account or otherwise in the same proportion as Portfolio shares for which instructions have been received from Contract owners, so long as and to the extent that the SEC continues to interpret the 1940 Act to require such voting by the insurance company.  The Company reserves the right to vote Fund shares in its own right, to the extent permitted by law.

 

3.7.           The Company shall be responsible for assuring that each of its separate accounts holding shares of a Portfolio calculates voting privileges as directed by the Fund and agreed to by the Company and the Fund.  The Fund agrees to promptly notify the Company of any changes of interpretations or amendments of the Mixed and Shared Funding Exemptive Order.

 

14



 

3.8.           The Fund will comply with all provisions of the 1940 Act requiring voting by shareholders, and in particular the Fund will either provide for annual meetings (except insofar as the SEC may interpret Section 16 of the 1940 Act not to require such meetings) or, as the Fund currently intends, comply with Section 16(c) of the 1940 Act (although the Fund is not one of the trusts described in Section 16(c) of that Act) as well as with Sections 16(a) and, if and when applicable, 16(b).  Further, the Fund will act in accordance with the SEC’s interpretation of the requirements of Section 16(a) with respect to periodic elections of directors or trustees and with whatever rules the SEC may promulgate with respect thereto.

 

ARTICLE IV.          Sales Material and Information

 

4.1.           The Company shall not give any information or make any representations or statements on behalf of the Fund in connection with the sale of the Contracts other than the information or representations contained in the registration statement, including the prospectus or SAI for the Fund shares, as the same may be amended or supplemented from time to time, or in sales literature or other promotional material approved by the Fund, a Distributor or an Adviser, except with the permission of the Fund, a Distributor or an Adviser.

 

4.2.           The Fund, the Distributors and the Advisers shall not give any information or make any representations on behalf of the Company or concerning the Company, the Accounts, or the Contracts other than the information or representations contained in a registration statement, including the prospectus or SAI for the Contracts, as the same may be amended or supplemented from time to time, or in sales literature or other promotional material approved by the Company or its designee, except with the permission of the Company.

 

4.3.           For purposes of Articles IV and VIII, the phrase “sales literature and other promotional material” includes, but is not limited to, advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media;

 

15



 

e.g. , on-line networks such as the Internet or other electronic media), sales literature ( i.e. , any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, and shareholder reports, and proxy materials (including solicitations for voting instructions) and any other material constituting sales literature or advertising under the NASD rules, the 1933 Act or the 1940 Act.

 

4.4.           At the request of any party to this Agreement, each other party will make available to the other party’s independent auditors and/or representatives of the appropriate regulatory agencies, all records, data and access to operating procedures that may be reasonably requested in connection with compliance and regulatory requirements related to this Agreement or any party’s obligations under this Agreement.

 

ARTICLE V.          Fees and Expenses

 

5.1.           In consideration of the services provided by the Company to the Fund that are set forth in sections 3.1, 3.2, 3.3 and 3.4 under Agreement, the Fund will pay the Company 0.10% on an annualized basis of the net asset value of shares of the Fund owned by separate accounts of the Company that are invested in the Fund.  Such amount shall be determined on the last day of each calendar quarter and is payable within 10 days after the end of such calendar quarter.   Except as otherwise provided in this Agreement, the Fund, the Distributors and the Advisers shall pay no fee or other compensation to the Company under this Agreement, and the Company shall pay no fee or other compensation to the Fund, a Distributor or an Adviser under this Agreement.  provided, however, the parties may enter into other agreements relating to the Company’s investment in the Fund, including services agreements.

 

16



 

ARTICLE VI.          Diversification and Qualification

 

6.1.           The Fund, the Distributors and the Advisers represent and warrant that the Fund and each Portfolio thereof will at all times comply with Section 817(h) of the Code and Treasury Regulation §1.817-5, as amended from time to time, and any Treasury interpretations thereof, relating to the diversification requirements for variable annuity, endowment, or life insurance contracts and any amendments or other modifications or successor provisions to such Section or Regulations.  The Fund, a Distributor or an Adviser shall provide to the Company a quarterly written diversification report, in the form attached hereto as Schedule A which shall show the results of the quarterly Section 817(h) diversification test and include a certification as to whether each Portfolio complies with the Section 817(h) diversification requirement.  The diversification report shall be provided to the Company within 10 calendar days of the end of a quarter.

 

6.2.           The Fund, the Distributors and the Advisers agree that shares of the Portfolios will be sold only to Participating Insurance Companies and their separate accounts and to Qualified Plans.  No shares of any Portfolio of the Fund will be sold to the general public.

 

6.3.           The Fund, the Distributors and the Advisers represent and warrant that the Fund and each Portfolio is currently qualified as a Regulated Investment Company under Subchapter M of the Code, and that each Portfolio will maintain such qualification (under Subchapter M or any successor or similar provisions) as long as this Agreement is in effect.

 

6.4.           The Fund, a Distributor or an Adviser will notify the Company immediately upon having a reasonable basis for believing that the Fund or any Portfolio has ceased to comply with the aforesaid Section 817(h) diversification or Subchapter M qualification requirements or might not so comply in the future.

 

6.5.           Without in any way limiting the effect of Sections 8.2, 8.3 and 8.4 hereof and without in any way limiting or restricting any other remedies available to the Company, an Adviser or a Distributor will pay all costs associated with or arising out of any failure, or any anticipated or reasonably foreseeable failure, of the Fund or any Portfolio to comply with

 

17



 

Sections 6.1, 6.2, or 6.3 hereof, including all costs associated with reasonable and appropriate corrections or responses to any such failure; such costs may include, but are not limited to, the costs involved in creating, organizing, and registering a new investment company as a funding medium for the Contracts and/or the costs of obtaining whatever regulatory authorizations are required to substitute shares of another investment company for those of the failed Portfolio (including but not limited to an order pursuant to Section 26(c) of the 1940 Act).

 

6.6.           The Company agrees that if the Internal Revenue Service (“IRS”) asserts in writing in connection with any governmental audit or review of the Company (or, to the Company’s knowledge, of any Contract owner) that any Portfolio has failed to comply with the diversification requirements of Section 817(h) of the Code or the Company otherwise becomes aware of any facts that could give rise to any claim against the Fund, a Distributor or an Adviser as a result of such a failure or alleged failure:

 

(a)            The Company shall promptly notify the Fund, the Distributors and the Advisers of such assertion or potential claim;

 

(b)            The Company shall consult with the Fund, the Distributors and the Advisers as to how to minimize any liability that may arise as a result of such failure or alleged failure;

 

(c)            The Company shall use its best efforts to minimize any liability of the Fund, the Distributors and the Advisers resulting from such failure, including, without limitation, demonstrating, pursuant to Treasury Regulations, Section 1.817-5(a)(2), to the commissioner of the IRS that such failure was inadvertent;

 

(d)            Any written materials to be submitted by the Company to the IRS, any Contract owner or any other claimant in connection with any of the foregoing proceedings or contests (including, without limitation, any such materials to be submitted to the IRS pursuant to Treasury Regulations, Section 1.817-5(a)(2)) shall be provided by the Company to the Fund, the

 

18



 

Distributors and the Advisers (together with any supporting information or analysis) within at least two (2) business days prior to submission;

 

(e)            The Company shall provide the Fund, the Distributors and the Advisers with such cooperation as the Fund, the Distributors and the Advisers shall reasonably request (including, without limitation, by permitting the Fund, the Distributors and the Advisers to review the relevant books and records of the Company) in order to facilitate review by the Fund, the Distributors and the Advisers of any written submissions provided to it or its assessment of the validity or amount of any claim against it arising from such failure or alleged failure;

 

(f)             The Company shall not with respect to any claim of the IRS or any Contract owner that would give rise to a claim against the Fund, the Distributors and the Adviser s(i) compromise or settle any claim, (ii) accept any adjustment on audit, or (iii) forego any allowable administrative or judicial appeals, without the express written consent of the Fund, the Distributors and the Advisers, which shall not be unreasonably withheld; provided that, the Company shall not be required to appeal any adverse judicial decision unless the Fund and the Advisers shall have provided an opinion of independent counsel to the effect that a reasonable basis exists for taking such appeal; and further provided that the Fund, the Distributors and the Advisers shall bear the costs and expenses, including reasonable attorney’s fees, incurred by the Company in complying with this clause (f).

 

ARTICLE VII.                        Potential Conflicts and Compliance With Mixed and Shared Funding Exemptive Order

 

7.1.           The Board will monitor the Fund for the existence of any material irreconcilable conflict between the interests of the contract owners of all separate accounts investing in the Fund.  An irreconcilable material conflict may arise for a variety of reasons, including:  (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance, tax, or securities laws or regulations, or a public ruling, private letter ruling, no-action or interpretative letter, or any similar action by insurance, tax, or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the

 

19



 

investments of any Portfolio is being managed; (e) a difference in voting instructions given by variable annuity contract and variable life insurance contract owners or by contract owners of different Participating Insurance Companies; or (f) a decision by a Participating Insurance Company to disregard the voting instructions of contract owners.  The Board shall promptly inform the Company if it determines that an irreconcilable material conflict exists and the implications thereof.

 

7.2.           The Company will report any potential or existing conflicts of which it is aware to the Board.  The Company will assist the Board in carrying out its responsibilities under the Mixed and Shared Funding Exemptive Order, by providing the Board with all information reasonably necessary for the Board to consider any issues raised.  This includes, but is not limited to, an obligation by the Company to inform the Board whenever Contract owner voting instructions are to be disregarded.  Such responsibilities shall be carried out by the Company with a view only to the interests of its Contract owners.

 

7.3.           If it is determined by a majority of the Board, or a majority of its trustees who are not interested persons of the Fund, the Distributor, the Adviser or any subadviser to any of the Portfolios (the “Independent Directors”), that a material irreconcilable conflict exists, the Company and other Participating Insurance Companies shall, at their expense and to the extent reasonably practicable (as determined by a majority of the Independent Directors), take whatever steps are necessary to remedy or eliminate the irreconcilable material conflict, up to and including:  (1) withdrawing the assets allocable to some or all of the separate accounts from the Fund or any Portfolio and reinvesting such assets in a different investment medium, including (but not limited to) another Portfolio, or submitting the question whether such segregation should be implemented to a vote of all affected contract owners and, as appropriate, segregating the assets of any appropriate group ( i.e. , annuity contract owners, life insurance contract owners, or variable contract owners of one or more Participating Insurance Companies) that votes in favor of such segregation, or offering to the affected contract owners the option of making such a change; and (2) establishing a new registered management investment company or managed separate account.

 

20



 

7.4.           If a material irreconcilable conflict arises because of a decision by the Company to disregard Contract owner voting instructions and that decision represents a minority position or would preclude a majority vote, the Company may be required, at the Fund’s election, to withdraw the Account’s investment in the Fund and terminate this Agreement; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the Independent Directors.  Any such withdrawal and termination must take place within six (6) months after the Fund gives written notice that this provision is being implemented, and until the end of that six-month period the Advisers, the Distributors and the Fund shall continue to accept and implement orders by the Company for the purchase (and redemption) of shares of the Fund.

 

7.5.           If a material irreconcilable conflict arises because a particular state insurance regulator’s decision applicable to the Company conflicts with the majority of other state regulators, then the Company will withdraw the Account’s investment in the Fund and terminate this Agreement within six months after the Board informs the Company in writing that it has determined that such decision has created an irreconcilable material conflict; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the Independent Directors.  Until the end of the foregoing six-month period, the Fund shall continue to accept and implement orders by the Company for the purchase (and redemption) of shares of the Fund.

 

7.6.           For purposes of Sections 7.3 through 7.5 of this Agreement, a majority of the Independent Directors shall determine whether any proposed action adequately remedies any irreconcilable material conflict, but in no event will the Fund be required to establish a new funding medium for the Contracts.  The Company shall not be required by Section 7.3 to establish a new funding medium for the Contracts if an offer to do so has been declined by vote of a majority of Contract owners affected by the irreconcilable material conflict.  In the event that the Board determines that any proposed action does not adequately remedy any irreconcilable material conflict, then the Company will withdraw the Account’s investment in the Fund and

 

21



 

terminate this Agreement within six (6) months after the Board informs the Company in writing of the foregoing determination; provided, however, that such withdrawal and termination shall be limited to the extent required by any such material irreconcilable conflict as determined by a majority of the Independent Directors.

 

7.7.           If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the Mixed and Shared Funding Exemptive Order) on terms and conditions materially different from those contained in the Mixed and Shared Funding Exemptive Order, then (a) the Fund and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary to comply with Rules 6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent such rules are applicable: and (b) Sections 3.5, 3.6, 3.7, 7.1, 7.2, 7.3, 7.4, and 7.5 of this Agreement shall continue in effect only to the extent that terms and conditions substantially identical to such Sections are contained in such Rule(s) as so amended or adopted.

 

22



 

ARTICLE VIII.                       Indemnification

 

8.1.           Indemnification By The Company

 

(a)            The Company agrees to indemnify and hold harmless the Fund, the Distributors and the Advisers and each of their respective officers and directors or trustees and each person, if any, who controls the Fund, a Distributor or an Adviser within the meaning of Section 15 of the 1933 Act (collectively, the “Indemnified Parties” for purposes of this Section 8.1) against any and all losses, claims, expenses, damages and liabilities (including amounts paid in settlement with the written consent of the Company) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, expenses, damages or liabilities (or actions in respect thereof) or settlements are related to the sale or acquisition of the Fund’s shares or the Contracts and:

 

(i)             arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in the registration statement or prospectus or SAI covering the Contracts or contained in the Contracts or sales literature or other promotional material for the Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this Agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of an Adviser, a Distributor or the Fund for use in the registration statement or prospectus for the Contracts or in the Contracts or sales literature or other promotional material (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or Fund shares; or

 

(ii)            arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus or sales literature or other promotional material of the Fund not supplied by the Company or persons under its control) or wrongful

 

23



 

conduct of the Company or persons under its control, with respect to the sale or distribution of the Contracts or Fund Shares; or

 

(iii)           arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI, or sales literature or other promotional material of the Fund, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, if such a statement or omission was made in reliance upon information furnished in writing to the Fund by or on behalf of the Company; or

 

(iv)           arise as a result of any failure by the Company to provide the services and furnish the materials under the terms of this Agreement; or

 

(v)            arise out of or result from any material breach of any representation and/or warranty made by the Company in this Agreement or arise out of or result from any other material breach of this Agreement by the Company, including without limitation Section 2.11 and Section 6.6 hereof, as limited by and in accordance with the provisions of Sections 8.1(b) and 8.1(c) hereof.

 

(b)            The Company shall not be liable under this indemnification provision with respect to any losses, claims, expenses, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Party’s willful misfeasance, bad faith, or negligence in the performance of such Indemnified Party’s duties or by reason of such Indemnified Party’s reckless disregard of obligations or duties under this Agreement or to any of the Indemnified Parties.

 

(c)            The Company shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Company in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Company of any such claim shall not relieve the Company from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the

 

24



 

extent that the Company has been prejudiced by such failure to give notice.  In case any such action is brought against the Indemnified Parties, the Company shall be entitled to participate, at its own expense, in the defense of such action.  The Company also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action.  After notice from the Company to such party of the Company’s election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Company will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.

 

(d)            The Indemnified Parties will promptly notify the Company of the commencement of any litigation or proceedings against them in connection with the issuance or sale of the Fund Shares or the Contracts or the operation of the Fund.

 

8.2.           Indemnification by the Advisers

 

(a)            Each Adviser agrees to indemnify and hold harmless the Company and its directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the “Indemnified Parties” for purposes of this Section 8.2) against any and all losses, claims, expenses, damages, liabilities (including amounts paid in settlement with the written consent of an Adviser) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Fund’s shares or the Contracts and:

 

(i)             arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement or prospectus or SAI or sales literature or other promotional material of the Fund prepared by the Fund, a Distributor or an Adviser (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the

 

25



 

statements therein not misleading, provided that this Agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to an Adviser, a Distributor or the Fund by or on behalf of the Company for use in the registration statement, prospectus or SAI for the Fund or in sales literature or other promotional material (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or the Fund shares; or

 

(ii)            arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, SAI or sales literature or other promotional material for the Contracts not supplied by the Adviser or persons under its control) or wrongful conduct of the Fund, a Distributor or an Adviser or persons under their control, with respect to the sale or distribution of the Contracts or Fund shares; or

 

(iii)           arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI, or sales literature or other promotional material covering the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished in writing to the Company by or on behalf of an Adviser, a Distributor or the Fund; or

 

(iv)           arise as a result of any failure by the Fund, a Distributor or an Adviser to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification and other qualification requirements specified in Article VI of this Agreement); or

 

(v)            arise out of or result from any material breach of any representation and/or warranty made by the Fund, a Distributor or an Adviser in this Agreement or arise out of or result from any other material breach of this Agreement by an Adviser, a Distributor or the Fund; or

 

(vi)           arise out of or result from the incorrect or untimely calculation or reporting by the Fund, a Distributor or an Adviser of the daily net asset value per share (subject to Section 1.10 of this Agreement) or dividend or capital gain distribution rate;

 

26



 

as limited by and in accordance with the provisions of Sections 8.2(b) and 8.2(c) hereof.  This indemnification is in addition to and apart from the responsibilities and obligations of the Advisers specified in Article VI hereof.

 

(b)            The Advisers shall not be liable under this indemnification provision with respect to any losses, claims, expenses, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Party’s willful misfeasance, bad faith, or negligence in the performance of such Indemnified Party’s duties or by reason of such Indemnified Party’s reckless disregard of obligations or duties under this Agreement or to any of the Indemnified Parties.

 

(c)            The Advisers shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Advisers in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Advisers of any such claim shall not relieve the Advisers from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the extent that the Advisers have been prejudiced by such failure to give notice.  In case any such action is brought against the Indemnified Parties, the Advisers will be entitled to participate, at their own expense, in the defense thereof.  The Advisers also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action.  After notice from the Advisers to such party of the Advisers’ election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Advisers will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.

 

27



 

(d)            The Company agrees promptly to notify the Advisers of the commencement of any litigation or proceedings against it or any of its officers or directors in connection with the issuance or sale of the Contracts or the operation of the Account.

 

ARTICLE IX.         Applicable Law

 

9.1.           This Agreement shall be construed and the provisions hereof interpreted under and in accordance with the laws of the State of New Jersey, without regard to the New Jersey conflict of laws provisions.

 

9.2.           This Agreement shall be subject to the provisions of the 1933, 1934 and 1940 Acts, and the rules and regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the SEC may grant (including, but not limited to, the Mixed and Shared Funding Exemptive Order) and the terms hereof shall be interpreted and construed in accordance therewith.

 

ARTICLE X.           Termination

 

10.1.         This Agreement shall terminate:

 

(a)            at the option of any party, with or without cause, with respect to some or all Portfolios, upon sixty (60) days advance written notice delivered to the other parties; or

 

(b)            at the option of the Company by written notice to the other parties with respect to any Portfolio based upon the Company’s determination that shares of such Portfolio are not reasonably available to meet the requirements of the Contracts; or

 

(c)            at the option of the Company by written notice to the other parties with respect to any Portfolio in the event any of the Portfolio’s shares are not registered, issued or sold in accordance with applicable state and/or federal law or such law precludes the use of such shares as the underlying investment media of the Contracts issued or to be issued by the Company; or

 

(d)            at the option of the Fund, a Distributor or an Adviser in the event that formal administrative proceedings are instituted against the Company by the NASD, the SEC, the Insurance Commissioner or like official of any state or any other regulatory body regarding the

 

28



 

Company’s duties under this Agreement or related to the sale of the Contracts, the operation of any Account, or the purchase of the Fund shares, if, in each case, the Fund, a Distributor or an Adviser, as the case may be, reasonably determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Company to perform its obligations under this Agreement; or

 

(e)            at the option of the Company in the event that formal administrative proceedings are instituted against the Fund, a Distributor or an Adviser by the NASD, the SEC, or any state securities or insurance department or any other regulatory body, if the Company reasonably determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Fund, a Distributor or an Adviser to perform their obligations under this Agreement; or

 

(f)             at the option of the Company by written notice to the Fund with respect to any Portfolio if the Company reasonably believes that the Portfolio will fail to meet the Section 817(h) diversification requirements or Subchapter M qualifications specified in Article VI hereof; or

 

(g)            at the option of any non-defaulting party hereto in the event of a material breach of this Agreement by any party hereto (the “defaulting party”) other than as described in Section 10.1(a)-(h); provided, that the non-defaulting party gives written notice thereof to the defaulting party, with copies of such notice to all other non-defaulting parties, and if such breach shall not have been remedied within thirty (30) days after such written notice is given, then the non-defaulting party giving such written notice may terminate this Agreement by giving thirty (30) days written notice of termination to the defaulting party; or

 

(h)            at any time upon written agreement of all parties to this Agreement.

 

10.2.         Notice Requirement

 

No termination of this Agreement shall be effective unless and until the party terminating this Agreement gives prior written notice to all other parties of its intent to terminate, which notice shall set forth the basis for the termination.  Furthermore,

 

(a)            in the event any termination is based upon the provisions of Article VII, or the provisions of Section 10.1(a) of this Agreement, the prior written notice shall be given in advance of the effective date of termination as required by those provisions unless such notice period is shortened by mutual written agreement of the parties;

 

29



 

(b)            in the event any termination is based upon the provisions of Section 10.1(d), 10.1(e) or 10.1(g) of this Agreement, the prior written notice shall be given at least sixty (60) days before the effective date of termination; and

 

(c)            in the event any termination is based upon the provisions of Section 10.1(b), 10.1(c) or 10.1(f), the prior written notice shall be given in advance of the effective date of termination, which date shall be determined by the party sending the notice.

 

10.3.         Effect of Termination

 

Notwithstanding any termination of this Agreement, other than as a result of a failure by either the Fund or the Company to meet Section 817(h) of the Code diversification requirements, the Fund, the Distributors and the Advisers shall, at the option of the Company, continue to make available additional shares of the Fund pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as “Existing Contracts”).  Specifically, without limitation, the owners of the Existing Contracts shall be permitted to reallocate investments in the Fund, redeem investments in the Fund and/or invest in the Fund upon the making of additional purchase payments under the Existing Contracts.  The parties agree that this Section 10.3 shall not apply to any terminations under Article VII and the effect of such Article VII terminations shall be governed by Article VII of this Agreement.

 

10.4.         Surviving Provisions

 

Notwithstanding any termination of this Agreement, each party’s obligations under Article VIII to indemnify other parties shall survive and not be affected by any termination of this Agreement.  In addition, with respect to Existing Contracts, all provisions of this Agreement shall also survive and not be affected by any termination of this Agreement.

 

30



 

ARTICLE XI.         Notices

 

Any notice shall be sufficiently given when sent by registered or certified mail to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other parties.

 

If to the Company:

 

Pruco Life Insurance Company

213 Washington Street

Newark, NJ 07102

Attention:  Secretary

 

If to the Fund:

 

American Skandia Trust

One Corporate Drive

Shelton, CT 06484

Attention:  Secretary

 

If to the Advisers:

 

American Skandia Investment Services, Inc.

One Corporate Drive

Shelton, CT 06484

Attention:  Secretary

 

Prudential Investments LLC

Gateway Center Three

100 Mulberry Street, 14 th Floor

Newark, NJ 07102-4077

Attention:  Secretary

 

If to the Distributors:

 

American Skandia Marketing, Inc.

One Corporate Drive

Shelton, CT 06484

Attention:  Secretary

 

31



 

Prudential Investment Management Services LLC

Gateway Center Three

100 Mulberry Street, 14 th Floor

Newark, NJ 07102-4077

Attention:  Secretary

 

ARTICLE XII.        Miscellaneous

 

12.1.         Subject to the requirements of legal process and regulatory authority, each party hereto shall treat as confidential the names and addresses of the owners of the Contracts and all information reasonably identified as confidential in writing by any other party hereto and, except as permitted by this Agreement, shall not disclose, disseminate or utilize such names and addresses and other confidential information without the express written consent of the affected party until such time as such information may come into the public domain.  Without limiting the foregoing, no party hereto shall disclose any information that another party has designated as proprietary.

 

12.2.         The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.

 

12.3.         This Agreement may be executed simultaneously in two or more counterparts, each of which taken together shall constitute one and the same instrument.

 

12.4.         If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.

 

12.5.         Each party hereto shall cooperate with each other party and all appropriate governmental authorities (including without limitation the SEC, the NASD and state insurance regulators) and shall permit such authorities reasonable access to its books and records in

 

32



 

connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.

 

12.6.         Any controversy or claim arising out of or relating to this Agreement, or breach thereof, shall be settled by arbitration in a forum jointly selected by the relevant parties (but if applicable law requires some other forum, then such other forum) in accordance with the Commercial Arbitration Rules of the American Arbitration Association, and judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof.

 

12.7.         The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under state and federal laws.

 

12.8.         This Agreement or any of the rights and obligations hereunder may not be assigned by any party without the prior written consent of all parties hereto.

 

12.9.         The Company agrees that the obligations assumed by the Fund, the Distributors and the Advisers pursuant to this Agreement shall be limited in any case to the Fund, the Distributors and the Advisers and their respective assets and the Company shall not seek satisfaction of any such obligation from the shareholders of the Fund, the Distributors or the Advisers, the Directors, officers, employees or agents of the Fund, a Distributor or an Adviser, or any of them.

 

12.10.       The Fund, the Distributors and the Advisers agree that the obligations assumed by the Company pursuant to this Agreement shall be limited in any case to the Company and its assets and neither the Fund, the Distributors nor the Advisers shall seek satisfaction of any such obligation from the shareholders of the Company, the directors, officers, employees or agents of the Company, or any of them.

 

33



 

12.11.       No provision of this Agreement may be deemed or construed to modify or supersede any contractual rights, duties, or indemnifications, as between the Advisers and the Fund, and the Distributors and the Fund.

 

34



 

IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and on its behalf by its duly authorized representative and its seal to be hereunder affixed hereto as of the date specified below.

 

 

PRUCO LIFE INSURANCE COMPANY,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

 

 

AMERICAN SKANDIA TRUST,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

 

 

AMERICAN SKANDIA INVESTMENT SERVICES, INC.,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

 

 

PRUDENTIAL INVESTMENTS LLC

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

 

 

AMERICAN SKANDIA MARKETING, INC.,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

35



 

 

PRUDENTIAL INVESTMENT MANAGEMENT SERVICES LLC,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

Title:

 

 

 

36



 

SCHEDULE A

Diversification Compliance Report and Certification

 

Name of fund:

 

Total Market Value as of                                                              

 

 

 

Four Largest
Investments

 

Market Value as of

 

Cumulative % of
Assets

 

I.R.C. Limitations
Greater than

1

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

 

 

3

 

 

 

 

 

 

 

 

4

 

 

 

 

 

 

 

 

5

 

 

 

 

 

 

 

 

 

Total Assets                                

 

Note: For purposes of diversification testing, all securities of the same issuer, all interests in the same real property project, and all interests in the same commodity are each treated as a single investment.  In the case of government securities each government agency or instrumentality is treated as a separate issuer.  See Treas. Reg. 1.817-5 for additional information.

 

Special Test for Variable Life Insurance

Where the only contracts based on the account are life insurance contracts (i.e., no annuity contracts), an account is adequately diversified to the extent it is invested in Treasury securities.  Treasury securities held through a custodial arrangement that is treated as a grantor trust (e.g. CATs and TGRs) will be treated as Treasury securities if substantially all of the assets of the trust are represented by Treasury securities.  Options on Treasury securities are not considered Treasury securities.  Where an account is invested in part in Treasury securities, revise the above general diversification test percentage limits by adding to them a product of .5 and the percentage of the value of the total assets invested in Treasury securities.  For example, if an account is 60% invested in Treasury securities, the percentage limit would be increased by 30% (0.5 x 60%) and would be applied to the assets of the account other than Treasury securities.

 

Alternate Test

If the alternative test under IRC Section 851 is used, those testing results should be attached.

 

Certification

The undersigned certifies that this Report and Certification, and any related attachments, have been prepared accurately and provide a true representation of account assets as of the last day of the quarter indicated above, and that the fund complies with IRC
Section 817(h).

 

 

 

 

 

 

Signed by

 

Date

 

37


Exhibit 99.(13)(e)

 

FUND PARTICIPATION AGREEMENT

 

 

Pruco Life Insurance Company of New Jersey,

 

American Skandia Trust,

 

American Skandia Investment Services, Inc.,

 

Prudential Investments LLC,

 

American Skandia Marketing, Inc.

 

and

 

Prudential Investment Management Services LLC

 

 

May 1, 2005, as Amended and Restated June 8, 2005

 



 

TABLE OF CONTENTS

 

ARTICLE I.

Sale of Fund Shares

4

 

 

 

ARTICLE II.

Representations and Warranties

8

 

 

 

ARTICLE III.

Prospectuses and Proxy Statements; Voting

12

 

 

 

ARTICLE IV.

Sales Material and Information

14

 

 

 

ARTICLE V.

Fees and Expenses

16

 

 

 

ARTICLE VI.

Diversification and Qualification

16

 

 

 

ARTICLE VII.

Potential Conflicts and Compliance With Mixed and Shared Funding Exemptive Order

19

 

 

 

ARTICLE VIII.

Indemnification

22

 

 

 

ARTICLE IX.

Applicable Law

27

 

 

 

ARTICLE X.

Termination

27

 

 

 

ARTICLE XI.

Notices

30

 

 

 

ARTICLE XII.

Miscellaneous

30

 

 

 

SCHEDULE A

Diversification Compliance Report and Certification

37

 



 

PARTICIPATION AGREEMENT

 

Among

 

PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY,

 

AMERICAN SKANDIA TRUST,

 

AMERICAN SKANDIA INVESTMENT SERVICES, INC.,

 

PRUDENTIAL INVESTMENTS LLC,

 

AMERICAN SKANDIA MARKETING, INC.

 

and

 

PRUDENTIAL INVESTMENT MANAGEMENT SERVICES LLC

 

 

THIS AGREEMENT, made and entered into as of this 1 st day of May, 2005 and amended and restated as of June 8, 2005, by and among PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY (the “Company”), a New Jersey life insurance company, on its own behalf and on behalf of its separate accounts (the “Accounts”); AMERICAN SKANDIA TRUST, an open-end management investment company organized under the laws of Massachusetts (the “Fund”); AMERICAN SKANDIA INVESTMENT SERVICES, INC., a Connecticut corporation (“ASISI”); PRUDENTIAL INVESTMENTS LLC (“PI,” and collectively with ASISI, the “Advisers” and each an “Adviser”), AMERICAN SKANDIA MARKETING, INC., a Delaware corporation (“ASM”); and PRUDENTIAL INVESTMENT MANAGEMENT SERVICES LLC, a Delaware limited liability company (“PIMS,” and collectively with ASM, the “Distributors” and each a “Distributor”).

 

WHEREAS, the Fund engages in business as an open-end management investment company and is available to act as the investment vehicle for separate accounts established for variable life insurance policies and/or variable annuity contracts (collectively, the “Variable Insurance Products”) to be offered by insurance companies, many of which have entered into

 

2



 

participation agreements similar to this Agreement (hereinafter “Participating Insurance Companies”); and

 

WHEREAS, the beneficial interest in the Fund is divided into several series of shares, each designated a “Portfolio” and representing the interest in a particular managed portfolio of securities and other assets; and

 

WHEREAS, the Fund has obtained an order from the Securities and Exchange Commission (hereinafter the “SEC”), dated August 1, 1995 (File No. 812-9384), granting Participating Insurance Companies and variable annuity and variable life insurance separate accounts exemptions from the provisions of sections 9(a), 13(a), 15(a), and 15(b) of the Investment Company Act of 1940, as amended, (hereinafter the “1940 Act”) and Rules 6e-2(b)(15) and 6e-3(T)(b)(15) thereunder, to the extent necessary to permit shares of the Fund to be sold to and held by variable annuity and variable life insurance separate accounts of life insurance companies that may or may not be affiliated with one another and qualified pension and retirement plans (“Qualified Plans”) (hereinafter the “Mixed and Shared Funding Exemptive Order”); and

 

WHEREAS, the Fund is registered as an open-end management investment company under the 1940 Act and shares of the Portfolio(s) are registered under the Securities Act of 1933, as amended (hereinafter the “1933 Act”); and

 

WHEREAS, each Adviser is duly registered as an investment adviser under the Investment Advisers Act of 1940, as amended; and

 

WHEREAS, each Distributor is duly registered as a broker-dealer under the Securities Exchange Act of 1934, as amended, (the “1934 Act”) and is a member in good standing of the National Association of Securities Dealers, Inc. (the “NASD”); and

 

3



 

WHEREAS, the Company has issued and plans to continue to issue certain variable life insurance policies and variable annuity contracts supported wholly or partially by the Accounts (the “Contracts”); and

 

WHEREAS, each Account is a duly organized, validly existing segregated asset account, established by resolution of the Board of Directors of the Company under the insurance laws of the State of Connecticut, to set aside and invest assets attributable to the Contracts; and

 

WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company intends to continue to purchase shares in the Portfolios on behalf of the Accounts to fund the Contracts, and the Fund is authorized to sell such shares to unit investment trusts such as the Accounts at net asset value; and

 

WHEREAS, to the extent permitted by applicable insurance laws and regulations, the Company also intends to continue to purchase shares in other open-end investment companies or series thereof not affiliated with the Fund (the “Unaffiliated Funds”) on behalf of the Accounts to fund the Contracts; and

 

WHEREAS, the parties wish to enter into a written agreement governing the arrangement already existing among the parties.

 

NOW, THEREFORE, in consideration of their mutual promises, the Company, the Fund, the Distributors and the Advisers agree as follows:

 

ARTICLE I.                  Sale of Fund Shares

 

1.1.                The Fund agrees to sell to the Company those shares of the Portfolios which the Account orders, executing such orders on each Business Day at the net asset value next computed after receipt by the Fund or its designee of the order for the shares of the Portfolios.  For purposes of this Section 1.1, the Company shall be the designee of the Fund for receipt of such orders and

 

4



 

receipt by such designee shall constitute receipt by the Fund, provided that the Fund receives notice of any such order by 10:00 a.m. Eastern time on the next following Business Day.  “Business Day” shall mean any day on which the New York Stock Exchange is open for trading and on which the Portfolio calculates its net asset value pursuant to the rules of the SEC.  “Valuation Time” shall mean the time as of which the Fund calculates net asset value for the shares of the Portfolios on the relevant Business Day.

 

1.2.                The Fund agrees to make shares of the Portfolios available for purchase at the applicable net asset value per share by the Company and the Accounts on those days on which the Fund calculates its Portfolios’ net asset value pursuant to rules of the SEC, and the Fund shall calculate such net asset value on each day which the New York Stock Exchange is open for trading.  Notwithstanding the foregoing, the Fund may refuse to sell shares of any Portfolio to any person, or suspend or terminate the offering of shares of any Portfolio if such action is required by law or by regulatory authorities having jurisdiction or is, in the sole discretion of the Fund acting in good faith, necessary or appropriate in the best interests of the shareholders of such Portfolio.  All orders accepted by the Company shall be subject to the terms of the then current prospectus of the Fund.  The Company shall use its best efforts, and shall reasonably cooperate with, the Fund to enforce stated prospectus policies regarding transactions in Portfolio shares.  The Company acknowledges that orders accepted by it in violation of the Fund’s stated policies may be subsequently revoked or cancelled by the Fund and that the Fund shall not be responsible for any losses incurred by the Company or the Contract owner as a result of such cancellation.  In addition, the Company acknowledges that the Fund has the right to refuse any purchase order for any reason, particularly if the Fund determines that a Portfolio would be unable to invest the money effectively in accordance with its investment policies or would otherwise be adversely affected due to the size of the transaction, frequency of trading, or other factors.

 

1.3.                The Fund will not sell shares of the Portfolios to any other Participating Insurance Company separate account unless an agreement containing provisions the substance of which are

 

5



 

the same as Sections 2.1, 2.2 (except with respect to designation of applicable law), 3.5, 3.6, 3.7, and Article VII of this Agreement is in effect to govern such sales.

 

1.4.                The Fund agrees to redeem for cash, on the Company’s request, any full or fractional shares of the Fund held by the Company, executing such requests on each Business Day at the net asset value next computed after receipt by the Fund or its designee of the request for redemption.  For purposes of this Section 1.4, the Company shall be the designee of the Fund for receipt of requests for redemption and receipt by such designee shall constitute receipt by the Fund, provided that the Fund receives notice of any such request for redemption by 10:00 a.m. Eastern time on the next following Business Day.

 

1.5.                The parties hereto acknowledge that the arrangement contemplated by this Agreement is not exclusive; the Fund’s shares may be sold to other Participating Insurance Companies (subject to Section 1.3) and the cash value of the Contracts may be invested in other investment companies.

 

1.6.                The Company shall pay for Fund shares by 3:00 p.m. Eastern time on the next Business Day after an order to purchase Fund shares is received in accordance with the provisions of Section 1.1 hereof.  Payment shall be in federal funds transmitted by wire and/or by a credit for any shares redeemed the same day as the purchase.

 

1.7.                The Fund shall pay and transmit the proceeds of redemptions of Fund shares by 11:00 a.m. Eastern Time on the next Business Day after a redemption order is received in accordance with Section 1.4 hereof; provided, however, that the Fund may delay payment in extraordinary circumstances to the extent permitted under Section 22(e) of the 1940 Act.  Payment shall be in federal funds transmitted by wire and/or a credit for any shares purchased the same day as the redemption.

 

1.8.                Issuance and transfer of the Fund’s shares will be by book entry only.  Stock certificates will not be issued to the Company or the Accounts.  Shares purchased from the Fund

 

6



 

will be recorded in an appropriate title for the relevant Account or the relevant sub-account of an Account.

 

1.9.                The Fund shall furnish same day notice (by electronic communication or telephone, followed by electronic confirmation) to the Company of any income, dividends or capital gain distributions payable on a Portfolio’s shares.  The Company hereby elects to receive all such income dividends and capital gain distributions as are payable on a Portfolio’s shares in additional shares of that Portfolio.  The Company reserves the right to revoke this election and to receive all such income dividends and capital gain distributions in cash.  The Fund shall notify the Company by the end of the next following Business Day of the number of shares so issued as payment of such dividends and distributions.

 

1.10.             The Fund shall make the net asset value per share for each Portfolio available to the Company on each Business Day as soon as reasonably practicable after the net asset value per share is calculated and shall use its best efforts to make such net asset value per share available by 6:00 p.m. Eastern time.  In the event of an error in the computation of a Portfolio’s net asset value per share (“NAV”) or any dividend or capital gain distribution (each, a “pricing error”), an Adviser or the Fund shall immediately notify the Company as soon as possible after discovery of the error.  Such notification may be verbal, but shall be confirmed promptly in writing.  A pricing error shall be corrected as follows:  (a) if the pricing error results in a difference between the erroneous NAV and the correct NAV of less than $0.01 per share, then no corrective action need be taken; (b) if the pricing error results in a difference between the erroneous NAV and the correct NAV equal to or greater than $0.01 per share, but less than 1/2 of 1% of the Portfolio’s NAV at the time of the error, then the Advisers shall reimburse the Portfolio for any loss, after taking into consideration any positive effect of such error; however, no adjustments to Contract owner accounts need be made; and (c) if the pricing error results in a difference between the erroneous NAV and the correct NAV equal to or greater than 1/2 of 1% of the Portfolio’s NAV at the time of the error, then the Advisers shall reimburse the Portfolio for any loss (without taking into consideration any positive effect of such error) and shall reimburse the Company for the costs of adjustments made to correct Contract owner accounts.  If an adjustment is necessary

 

7



 

to correct a material error which has caused Contract owners to receive less than the amount to which they are entitled, the number of shares of the applicable sub-account of such Contract owners will be adjusted and the amount of any underpayments shall be credited by the Advisers to the Company for crediting of such amounts to the applicable Contract owners accounts.  Upon notification by an Adviser of any overpayment due to a material error, the Company shall promptly remit to the Advisers any overpayment that has not been paid to Contract owners.  In no event shall the Company be liable to Contract owners for any such adjustments or underpayment amounts.  A pricing error within categories (b) or (c) above shall be deemed to be “materially incorrect” or constitute a “material error” for purposes of this Agreement.  The standards set forth in this Section 1.10 are based on the parties’ understanding of the views expressed by the staff of the SEC as of the date of this Agreement.  In the event the views of the SEC staff are later modified or superseded by SEC or judicial interpretation, the parties shall amend the foregoing provisions of this Agreement to comport with the appropriate applicable standards, on terms mutually satisfactory to all parties.

 

1.11.             The parties agree to mutually cooperate with respect to any state insurance law restriction or requirement applicable to the Fund’s investments; provided, however, that the Fund reserves the right not to implement restrictions or take other actions required by state insurance law if the Fund or an Adviser determines that the implementation of the restriction or other action is not in the best interest of Fund shareholders.

 

ARTICLE II.                Representations and Warranties

 

2.1.                The Company represents and warrants that:  (a) the securities deemed to be issued by the Accounts under the Contracts are or will be registered under the 1933 Act, or are not so registered in proper reliance upon an exemption from such registration requirements; (b) the Contracts will be issued and sold in compliance in all material respects with all applicable federal and state laws; and (c) the sale of the Contracts shall comply in all material respects with state insurance suitability requirements.

 

8



 

2.2.                The Company represents and warrants that:  (a) it is an insurance company duly organized and in good standing under applicable law; (b) it has legally and validly established each Account prior to any issuance or sale of units thereof as a segregated asset account under Connecticut law; and (c) it has registered each Account as a unit investment trust in accordance with the provisions of the 1940 Act to serve as a segregated investment account for the Contracts will maintain such registration for so long as any Contracts are outstanding as required by applicable law or, alternatively, the Company has not registered one or more Accounts in proper reliance upon an exclusion from such registration requirements.

 

2.3.                The Fund represents and warrants that:  (a) the Fund shares sold pursuant to this Agreement shall be registered under the 1933 Act; (b) the Fund shares sold pursuant to this Agreement shall be duly authorized for issuance and sold in compliance with all applicable federal securities laws including without limitation the 1933 Act, the 1934 Act, and the 1940 Act; (c) the Fund is and shall remain registered under the 1940 Act; and (d) the Fund shall amend the registration statement for its shares under the 1933 Act and the 1940 Act from time to time as required in order to effect the continuous offering of its shares.

 

2.4.                The parties acknowledge that the Fund reserves the right to adopt one or more plans pursuant to Rule 12b-1 under the 1940 Act and to impose an asset-based or other charge to finance distribution expenses as permitted by applicable law and regulation.  The Fund and the Advisers agree to comply with applicable provisions and SEC interpretation of the 1940 Act with respect to any distribution plan.

 

2.5.                The Fund represents and warrants that it shall register and qualify the shares for sale in accordance with the laws of the various states if and to the extent required by applicable law.

 

2.6.                The Fund represents and warrants that it is lawfully organized and validly existing under the laws of the Commonwealth of Massachusetts and that it does and will comply in all material respects with the 1940 Act.

 

9



 

2.7.                Each Adviser represents and warrants that it is and shall remain duly registered under all applicable federal and state securities laws and that it shall perform its obligations for the Fund in compliance in all material respects with any applicable state and federal securities laws.

 

2.8.                Each Distributor represents and warrants that it is and shall remain duly registered under all applicable federal and state securities laws and that it shall perform its obligations for the Fund in compliance in all material respects with the laws of any applicable state and federal securities laws.

 

2.9.                The Fund and the Advisers represent and warrant that all of their respective officers, employees, investment advisers, and other individuals or entities dealing with the money and/or securities of the Fund are, and shall continue to be at all times, covered by one or more blanket fidelity bonds or similar coverage for the benefit of the Fund in an amount not less than the minimal coverage required by Rule 17g-1 under the 1940 Act or related provisions as may be promulgated from time to time.  The aforesaid bonds shall include coverage for larceny and embezzlement and shall be issued by a reputable bonding company.

 

2.10.             The Fund and the Advisers represent and warrant that they will provide the Company with as much advance notice as is reasonably practicable of any material change affecting the Portfolios (including, but not limited to, any material change in the registration statement or prospectus affecting the Portfolios) and any proxy solicitation affecting the Portfolios and consult with the Company in order to implement any such change in an orderly manner, recognizing the expenses of changes and attempting to minimize such expenses by implementing them in conjunction with regular annual updates of the prospectus for the Contracts.

 

2.11               The Company represents and warrants, for purposes other than diversification under Section 817 of the Internal Revenue Code of 1986 as amended (the “Code”), that the

 

10



 

Contracts are currently and at the time of issuance will be treated as annuity contracts or life insurance policies under applicable provisions of the Code, and that it will make every effort to maintain such treatment and that it will notify the Fund, the Distributors and the Advisers immediately upon having a reasonable basis for believing that the Contracts have ceased to be so treated or that they might not be so treated in the future.  In addition, the Company represents and warrants that each Account is a “segregated asset account” and that interests in each Account are offered exclusively through the purchase of or transfer into a “variable contract” within the meaning of such terms under Section 817 of the Code and the regulations thereunder.  The Company will use every effort to continue to meet such definitional requirements, and it will notify the Fund, the Distributors and the Advisers immediately upon having a reasonable basis for believing that such requirements have ceased to be met or that they might not be met in the future.  The Company represents and warrants that it will not purchase Fund shares with assets derived from tax-qualified retirement plans except, indirectly, through Contracts purchased in connection with such plans.

 

2.12               The Company represents and warrants that it is currently in compliance, and will remain in compliance, with all applicable anti-money laundering laws, regulations, and requirements.  In addition, the Company represents and warrants that it has adopted and implemented policies and procedures reasonably designed to achieve compliance with the applicable requirements administered by the Office of Foreign Assets Control (“OFAC”) of the U.S. Department of the Treasury.

 

2.13               The Company represents and warrants that it is currently in compliance, and will remain in compliance, with all applicable laws, rules and regulations relating to consumer privacy, including, but not limited to, Regulation S-P.

 

2.14               The Company represents and warrants that it has adopted, and will at all times during the term of this Agreement maintain, reasonable and appropriate procedures (“Late Trading Procedures”) designed to ensure that any and all orders relating to the purchase, sale or exchange of Fund shares communicated to the Fund to be treated in accordance with Article I of

 

11



 

this Agreement as having been received on a Business Day have been received by the Valuation Time on such Business Day and were not modified after the Valuation Time, and that all orders received from Contract owners but not rescinded by the Valuation Time were communicated to the Fund or its agent as received for that Business Day.  Each transmission of orders by the Company shall constitute a representation by the Company that such orders are accurate and complete and relate to orders received by the Company by the Valuation Time on the Business Day for which the order is to be priced and that such transmission includes all orders relating to Fund shares received from Contract owners but not rescinded by the Valuation Time.  The Company agrees to provide the Fund or its designee with a copy of the Late Trading Procedures and such certifications and representations regarding the Late Trading Procedures as the Fund or its designee may reasonably request.  The Company will promptly notify the Fund in writing of any material change to the Late Trading Procedures.

 

2.15.             The Company represents and warrants that it has adopted, and will at all times during the term of this Agreement maintain, reasonable and appropriate procedures (“Market Timing Procedures”) designed to minimize any adverse impact on other Fund investors due to excessive trading.  The Company agrees to provide the Fund or its designee with a copy of the Market Timing Procedures and such certifications and representations regarding the Market Timing Procedures as the Fund or its designee may reasonably request.  The Company will promptly notify the Fund in writing of any material change to the Market Timing Procedures.  The parties agree to cooperate in light of any conflict between the Market Timing Procedures and actions taken or policies adopted by the Fund designed to minimize any adverse impact on other Fund investors due to excessive trading.

 

ARTICLE III.

Printing and Distribution of Fund Documents and other Administrative Services Provided by the Company to the Fund

 

3.1.                At least annually, an Adviser or Distributor shall provide the Company with camera-ready copy of the Fund’s prospectus and any supplements thereto for printing and delivery by the Company to all Contract owners. If requested by the Company in lieu thereof, an

 

12



 

Adviser, a Distributor or the Fund shall provide camera-ready copy (including an electronic version of the current prospectus) to the Company and other assistance as is reasonably necessary in order for the Company once each year (or more frequently if the prospectus for the Fund is amended) to have the prospectus for the Contracts and the prospectus for the Fund printed together in one document and delivered to all Contract owners

 

3.2.                If applicable state or federal laws or regulations require that the Statement of Additional Information (“SAI”) for the Fund be distributed to all Contract owners, then the Fund, a Distributor and/or an Adviser shall provide the Company with camera-ready copy of the Fund’s SAI and any supplements thereto for printing and delivery to all Contract ownersSchedule B An Adviser, a Distributor and/or the Fund shall also provide camera-ready copy of the SAI to the Company for printing and delivery to any Contract owner or prospective owner who requests such SAI from the Fund.

 

3.3.                The Fund, a Distributor and/or an Adviser shall provide the Company with copies of the Fund’s proxy material, reports to shareholders and other communications to shareholders suitable for printing to permit Schedule B timely distribution thereof by the Company to Contract owners.

 

3.4                  The Company shall also provide the following administrative services to the Fund:

 

Maintenance of books and records

         In the general ledger, reconcile and balance ASLAC’s separate account investments in the various portfolios of the Fund

 

Purchase and Redemption Orders

         Reconcile and provide notice to AST of (a) net cash flow into AST, and (b) cash required for net redemption orders with confirmation thereof to AST

 

AST-Related Contract Owner Services

         Assist AST with proxy solicitations, specifically with respect to soliciting voting instructions from contract owners

 

13



 

         Investigate and respond to inquiries from contract owners that relate to AST and not to the separate account

 

Reports

         Periodic information reporting to AST

         Preparation of reports regarding AST for third-party reporting services

 

3.5.                It is understood and agreed that, except with respect to information regarding the Company provided in writing by that party, the Company shall not be responsible for the content of the prospectus or SAI for the Fund.  It is also understood and agreed that, except with respect to information regarding the Fund, the Distributors, the Advisers or the Portfolios provided in writing by the Fund, a Distributor or an Adviser, neither the Fund, the Distributors nor the Advisers are responsible for the content of the prospectus or SAI for the Contracts.

 

3.6.                If and to the extent required by law the Company shall:

 

(a)                  solicit voting instructions from Contract owners;

 

(b)                  vote the Portfolio shares held in the Accounts in accordance with instructions received from Contract owners;

 

(c)                  vote Portfolio shares held in the Accounts for which no instructions have been received in the same proportion as Portfolio shares for which instructions have been received from Contract owners, so long as and to the extent that the SEC continues to interpret the 1940 Act to require pass-through voting privileges for variable contract owners; and

 

(d)                  vote Portfolio shares held in its general account or otherwise in the same proportion as Portfolio shares for which instructions have been received from Contract owners, so long as and to the extent that the SEC continues to interpret the 1940 Act to require such voting by the insurance company.  The Company reserves the right to vote Fund shares in its own right, to the extent permitted by law.

 

3.7.                The Company shall be responsible for assuring that each of its separate accounts holding shares of a Portfolio calculates voting privileges as directed by the Fund and agreed to by the Company and the Fund.  The Fund agrees to promptly notify the Company of any changes of interpretations or amendments of the Mixed and Shared Funding Exemptive Order.

 

14



 

3.8.                The Fund will comply with all provisions of the 1940 Act requiring voting by shareholders, and in particular the Fund will either provide for annual meetings (except insofar as the SEC may interpret Section 16 of the 1940 Act not to require such meetings) or, as the Fund currently intends, comply with Section 16(c) of the 1940 Act (although the Fund is not one of the trusts described in Section 16(c) of that Act) as well as with Sections 16(a) and, if and when applicable, 16(b).  Further, the Fund will act in accordance with the SEC’s interpretation of the requirements of Section 16(a) with respect to periodic elections of directors or trustees and with whatever rules the SEC may promulgate with respect thereto.

 

ARTICLE IV.              Sales Material and Information

 

4.1.                The Company shall not give any information or make any representations or statements on behalf of the Fund in connection with the sale of the Contracts other than the information or representations contained in the registration statement, including the prospectus or SAI for the Fund shares, as the same may be amended or supplemented from time to time, or in sales literature or other promotional material approved by the Fund, a Distributor or an Adviser, except with the permission of the Fund, a Distributor or an Adviser.

 

4.2.                The Fund, the Distributors and the Advisers shall not give any information or make any representations on behalf of the Company or concerning the Company, the Accounts, or the Contracts other than the information or representations contained in a registration statement, including the prospectus or SAI for the Contracts, as the same may be amended or supplemented from time to time, or in sales literature or other promotional material approved by the Company or its designee, except with the permission of the Company.

 

4.3.                For purposes of Articles IV and VIII, the phrase “sales literature and other promotional material” includes, but is not limited to, advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media;

 

15



 

e.g. , on-line networks such as the Internet or other electronic media), sales literature ( i.e. , any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, and shareholder reports, and proxy materials (including solicitations for voting instructions) and any other material constituting sales literature or advertising under the NASD rules, the 1933 Act or the 1940 Act.

 

4.4.                At the request of any party to this Agreement, each other party will make available to the other party’s independent auditors and/or representatives of the appropriate regulatory agencies, all records, data and access to operating procedures that may be reasonably requested in connection with compliance and regulatory requirements related to this Agreement or any party’s obligations under this Agreement.

 

ARTICLE V.                Fees and Expenses

 

5.1.                In consideration of the services provided by the Company to the Fund that are set forth in sections 3.1, 3.2, 3.3 and 3.4 under Agreement, the Fund will pay the Company 0.10% on an annualized basis of the net asset value of shares of the Fund owned by separate accounts of the Company that are invested in the Fund.  Such amount shall be determined on the last day of each calendar quarter and is payable within 10 days after the end of such calendar quarter.   Except as otherwise provided in this Agreement, the Fund, the Distributors and the Advisers shall pay no fee or other compensation to the Company under this Agreement, and the Company shall pay no fee or other compensation to the Fund, a Distributor or an Adviser under this Agreement.  provided, however, the parties may enter into other agreements relating to the Company’s investment in the Fund, including services agreements.

 

16



 

ARTICLE VI.              Diversification and Qualification

 

6.1.                The Fund, the Distributors and the Advisers represent and warrant that the Fund and each Portfolio thereof will at all times comply with Section 817(h) of the Code and Treasury Regulation §1.817-5, as amended from time to time, and any Treasury interpretations thereof, relating to the diversification requirements for variable annuity, endowment, or life insurance contracts and any amendments or other modifications or successor provisions to such Section or Regulations.  The Fund, a Distributor or an Adviser shall provide to the Company a quarterly written diversification report, in the form attached hereto as Schedule A which shall show the results of the quarterly Section 817(h) diversification test and include a certification as to whether each Portfolio complies with the Section 817(h) diversification requirement.  The diversification report shall be provided to the Company within 10 calendar days of the end of a quarter.

 

6.2.                The Fund, the Distributors and the Advisers agree that shares of the Portfolios will be sold only to Participating Insurance Companies and their separate accounts and to Qualified Plans.  No shares of any Portfolio of the Fund will be sold to the general public.

 

6.3.                The Fund, the Distributors and the Advisers represent and warrant that the Fund and each Portfolio is currently qualified as a Regulated Investment Company under Subchapter M of the Code, and that each Portfolio will maintain such qualification (under Subchapter M or any successor or similar provisions) as long as this Agreement is in effect.

 

6.4.                The Fund, a Distributor or an Adviser will notify the Company immediately upon having a reasonable basis for believing that the Fund or any Portfolio has ceased to comply with the aforesaid Section 817(h) diversification or Subchapter M qualification requirements or might not so comply in the future.

 

6.5.                Without in any way limiting the effect of Sections 8.2, 8.3 and 8.4 hereof and without in any way limiting or restricting any other remedies available to the Company, an Adviser or a Distributor will pay all costs associated with or arising out of any failure, or any anticipated or reasonably foreseeable failure, of the Fund or any Portfolio to comply with

 

17



 

Sections 6.1, 6.2, or 6.3 hereof, including all costs associated with reasonable and appropriate corrections or responses to any such failure; such costs may include, but are not limited to, the costs involved in creating, organizing, and registering a new investment company as a funding medium for the Contracts and/or the costs of obtaining whatever regulatory authorizations are required to substitute shares of another investment company for those of the failed Portfolio (including but not limited to an order pursuant to Section 26(c) of the 1940 Act).

 

6.6.                The Company agrees that if the Internal Revenue Service (“IRS”) asserts in writing in connection with any governmental audit or review of the Company (or, to the Company’s knowledge, of any Contract owner) that any Portfolio has failed to comply with the diversification requirements of Section 817(h) of the Code or the Company otherwise becomes aware of any facts that could give rise to any claim against the Fund, a Distributor or an Adviser as a result of such a failure or alleged failure:

 

(a)                  The Company shall promptly notify the Fund, the Distributors and the Advisers of such assertion or potential claim;

 

(b)                  The Company shall consult with the Fund, the Distributors and the Advisers as to how to minimize any liability that may arise as a result of such failure or alleged failure;

 

(c)                  The Company shall use its best efforts to minimize any liability of the Fund, the Distributors and the Advisers resulting from such failure, including, without limitation, demonstrating, pursuant to Treasury Regulations, Section 1.817-5(a)(2), to the commissioner of the IRS that such failure was inadvertent;

 

(d)                  Any written materials to be submitted by the Company to the IRS, any Contract owner or any other claimant in connection with any of the foregoing proceedings or contests (including, without limitation, any such materials to be submitted to the IRS pursuant to Treasury Regulations, Section 1.817-5(a)(2)) shall be provided by the Company to the Fund, the

 

18



 

Distributors and the Advisers (together with any supporting information or analysis) within at least two (2) business days prior to submission;

 

(e)                  The Company shall provide the Fund, the Distributors and the Advisers with such cooperation as the Fund, the Distributors and the Advisers shall reasonably request (including, without limitation, by permitting the Fund, the Distributors and the Advisers to review the relevant books and records of the Company) in order to facilitate review by the Fund, the Distributors and the Advisers of any written submissions provided to it or its assessment of the validity or amount of any claim against it arising from such failure or alleged failure;

 

(f)                   The Company shall not with respect to any claim of the IRS or any Contract owner that would give rise to a claim against the Fund, the Distributors and the Adviser s(i) compromise or settle any claim, (ii) accept any adjustment on audit, or (iii) forego any allowable administrative or judicial appeals, without the express written consent of the Fund, the Distributors and the Advisers, which shall not be unreasonably withheld; provided that, the Company shall not be required to appeal any adverse judicial decision unless the Fund and the Advisers shall have provided an opinion of independent counsel to the effect that a reasonable basis exists for taking such appeal; and further provided that the Fund, the Distributors and the Advisers shall bear the costs and expenses, including reasonable attorney’s fees, incurred by the Company in complying with this clause (f).

 

ARTICLE VII.            Potential Conflicts and Compliance With Mixed and Shared Funding Exemptive Order

 

7.1.                The Board will monitor the Fund for the existence of any material irreconcilable conflict between the interests of the contract owners of all separate accounts investing in the Fund.  An irreconcilable material conflict may arise for a variety of reasons, including:  (a) an action by any state insurance regulatory authority; (b) a change in applicable federal or state insurance, tax, or securities laws or regulations, or a public ruling, private letter ruling, no-action or interpretative letter, or any similar action by insurance, tax, or securities regulatory authorities; (c) an administrative or judicial decision in any relevant proceeding; (d) the manner in which the

 

19



 

investments of any Portfolio is being managed; (e) a difference in voting instructions given by variable annuity contract and variable life insurance contract owners or by contract owners of different Participating Insurance Companies; or (f) a decision by a Participating Insurance Company to disregard the voting instructions of contract owners.  The Board shall promptly inform the Company if it determines that an irreconcilable material conflict exists and the implications thereof.

 

7.2.                The Company will report any potential or existing conflicts of which it is aware to the Board.  The Company will assist the Board in carrying out its responsibilities under the Mixed and Shared Funding Exemptive Order, by providing the Board with all information reasonably necessary for the Board to consider any issues raised.  This includes, but is not limited to, an obligation by the Company to inform the Board whenever Contract owner voting instructions are to be disregarded.  Such responsibilities shall be carried out by the Company with a view only to the interests of its Contract owners.

 

7.3.                If it is determined by a majority of the Board, or a majority of its trustees who are not interested persons of the Fund, the Distributor, the Adviser or any subadviser to any of the Portfolios (the “Independent Directors”), that a material irreconcilable conflict exists, the Company and other Participating Insurance Companies shall, at their expense and to the extent reasonably practicable (as determined by a majority of the Independent Directors), take whatever steps are necessary to remedy or eliminate the irreconcilable material conflict, up to and including:  (1) withdrawing the assets allocable to some or all of the separate accounts from the Fund or any Portfolio and reinvesting such assets in a different investment medium, including (but not limited to) another Portfolio, or submitting the question whether such segregation should be implemented to a vote of all affected contract owners and, as appropriate, segregating the assets of any appropriate group ( i.e. , annuity contract owners, life insurance contract owners, or variable contract owners of one or more Participating Insurance Companies) that votes in favor of such segregation, or offering to the affected contract owners the option of making such a change; and (2) establishing a new registered management investment company or managed separate account.

 

20



 

7.4.                If a material irreconcilable conflict arises because of a decision by the Company to disregard Contract owner voting instructions and that decision represents a minority position or would preclude a majority vote, the Company may be required, at the Fund’s election, to withdraw the Account’s investment in the Fund and terminate this Agreement; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the Independent Directors.  Any such withdrawal and termination must take place within six (6) months after the Fund gives written notice that this provision is being implemented, and until the end of that six-month period the Advisers, the Distributors and the Fund shall continue to accept and implement orders by the Company for the purchase (and redemption) of shares of the Fund.

 

7.5.                If a material irreconcilable conflict arises because a particular state insurance regulator’s decision applicable to the Company conflicts with the majority of other state regulators, then the Company will withdraw the Account’s investment in the Fund and terminate this Agreement within six months after the Board informs the Company in writing that it has determined that such decision has created an irreconcilable material conflict; provided, however, that such withdrawal and termination shall be limited to the extent required by the foregoing material irreconcilable conflict as determined by a majority of the Independent Directors.  Until the end of the foregoing six-month period, the Fund shall continue to accept and implement orders by the Company for the purchase (and redemption) of shares of the Fund.

 

7.6.                For purposes of Sections 7.3 through 7.5 of this Agreement, a majority of the Independent Directors shall determine whether any proposed action adequately remedies any irreconcilable material conflict, but in no event will the Fund be required to establish a new funding medium for the Contracts.  The Company shall not be required by Section 7.3 to establish a new funding medium for the Contracts if an offer to do so has been declined by vote of a majority of Contract owners affected by the irreconcilable material conflict.  In the event that the Board determines that any proposed action does not adequately remedy any irreconcilable material conflict, then the Company will withdraw the Account’s investment in the Fund and

 

21



 

terminate this Agreement within six (6) months after the Board informs the Company in writing of the foregoing determination; provided, however, that such withdrawal and termination shall be limited to the extent required by any such material irreconcilable conflict as determined by a majority of the Independent Directors.

 

7.7.                If and to the extent that Rule 6e-2 and Rule 6e-3(T) are amended, or Rule 6e-3 is adopted, to provide exemptive relief from any provision of the 1940 Act or the rules promulgated thereunder with respect to mixed or shared funding (as defined in the Mixed and Shared Funding Exemptive Order) on terms and conditions materially different from those contained in the Mixed and Shared Funding Exemptive Order, then (a) the Fund and/or the Participating Insurance Companies, as appropriate, shall take such steps as may be necessary to comply with Rules 6e-2 and 6e-3(T), as amended, and Rule 6e-3, as adopted, to the extent such rules are applicable: and (b) Sections 3.5, 3.6, 3.7, 7.1, 7.2, 7.3, 7.4, and 7.5 of this Agreement shall continue in effect only to the extent that terms and conditions substantially identical to such Sections are contained in such Rule(s) as so amended or adopted.

 

22



 

ARTICLE VIII.          Indemnification

 

8.1.                Indemnification By The Company

 

(a)                  The Company agrees to indemnify and hold harmless the Fund, the Distributors and the Advisers and each of their respective officers and directors or trustees and each person, if any, who controls the Fund, a Distributor or an Adviser within the meaning of Section 15 of the 1933 Act (collectively, the “Indemnified Parties” for purposes of this Section 8.1) against any and all losses, claims, expenses, damages and liabilities (including amounts paid in settlement with the written consent of the Company) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, expenses, damages or liabilities (or actions in respect thereof) or settlements are related to the sale or acquisition of the Fund’s shares or the Contracts and:

 

(i)                    arise out of or are based upon any untrue statements or alleged untrue statements of any material fact contained in the registration statement or prospectus or SAI covering the Contracts or contained in the Contracts or sales literature or other promotional material for the Contracts (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, provided that this Agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to the Company by or on behalf of an Adviser, a Distributor or the Fund for use in the registration statement or prospectus for the Contracts or in the Contracts or sales literature or other promotional material (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or Fund shares; or

 

(ii)                  arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus or sales literature or other promotional material of the Fund not supplied by the Company or persons under its control) or wrongful

 

23



 

conduct of the Company or persons under its control, with respect to the sale or distribution of the Contracts or Fund Shares; or

 

(iii)                 arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI, or sales literature or other promotional material of the Fund, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, if such a statement or omission was made in reliance upon information furnished in writing to the Fund by or on behalf of the Company; or

 

(iv)                arise as a result of any failure by the Company to provide the services and furnish the materials under the terms of this Agreement; or

 

(v)                  arise out of or result from any material breach of any representation and/or warranty made by the Company in this Agreement or arise out of or result from any other material breach of this Agreement by the Company, including without limitation Section 2.11 and Section 6.6 hereof,

 

as limited by and in accordance with the provisions of Sections 8.1(b) and 8.1(c) hereof.

 

(b)                  The Company shall not be liable under this indemnification provision with respect to any losses, claims, expenses, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Party’s willful misfeasance, bad faith, or negligence in the performance of such Indemnified Party’s duties or by reason of such Indemnified Party’s reckless disregard of obligations or duties under this Agreement or to any of the Indemnified Parties.

 

(c)                  The Company shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Company in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Company of any such claim shall not relieve the Company from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the

 

24



 

extent that the Company has been prejudiced by such failure to give notice.  In case any such action is brought against the Indemnified Parties, the Company shall be entitled to participate, at its own expense, in the defense of such action.  The Company also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action.  After notice from the Company to such party of the Company’s election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Company will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.

 

(d)                  The Indemnified Parties will promptly notify the Company of the commencement of any litigation or proceedings against them in connection with the issuance or sale of the Fund Shares or the Contracts or the operation of the Fund.

 

8.2.                Indemnification by the Advisers

 

(a)                  Each Adviser agrees to indemnify and hold harmless the Company and its directors and officers and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act (collectively, the “Indemnified Parties” for purposes of this Section 8.2) against any and all losses, claims, expenses, damages, liabilities (including amounts paid in settlement with the written consent of an Adviser) or litigation (including reasonable legal and other expenses) to which the Indemnified Parties may become subject under any statute or regulation, at common law or otherwise, insofar as such losses, claims, damages, liabilities or expenses (or actions in respect thereof) or settlements are related to the sale or acquisition of the Fund’s shares or the Contracts and:

 

(i)                    arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement or prospectus or SAI or sales literature or other promotional material of the Fund prepared by the Fund, a Distributor or an Adviser (or any amendment or supplement to any of the foregoing), or arise out of or are based upon the omission or the alleged omission to state therein a material fact required to be stated therein or necessary to make the

 

25



 

statements therein not misleading, provided that this Agreement to indemnify shall not apply as to any Indemnified Party if such statement or omission or such alleged statement or omission was made in reliance upon and in conformity with information furnished in writing to an Adviser, a Distributor or the Fund by or on behalf of the Company for use in the registration statement, prospectus or SAI for the Fund or in sales literature or other promotional material (or any amendment or supplement to any of the foregoing) or otherwise for use in connection with the sale of the Contracts or the Fund shares; or

 

(ii)                  arise out of or as a result of statements or representations (other than statements or representations contained in the registration statement, prospectus, SAI or sales literature or other promotional material for the Contracts not supplied by the Adviser or persons under its control) or wrongful conduct of the Fund, a Distributor or an Adviser or persons under their control, with respect to the sale or distribution of the Contracts or Fund shares; or

 

(iii)                 arise out of any untrue statement or alleged untrue statement of a material fact contained in a registration statement, prospectus, SAI, or sales literature or other promotional material covering the Contracts, or any amendment thereof or supplement thereto, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statement or statements therein not misleading, if such statement or omission was made in reliance upon information furnished in writing to the Company by or on behalf of an Adviser, a Distributor or the Fund; or

 

(iv)                arise as a result of any failure by the Fund, a Distributor or an Adviser to provide the services and furnish the materials under the terms of this Agreement (including a failure, whether unintentional or in good faith or otherwise, to comply with the diversification and other qualification requirements specified in Article VI of this Agreement); or

 

(v)                  arise out of or result from any material breach of any representation and/or warranty made by the Fund, a Distributor or an Adviser in this Agreement or arise out of or result from any other material breach of this Agreement by an Adviser, a Distributor or the Fund; or

 

(vi)                arise out of or result from the incorrect or untimely calculation or reporting by the Fund, a Distributor or an Adviser of the daily net asset value per share (subject to Section 1.10 of this Agreement) or dividend or capital gain distribution rate;

 

26



 

as limited by and in accordance with the provisions of Sections 8.2(b) and 8.2(c) hereof.  This indemnification is in addition to and apart from the responsibilities and obligations of the Advisers specified in Article VI hereof.

 

(b)                  The Advisers shall not be liable under this indemnification provision with respect to any losses, claims, expenses, damages, liabilities or litigation to which an Indemnified Party would otherwise be subject by reason of such Indemnified Party’s willful misfeasance, bad faith, or negligence in the performance of such Indemnified Party’s duties or by reason of such Indemnified Party’s reckless disregard of obligations or duties under this Agreement or to any of the Indemnified Parties.

 

(c)                  The Advisers shall not be liable under this indemnification provision with respect to any claim made against an Indemnified Party unless such Indemnified Party shall have notified the Advisers in writing within a reasonable time after the summons or other first legal process giving information of the nature of the claim shall have been served upon such Indemnified Party (or after such Indemnified Party shall have received notice of such service on any designated agent), but failure to notify the Advisers of any such claim shall not relieve the Advisers from any liability which it may have to the Indemnified Party against whom such action is brought otherwise than on account of this indemnification provision, except to the extent that the Advisers have been prejudiced by such failure to give notice.  In case any such action is brought against the Indemnified Parties, the Advisers will be entitled to participate, at their own expense, in the defense thereof.  The Advisers also shall be entitled to assume the defense thereof, with counsel satisfactory to the party named in the action.  After notice from the Advisers to such party of the Advisers’ election to assume the defense thereof, the Indemnified Party shall bear the fees and expenses of any additional counsel retained by it, and the Advisers will not be liable to such party under this Agreement for any legal or other expenses subsequently incurred by such party independently in connection with the defense thereof other than reasonable costs of investigation.

 

27



 

(d)                  The Company agrees promptly to notify the Advisers of the commencement of any litigation or proceedings against it or any of its officers or directors in connection with the issuance or sale of the Contracts or the operation of the Account.

 

ARTICLE IX.              Applicable Law

 

9.1.                This Agreement shall be construed and the provisions hereof interpreted under and in accordance with the laws of the State of New Jersey, without regard to the New Jersey conflict of laws provisions.

 

9.2.                This Agreement shall be subject to the provisions of the 1933, 1934 and 1940 Acts, and the rules and regulations and rulings thereunder, including such exemptions from those statutes, rules and regulations as the SEC may grant (including, but not limited to, the Mixed and Shared Funding Exemptive Order) and the terms hereof shall be interpreted and construed in accordance therewith.

 

ARTICLE X.                Termination

 

10.1.             This Agreement shall terminate:

 

(a)                  at the option of any party, with or without cause, with respect to some or all Portfolios, upon sixty (60) days advance written notice delivered to the other parties; or

 

(b)                  at the option of the Company by written notice to the other parties with respect to any Portfolio based upon the Company’s determination that shares of such Portfolio are not reasonably available to meet the requirements of the Contracts; or

 

(c)                  at the option of the Company by written notice to the other parties with respect to any Portfolio in the event any of the Portfolio’s shares are not registered, issued or sold in accordance with applicable state and/or federal law or such law precludes the use of such shares as the underlying investment media of the Contracts issued or to be issued by the Company; or

 

(d)                  at the option of the Fund, a Distributor or an Adviser in the event that formal administrative proceedings are instituted against the Company by the NASD, the SEC, the Insurance Commissioner or like official of any state or any other regulatory body regarding the

 

28



 

Company’s duties under this Agreement or related to the sale of the Contracts, the operation of any Account, or the purchase of the Fund shares, if, in each case, the Fund, a Distributor or an Adviser, as the case may be, reasonably determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Company to perform its obligations under this Agreement; or

 

(e)                  at the option of the Company in the event that formal administrative proceedings are instituted against the Fund, a Distributor or an Adviser by the NASD, the SEC, or any state securities or insurance department or any other regulatory body, if the Company reasonably determines in its sole judgment exercised in good faith, that any such administrative proceedings will have a material adverse effect upon the ability of the Fund, a Distributor or an Adviser to perform their obligations under this Agreement; or

 

(f)                   at the option of the Company by written notice to the Fund with respect to any Portfolio if the Company reasonably believes that the Portfolio will fail to meet the Section 817(h) diversification requirements or Subchapter M qualifications specified in Article VI hereof; or

 

(g)                  at the option of any non-defaulting party hereto in the event of a material breach of this Agreement by any party hereto (the “defaulting party”) other than as described in Section 10.1(a)-(h); provided, that the non-defaulting party gives written notice thereof to the defaulting party, with copies of such notice to all other non-defaulting parties, and if such breach shall not have been remedied within thirty (30) days after such written notice is given, then the non-defaulting party giving such written notice may terminate this Agreement by giving thirty (30) days written notice of termination to the defaulting party; or

 

(h)                  at any time upon written agreement of all parties to this Agreement.

 

10.2.             Notice Requirement

 

No termination of this Agreement shall be effective unless and until the party terminating this Agreement gives prior written notice to all other parties of its intent to terminate, which notice shall set forth the basis for the termination.  Furthermore,

 

(a)                  in the event any termination is based upon the provisions of Article VII, or the provisions of Section 10.1(a) of this Agreement, the prior written notice shall be given in advance of the effective date of termination as required by those provisions unless such notice period is shortened by mutual written agreement of the parties;

 

29



 

(b)                  in the event any termination is based upon the provisions of Section 10.1(d), 10.1(e) or 10.1(g) of this Agreement, the prior written notice shall be given at least sixty (60) days before the effective date of termination; and

 

(c)                  in the event any termination is based upon the provisions of Section 10.1(b), 10.1(c) or 10.1(f), the prior written notice shall be given in advance of the effective date of termination, which date shall be determined by the party sending the notice.

 

10.3.             Effect of Termination

 

Notwithstanding any termination of this Agreement, other than as a result of a failure by either the Fund or the Company to meet Section 817(h) of the Code diversification requirements, the Fund, the Distributors and the Advisers shall, at the option of the Company, continue to make available additional shares of the Fund pursuant to the terms and conditions of this Agreement, for all Contracts in effect on the effective date of termination of this Agreement (hereinafter referred to as “Existing Contracts”).  Specifically, without limitation, the owners of the Existing Contracts shall be permitted to reallocate investments in the Fund, redeem investments in the Fund and/or invest in the Fund upon the making of additional purchase payments under the Existing Contracts.  The parties agree that this Section 10.3 shall not apply to any terminations under Article VII and the effect of such Article VII terminations shall be governed by Article VII of this Agreement.

 

10.4.             Surviving Provisions

 

Notwithstanding any termination of this Agreement, each party’s obligations under Article VIII to indemnify other parties shall survive and not be affected by any termination of this Agreement.  In addition, with respect to Existing Contracts, all provisions of this Agreement shall also survive and not be affected by any termination of this Agreement.

 

30



 

ARTICLE XI.              Notices

 

Any notice shall be sufficiently given when sent by registered or certified mail to the other party at the address of such party set forth below or at such other address as such party may from time to time specify in writing to the other parties.

 

If to the Company:

 

Pruco Life Insurance Company of New Jersey

213 Washington Street

Newark, NJ 07102

Attention:  Secretary

 

If to the Fund:

 

American Skandia Trust

One Corporate Drive

Shelton, CT 06484

Attention:  Secretary

 

If to the Advisers:

 

American Skandia Investment Services, Inc.

One Corporate Drive

Shelton, CT 06484

Attention:  Secretary

 

Prudential Investments LLC

Gateway Center Three

100 Mulberry Street, 14 th Floor

Newark, NJ 07102-4077

Attention:  Secretary

 

If to the Distributors:

 

American Skandia Marketing, Inc.

One Corporate Drive

Shelton, CT 06484

Attention:  Secretary

 

31



 

Prudential Investment Management Services LLC

Gateway Center Three

100 Mulberry Street, 14 th Floor

Newark, NJ 07102-4077

Attention:  Secretary

 

ARTICLE XII.            Miscellaneous

 

12.1.             Subject to the requirements of legal process and regulatory authority, each party hereto shall treat as confidential the names and addresses of the owners of the Contracts and all information reasonably identified as confidential in writing by any other party hereto and, except as permitted by this Agreement, shall not disclose, disseminate or utilize such names and addresses and other confidential information without the express written consent of the affected party until such time as such information may come into the public domain.  Without limiting the foregoing, no party hereto shall disclose any information that another party has designated as proprietary.

 

12.2.             The captions in this Agreement are included for convenience of reference only and in no way define or delineate any of the provisions hereof or otherwise affect their construction or effect.

 

12.3.             This Agreement may be executed simultaneously in two or more counterparts, each of which taken together shall constitute one and the same instrument.

 

12.4.             If any provision of this Agreement shall be held or made invalid by a court decision, statute, rule or otherwise, the remainder of the Agreement shall not be affected thereby.

 

12.5.             Each party hereto shall cooperate with each other party and all appropriate governmental authorities (including without limitation the SEC, the NASD and state insurance regulators) and shall permit such authorities reasonable access to its books and records in

 

32



 

connection with any investigation or inquiry relating to this Agreement or the transactions contemplated hereby.

 

12.6.             Any controversy or claim arising out of or relating to this Agreement, or breach thereof, shall be settled by arbitration in a forum jointly selected by the relevant parties (but if applicable law requires some other forum, then such other forum) in accordance with the Commercial Arbitration Rules of the American Arbitration Association, and judgment upon the award rendered by the arbitrators may be entered in any court having jurisdiction thereof.

 

12.7.             The rights, remedies and obligations contained in this Agreement are cumulative and are in addition to any and all rights, remedies and obligations, at law or in equity, which the parties hereto are entitled to under state and federal laws.

 

12.8.             This Agreement or any of the rights and obligations hereunder may not be assigned by any party without the prior written consent of all parties hereto.

 

12.9.             The Company agrees that the obligations assumed by the Fund, the Distributors and the Advisers pursuant to this Agreement shall be limited in any case to the Fund, the Distributors and the Advisers and their respective assets and the Company shall not seek satisfaction of any such obligation from the shareholders of the Fund, the Distributors or the Advisers, the Directors, officers, employees or agents of the Fund, a Distributor or an Adviser, or any of them.

 

12.10.          The Fund, the Distributors and the Advisers agree that the obligations assumed by the Company pursuant to this Agreement shall be limited in any case to the Company and its assets and neither the Fund, the Distributors nor the Advisers shall seek satisfaction of any such obligation from the shareholders of the Company, the directors, officers, employees or agents of the Company, or any of them.

 

33



 

12.11.          No provision of this Agreement may be deemed or construed to modify or supersede any contractual rights, duties, or indemnifications, as between the Advisers and the Fund, and the Distributors and the Fund.

 

34



 

IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed in its name and on its behalf by its duly authorized representative and its seal to be hereunder affixed hereto as of the date specified below.

 

 

PRUCO LIFE INSURANCE COMPANY OF NEW JERSEY,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

 

 

 

 

AMERICAN SKANDIA TRUST,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

 

 

 

 

AMERICAN SKANDIA INVESTMENT SERVICES, INC.,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

 

 

 

 

PRUDENTIAL INVESTMENTS LLC

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

 

 

 

 

AMERICAN SKANDIA MARKETING, INC.,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

 

Title:

 

 

 

35



 

 

PRUDENTIAL INVESTMENT MANAGEMENT SERVICES LLC,

 

 

 

By its authorized officer,

 

 

 

By:

 

 

 

Title:

 

 

 

36



 

SCHEDULE A

Diversification Compliance Report and Certification

 

Name of fund:

 

Total Market Value as of

 

 

 

 

Four Largest
Investments

 

Market Value as of

 

Cumulative % of
Assets

 

I.R.C. Limitations
Greater than

 

1

 

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

 

 

 

3

 

 

 

 

 

 

 

 

 

4

 

 

 

 

 

 

 

 

 

5

 

 

 

 

 

 

 

 

 

 

Total Assets

 

Note: For purposes of diversification testing, all securities of the same issuer, all interests in the same real property project, and all interests in the same commodity are each treated as a single investment.  In the case of government securities each government agency or instrumentality is treated as a separate issuer.  See Treas. Reg. 1.817-5 for additional information.

 

Special Test for Variable Life Insurance

 

Where the only contracts based on the account are life insurance contracts (i.e., no annuity contracts), an account is adequately diversified to the extent it is invested in Treasury securities.  Treasury securities held through a custodial arrangement that is treated as a grantor trust (e.g. CATs and TGRs) will be treated as Treasury securities if substantially all of the assets of the trust are represented by Treasury securities.  Options on Treasury securities are not considered Treasury securities.  Where an account is invested in part in Treasury securities, revise the above general diversification test percentage limits by adding to them a product of .5 and the percentage of the value of the total assets invested in Treasury securities.  For example, if an account is 60% invested in Treasury securities, the percentage limit would be increased by 30% (0.5 x 60%) and would be applied to the assets of the account other than Treasury securities.

 

Alternate Test

 

If the alternative test under IRC Section 851 is used, those testing results should be attached.

 

Certification

 

The undersigned certifies that this Report and Certification, and any related attachments, have been prepared accurately and provide a true representation of account assets as of the last day of the quarter indicated above, and that the fund complies with IRC Section 817(h).

 

 

 

 

 

 

  Signed by

 

  Date

 

37


Exhibit 99.14

 

KPMG LLP

 

345 Park Avenue

 

New York, NY 10154

 

Consent of Independent Registered Public Accounting Firm

 

The Board of Trustees and Shareholders of

American Skandia Trust:

 

We consent to the incorporation by reference, in this registration statement on Form N-14 of our report dated February 9, 2005 on the statements of assets and liabilities of the AST AllianceBernstein Managed Index 500 Portfolio and AST AllianceBernstein Growth + Value Portfolio (series of American Skandia Trust, hereafter referred to as the “Portfolios”), including the schedules of investments as of December 31, 2004, and the related statements of operations, the statements of changes in net assets and the financial highlights for each of the years in the two-year period then ended. These financial statements and financial highlights and our report thereon are included in the Annual Report of the Portfolios as filed on Form N-CSR.

 

We also consent to the reference to our firm under the heading “Representations and Warranties by the Fund on behalf of the Acquired Portfolio” in this registration statement on Form N-14.

 

 

New York, New York

July 8, 2005

 

KPMG LLP, a U.S limited liability partnership, is the U.S.

member firm of KPMG International, a Swiss cooperative.

 


Exhibit 99.17

 

AST ALLIANCEBERNSTEIN GROWTH + VALUE

 

Of

 

AMERICAN SKANDIA TRUST

 

Special Meeting of Shareholders-October 14, 2005

 

Shareholder Voting Ballot

 

PROPOSAL 1:

 

To approve or disapprove a Plan of Reorganization of the Trust on behalf of the AST AllianceBernstein Growth + Value Portfolio and the AST AllianceBernstein Managed Index 500 Portfolio of the Trust, that provides for the acquisition of all of the net assets of the AST AllianceBernstein Growth + Value Portfolio in exchange for shares of the AST AllianceBernstein Managed Index 500 Portfolio, the distribution of such shares to the shareholders of the AST AllianceBernstein Growth + Value Portfolio, and the liquidation and dissolution of the AST AllianceBernstein Growth + Value Portfolio.

 

RESOLVED, that the Plan of Reorganization of the Trust on behalf of the AST AllianceBernstein Growth + Value Portfolio and the AST AllianceBernstein Managed Index 500 Portfolio of the Trust, that provides for the acquisition of all of the net assets of the AST AllianceBernstein Growth + Value Portfolio in exchange for shares of the AST AllianceBernstein Managed Index 500 Portfolio, the distribution of such shares to the shareholders of the AST AllianceBcmstcm Growth + Value Portfolio, and the liquidation and dissolution of the AST AllianceBernstein Growth + Value Portfolio is hereby approved.

 

 

(   ) FOR

 

(   ) AGAINST

 

(   ) ABSTAIN

 

 

Date:                                              , 2005

 

 

 

 

 

Name of Shareholder

 

 

 

 

 

Signature of Shareholder